{
  "file_name": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
  "total_pages": 84,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "14.028532981872559": 1,
      "21.333560943603516": 3,
      "21.94206428527832": 1,
      "8.992650032043457": 2,
      "17.02608299255371": 1,
      "15.0": 2,
      "12.0": 41,
      "9.960000038146973": 999,
      "17.03999900817871": 1,
      "11.039999961853027": 1293,
      "8.039999961853027": 55,
      "21.959999084472656": 10,
      "12.72218132019043": 9,
      "12.829745292663574": 9,
      "11.879393577575684": 52,
      "8.759956359863281": 79,
      "17.758378982543945": 4,
      "9.725613594055176": 17,
      "9.840714454650879": 18,
      "15.719986915588379": 1,
      "13.799982070922852": 48,
      "10.797332763671875": 37,
      "18.0": 4,
      "14.039999961853027": 2,
      "7.079999923706055": 1,
      "9.0": 200,
      "12.839439392089844": 2,
      "5.759999752044678": 2,
      "9.719964981079102": 11,
      "15.718777656555176": 2
    },
    "heading_sizes": [
      21.959999084472656,
      21.333560943603516,
      18.0,
      17.758378982543945,
      15.718777656555176,
      15.0,
      14.039999961853027,
      13.799982070922852,
      12.839439392089844,
      12.829745292663574,
      12.72218132019043,
      12.0,
      11.879393577575684
    ]
  },
  "table_analysis": {
    "total_tables": 16,
    "tables_info": [
      {
        "bbox": [
          119.75999450683594,
          373.41033935546875,
          479.7259826660156,
          550.1703491210938
        ],
        "num_rows": 5,
        "num_cols": 2
      },
      {
        "bbox": [
          117.5999984741211,
          250.80943298339844,
          483.7863464355469,
          587.063232421875
        ],
        "num_rows": 9,
        "num_cols": 2
      },
      {
        "bbox": [
          113.63999938964844,
          199.5632781982422,
          481.99652099609375,
          499.3232727050781
        ],
        "num_rows": 7,
        "num_cols": 3
      },
      {
        "bbox": [
          116.5199966430664,
          177.60328674316406,
          476.7157897949219,
          366.36328125
        ],
        "num_rows": 8,
        "num_cols": 3
      },
      {
        "bbox": [
          234.239990234375,
          336.64459228515625,
          466.0478210449219,
          409.3352966308594
        ],
        "num_rows": 5,
        "num_cols": 3
      },
      {
        "bbox": [
          124.79999542236328,
          278.8045959472656,
          452.7982177734375,
          560.9703369140625
        ],
        "num_rows": 11,
        "num_cols": 3
      },
      {
        "bbox": [
          124.79999542236328,
          303.4045715332031,
          469.0043640136719,
          564.2103271484375
        ],
        "num_rows": 9,
        "num_cols": 5
      },
      {
        "bbox": [
          113.39999389648438,
          220.7606201171875,
          470.1000061035156,
          356.0653076171875
        ],
        "num_rows": 7,
        "num_cols": 3
      },
      {
        "bbox": [
          118.55999755859375,
          198.69033813476562,
          499.4873962402344,
          667.1703491210938
        ],
        "num_rows": 21,
        "num_cols": 3
      },
      {
        "bbox": [
          118.55999755859375,
          174.69033813476562,
          499.4873962402344,
          677.6103515625
        ],
        "num_rows": 26,
        "num_cols": 4
      },
      {
        "bbox": [
          118.55999755859375,
          187.5303497314453,
          497.8074035644531,
          693.6903076171875
        ],
        "num_rows": 16,
        "num_cols": 4
      },
      {
        "bbox": [
          118.55999755859375,
          187.5303497314453,
          499.4873962402344,
          677.6103515625
        ],
        "num_rows": 20,
        "num_cols": 4
      },
      {
        "bbox": [
          118.55999755859375,
          187.5303497314453,
          497.8074035644531,
          664.7703247070312
        ],
        "num_rows": 17,
        "num_cols": 4
      },
      {
        "bbox": [
          118.55999755859375,
          203.49034118652344,
          497.8074035644531,
          685.6503295898438
        ],
        "num_rows": 14,
        "num_cols": 4
      },
      {
        "bbox": [
          118.55999755859375,
          171.45034790039062,
          499.4873962402344,
          690.4503173828125
        ],
        "num_rows": 24,
        "num_cols": 4
      },
      {
        "bbox": [
          118.55999755859375,
          187.5303497314453,
          497.8074035644531,
          674.4902954101562
        ],
        "num_rows": 14,
        "num_cols": 3
      }
    ]
  },
  "text_blocks": [
    {
      "text": "체외진단용 의료기기",
      "font_size": 14.028532981872559,
      "font_name": "H2hdrM",
      "bbox": [
        110.46013641357422,
        197.4922637939453,
        243.22769165039062,
        211.51693725585938
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 의료기기 중 심장성",
      "font_size": 21.333560943603516,
      "font_name": "H2hdrM",
      "bbox": [
        129.1699981689453,
        358.3819885253906,
        478.80718994140625,
        379.35906982421875
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "트로포닌 검사제품의 허가․심사",
      "font_size": 21.333560943603516,
      "font_name": "H2hdrM",
      "bbox": [
        139.96414184570312,
        391.9453125,
        468.0142822265625,
        412.9223937988281
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인 [민원인 안내서]",
      "font_size": 21.333560943603516,
      "font_name": "H2hdrM",
      "bbox": [
        145.84095764160156,
        425.50860595703125,
        454.70245361328125,
        446.4856872558594
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2018. 7.",
      "font_size": 21.94206428527832,
      "font_name": "H2hdrM",
      "bbox": [
        255.34161376953125,
        551.5068969726562,
        339.5438232421875,
        573.4429321289062
      ],
      "page_num": 1,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발간등록번호",
      "font_size": 8.992650032043457,
      "font_name": "Haansoft Batang",
      "bbox": [
        151.7177734375,
        161.2981414794922,
        205.68850708007812,
        170.28831481933594
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서-0637-02",
      "font_size": 8.992650032043457,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.00303649902344,
        175.9221649169922,
        215.37179565429688,
        184.91233825683594
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정 이력서",
      "font_size": 17.02608299255371,
      "font_name": "H2gtrE",
      "bbox": [
        233.75331115722656,
        167.58973693847656,
        361.125,
        184.61114501953125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심장성 트로포닌 검사제품",
      "font_size": 15.0,
      "font_name": "T4",
      "bbox": [
        129.239990234375,
        224.27999877929688,
        465.3599853515625,
        242.27999877929688
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가․심사 가이드라인 [민원인 안내서]",
      "font_size": 15.0,
      "font_name": "T4",
      "bbox": [
        151.55999755859375,
        248.27999877929688,
        442.9949951171875,
        266.2799987792969
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제․개정",
      "font_size": 12.0,
      "font_name": "T4",
      "bbox": [
        124.43999481201172,
        289.55999755859375,
        175.3199920654297,
        303.9599914550781
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 12.0,
      "font_name": "T4",
      "bbox": [
        137.39999389648438,
        297.3599853515625,
        395.3999938964844,
        319.55999755859375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "승인일자",
      "font_size": 12.0,
      "font_name": "T4",
      "bbox": [
        137.39999389648438,
        297.3599853515625,
        395.3999938964844,
        319.55999755859375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요 내용",
      "font_size": 12.0,
      "font_name": "T4",
      "bbox": [
        137.39999389648438,
        297.3599853515625,
        395.3999938964844,
        319.55999755859375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        264.6000061035156,
        331.41033935546875,
        473.12579345703125,
        341.3703308105469
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제정",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        357.8399963378906,
        347.3703308105469,
        376.559814453125,
        357.330322265625
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B1-2016-5-",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        119.75999450683594,
        373.41033935546875,
        180.71568298339844,
        383.3703308105469
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "157",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        141.36000061035156,
        389.4903259277344,
        159.1665802001953,
        399.4503173828125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2015.2.",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        200.87998962402344,
        381.4503479003906,
        238.5746612548828,
        391.41033935546875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        264.6000061035156,
        373.41033935546875,
        473.12579345703125,
        383.3703308105469
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개정",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        357.8399963378906,
        389.4903259277344,
        376.559814453125,
        399.4503173828125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-0637",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        119.75999450683594,
        444.6903381347656,
        180.64691162109375,
        454.65032958984375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-01",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        141.239990234375,
        460.65032958984375,
        159.16708374023438,
        470.6103210449219
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2017.5.",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        200.87998962402344,
        452.6103515625,
        238.5746612548828,
        462.5703430175781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢체외진단용 시약 중 심장성 트로포닌 검사제품의",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        258.239990234375,
        428.6103515625,
        479.6058044433594,
        438.5703430175781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        258.0,
        444.6903381347656,
        479.7259826660156,
        454.65032958984375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제·개정 점검표 등 추가 [근거: ｢식품의약품안전처",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        264.6000061035156,
        460.65032958984375,
        473.1257629394531,
        470.6103210449219
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1]",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        273.3599853515625,
        476.6103515625,
        460.9794006347656,
        486.5703430175781
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-0637",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        119.75999450683594,
        524.2503662109375,
        180.64691162109375,
        534.2103271484375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-02",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        141.239990234375,
        532.2903442382812,
        238.5746612548828,
        550.1703491210938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2018.7.",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        141.239990234375,
        532.2903442382812,
        238.5746612548828,
        550.1703491210938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢체외진단용 시약 중 심장성 트로포닌 검사제품의",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        258.239990234375,
        516.2103881835938,
        479.6058044433594,
        526.1703491210938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가․심사 가이드라인 [민원인 안내서]｣ 개정",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        276.1199951171875,
        532.2903442382812,
        458.2801818847656,
        542.2503051757812
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(현재 적용중인 의료기기 허가규정의 개정내용을 반영)",
      "font_size": 9.960000038146973,
      "font_name": "Dotum",
      "bbox": [
        259.79998779296875,
        548.2503662109375,
        474.4949645996094,
        558.2103271484375
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침서ᆞ안내서 제ᆞ개정 점검표",
      "font_size": 17.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        171.59999084472656,
        165.61288452148438,
        426.6000061035156,
        182.6528778076172
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        129.47999572753906,
        194.63999938964844,
        460.79998779296875,
        218.66836547851562
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심장성 트로포닌 검사제품",
      "font_size": 12.0,
      "font_name": "T4",
      "bbox": [
        129.47999572753906,
        194.63999938964844,
        460.79998779296875,
        218.66836547851562
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가․심사 가이드라인 [민원인 안내서]",
      "font_size": 12.0,
      "font_name": "T4",
      "bbox": [
        210.1199951171875,
        213.83999633789062,
        442.83599853515625,
        228.239990234375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        168.59999084472656,
        231.58428955078125,
        429.9693603515625,
        246.2683563232422
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        123.5999984741211,
        354.6094055175781,
        155.64019775390625,
        365.3032531738281
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        131.63999938964844,
        367.32940673828125,
        147.71998596191406,
        378.02325439453125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        250.80943298339844,
        383.3467712402344,
        261.5032653808594
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서가 있습니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.72000122070312,
        262.8094177246094,
        296.2266540527344,
        273.5032653808594
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        251.16941833496094,
        457.8002014160156,
        273.14324951171875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        251.16941833496094,
        457.8002014160156,
        273.14324951171875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        282.84942626953125,
        483.7863464355469,
        293.54327392578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        294.84942626953125,
        481.0799865722656,
        317.54327392578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        294.84942626953125,
        481.0799865722656,
        317.54327392578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(사유 :                                                 )",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        318.84942626953125,
        395.08966064453125,
        329.54327392578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        337.9294128417969,
        414.3065490722656,
        348.6232604980469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용을 단순 편집 또는 나열한 것입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.72000122070312,
        349.9294128417969,
        338.22686767578125,
        360.6232604980469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        338.2893981933594,
        457.8002014160156,
        360.26324462890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        338.2893981933594,
        457.8002014160156,
        360.26324462890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        360.7294006347656,
        457.8002014160156,
        382.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        360.7294006347656,
        457.8002014160156,
        382.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        360.7294006347656,
        457.8002014160156,
        382.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        382.8094177246094,
        403.74676513671875,
        393.5032653808594
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        393.96942138671875,
        232.6580810546875,
        404.66326904296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        382.8094177246094,
        457.8002014160156,
        404.66326904296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        382.8094177246094,
        457.8002014160156,
        404.66326904296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        404.7694091796875,
        457.8002014160156,
        426.7432556152344
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        404.7694091796875,
        457.8002014160156,
        426.7432556152344
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        404.7694091796875,
        457.8002014160156,
        426.7432556152344
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        426.8493957519531,
        395.3465576171875,
        437.5432434082031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정리한 자료입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        438.0093994140625,
        263.4666442871094,
        448.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        426.8493957519531,
        457.8002014160156,
        448.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        426.8493957519531,
        457.8002014160156,
        448.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        454.44940185546875,
        459.54669189453125,
        477.14324951171875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        454.44940185546875,
        459.54669189453125,
        477.14324951171875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        118.07999420166016,
        503.2893981933594,
        163.98486328125,
        513.9832153320312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        132.72000122070312,
        516.0094604492188,
        146.63963317871094,
        526.7032470703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        484.56939697265625,
        411.6006164550781,
        495.26324462890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        495.7294006347656,
        379.4896545410156,
        506.4232482910156
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예(☞지침서)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        484.56939697265625,
        477.1864929199219,
        506.4232482910156
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        484.56939697265625,
        477.1864929199219,
        506.4232482910156
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        511.0893859863281,
        411.6000061035156,
        521.783203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        522.2494506835938,
        414.306396484375,
        544.2232055664062
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것입니까? (민원인용)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        522.2494506835938,
        414.306396484375,
        544.2232055664062
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예(☞안내서)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        516.7294311523438,
        478.0264892578125,
        538.583251953125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        516.7294311523438,
        478.0264892578125,
        538.583251953125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 확인사",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.5999984741211,
        561.8494262695312,
        161.64019775390625,
        572.543212890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        135.59999084472656,
        574.689453125,
        143.63998413085938,
        585.3832397460938
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        550.2094116210938,
        391.2671813964844,
        560.9031982421875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        561.4894409179688,
        324.6980895996094,
        572.1832275390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        550.2094116210938,
        457.8002014160156,
        572.1832275390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.79998779296875,
        550.2094116210938,
        457.8002014160156,
        572.1832275390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        172.44000244140625,
        576.3694458007812,
        483.7863464355469,
        587.063232421875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제ㆍ개정 절차를 진행하시기 바랍니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        189.0,
        588.3694458007812,
        323.71875,
        599.063232421875
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        239.51998901367188,
        600.1294555664062,
        359.9442138671875,
        610.8232421875
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2018 년    7 월   31  일",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        234.59999084472656,
        623.6494140625,
        353.5199890136719,
        634.3432006835938
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담당자",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        340.67999267578125,
        653.16943359375,
        394.9175720214844,
        674.1832275390625
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확  인(부서장)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        340.67999267578125,
        653.16943359375,
        394.9175720214844,
        674.1832275390625
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우 승 민",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        421.0799865722656,
        651.9694213867188,
        453.1199951171875,
        662.6632080078125
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 원 규",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.8399963378906,
        664.689453125,
        453.3599853515625,
        675.3832397460938
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        580.699462890625,
        484.67999267578125,
        596.660400390625
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        136.8000030517578,
        599.8994140625,
        481.54498291015625,
        615.8603515625
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 전화번호 : 043-719-4652~4665",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        120.47999572753906,
        627.1394653320312,
        310.6893615722656,
        643.1004028320312
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 팩스번호 : 043-719-4650",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        120.47999572753906,
        653.41943359375,
        275.8893737792969,
        669.38037109375
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        224.0242919921875,
        481.84124755859375,
        238.70835876464844
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        247.0642852783203,
        481.96124267578125,
        261.74835205078125
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전처의 입장을 기술한 것입니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        270.2242736816406,
        342.4013366699219,
        284.9083557128906
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        303.3442687988281,
        478.0796203613281,
        318.0283508300781
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        326.5042724609375,
        481.84124755859375,
        341.1883544921875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항이 아님을 알려드립니다. 또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        349.5442810058594,
        481.96124267578125,
        364.2283630371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        372.70428466796875,
        481.8400573730469,
        387.38836669921875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        395.8642883300781,
        373.7213439941406,
        410.5483703613281
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        119.63999938964844,
        436.5442810058594,
        481.96099853515625,
        451.2283630371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        143.75999450683594,
        450.82427978515625,
        481.9611511230469,
        494.1883544921875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        143.75999450683594,
        450.82427978515625,
        481.9611511230469,
        494.1883544921875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정 제2조)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        143.75999450683594,
        450.82427978515625,
        481.9611511230469,
        494.1883544921875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목  차",
      "font_size": 21.959999084472656,
      "font_name": "MalgunGothic",
      "bbox": [
        374.1600036621094,
        161.3791961669922,
        440.15997314453125,
        190.58770751953125
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ. 개요",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        218.1599884033203,
        442.885009765625,
        233.7119903564453
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        218.1599884033203,
        442.885009765625,
        233.7119903564453
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        247.5599822998047,
        442.885009765625,
        263.11199951171875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        247.5599822998047,
        442.885009765625,
        263.11199951171875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ. 관련 규정",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        276.9599914550781,
        442.6454772949219,
        292.5119934082031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        276.9599914550781,
        442.6454772949219,
        292.5119934082031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅳ. 신청서 기재 항목 및 기술문서 제출자료",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        306.3600158691406,
        442.6454772949219,
        321.9120178222656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        306.3600158691406,
        442.6454772949219,
        321.9120178222656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제조․수입허가신청서",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        329.8800048828125,
        285.3608703613281,
        344.2799987792969
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 기술문서에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        351.47998046875,
        442.6566162109375,
        365.86798095703125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        351.47998046875,
        442.6566162109375,
        365.86798095703125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재항목",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        378.9599914550781,
        442.6454772949219,
        394.5119934082031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        378.9599914550781,
        442.6454772949219,
        394.5119934082031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 명칭(제품명, 품목명, 모델명)",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        402.47998046875,
        442.6566162109375,
        416.86798095703125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        402.47998046875,
        442.6566162109375,
        416.86798095703125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 모양 및 구조",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        424.0799865722656,
        442.6566162109375,
        438.4679870605469
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        424.0799865722656,
        442.6566162109375,
        438.4679870605469
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 원재료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        445.67999267578125,
        442.6566162109375,
        460.0679931640625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        445.67999267578125,
        442.6566162109375,
        460.0679931640625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 제조방법",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        467.2799987792969,
        442.6566162109375,
        481.6679992675781
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        467.2799987792969,
        442.6566162109375,
        481.6679992675781
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 사용목적(성능)",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        488.8799743652344,
        442.6566162109375,
        503.2679748535156
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        488.8799743652344,
        442.6566162109375,
        503.2679748535156
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 사용방법",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        510.47998046875,
        442.6566162109375,
        524.8679809570312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        510.47998046875,
        442.6566162109375,
        524.8679809570312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 사용시 주의사항",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        532.0800170898438,
        442.6566162109375,
        546.468017578125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "31",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        532.0800170898438,
        442.6566162109375,
        546.468017578125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 포장단위",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        553.6799926757812,
        442.6566162109375,
        568.0679931640625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        553.6799926757812,
        442.6566162109375,
        568.0679931640625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 저장방법 및 사용기간",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        575.2799682617188,
        442.6566162109375,
        589.66796875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "32",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        575.2799682617188,
        442.6566162109375,
        589.66796875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10. 시험규격",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        596.8800048828125,
        442.6566162109375,
        611.2680053710938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "33",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        596.8800048828125,
        442.6566162109375,
        611.2680053710938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11. 제조원",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        618.47998046875,
        442.6566162109375,
        632.8679809570312
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "35",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        618.47998046875,
        442.6566162109375,
        632.8679809570312
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        213.71998596191406,
        442.28546142578125,
        229.27198791503906
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "37",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        213.71998596191406,
        442.28546142578125,
        229.27198791503906
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 개발경위, 측정원리·방법 및 국내․외 사용현황에",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        237.239990234375,
        448.2005920410156,
        251.63998413085938
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 13,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.0,
        258.8399963378906,
        442.2966003417969,
        273.2279968261719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "39",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        171.0,
        258.8399963378906,
        442.2966003417969,
        273.2279968261719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 원재료 및 제조방법에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        280.44000244140625,
        442.2966003417969,
        294.8280029296875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        280.44000244140625,
        442.2966003417969,
        294.8280029296875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 사용목적에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        302.03997802734375,
        442.2966003417969,
        316.427978515625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        302.03997802734375,
        442.2966003417969,
        316.427978515625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 저장방법 및 사용기간(유효기간)에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        323.6399841308594,
        442.2966003417969,
        338.0279846191406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "41",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        323.6399841308594,
        442.2966003417969,
        338.0279846191406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 제품의 성능을 확인하기 위한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        345.239990234375,
        442.2966003417969,
        359.62799072265625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "42",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        345.239990234375,
        442.2966003417969,
        359.62799072265625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 체외진단용 의료기기의 취급자 안전에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        366.8399963378906,
        442.2958984375,
        381.2279968261719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "42",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        366.8399963378906,
        442.2958984375,
        381.2279968261719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        145.44000244140625,
        415.9200134277344,
        442.28546142578125,
        431.4720153808594
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "44",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        145.44000244140625,
        415.9200134277344,
        442.28546142578125,
        431.4720153808594
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 분석적 성능시험에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        439.44000244140625,
        442.2966003417969,
        453.8280029296875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        439.44000244140625,
        442.2966003417969,
        453.8280029296875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 임상적 성능시험에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        461.03997802734375,
        442.2966003417969,
        475.427978515625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "56",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        461.03997802734375,
        442.2966003417969,
        475.427978515625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 완제품의 품질관리 시험성적서 또는 시험에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        482.6399841308594,
        442.2966003417969,
        497.0279846191406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "63",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        482.6399841308594,
        442.2966003417969,
        497.0279846191406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 완제품 품질관리 시험에 사용된 표준물질에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        504.239990234375,
        442.2966003417969,
        518.6279907226562
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "64",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        504.239990234375,
        442.2966003417969,
        518.6279907226562
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 검체보관 및 취급상(온도, 습도 등)의 조건 설정",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        525.8399658203125,
        421.20013427734375,
        540.2279663085938
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.0,
        547.4400024414062,
        442.2966003417969,
        561.8280029296875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "64",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        171.0,
        547.4400024414062,
        442.2966003417969,
        561.8280029296875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 상관성 평가",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        569.0399780273438,
        442.2966003417969,
        583.427978515625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        156.83999633789062,
        569.0399780273438,
        442.2966003417969,
        583.427978515625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅷ. 참고문헌",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        602.5199584960938,
        442.28546142578125,
        618.0719604492188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "67",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        602.5199584960938,
        442.28546142578125,
        618.0719604492188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        661.3199462890625,
        442.28546142578125,
        676.8719482421875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "69",
      "font_size": 12.829745292663574,
      "font_name": "T9",
      "bbox": [
        151.55999755859375,
        661.3199462890625,
        442.28546142578125,
        676.8719482421875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7. 이미 허가·인증받은 제품과 비교한 자료..................43",
      "font_size": 11.879393577575684,
      "font_name": "T12",
      "bbox": [
        155.51998901367188,
        384.7200012207031,
        441.3374328613281,
        399.1199951171875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        123.36000061035156,
        160.07998657226562,
        222.83999633789062,
        186.43199157714844
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개  요",
      "font_size": 17.758378982543945,
      "font_name": "H2hdrM",
      "bbox": [
        123.36000061035156,
        160.07998657226562,
        222.83999633789062,
        186.43199157714844
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 목적",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        476.2991943359375,
        150.95999145507812,
        488.2991943359375
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        500.28326416015625,
        484.6797790527344,
        511.3232727050781
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        522.2432250976562,
        488.35638427734375,
        533.2832641601562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        544.3232421875,
        441.796630859375,
        555.36328125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로",
      "font_size": 11.039999961853027,
      "font_name": "Dotum",
      "bbox": [
        110.5199966430664,
        588.2432250976562,
        488.2459716796875,
        599.2832641601562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시",
      "font_size": 11.039999961853027,
      "font_name": "Dotum",
      "bbox": [
        110.5199966430664,
        610.3232421875,
        488.3668518066406,
        621.36328125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고하시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "Dotum",
      "bbox": [
        110.5199966430664,
        632.2832641601562,
        219.17999267578125,
        643.3233032226562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.43999481201172,
        236.40750122070312,
        480.5563659667969,
        249.06375122070312
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        118.43999481201172,
        253.91998291015625,
        476.8799743652344,
        268.3199768066406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        118.43999481201172,
        274.8074951171875,
        476.7599792480469,
        287.4637451171875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설명하였습니다. 다만, 가이드라인에 기술한 사항은 현재까지의 경험과",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        118.43999481201172,
        292.32000732421875,
        476.8799743652344,
        306.7080078125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        118.43999481201172,
        311.5199890136719,
        482.8799743652344,
        325.9079895019531
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련 규정이 개정될 경우 추후 변경될 수 있습니다.",
      "font_size": 12.0,
      "font_name": "T12",
      "bbox": [
        118.43999481201172,
        330.7200012207031,
        402.9360046386719,
        345.1080017089844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        124.07999420166016,
        359.5199890136719,
        476.8799743652344,
        373.91998291015625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        118.43999481201172,
        380.4075012207031,
        476.8799743652344,
        393.0637512207031
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        118.43999481201172,
        397.91998291015625,
        482.7599792480469,
        412.3079833984375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "알려드립니다.",
      "font_size": 12.0,
      "font_name": "T12",
      "bbox": [
        118.43999481201172,
        417.1199951171875,
        191.25599670410156,
        431.50799560546875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅰ. 개 요",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        446.7599792480469,
        117.55441284179688,
        481.4462890625,
        126.55441284179688
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 적용범위",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.8992156982422,
        174.95999145507812,
        167.8992156982422
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        179.76327514648438,
        484.6797790527344,
        190.8032684326172
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        201.72328186035156,
        488.3560485839844,
        212.76327514648438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용되는 허가․심사 가이드라인이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        223.80328369140625,
        310.276611328125,
        234.84327697753906
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        245.76327514648438,
        488.35638427734375,
        256.80328369140625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        267.7232666015625,
        488.35638427734375,
        278.7632751464844
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        289.80328369140625,
        488.3560485839844,
        300.8432922363281
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위한 보조 수단으로서 사용된다. 급성심근경색증 발생 시 심장성 TnI와",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        311.7632751464844,
        488.35638427734375,
        322.80328369140625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        333.7232666015625,
        488.35638427734375,
        344.7632751464844
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        355.80328369140625,
        488.35638427734375,
        366.8432922363281
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결합하여 근육 수축을 조절한다. TnI과 TnT는 급성심근경색증 환자의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        377.7632751464844,
        488.3560485839844,
        388.80328369140625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        399.7232666015625,
        488.35638427734375,
        410.7632751464844
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        421.80328369140625,
        484.6796875,
        432.8432922363281
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근경색증이 확인되는 환자의 95%를 검출한다. TnI의 혈장 농도는 며칠",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        443.7632751464844,
        488.35638427734375,
        454.80328369140625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        465.7232666015625,
        488.35626220703125,
        476.7632751464844
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제공한다. 또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        487.80328369140625,
        488.35638427734375,
        498.8432922363281
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사망 위험을 예측하기 위한 값을 보여준다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        509.7632751464844,
        343.17279052734375,
        520.8032836914062
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 4 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        116.15999603271484,
        160.67999267578125,
        255.23989868164062,
        187.03199768066406
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용어의 정의",
      "font_size": 17.758378982543945,
      "font_name": "H2hdrM",
      "bbox": [
        116.15999603271484,
        160.67999267578125,
        255.23989868164062,
        187.03199768066406
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        206.88328552246094,
        499.2756652832031,
        217.92327880859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "돕기 위해 사용되는 것이므로 단순 참고용임",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        228.84327697753906,
        352.4396667480469,
        239.88327026367188
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간섭 (Interference)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        260.8832702636719,
        211.29251098632812,
        271.92327880859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        282.8432922363281,
        484.68096923828125,
        293.88330078125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        304.92327880859375,
        444.2404479980469,
        315.9632873535156
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        326.8832702636719,
        488.35662841796875,
        337.92327880859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        348.84326171875,
        488.3564758300781,
        359.8832702636719
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원인에 기인하기도 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        370.92327880859375,
        249.09280395507812,
        381.9632873535156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검출한계 (Limit of detection, LoD)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        402.84326171875,
        288.69232177734375,
        413.8832702636719
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출될 수 있는 분석 물질의 최소량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        424.92327880859375,
        291.9596862792969,
        435.9632873535156
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공란한계 (Limit of blank, LoB)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        456.84326171875,
        269.3558349609375,
        467.8832702636719
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        478.92327880859375,
        389.9996643066406,
        489.9632873535156
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교차반응 (Cross-reactivity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        510.8432922363281,
        252.572509765625,
        521.88330078125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        532.9232177734375,
        488.35638427734375,
        543.9632568359375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체가 반응하는 현상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        554.8832397460938,
        220.5599822998047,
        565.9232788085938
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기질효과 (Matrix effect)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        586.9232177734375,
        236.4944305419922,
        597.9632568359375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        608.8832397460938,
        488.3565673828125,
        619.9232788085938
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미치는 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        630.84326171875,
        169.56008911132812,
        641.88330078125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        652.9232177734375,
        488.35638427734375,
        663.9632568359375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요인이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        674.8832397460938,
        174.69281005859375,
        685.9232788085938
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.1600036621094,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조물질 (Control / Control material)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        310.6365966796875,
        176.76327514648438
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정도 관리를 위해 이용되는 물질",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        110.5199966430664,
        187.79249572753906,
        280.91998291015625,
        199.43624877929688
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역분석법, 면역측정법 (Immunoassay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        219.72328186035156,
        314.8388977050781,
        230.76327514648438
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        482.76007080078125,
        252.84327697753906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        488.35638427734375,
        274.80328369140625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        285.7232666015625,
        488.3560485839844,
        296.7632751464844
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        307.80328369140625,
        488.3560485839844,
        318.8432922363281
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        329.7632751464844,
        172.8766326904297,
        340.80328369140625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이어스 (Bias)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        192.0765380859375,
        372.8432922363281
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 결과의 예상치와 허용된 기준치 사이의 차이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        363.4800109863281,
        394.80328369140625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간섭물질 (Interfering substances)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        415.80328369140625,
        292.2780456542969,
        426.8432922363281
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        437.7632751464844,
        488.3568115234375,
        448.80328369140625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        484.67974853515625,
        470.7632751464844
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        190.1997528076172,
        492.8432922363281
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보관 시 안정성 (Storage stability)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        513.7232666015625,
        287.2533264160156,
        524.7633056640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최종 디자인(포장) 상태에서 시약의 유효기간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        341.5196838378906,
        546.84326171875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정 (Calibration)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        567.7232666015625,
        200.73277282714844,
        578.7633056640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        589.80322265625,
        484.6803283691406,
        600.84326171875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        611.7632446289062,
        488.3560485839844,
        622.8032836914062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립하는 일련의 조작",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        633.7232666015625,
        220.5599822998047,
        644.7633056640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정물질 (Calibrator / Calibration material)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        665.7632446289062,
        338.1330871582031,
        676.8032836914062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        687.7232666015625,
        488.3566589355469,
        698.7633056640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 6 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        474.3600769042969,
        166.8032684326172
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        199.80328369140625,
        488.3560485839844,
        210.84327697753906
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정하는데 사용될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        221.76327514648438,
        283.17279052734375,
        232.8032684326172
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        243.72328186035156,
        484.67999267578125,
        254.76327514648438
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "져야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        265.80328369140625,
        197.2528076171875,
        276.8432922363281
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        287.7632751464844,
        484.67999267578125,
        298.80328369140625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        309.7232666015625,
        213.69281005859375,
        320.7632751464844
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        331.80328369140625,
        484.6961669921875,
        342.8432922363281
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 ISO에서 사용되고 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        353.7632751464844,
        281.9727783203125,
        364.80328369140625
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석물질 (Analyte)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        385.80328369140625,
        204.93382263183594,
        396.8432922363281
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사실이 수행하는 검사의 물질 또는 구성요소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        407.7632751464844,
        346.919677734375,
        418.80328369140625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석적 특이도 (Analytical specificity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        439.80328369140625,
        307.0365905761719,
        450.8432922363281
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        461.7632751464844,
        484.6800842285156,
        472.80328369140625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되지 않는 분석법의 능력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        483.7232666015625,
        234.48040771484375,
        494.7632751464844
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비정밀도 (Imprecision)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        515.7632446289062,
        227.37481689453125,
        526.8032836914062
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        537.7232666015625,
        416.59637451171875,
        548.7633056640625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 표준편차나 변이계수 등의 숫자로 표시된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        559.80322265625,
        350.1327819824219,
        570.84326171875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비특이도 (Nonspecificity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        591.7232666015625,
        243.79783630371094,
        602.7633056640625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        613.80322265625,
        401.8796691894531,
        624.84326171875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        635.7632446289062,
        488.35662841796875,
        646.8032836914062
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효소, ionophore, 시약에 의해 발생한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        657.7232666015625,
        329.4927978515625,
        668.7633056640625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용 시 안정성 (in–use stability)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        689.7632446289062,
        282.4371337890625,
        700.8032836914062
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.1600036621094,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 7 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        488.3560485839844,
        166.8032684326172
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유효기간내의 검사수행능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        236.9993133544922,
        188.76327514648438
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상관계수 (Correlation coefficient, r)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        304.6358337402344,
        220.8032684326172
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        231.72328186035156,
        488.35638427734375,
        242.76327514648438
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표준편차의 곱의 비(ratio)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        253.80328369140625,
        243.83892822265625,
        264.8432922363281
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수송 안정성 실험 (Transport stability test)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        334.0523376464844,
        296.7632751464844
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        484.67999267578125,
        318.8432922363281
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 것",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.7632751464844,
        149.0399932861328,
        340.80328369140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 최악의 상황을 시험해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        351.7232666015625,
        278.61279296875,
        362.7632751464844
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신뢰구간 (Confidence interval)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        275.3563537597656,
        394.80328369140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        405.7232666015625,
        488.3560485839844,
        416.7632751464844
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것으로 예상되는 계산된 구간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.80328369140625,
        258.9596862792969,
        438.8432922363281
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실시간 안정성 실험 (Real time stability)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        318.45330810546875,
        470.7632751464844
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        488.35638427734375,
        492.8432922363281
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        503.7632751464844,
        132.59999084472656,
        514.8032836914062
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 예측도 (Predictive value of positive result, PPV)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        399.5574645996094,
        546.84326171875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.7632446289062,
        488.3560485839844,
        568.8032836914062
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 결과를 보이는 비율(100을 곱한 값)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        579.7232666015625,
        322.1999816894531,
        590.7633056640625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        601.80322265625,
        484.67999267578125,
        612.84326171875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 결정되는)의 유병률에 맞추어 해석해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        623.7632446289062,
        391.27630615234375,
        634.8032836914062
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        645.7232666015625,
        484.679443359375,
        656.7633056640625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 100xTP/(TP+FP)로 계산된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        667.80322265625,
        318.2127990722656,
        678.84326171875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 8 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        415.5632629394531,
        449.8811950683594,
        426.603271484375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        437.5232849121094,
        449.8815612792969,
        448.56329345703125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 일치율(Overall percent agreement)          = 100×(a+d)/n",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        459.603271484375,
        448.2939147949219,
        470.6432800292969
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성 예측도 (Predictive value of negative result, NPV)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        491.5232849121094,
        403.9963073730469,
        502.56329345703125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        513.603271484375,
        488.35638427734375,
        524.643310546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "곱한 값)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        535.563232421875,
        154.6800079345703,
        546.603271484375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.5232543945312,
        379.7727966308594,
        568.5632934570312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위양성 (False positive, FP)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        589.563232421875,
        248.37246704101562,
        600.603271484375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        611.5232543945312,
        427.51605224609375,
        622.5632934570312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        633.6032104492188,
        389.0396728515625,
        644.6432495117188
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위음성 (False negative, FN)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        665.5232543945312,
        256.63763427734375,
        676.5632934570312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 환자나 양성 검체에서의 음성검사 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        687.6032104492188,
        336.0,
        698.6432495117188
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단정확도기준",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        272.0400085449219,
        162.92062377929688,
        440.58837890625,
        173.42530822753906
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.95999145507812,
        184.16062927246094,
        447.61639404296875,
        194.66531372070312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.95999145507812,
        184.16062927246094,
        447.61639404296875,
        194.66531372070312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        249.95999145507812,
        184.16062927246094,
        447.61639404296875,
        194.66531372070312
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법 X",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        216.20062255859375,
        150.15158081054688,
        226.70530700683594
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        205.5206298828125,
        471.7229919433594,
        216.0253143310547
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "# 진양성 TP",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        205.5206298828125,
        471.7229919433594,
        216.0253143310547
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "# 위양성 FP",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        205.5206298828125,
        471.7229919433594,
        216.0253143310547
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진양성+ 위양성",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        205.5206298828125,
        471.7229919433594,
        216.0253143310547
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        226.7606201171875,
        474.0024108886719,
        237.2653045654297
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "# 위음성 FN",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        226.7606201171875,
        474.0024108886719,
        237.2653045654297
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "# 진음성 TN",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        226.7606201171875,
        474.0024108886719,
        237.2653045654297
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위음성 + 진음성",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.44000244140625,
        226.7606201171875,
        474.0024108886719,
        237.2653045654297
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        132.59999084472656,
        248.12062072753906,
        441.6024475097656,
        258.62530517578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진양성 + 위음성",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        132.59999084472656,
        248.12062072753906,
        441.6024475097656,
        258.62530517578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위양성 + 진음성",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        132.59999084472656,
        248.12062072753906,
        441.6024475097656,
        258.62530517578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "N",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        132.59999084472656,
        248.12062072753906,
        441.6024475097656,
        258.62530517578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교방법",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        317.2799987792969,
        285.32061767578125,
        446.828369140625,
        295.8253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        291.6000061035156,
        307.4006042480469,
        453.97698974609375,
        317.9053039550781
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        291.6000061035156,
        307.4006042480469,
        453.97698974609375,
        317.9053039550781
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        291.6000061035156,
        307.4006042480469,
        453.97698974609375,
        317.9053039550781
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "후보",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        144.83999633789062,
        333.80059814453125,
        168.90853881835938,
        344.3052978515625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검사법",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        140.16000366210938,
        349.7605895996094,
        168.6160430908203,
        360.2652893066406
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        330.32061767578125,
        456.7192077636719,
        340.8253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        330.32061767578125,
        456.7192077636719,
        340.8253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        330.32061767578125,
        456.7192077636719,
        340.8253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a + b",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        330.32061767578125,
        456.7192077636719,
        340.8253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        353.7206115722656,
        456.49737548828125,
        364.2253112792969
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        353.7206115722656,
        456.49737548828125,
        364.2253112792969
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "d",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        353.7206115722656,
        456.49737548828125,
        364.2253112792969
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c + d",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        222.0,
        353.7206115722656,
        456.49737548828125,
        364.2253112792969
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 9.725613594055176,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        152.0399932861328,
        376.1606140136719,
        447.3151550292969,
        386.6653137207031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a + c",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        152.0399932861328,
        376.1606140136719,
        447.3151550292969,
        386.6653137207031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b + d",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        152.0399932861328,
        376.1606140136719,
        447.3151550292969,
        386.6653137207031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "n",
      "font_size": 9.840714454650879,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        152.0399932861328,
        376.1606140136719,
        447.3151550292969,
        386.6653137207031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.1600036621094,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 민감도 (Clinical sensitivity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        289.6526184082031,
        176.76327514648438
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        467.8800048828125,
        198.84327697753906
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 보고가능범위 (Clinically reportable range, CCR)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        219.72328186035156,
        401.35675048828125,
        230.76327514648438
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        484.6796875,
        252.84327697753906
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        440.3999938964844,
        274.80328369140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 특이도 (Clinical specificity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        295.80328369140625,
        290.6141662597656,
        306.8432922363281
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        317.7632751464844,
        484.4400939941406,
        328.80328369140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현성 조건 (Reproducibility condition)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        349.80328369140625,
        318.43682861328125,
        360.8432922363281
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        371.7632751464844,
        484.67999267578125,
        382.80328369140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "른 장비를 사용하여 검사 결과를 얻는 조건",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        393.7232666015625,
        330.4800109863281,
        404.7632751464844
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현성 (Reproducibility)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        425.7632751464844,
        236.4779815673828,
        436.80328369140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        447.7232666015625,
        484.5601806640625,
        458.7632751464844
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정규분포 (Normal distribution)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        479.7632751464844,
        267.5716857910156,
        490.80328369140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        501.7232666015625,
        484.67999267578125,
        512.7632446289062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 y축에 표시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        523.80322265625,
        182.87965393066406,
        534.84326171875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        545.7632446289062,
        484.67999267578125,
        556.8032836914062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형곡선을 갖는다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        567.7232666015625,
        213.2128143310547,
        578.7633056640625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정량분석 (Quantitative assay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        599.7632446289062,
        264.93389892578125,
        610.8032836914062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체에서 분석물질의 농도를 측정할 수 있는 시스템",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        621.7232666015625,
        374.3996887207031,
        632.7633056640625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        643.80322265625,
        488.35638427734375,
        654.84326171875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보간법(Interpolation)1)을 통해 이루어진다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        665.7632446289062,
        347.2527770996094,
        676.8032836914062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        699.5543823242188,
        483.0066223144531,
        708.5543823242188
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 10 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정밀도 (Precision)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        203.97299194335938,
        176.76327514648438
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        484.44000244140625,
        198.84327697753906
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        488.3560485839844,
        220.8032684326172
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        231.72328186035156,
        458.2799987792969,
        242.76327514648438
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정성분석 (Qualitative assay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        257.1335754394531,
        274.80328369140625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        488.35638427734375,
        296.7632751464844
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        147.19606018066406,
        318.8432922363281
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.7632751464844,
        484.67999267578125,
        340.80328369140625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        351.7232666015625,
        488.35638427734375,
        362.7632751464844
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구해진다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        373.80328369140625,
        178.39663696289062,
        384.8432922363281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확도 (Accuracy)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        405.7232666015625,
        203.85377502441406,
        416.7632751464844
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정치와 참값 사이의 일치도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.80328369140625,
        258.9596862792969,
        438.8432922363281
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        449.7632751464844,
        488.3566589355469,
        460.80328369140625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공인된 참고값(accepted reference value)사이의 일치 근접도(closeness",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.07999420166016,
        471.7232666015625,
        488.35546875,
        482.7632751464844
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of agreement)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.07999420166016,
        493.80328369140625,
        199.43792724609375,
        504.8432922363281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직선성 (Linearity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        525.7232666015625,
        199.41236877441406,
        536.7633056640625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        547.80322265625,
        488.35638427734375,
        558.84326171875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 능력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        569.7632446289062,
        160.07998657226562,
        580.8032836914062
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단검사 (Diagnostic test)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        601.80322265625,
        248.0123291015625,
        612.84326171875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        623.7632446289062,
        488.3560485839844,
        634.8032836914062
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손상 정도를 평가하기 위한 목적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        645.7232666015625,
        275.5199890136719,
        656.7633056640625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 진단적 검체의 측정 또는 검사를 칭한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        667.80322265625,
        337.276611328125,
        678.84326171875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.1600036621094,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 11 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진양성 (True positive, TP)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        248.83653259277344,
        176.76327514648438
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자의 질병 상태와 검사의 양성판정이 일치하는 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        385.44000244140625,
        198.84327697753906
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진음성 (True negative, TN)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        219.72328186035156,
        253.39678955078125,
        230.76327514648438
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자의 질병 상태와 검사의 음성판정이 일치하는 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        385.44000244140625,
        252.84327697753906
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고구간 (Reference interval)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        273.7232666015625,
        267.0928649902344,
        284.7632751464844
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상하 두 개의 참고 한계치 내의 간격",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        295.80328369140625,
        297.4800109863281,
        306.8432922363281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        317.7632751464844,
        421.53277587890625,
        328.80328369140625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고물질 / 참고제작 (Reference material / Reference preparation, RM)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        349.80328369140625,
        478.8929138183594,
        360.8432922363281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        371.7632751464844,
        484.6796875,
        382.80328369140625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        129.47999572753906,
        393.7232666015625,
        437.3999938964844,
        404.7632751464844
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        415.80328369140625,
        484.67999267578125,
        426.8432922363281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        129.47999572753906,
        437.7632751464844,
        484.67999267578125,
        448.80328369140625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나 또는 그 이상의 값을 갖는 참고물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        129.47999572753906,
        459.7232666015625,
        327.47967529296875,
        470.7632751464844
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        488.35638427734375,
        492.8432922363281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        503.7632751464844,
        484.6796875,
        514.8032836914062
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        525.7232666015625,
        488.35638427734375,
        536.7633056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        547.80322265625,
        484.6860656738281,
        558.84326171875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라고 정의한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        569.7632446289062,
        220.8766326904297,
        580.8032836914062
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        591.7232666015625,
        484.6796875,
        602.7633056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        613.80322265625,
        484.6793518066406,
        624.84326171875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        635.7632446289062,
        484.6796875,
        646.8032836914062
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        657.7232666015625,
        171.43663024902344,
        668.7633056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 12 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고치 (Reference value)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        248.3575439453125,
        176.76327514648438
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        390.9599914550781,
        198.84327697753906
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 분석 오차 (Total analytical error)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        219.72328186035156,
        306.0752258300781,
        230.76327514648438
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        484.67999267578125,
        252.84327697753906
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        150.4366455078125,
        274.80328369140625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정가능범위 (Analytical measurement range, AMR)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        295.80328369140625,
        385.63714599609375,
        306.8432922363281
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        317.7632751464844,
        488.3564758300781,
        328.80328369140625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        339.7232666015625,
        409.8000793457031,
        350.7632751464844
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정 시스템의 민감도 (Sensitivity of a measuring system)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        371.7632751464844,
        417.8130798339844,
        382.80328369140625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        393.7232666015625,
        423.8396911621094,
        404.7632751464844
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        415.80328369140625,
        488.2360534667969,
        426.8432922363281
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        437.7632751464844,
        445.05279541015625,
        448.80328369140625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "친화력, 친화성 (Affinity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        469.80328369140625,
        235.99644470214844,
        480.8432922363281
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        491.7632751464844,
        484.32000732421875,
        502.80328369140625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판정기준치 (Cut-off value)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        523.80322265625,
        250.17372131347656,
        534.84326171875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        545.7632446289062,
        488.3569030761719,
        556.8032836914062
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있는 경계값을 말한다. 정량검사에서는 측정 결과가 임상적 또는 분석",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        567.7232666015625,
        484.6804504394531,
        578.7633056640625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        589.80322265625,
        484.6800842285156,
        600.84326171875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는데 사용되는 측정물질의 정량값",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        611.7632446289062,
        288.24053955078125,
        622.8032836914062
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 (Antigen)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        643.80322265625,
        187.3974609375,
        654.84326171875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        665.7632446289062,
        476.9560546875,
        676.8032836914062
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.1600036621094,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 13 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원결정인자 / 에피토프 (Antigenic determinant / epitope)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        421.05230712890625,
        176.76327514648438
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        488.35736083984375,
        198.84327697753906
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정하는 부위의 화학적 구조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        255.9600830078125,
        220.8032684326172
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원항체결합력 (Avidity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        233.37318420410156,
        252.84327697753906
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항혈청 또는 항체의 복합적인 반응 강도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        313.919677734375,
        274.80328369140625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        484.6796875,
        296.7632751464844
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로분자의 항원결정기와의 친화력 함수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        307.80328369140625,
        323.5960693359375,
        318.8432922363281
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항체 (Antibody)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        339.7232666015625,
        192.91744995117188,
        350.7632751464844
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        473.3999938964844,
        372.8432922363281
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        484.6793518066406,
        394.80328369140625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 면역원(immunogen)과 결합한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        405.7232666015625,
        308.9727783203125,
        416.7632751464844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용 오차 (Allowable error)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        437.7632751464844,
        254.85137939453125,
        448.80328369140625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        484.67999267578125,
        470.7632751464844
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        488.3560485839844,
        492.8432922363281
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만족시킬 수 있는 변이의 정도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        503.7632751464844,
        264.47998046875,
        514.8032836914062
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후크효과 (Hook effect)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        231.0925750732422,
        546.84326171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.7632446289062,
        484.67999267578125,
        568.8032836914062
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 나타나는 현상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        579.7232666015625,
        198.47964477539062,
        590.7633056640625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회복, 회수 (Recovery)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        611.7632446289062,
        227.3583984375,
        622.8032836914062
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        633.7232666015625,
        488.3560485839844,
        644.7633056640625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        655.80322265625,
        132.59999084472656,
        666.84326171875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        677.7632446289062,
        484.6796875,
        688.8032836914062
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 14 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 증가가 첨가된 양과 동등한 지 분석한다. 첨가된 물질의 양을 확인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        155.76327514648438,
        484.67999267578125,
        166.8032684326172
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        177.72328186035156,
        466.03662109375,
        188.76327514648438
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 회수실험의 다른 형태는 희석-회수분석이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        199.80328369140625,
        353.852783203125,
        210.84327697753906
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        117.47999572753906,
        248.6400146484375,
        232.5596923828125,
        274.99200439453125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관련규정",
      "font_size": 17.758378982543945,
      "font_name": "H2hdrM",
      "bbox": [
        117.47999572753906,
        248.6400146484375,
        232.5596923828125,
        274.99200439453125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법」제3조 (제조업의 허가의 신청절차)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        312.8432922363281,
        380.8799743652344,
        323.88330078125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법」제10조 (임상시험계획의 승인 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        334.92327880859375,
        376.3199768066406,
        345.9632873535156
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법」제29조 (수입업 허가신청 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        356.8832702636719,
        354.239990234375,
        367.92327880859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        378.84326171875,
        380.8799743652344,
        389.8832702636719
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        400.92327880859375,
        380.8799743652344,
        411.9632873535156
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        422.8832702636719,
        380.8799743652344,
        433.92327880859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        444.84326171875,
        397.3199768066406,
        455.8832702636719
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        466.92327880859375,
        425.7599792480469,
        477.9632873535156
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        488.8832702636719,
        480.719970703125,
        499.92327880859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        510.8432922363281,
        392.7599792480469,
        521.88330078125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        532.9232177734375,
        403.79998779296875,
        543.9632568359375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        554.8832397460938,
        409.3199768066406,
        565.9232788085938
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        576.84326171875,
        409.3199768066406,
        587.88330078125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기 허가․신고․심사 등에 관한 규정」",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        598.9232177734375,
        350.760009765625,
        609.9632568359375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기 품목 및 품목별 등급에 관한 규정」",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        620.8832397460938,
        368.8800048828125,
        631.9232788085938
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "■ 「의료기기 안정성시험 기준」",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        642.84326171875,
        281.0400085449219,
        653.88330078125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ. 신청서 기재 항목 및 기술문서 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        315.6000061035156,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        117.23999786376953,
        160.07998657226562,
        427.56353759765625,
        186.43199157714844
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신청서 기재 항목 및 기술문서 제출자료",
      "font_size": 15.719986915588379,
      "font_name": "H2hdrM",
      "bbox": [
        117.23999786376953,
        160.07998657226562,
        427.56353759765625,
        186.43199157714844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        248.94808959960938,
        271.3235168457031,
        263.7080993652344
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조․수입허가신청서",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        248.94808959960938,
        271.3235168457031,
        263.7080993652344
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 명칭(제품명, 품목명, 모델명)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        285.8432922363281,
        277.44000244140625,
        296.88330078125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 분류번호(등급)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        307.80328369140625,
        210.0,
        318.8432922363281
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 모양 및 구조",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        329.7632751464844,
        200.40017700195312,
        340.80328369140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 원재료",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        351.84326171875,
        170.7603759765625,
        362.8832702636719
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 제조방법",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        373.80328369140625,
        180.60018920898438,
        384.8432922363281
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 사용목적(성능)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        395.7632751464844,
        210.0,
        406.80328369140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 사용방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        417.84326171875,
        184.3196563720703,
        428.8832702636719
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 사용 시 주의사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        439.80328369140625,
        228.35964965820312,
        450.8432922363281
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 포장단위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        461.7632751464844,
        184.3196563720703,
        472.80328369140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 저장방법 및 사용기간",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        483.84326171875,
        240.12017822265625,
        494.8832702636719
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 시험규격",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        505.8032531738281,
        180.60018920898438,
        516.84326171875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        527.7632446289062,
        350.1600036621094,
        538.8032836914062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 허가조건",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        549.84326171875,
        184.3196563720703,
        560.88330078125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 비고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        571.80322265625,
        162.3599853515625,
        582.84326171875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 16 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        183.06808471679688,
        282.36395263671875,
        197.9480743408203
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술문서에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        183.06808471679688,
        282.36395263671875,
        197.9480743408203
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        229.92327880859375,
        421.6796875,
        240.96327209472656
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 원재료 및 제조방법에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        257.5232849121094,
        291.9599914550781,
        268.56329345703125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 사용목적에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        285.123291015625,
        236.99998474121094,
        296.1632995605469
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 저장방법과 사용기간(유효기간)에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        312.7232666015625,
        349.79998779296875,
        323.7632751464844
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 성능시험에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        340.3232727050781,
        236.99998474121094,
        351.36328125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 체외진단용 의료기기의 취급자 안전에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        367.92327880859375,
        374.3996887207031,
        378.9632873535156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        395.5232849121094,
        409.52154541015625,
        406.56329345703125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 17 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        117.47999572753906,
        160.07998657226562,
        422.1600036621094,
        186.43199157714844
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조․수입허가 신청서 기재항목",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        117.47999572753906,
        160.07998657226562,
        422.1600036621094,
        186.43199157714844
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        255.9080810546875,
        343.0067443847656,
        274.6280822753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭 (제품명, 품목명, 모델명)",
      "font_size": 14.039999961853027,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        255.9080810546875,
        343.0067443847656,
        274.6280822753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.3232727050781,
        435.8127746582031,
        318.36328125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 상품명이 없는 경우, 생략 가능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        329.28326416015625,
        302.3999938964844,
        340.3232727050781
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        351.36328125,
        482.15985107421875,
        362.4032897949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        373.3232727050781,
        488.3560485839844,
        384.36328125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(수출용 의료기기 제외) 불가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        395.28326416015625,
        293.0400085449219,
        406.3232727050781
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        439.3232727050781,
        484.6796875,
        450.36328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        461.28326416015625,
        484.67999267578125,
        472.3232727050781
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사 제품에 한하여 가능함.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        483.36328125,
        275.1327819824219,
        494.4032897949219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(주)오송진단         심질환표지자검사시약      OS-Troponin I Test",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.16000366210938,
        509.6103210449219,
        468.0770263671875,
        519.5703125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "↓                     ↓                        ↓",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.16000366210938,
        525.6903686523438,
        411.1199951171875,
        535.6503295898438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조수입업소명           품목류명                   모델명",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.16000366210938,
        541.650390625,
        424.39630126953125,
        551.6103515625
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 별첨 기재시의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        588.84326171875,
        233.2799835205078,
        599.88330078125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<제품명>",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        132.1199951171875,
        615.0903930664062,
        174.5850067138672,
        625.0503540039062
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 품목명 : 심질환표지자검사시약",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        132.1199951171875,
        631.1703491210938,
        289.19854736328125,
        641.1303100585938
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 모델명 : OS-Troponin I",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        132.1199951171875,
        647.13037109375,
        262.80865478515625,
        657.09033203125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 품목분류번호 : D04030.01",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        132.1199951171875,
        663.0903930664062,
        271.254150390625,
        673.0503540039062
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 등급 : 3등급",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        132.1199951171875,
        679.1703491210938,
        205.1999969482422,
        689.1303100585938
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 18 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        205.14808654785156,
        229.083984375,
        219.9080810546875
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모양 및 구조",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        205.14808654785156,
        229.083984375,
        219.9080810546875
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 모양 및 구조 - 작용원리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        251.88327026367188,
        255.7196502685547,
        262.92327880859375
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        273.9632873535156,
        488.3560485839844,
        285.0032958984375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        295.92327880859375,
        488.35650634765625,
        306.9632873535156
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의의 등을 포함하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        317.8832702636719,
        265.7566223144531,
        328.92327880859375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        361.92327880859375,
        488.35638427734375,
        372.9632873535156
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 기재할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        383.8832702636719,
        249.09280395507812,
        394.92327880859375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        405.9632873535156,
        169.99606323242188,
        417.0032958984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다. 트로포닌",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        428.0103454589844,
        484.55950927734375,
        437.9703369140625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        448.0503234863281,
        484.6790466308594,
        458.01031494140625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        467.9703369140625,
        487.9963073730469,
        477.9303283691406
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주기적으로 발견된다. 트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        488.0103454589844,
        487.9967956542969,
        497.9703369140625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        508.0503234863281,
        484.67950439453125,
        518.0103149414062
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        527.9703369140625,
        484.67950439453125,
        537.9302978515625
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        548.0103759765625,
        487.9963073730469,
        557.9703369140625
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조절하여 근육 수축에서 매우 중요한 역할을 한다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        568.0503540039062,
        378.3882141113281,
        578.0103149414062
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        587.9703369140625,
        487.9963073730469,
        597.9302978515625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        608.0103759765625,
        487.9963073730469,
        617.9703369140625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "괴사의 지표가 된다. 그 외에 트로포닌 수치의 상승을 일으키는 상태로는",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        628.0503540039062,
        487.87628173828125,
        638.0103149414062
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        647.9703369140625,
        487.9967346191406,
        657.9302978515625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        668.0103759765625,
        487.87628173828125,
        677.9703369140625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함하나 이에 국한되지는 않는다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        688.0503540039062,
        303.3882141113281,
        698.0103149414062
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 19 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        175.80328369140625,
        476.372802734375,
        186.84327697753906
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        197.76327514648438,
        166.4399871826172,
        208.8032684326172
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정원리는 동종 샌드위치 화학발광 면역측정법이다. 시약에는 두 개의",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        219.3621063232422,
        487.9963073730469,
        231.58804321289062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        241.8903350830078,
        484.5599670410156,
        251.850341796875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체가 포함되어있다. 첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        261.8103332519531,
        484.67999267578125,
        271.77032470703125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고 감광제 염료가 포함되어 있다. 두 번째 비드 시약은 Cardiac",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        281.850341796875,
        487.87725830078125,
        291.8103332519531
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Troponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        301.8903503417969,
        484.55950927734375,
        311.850341796875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어 있다. 검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        321.8103332519531,
        487.9958190917969,
        331.77032470703125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다. 첫",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        341.850341796875,
        487.9963073730469,
        351.8103332519531
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        361.8903503417969,
        487.9963073730469,
        371.850341796875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형성한다. 복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        381.8103332519531,
        484.67950439453125,
        391.77032470703125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        401.850341796875,
        484.5599670410156,
        411.8103332519531
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 일으킨다. 결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        421.8903503417969,
        487.9977722167969,
        431.850341796875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Troponin I 농도에 대해 정비례한다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.47999572753906,
        441.8103332519531,
        317.42822265625,
        451.77032470703125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 모양 및 구조 - 외형",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        483.7232666015625,
        233.75999450683594,
        494.7632751464844
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        505.8032531738281,
        488.2360534667969,
        516.84326171875
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        208.44000244140625,
        527.7632446289062,
        484.05279541015625,
        538.8032836914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        549.7232666015625,
        488.3560485839844,
        560.7633056640625
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        205.44000244140625,
        571.80322265625,
        484.67999267578125,
        582.84326171875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        205.44000244140625,
        593.7632446289062,
        269.1327819824219,
        604.8032836914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        615.7232666015625,
        488.35662841796875,
        626.7633056640625
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.0399932861328,
        637.80322265625,
        484.67999267578125,
        648.84326171875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.0399932861328,
        659.7632446289062,
        207.2128143310547,
        670.8032836914062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 20 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그림 1. 외관사진 첨부 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        241.07998657226562,
        166.8032684326172
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약: OS-Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        214.55999755859375,
        199.80328369140625,
        380.70001220703125,
        210.84327697753906
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 1. 구성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        489.0032653808594,
        191.63998413085938,
        500.04327392578125
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련번호",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        119.39999389648438,
        525.0032348632812,
        440.0396728515625,
        536.0432739257812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명 칭",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        119.39999389648438,
        525.0032348632812,
        440.0396728515625,
        536.0432739257812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부 구성",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        119.39999389648438,
        525.0032348632812,
        440.0396728515625,
        536.0432739257812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외관상 특징",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        119.39999389648438,
        525.0032348632812,
        440.0396728515625,
        536.0432739257812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        561.0032348632812,
        455.1600036621094,
        572.1632690429688
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "P",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        561.0032348632812,
        455.1600036621094,
        572.1632690429688
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단일구성",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        561.0032348632812,
        455.1600036621094,
        572.1632690429688
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투명한 액상 시약",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        561.0032348632812,
        455.1600036621094,
        572.1632690429688
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        601.4432373046875,
        455.1600036621094,
        612.603271484375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Q",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        601.4432373046875,
        455.1600036621094,
        612.603271484375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단일구성",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        601.4432373046875,
        455.1600036621094,
        612.603271484375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투명한 액상 시약",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        601.4432373046875,
        455.1600036621094,
        612.603271484375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        644.4032592773438,
        455.1600036621094,
        655.4432983398438
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "R",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        644.4032592773438,
        455.1600036621094,
        655.4432983398438
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단일구성",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        644.4032592773438,
        455.1600036621094,
        655.4432983398438
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투명한 액상 시약",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        138.1199951171875,
        644.4032592773438,
        455.1600036621094,
        655.4432983398438
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 21 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그림 2. 외관사진 첨부 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        241.07998657226562,
        166.8032684326172
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "별도판매구성품: OS-Troponin I Calibrator",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        190.3199920654297,
        199.80328369140625,
        404.9124755859375,
        210.84327697753906
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "< Troponin I CalSet >",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        239.63999938964844,
        224.61033630371094,
        350.0249938964844,
        234.57034301757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 구성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        496.80328369140625,
        191.63998413085938,
        507.8432922363281
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.27999877929688,
        521.6432495117188,
        138.23965454101562,
        532.6832885742188
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.27999877929688,
        530.5232543945312,
        455.6399841308594,
        550.3233032226562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명 칭",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.27999877929688,
        530.5232543945312,
        455.6399841308594,
        550.3233032226562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세부 구성",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.27999877929688,
        530.5232543945312,
        455.6399841308594,
        550.3233032226562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외관상 특징",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.27999877929688,
        530.5232543945312,
        455.6399841308594,
        550.3233032226562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        123.95999908447266,
        583.6832275390625,
        244.0809326171875,
        601.8032836914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "OS-Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        123.95999908447266,
        583.6832275390625,
        244.0809326171875,
        601.8032836914062
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CalSet",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        182.1599884033203,
        597.9632568359375,
        221.76715087890625,
        609.0032958984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "① Cal 1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        557.2832641601562,
        461.1600036621094,
        568.4432983398438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동결건조 시약",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        557.2832641601562,
        461.1600036621094,
        568.4432983398438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② Cal 2",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        579.603271484375,
        461.1600036621094,
        590.643310546875
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동결건조 시약",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        579.603271484375,
        461.1600036621094,
        590.643310546875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③ Snap-cap bottle",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        601.9232177734375,
        459.7200012207031,
        612.9632568359375
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소분용 빈 병",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        601.9232177734375,
        459.7200012207031,
        612.9632568359375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "④ Snap-cap bottle",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        624.2432250976562,
        459.7200012207031,
        635.2832641601562
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소분용 빈 병",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        266.0400085449219,
        624.2432250976562,
        459.7200012207031,
        635.2832641601562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 22 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        189.12388610839844,
        175.86807250976562
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원재료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        189.12388610839844,
        175.86807250976562
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 원재료는 다음 양식의 표를 사용하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        207.96328735351562,
        365.2527770996094,
        219.00328063964844
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        316.68328857421875,
        424.41278076171875,
        327.7232971191406
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        338.6432800292969,
        484.6796875,
        349.68328857421875
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        180.47999572753906,
        360.603271484375,
        484.67999267578125,
        371.6432800292969
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 경우에는 세트별로 구분하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        180.47999572753906,
        382.68328857421875,
        403.6528015136719,
        393.7232971191406
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        404.6432800292969,
        488.3557434082031,
        415.68328857421875
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        205.55999755859375,
        426.603271484375,
        252.69281005859375,
        437.6432800292969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        448.68328857421875,
        488.2357482910156,
        459.7232971191406
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        275.5199890136719,
        470.6432800292969,
        322.7727966308594,
        481.68328857421875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 분량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        492.603271484375,
        167.2799835205078,
        503.6432800292969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        514.6832275390625,
        488.3560485839844,
        525.7232666015625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역가를 기재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        536.6432495117188,
        218.0399932861328,
        547.6832885742188
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        558.603271484375,
        488.35662841796875,
        569.643310546875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응정지제, 희석액 등) 성분은 적량으로 표시 가능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.0800018310547,
        580.6832275390625,
        421.67999267578125,
        591.7232666015625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        602.6432495117188,
        482.2796630859375,
        613.6832885742188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마. 규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        646.6832275390625,
        484.5599670410156,
        657.7232666015625
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        184.44000244140625,
        668.6432495117188,
        467.9727783203125,
        679.6832885742188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        690.6032104492188,
        470.852783203125,
        701.6432495117188
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        237.09034729003906,
        137.27996826171875,
        247.05035400390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        245.13034057617188,
        241.5171356201172,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        245.13034057617188,
        241.5171356201172,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배합목적",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        245.13034057617188,
        241.5171356201172,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원재료명 또는",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        260.3999938964844,
        237.09034729003906,
        326.95672607421875,
        247.05035400390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성분명",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        245.13034057617188,
        473.2804260253906,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        245.13034057617188,
        473.2804260253906,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        245.13034057617188,
        473.2804260253906,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비고",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        245.13034057617188,
        473.2804260253906,
        263.0103454589844
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 23 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 3. 원재료 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        235.5599822998047,
        166.8032684326172
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 체외진단용 시약 : OS-Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        303.6763916015625,
        188.76327514648438
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) oxypyrion : 1-hydroxy-2(1H)-pyridinone",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        622.7703857421875,
        328.6612548828125,
        632.7303466796875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        113.63999938964844,
        199.5632781982422,
        135.72000122070312,
        210.603271484375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번호 명칭 배합목적",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        113.63999938964844,
        208.4432830810547,
        342.9596862792969,
        228.24327087402344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원재료명 또는 성분명",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        113.63999938964844,
        208.4432830810547,
        342.9596862792969,
        228.24327087402344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분량",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        364.67999267578125,
        199.5632781982422,
        386.760009765625,
        210.603271484375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "w/v",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        366.0,
        208.4432830810547,
        474.6000061035156,
        228.24327087402344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        366.0,
        208.4432830810547,
        474.6000061035156,
        228.24327087402344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        366.0,
        208.4432830810547,
        474.6000061035156,
        228.24327087402344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        121.31999969482422,
        231.00328063964844,
        327.6773681640625,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "P",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        121.31999969482422,
        231.00328063964844,
        327.6773681640625,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        121.31999969482422,
        231.00328063964844,
        327.6773681640625,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Streptavidin-coated",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        121.31999969482422,
        231.00328063964844,
        327.6773681640625,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "microparticles",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        218.75999450683594,
        248.64328002929688,
        293.8565979003906,
        259.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        372.3599853515625,
        231.00328063964844,
        481.99652099609375,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        372.3599853515625,
        231.00328063964844,
        481.99652099609375,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1x6.5",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        372.3599853515625,
        231.00328063964844,
        481.99652099609375,
        250.8032684326172
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        455.2799987792969,
        248.64328002929688,
        471.6906433105469,
        259.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        122.39999389648438,
        359.6432800292969,
        156.11061096191406,
        370.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Q",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        122.39999389648438,
        359.6432800292969,
        156.11061096191406,
        370.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        172.44000244140625,
        297.603271484375,
        205.4396514892578,
        308.6432800292969
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Troponin I antibody",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        221.63999938964844,
        262.4432678222656,
        332.59722900390625,
        273.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "concentrate (Biotinylated",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        221.63999938964844,
        280.0832824707031,
        360.1979675292969,
        291.123291015625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mouse monoclonal",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        221.63999938964844,
        297.603271484375,
        324.1981506347656,
        308.6432800292969
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "cardiac Troponin-I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        221.63999938964844,
        315.2432861328125,
        327.31658935546875,
        326.2832946777344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "antibody fragment)",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        221.63999938964844,
        332.8832702636719,
        323.2421875,
        343.92327880859375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        368.3999938964844,
        297.603271484375,
        438.35968017578125,
        308.6432800292969
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1x10",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        450.3599853515625,
        350.8832702636719,
        476.73675537109375,
        361.92327880859375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        455.2799987792969,
        368.4032897949219,
        471.6906433105469,
        379.44329833984375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        347.6432800292969,
        438.35968017578125,
        358.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bovine serum albumin",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        347.6432800292969,
        438.35968017578125,
        358.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        347.6432800292969,
        438.35968017578125,
        358.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        363.4832763671875,
        438.35968017578125,
        374.5232849121094
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bovine IgG",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        363.4832763671875,
        438.35968017578125,
        374.5232849121094
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        363.4832763671875,
        438.35968017578125,
        374.5232849121094
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        379.4432678222656,
        438.35968017578125,
        390.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEPES",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        379.4432678222656,
        438.35968017578125,
        390.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        379.4432678222656,
        438.35968017578125,
        390.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        395.28326416015625,
        438.35968017578125,
        406.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mouse IgG",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        395.28326416015625,
        438.35968017578125,
        406.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        395.28326416015625,
        438.35968017578125,
        406.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        433.4432678222656,
        438.35968017578125,
        444.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dextran T-500",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        433.4432678222656,
        438.35968017578125,
        444.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        433.4432678222656,
        438.35968017578125,
        444.4832763671875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        122.39999389648438,
        539.043212890625,
        155.73748779296875,
        550.083251953125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "R",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        122.39999389648438,
        539.043212890625,
        155.73748779296875,
        550.083251953125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        172.44000244140625,
        488.28326416015625,
        205.4396514892578,
        499.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mouse monoclonal",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        223.9199981689453,
        470.6432800292969,
        326.9581298828125,
        481.68328857421875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "cardiac    troponin-I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        223.9199981689453,
        488.28326416015625,
        341.7177429199219,
        499.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "antibody fragment",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        223.9199981689453,
        505.9232482910156,
        321.3680725097656,
        516.9632568359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        372.3599853515625,
        488.28326416015625,
        438.35968017578125,
        499.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        372.3599853515625,
        488.28326416015625,
        438.35968017578125,
        499.3232727050781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1x10",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        450.3599853515625,
        530.2832641601562,
        476.73675537109375,
        541.3233032226562
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        455.2799987792969,
        547.9232177734375,
        471.6906433105469,
        558.9632568359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        522.1232299804688,
        438.35968017578125,
        533.1632690429688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bovine serum albumin",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        522.1232299804688,
        438.35968017578125,
        533.1632690429688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        522.1232299804688,
        438.35968017578125,
        533.1632690429688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        544.083251953125,
        438.35968017578125,
        555.123291015625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bovine IgG",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        544.083251953125,
        438.35968017578125,
        555.123291015625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        544.083251953125,
        438.35968017578125,
        555.123291015625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        565.9232177734375,
        438.35968017578125,
        576.9632568359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Phosphate buffer",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        565.9232177734375,
        438.35968017578125,
        576.9632568359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        565.9232177734375,
        438.35968017578125,
        576.9632568359375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        584.6432495117188,
        438.35968017578125,
        595.6832885742188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Neomycin sulfate",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        584.6432495117188,
        438.35968017578125,
        595.6832885742188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        584.6432495117188,
        438.35968017578125,
        595.6832885742188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        602.8025512695312,
        438.35968017578125,
        615.2432861328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Oxypyrion1)",
      "font_size": 7.079999923706055,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        602.8025512695312,
        438.35968017578125,
        615.2432861328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적량 자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        168.239990234375,
        602.8025512695312,
        438.35968017578125,
        615.2432861328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 24 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 별도판매구성품 : OS-Troponin I CalSet",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        335.7668151855469,
        166.8032684326172
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        442.028076171875,
        202.4438018798828,
        456.7880859375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조방법",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        442.028076171875,
        202.4438018798828,
        456.7880859375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. '제조원의 제조방법에 따른다.’라고 기재한다. 다만, 다음 각 호에 해당",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        488.8832702636719,
        484.67999267578125,
        499.92327880859375
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 경우에는 해당사항을 부가하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        510.8432922363281,
        361.6528015136719,
        521.88330078125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        532.9232177734375,
        493.8761901855469,
        543.9632568359375
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        554.8832397460938,
        493.8766174316406,
        565.9232788085938
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        576.84326171875,
        441.6927795410156,
        587.88330078125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.5199966430664,
        177.60328674316406,
        138.59999084472656,
        188.64328002929688
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번호",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        116.5199966430664,
        195.2432861328125,
        138.59999084472656,
        206.2832794189453
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        150.59999084472656,
        177.60328674316406,
        339.91607666015625,
        197.4032745361328
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        150.59999084472656,
        177.60328674316406,
        339.91607666015625,
        197.4032745361328
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원재료명 또는",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        150.59999084472656,
        177.60328674316406,
        339.91607666015625,
        197.4032745361328
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성분명",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        284.0400085449219,
        195.2432861328125,
        317.0396728515625,
        206.2832794189453
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분량",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        356.1600036621094,
        177.60328674316406,
        378.11968994140625,
        188.64328002929688
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        356.03997802734375,
        195.2432861328125,
        378.2113037109375,
        206.2832794189453
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        410.03997802734375,
        186.36328125,
        477.4800109863281,
        197.4032745361328
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비고",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        410.03997802734375,
        186.36328125,
        477.4800109863281,
        197.4032745361328
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        124.31999969482422,
        304.2032775878906,
        130.8965606689453,
        315.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cal1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        152.39999389648438,
        253.20327758789062,
        175.89646911621094,
        264.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보정물질",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        213.2432861328125,
        321.5565185546875,
        233.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        213.2432861328125,
        321.5565185546875,
        233.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(recombinant)",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        230.88328552246094,
        333.921142578125,
        241.92327880859375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "approx.",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        347.2799987792969,
        213.2432861328125,
        390.67718505859375,
        224.2832794189453
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.6",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        358.91998291015625,
        230.88328552246094,
        378.9167785644531,
        241.92327880859375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        399.0,
        222.00328063964844,
        443.0396728515625,
        233.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        458.2799987792969,
        235.5632781982422,
        474.5772705078125,
        246.603271484375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "x1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        459.8399963378906,
        253.20327758789062,
        476.7157897949219,
        264.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        458.2799987792969,
        270.7232666015625,
        474.5713806152344,
        281.7632751464844
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        253.20327758789062,
        443.0396728515625,
        264.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Human serum",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        253.20327758789062,
        443.0396728515625,
        264.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        253.20327758789062,
        443.0396728515625,
        264.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        253.20327758789062,
        443.0396728515625,
        264.2432861328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        275.5232849121094,
        319.0377197265625,
        295.3232727050781
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Phosphate",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        275.5232849121094,
        319.0377197265625,
        295.3232727050781
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "buffer",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        284.28326416015625,
        443.0396728515625,
        304.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        284.28326416015625,
        443.0396728515625,
        304.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        284.28326416015625,
        443.0396728515625,
        304.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cal2",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        152.39999389648438,
        355.3232727050781,
        175.89646911621094,
        366.36328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보정물질",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        324.2432861328125,
        241.79965209960938,
        335.2832946777344
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        315.36328125,
        321.5565185546875,
        326.4032897949219
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(recombinant)",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        333.0032653808594,
        333.921142578125,
        344.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "approx.",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        347.2799987792969,
        315.36328125,
        390.67718505859375,
        326.4032897949219
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        360.6000061035156,
        324.2432861328125,
        443.0396728515625,
        344.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        360.6000061035156,
        324.2432861328125,
        443.0396728515625,
        344.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        458.2799987792969,
        337.68328857421875,
        474.5772705078125,
        348.7232971191406
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "x1",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        459.8399963378906,
        355.3232727050781,
        476.7157897949219,
        366.36328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        458.2799987792969,
        372.84326171875,
        474.5713806152344,
        383.8832702636719
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        355.3232727050781,
        443.0396728515625,
        366.36328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Human serum",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        355.3232727050781,
        443.0396728515625,
        366.36328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        355.3232727050781,
        443.0396728515625,
        366.36328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        355.3232727050781,
        443.0396728515625,
        366.36328125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보조성분",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        377.6432800292969,
        319.0377197265625,
        397.44329833984375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Phosphate",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        197.75999450683594,
        377.6432800292969,
        319.0377197265625,
        397.44329833984375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "buffer",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        386.4032897949219,
        443.0396728515625,
        406.2032775878906
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        386.4032897949219,
        443.0396728515625,
        406.2032775878906
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사규격",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        260.8800048828125,
        386.4032897949219,
        443.0396728515625,
        406.2032775878906
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 25 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        238.5543212890625,
        175.86807250976562
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용목적(성능)",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        238.5543212890625,
        175.86807250976562
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 사용목적은 성능을 포함하여 다음에 따라 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        207.96328735351562,
        387.2127990722656,
        219.00328063964844
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        228.96327209472656,
        488.3560485839844,
        240.00326538085938
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        250.92327880859375,
        403.29278564453125,
        261.9632873535156
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 :",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        272.8832702636719,
        190.15640258789062,
        283.92327880859375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        120.47999572753906,
        294.9632873535156,
        487.99676513671875,
        306.0032958984375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        147.95999145507812,
        317.0103454589844,
        472.8282165527344,
        326.9703369140625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 검사대상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        336.9632873535156,
        189.23965454101562,
        348.0032958984375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        358.92327880859375,
        470.9727783203125,
        369.9632873535156
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        380.8832702636719,
        417.2127990722656,
        391.92327880859375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 검사항목",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        402.9632873535156,
        189.23965454101562,
        414.0032958984375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 검출대상이 되는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        424.92327880859375,
        265.4404296875,
        435.9632873535156
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 : cardiac Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        155.51998901367188,
        446.8832702636719,
        304.3209533691406,
        457.92327880859375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 측정원리 : 측정에 사용된 검사 원리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        468.9632873535156,
        330.3600158691406,
        480.0032958984375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 : 화학발광 면역측정법",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        125.5199966430664,
        490.92327880859375,
        291.47967529296875,
        501.9632873535156
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        512.8832397460938,
        484.55999755859375,
        523.9232788085938
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "량, 반정량 검사용 등을 명확하게 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        534.9632568359375,
        363.3327941894531,
        546.0032958984375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        556.9232177734375,
        172.3196563720703,
        567.9632568359375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        578.8832397460938,
        484.67999267578125,
        589.9232788085938
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.95999145507812,
        600.9632568359375,
        488.3560485839844,
        612.0032958984375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시약이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.95999145507812,
        622.9232177734375,
        195.09280395507812,
        633.9632568359375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 성능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        644.8832397460938,
        147.5996551513672,
        655.9232788085938
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        666.9632568359375,
        484.67999267578125,
        678.0032958984375
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치적으로 제시된 성능 기재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        688.9232177734375,
        279.9596862792969,
        699.9632568359375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 26 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        155.76327514648438,
        488.3560485839844,
        166.8032684326172
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않는 성능 배제하고 구체적 근거 자료로 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        177.72328186035156,
        406.6528015136719,
        188.76327514648438
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 4. 성능 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        221.76327514648438,
        224.51998901367188,
        232.8032684326172
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.7199935913086,
        255.09033203125,
        372.8399963378906,
        265.0503234863281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능항목",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.7199935913086,
        255.09033203125,
        372.8399963378906,
        265.0503234863281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법 및 결과",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.7199935913086,
        255.09033203125,
        372.8399963378906,
        265.0503234863281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        434.2503356933594,
        188.03952026367188,
        444.2103271484375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        434.2503356933594,
        188.03952026367188,
        444.2103271484375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(CLSI EP5-A2 실험 결과치)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        276.5703430175781,
        344.70001220703125,
        286.53033447265625
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈청풀(pooled human sera) 및 관리물질 (controls)을",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        292.53033447265625,
        460.75628662109375,
        302.4903259277344
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84);",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        308.4903259277344,
        475.99658203125,
        318.4503173828125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Repeatability",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        328.44000244140625,
        336.64459228515625,
        384.16314697265625,
        348.61529541015625
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(within run)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        330.6000061035156,
        351.0445861816406,
        378.82220458984375,
        363.0152893066406
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Intermediate",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        411.239990234375,
        336.64459228515625,
        466.0037536621094,
        348.61529541015625
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "precision",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        418.79998779296875,
        351.0445861816406,
        455.3231201171875,
        363.0152893066406
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검체",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        234.239990234375,
        383.6845703125,
        252.239990234375,
        395.6552734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mean",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.2799987792969,
        363.4045715332031,
        467.94879150390625,
        375.3752746582031
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SD",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.2799987792969,
        363.4045715332031,
        467.94879150390625,
        375.3752746582031
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CV",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.2799987792969,
        363.4045715332031,
        467.94879150390625,
        375.3752746582031
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SD",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.2799987792969,
        363.4045715332031,
        467.94879150390625,
        375.3752746582031
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CV",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.2799987792969,
        363.4045715332031,
        467.94879150390625,
        375.3752746582031
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        287.2799987792969,
        375.76458740234375,
        304.0801086425781,
        387.73529052734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ng/m",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        283.32000732421875,
        390.1645812988281,
        308.158935546875,
        402.1352844238281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "L)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        292.1999816894531,
        404.5645751953125,
        299.2621765136719,
        416.5352783203125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        330.3599853515625,
        382.9645690917969,
        347.2798156738281,
        394.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ng/mL)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        322.79998779296875,
        397.3645935058594,
        354.7021789550781,
        409.3352966308594
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        375.3599853515625,
        390.1645812988281,
        382.8878173828125,
        402.1352844238281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        411.8399963378906,
        382.9645690917969,
        428.75982666015625,
        394.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ng/mL)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        404.2799987792969,
        397.3645935058594,
        436.1830749511719,
        409.3352966308594
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        458.5199890136719,
        390.1645812988281,
        466.0478210449219,
        402.1352844238281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H u m a n",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        416.3245849609375,
        274.9631652832031,
        428.2952880859375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum 1",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        430.7245788574219,
        248.91702270507812,
        442.6952819824219
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.180",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        423.5245666503906,
        470.6770324707031,
        435.4952697753906
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.026",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        423.5245666503906,
        470.6770324707031,
        435.4952697753906
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14.2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        423.5245666503906,
        470.6770324707031,
        435.4952697753906
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.029",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        423.5245666503906,
        470.6770324707031,
        435.4952697753906
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15.9",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        423.5245666503906,
        470.6770324707031,
        435.4952697753906
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H u m a n",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        442.6045837402344,
        274.9631652832031,
        454.5752868652344
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum 2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        457.00457763671875,
        248.91702270507812,
        468.97528076171875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.197",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        449.8045654296875,
        470.6770324707031,
        461.7752685546875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.020",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        449.8045654296875,
        470.6770324707031,
        461.7752685546875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10.0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        449.8045654296875,
        470.6770324707031,
        461.7752685546875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.026",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        449.8045654296875,
        470.6770324707031,
        461.7752685546875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13.4",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        449.8045654296875,
        470.6770324707031,
        461.7752685546875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H u m a n",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        468.76458740234375,
        274.9631652832031,
        480.73529052734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum 3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        483.1645812988281,
        248.91702270507812,
        495.1352844238281
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.322",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        475.9645690917969,
        468.27764892578125,
        487.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.017",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        475.9645690917969,
        468.27764892578125,
        487.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        475.9645690917969,
        468.27764892578125,
        487.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.028",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        475.9645690917969,
        468.27764892578125,
        487.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.7",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        475.9645690917969,
        468.27764892578125,
        487.9352722167969
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H u m a n",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        495.0445861816406,
        274.9631652832031,
        507.0152893066406
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum 4",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        509.444580078125,
        248.91702270507812,
        521.415283203125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.425",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        502.24456787109375,
        468.27764892578125,
        514.2152709960938
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.022",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        502.24456787109375,
        468.27764892578125,
        514.2152709960938
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        502.24456787109375,
        468.27764892578125,
        514.2152709960938
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.031",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        502.24456787109375,
        468.27764892578125,
        514.2152709960938
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.3",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        502.24456787109375,
        468.27764892578125,
        514.2152709960938
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H u m a n",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        521.20458984375,
        274.9631652832031,
        533.17529296875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum 5",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        528.4046020507812,
        468.27764892578125,
        547.5752563476562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17.6",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        528.4046020507812,
        468.27764892578125,
        547.5752563476562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.479",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        528.4046020507812,
        468.27764892578125,
        547.5752563476562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.7",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        528.4046020507812,
        468.27764892578125,
        547.5752563476562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.823",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        528.4046020507812,
        468.27764892578125,
        547.5752563476562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.7",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        528.4046020507812,
        468.27764892578125,
        547.5752563476562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OS -Control",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        547.4845581054688,
        274.96405029296875,
        559.4552612304688
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tn1",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        561.8845825195312,
        229.47640991210938,
        573.8552856445312
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.340",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        554.6845703125,
        468.27764892578125,
        566.6552734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.024",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        554.6845703125,
        468.27764892578125,
        566.6552734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        554.6845703125,
        468.27764892578125,
        566.6552734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.027",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        554.6845703125,
        468.27764892578125,
        566.6552734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        284.7599792480469,
        554.6845703125,
        468.27764892578125,
        566.6552734375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OS -Control",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        573.6445922851562,
        274.96405029296875,
        585.6152954101562
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tn2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        580.8446044921875,
        468.27764892578125,
        600.0152587890625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18.0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        580.8446044921875,
        468.27764892578125,
        600.0152587890625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.475",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        580.8446044921875,
        468.27764892578125,
        600.0152587890625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.6",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        580.8446044921875,
        468.27764892578125,
        600.0152587890625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.783",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        580.8446044921875,
        468.27764892578125,
        600.0152587890625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.4",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        214.55999755859375,
        580.8446044921875,
        468.27764892578125,
        600.0152587890625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        633.0903930664062,
        191.35626220703125,
        650.9703369140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석적",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        633.0903930664062,
        191.35626220703125,
        650.9703369140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "민감도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.0399932861328,
        649.0503540039062,
        188.03952026367188,
        659.0103149414062
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        609.0903930664062,
        459.4373474121094,
        619.0503540039062
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험 결과치)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        625.1703491210938,
        266.3399963378906,
        635.1303100585938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출 한계(LoD) : 0.15 ng/mL [μg/L]",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        641.13037109375,
        386.4767761230469,
        651.09033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정량 한계(LoB) : 0.28 ng/mL [μg/L]",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        657.0903930664062,
        382.7392272949219,
        667.0503540039062
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        673.1703491210938,
        459.2992248535156,
        683.1303100585938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        692.2503662109375,
        452.3562927246094,
        702.2103271484375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후크 효과",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        692.2503662109375,
        452.3562927246094,
        702.2103271484375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        692.2503662109375,
        452.3562927246094,
        702.2103271484375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 27 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않는다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        165.8103485107422,
        239.2985076904297,
        175.77035522460938
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        290.2503356933594,
        130.60675048828125,
        300.2103271484375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석적",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.8000030517578,
        282.2103271484375,
        176.11627197265625,
        292.1703186035156
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특이도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.8000030517578,
        298.29034423828125,
        172.7995147705078,
        308.2503356933594
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간섭",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.75999450683594,
        197.850341796875,
        199.6800079345703,
        207.8103485107422
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반응",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.75999450683594,
        213.8103485107422,
        199.6800079345703,
        223.77035522460938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        189.8103485107422,
        441.9165954589844,
        199.77035522460938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "농도에서 간섭 반응이 나타나지 않았다. 헤모글로빈:",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        205.89035034179688,
        443.35626220703125,
        215.85035705566406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        221.850341796875,
        445.9048767089844,
        231.8103485107422
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "교차",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.75999450683594,
        308.850341796875,
        199.6800079345703,
        318.8103332519531
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반응",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.75999450683594,
        324.9303283691406,
        199.6800079345703,
        334.89031982421875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        238.8903350830078,
        441.9165954589844,
        248.850341796875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "농도에서 의미 있는 교차 반응이 나타나지 않았다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        254.9703369140625,
        435.19720458984375,
        264.9303283691406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "교차 반응물질",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        238.3199920654297,
        278.8045959472656,
        414.9599914550781,
        290.7752990722656
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "농도",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        238.3199920654297,
        278.8045959472656,
        414.9599914550781,
        290.7752990722656
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SI단위",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        238.3199920654297,
        278.8045959472656,
        414.9599914550781,
        290.7752990722656
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "교차반응",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        432.3599853515625,
        271.6045837402344,
        468.3599853515625,
        283.5752868652344
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(%)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        443.7599792480469,
        286.00457763671875,
        456.8224792480469,
        297.97528076171875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "트로포닌-C(심장)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        305.0845947265625,
        281.7421875,
        317.0552978515625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 0 0 0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        332.5199890136719,
        297.88458251953125,
        376.7231750488281,
        309.85528564453125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ng/mL",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        332.5199890136719,
        312.2845764160156,
        358.9204406738281,
        324.2552795410156
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 0 0 0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        297.88458251953125,
        424.00494384765625,
        309.85528564453125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "µg/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        305.0845947265625,
        452.7982177734375,
        324.2552795410156
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.005",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        305.0845947265625,
        452.7982177734375,
        324.2552795410156
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "트로포닌-T(사람심장)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        324.0445861816406,
        376.7231750488281,
        343.21527099609375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 0 0 0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        324.0445861816406,
        376.7231750488281,
        343.21527099609375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ng/mL",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        332.5199890136719,
        338.444580078125,
        358.9204406738281,
        350.415283203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 0 0 0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        324.0445861816406,
        424.00494384765625,
        336.0152893066406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "µg/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        338.444580078125,
        402.360107421875,
        350.415283203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.06",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        431.03997802734375,
        331.24456787109375,
        447.8779296875,
        343.21527099609375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "트로포닌-I(사람골격근)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        350.3245849609375,
        376.7231750488281,
        369.4952697753906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 0 0 0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        350.3245849609375,
        376.7231750488281,
        369.4952697753906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ng/mL",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        332.5199890136719,
        364.7245788574219,
        358.9204406738281,
        376.6952819824219
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1 0 0 0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        350.3245849609375,
        424.00494384765625,
        362.2952880859375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "µg/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        364.7245788574219,
        402.360107421875,
        376.6952819824219
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.12",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        431.03997802734375,
        357.5245666503906,
        447.8779296875,
        369.4952697753906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "트로포닌-I(사람골격근)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        376.4845886230469,
        376.72406005859375,
        395.6552734375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        376.4845886230469,
        376.72406005859375,
        395.6552734375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        376.4845886230469,
        376.72406005859375,
        395.6552734375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        212.87998962402344,
        376.4845886230469,
        376.72406005859375,
        395.6552734375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ng/mL",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        332.5199890136719,
        390.88458251953125,
        358.9204406738281,
        402.85528564453125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        376.4845886230469,
        424.00494384765625,
        388.4552917480469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        376.4845886230469,
        424.00494384765625,
        388.4552917480469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        376.4845886230469,
        424.00494384765625,
        388.4552917480469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "µg/L",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        383.7599792480469,
        390.88458251953125,
        402.360107421875,
        402.85528564453125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.13",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        431.03997802734375,
        383.6845703125,
        447.8779296875,
        395.6552734375
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        551.0103759765625,
        130.60675048828125,
        560.9703369140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상적",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.0399932861328,
        535.0503540039062,
        191.35626220703125,
        545.0103149414062
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특이도/민감",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.39999389648438,
        551.0103759765625,
        199.6800079345703,
        560.9703369140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        168.1199951171875,
        566.9703369140625,
        178.0800018310547,
        576.9302978515625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "응급실에서 흉통 환자에 대한 후향적 연구(prospective",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        415.0503234863281,
        455.1153564453125,
        425.01031494140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "study)에 독일 1개 및 미국 1개 병원이 참여하였다. 다음의",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        431.0103454589844,
        476.356689453125,
        440.9703369140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준에 의해 선택된 358명의 피험자의 민감도와 특이도를",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        446.9703369140625,
        469.0371398925781,
        456.9303283691406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        463.0503234863281,
        461.47674560546875,
        473.01031494140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        479.0103454589844,
        462.6767272949219,
        488.9703369140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        494.9703369140625,
        456.5566711425781,
        504.9303283691406
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없음. 또 다른 기준으로는 동시에 측정된 상용화된 troponin",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        511.0503234863281,
        476.8358154296875,
        521.0103149414062
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "I 검사 결과의 유효성(availability)이 사용되었다. 비혈관",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        527.0103759765625,
        463.3971862792969,
        536.9703369140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심장병(non-vascular cardiac disease) 환자는 결과",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        542.9703369140625,
        441.5567321777344,
        552.9302978515625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산출에서 배제하였다. 환자는 일반적인 troponin 검사법들에",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        559.0503540039062,
        477.0771179199219,
        569.0103149414062
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의한 결과를 포함하여 급성 심근경색(acute myocardial",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        575.0103759765625,
        456.316650390625,
        584.9703369140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "infarction)의 평가에 대한 현재 지침(guideline)에 따라",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        590.9703369140625,
        456.916748046875,
        600.9302978515625
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단되었다. 69명의 환자는 심근경색으로 진단받았고,",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        607.0503540039062,
        449.47674560546875,
        617.0103149414062
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "80명의 환자는 불안정협심증(unstable angina pectoris)으로,",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        623.0103759765625,
        480.07720947265625,
        632.9703369140625
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "209명의 환자는 심장 손상(cardiac injury) 원인이 아닌",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        638.9703369140625,
        458.59674072265625,
        648.9302978515625
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가슴통증(chest pain)으로 발전되었다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        655.0503540039062,
        380.3572082519531,
        665.0103149414062
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수신자조작특성곡선(Receiver operating characteristic(ROC)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        671.0103759765625,
        482.2373352050781,
        680.9703369140625
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "curve)은 troponin 값 최고점에서 계산되었다. ROC 곡선은",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        686.9703369140625,
        473.11669921875,
        696.9302978515625
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 28 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        626.6432495117188,
        488.3559265136719,
        637.6832885742188
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 성능 항목을 가감할 수 있음",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.27999877929688,
        648.6032104492188,
        296.8800048828125,
        659.6432495117188
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.96의 곡선아래 면적(area under the curve, AUC)을",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        158.6103515625,
        452.5967712402344,
        168.5703582763672
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나타낸다(95% 신뢰구간은 0.91-0.98). 급성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        174.69033813476562,
        411.5567321777344,
        184.6503448486328
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심근경색(acute myocardial infarction)을 평가하기 위한",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        190.6503448486328,
        460.15673828125,
        200.6103515625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적정 기준(optimal cut-off)은 troponin I의 최고값으로부터",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        206.61033630371094,
        477.0775146484375,
        216.57034301757812
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다. ROC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        222.69033813476562,
        464.2362976074219,
        232.6503448486328
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석에 의한 적정 기준(optimized cut-off) (0.30",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        238.6503448486328,
        432.677978515625,
        248.6103515625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        254.6103515625,
        439.1567687988281,
        264.5703430175781
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특이도(specificity)는 아래 표와 같다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        270.6903381347656,
        380.1167297363281,
        280.65032958984375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cut-off",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        216.0,
        303.4045715332031,
        244.88735961914062,
        315.3752746582031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L(ng/",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        213.59999084472656,
        317.8045959472656,
        247.40394592285156,
        329.7752990722656
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.95999145507812,
        332.20458984375,
        237.9421844482422,
        344.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sens.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        258.3599853515625,
        310.6045837402344,
        279.1694030761719,
        322.5752868652344
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        264.9599914550781,
        317.8045959472656,
        304.8462219238281,
        336.97528076171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        264.9599914550781,
        317.8045959472656,
        304.8462219238281,
        336.97528076171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        326.7599792480469,
        303.4045715332031,
        347.32464599609375,
        315.3752746582031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "confi.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        324.6000061035156,
        317.8045959472656,
        349.6043701171875,
        329.7752990722656
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "inter.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        325.1999816894531,
        332.20458984375,
        345.7681579589844,
        344.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Speci.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        357.8399963378906,
        310.6045837402344,
        381.2890319824219,
        322.5752868652344
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        365.7599792480469,
        317.8045959472656,
        412.7262268066406,
        336.97528076171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        365.7599792480469,
        317.8045959472656,
        412.7262268066406,
        336.97528076171875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        444.5999755859375,
        303.4045715332031,
        465.1646423339844,
        315.3752746582031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "confi.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        442.3199768066406,
        317.8045959472656,
        467.3234558105469,
        329.7752990722656
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "inte",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        445.67999267578125,
        332.20458984375,
        460.9364013671875,
        344.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.30",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "84",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "58/69",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "74-91",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "94",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "272/289",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "91-96",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        343.9645690917969,
        465.0373229980469,
        355.9352722167969
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        379.8903503417969,
        475.27685546875,
        389.850341796875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        395.9703369140625,
        460.9967346191406,
        405.9303283691406
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        411.9303283691406,
        450.5567626953125,
        421.89031982421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산출되었다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        427.8903503417969,
        260.95721435546875,
        437.850341796875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cut-off",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        216.0,
        444.64459228515625,
        244.88735961914062,
        456.61529541015625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L(ng/",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        213.59999084472656,
        459.0445861816406,
        247.40394592285156,
        471.0152893066406
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL)",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.95999145507812,
        473.444580078125,
        237.9421844482422,
        485.415283203125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sens.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        258.3599853515625,
        451.8445739746094,
        279.1694030761719,
        463.8152770996094
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        264.9599914550781,
        459.0445861816406,
        305.68621826171875,
        478.21527099609375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        264.9599914550781,
        459.0445861816406,
        305.68621826171875,
        478.21527099609375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        328.32000732421875,
        444.64459228515625,
        349.00433349609375,
        456.61529541015625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "confi.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        326.1600036621094,
        459.0445861816406,
        351.1634826660156,
        471.0152893066406
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "inter.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        326.8800048828125,
        473.444580078125,
        347.3284606933594,
        485.415283203125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Speci.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        359.3999938964844,
        451.8445739746094,
        382.96875,
        463.8152770996094
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        367.44000244140625,
        459.0445861816406,
        414.2862243652344,
        478.21527099609375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        367.44000244140625,
        459.0445861816406,
        414.2862243652344,
        478.21527099609375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "95%",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        446.1600036621094,
        444.64459228515625,
        466.7246398925781,
        456.61529541015625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "confi.",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        444.0,
        459.0445861816406,
        469.0043640136719,
        471.0152893066406
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "inte",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        447.239990234375,
        473.444580078125,
        462.49639892578125,
        485.415283203125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.50",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "61",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "42/69",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "49-72",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "289/289",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99-100",
      "font_size": 9.0,
      "font_name": "MalgunGothic",
      "bbox": [
        222.0,
        482.3703308105469,
        480.916748046875,
        497.17529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        554.2503662109375,
        188.03952026367188,
        564.2103271484375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상관성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.79999542236328,
        554.2503662109375,
        188.03952026367188,
        564.2103271484375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 제품과 자사 기허가 제품(제 수허 00-0000호)과의",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        522.2103881835938,
        463.0362854003906,
        532.1703491210938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        538.2903442382812,
        459.7969665527344,
        548.2503051757812
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24.6 ug/L(ng/mL)] 검체로 확인한 결과",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        554.2503662109375,
        390.8395080566406,
        564.2103271484375
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Passing/Bablok : y = 0.982x - 0.003 (T = 0.974)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        570.2103881835938,
        456.659912109375,
        580.1703491210938
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Linear regression : y = 0.991x - 0.045 (r = 0.996)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        206.39999389648438,
        586.2903442382812,
        466.6214294433594,
        596.2503051757812
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 29 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        202.4438018798828,
        175.86807250976562
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용방법",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        202.4438018798828,
        175.86807250976562
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        207.96328735351562,
        484.67999267578125,
        219.00328063964844
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        229.92327880859375,
        488.3560485839844,
        240.96327209472656
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약을 중심으로 사용방법을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        251.88327026367188,
        383.61279296875,
        262.92327880859375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 검체준비 및 저장방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        273.9632873535156,
        255.23965454101562,
        285.0032958984375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 검체대상 및 채취방법 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        295.92327880859375,
        288.0763854980469,
        306.9632873535156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검체 종류별 사용 가능한 항응고제",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        317.8832702636719,
        337.51605224609375,
        328.92327880859375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 사용되는 검체의 종류별 필요 분량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        339.9632873535156,
        333.8396911621094,
        351.0032958984375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 검체 보관조건, 방법 및 사용기간 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        361.92327880859375,
        342.6000061035156,
        372.9632873535156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 냉동 및 해동된 검체의 사용 가능성 및 제한점",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        383.8832702636719,
        397.9960632324219,
        394.92327880859375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 원심분리 조건 등을 포함한 검체 전처리과정 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        405.9632873535156,
        399.8399963378906,
        417.0032958984375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 검사 전 준비사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        427.92327880859375,
        233.15965270996094,
        438.9632873535156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        449.8832702636719,
        488.23541259765625,
        460.92327880859375
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기구 및 조건 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        471.9632873535156,
        280.17279052734375,
        483.0032958984375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        493.92327880859375,
        452.4927978515625,
        504.9632873535156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        515.8832397460938,
        436.05279541015625,
        526.9232788085938
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        537.9632568359375,
        488.35638427734375,
        549.0032958984375
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어의 회사명, 모델명 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        559.9232177734375,
        383.852783203125,
        570.9632568359375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        581.8832397460938,
        483.2127990722656,
        592.9232788085938
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 검사과정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        603.9632568359375,
        189.23965454101562,
        615.0032958984375
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        625.9232177734375,
        488.3560485839844,
        636.9632568359375
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다. 환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        647.8832397460938,
        488.35638427734375,
        658.9232788085938
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        669.9632568359375,
        488.35638427734375,
        681.0032958984375
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        691.9232177734375,
        488.1166076660156,
        702.9632568359375
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 30 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 결과판정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        155.76327514648438,
        189.23965454101562,
        166.8032684326172
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경계값(equivocal),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미확정(indeterminate),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "무효",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        199.80328369140625,
        488.3560485839844,
        210.84327697753906
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해석을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        221.76327514648438,
        221.2528076171875,
        232.8032684326172
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        243.72328186035156,
        488.35638427734375,
        254.76327514648438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어떻게 처리해야 하는지에 대한 지침을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.44000244140625,
        265.80328369140625,
        399.0928039550781,
        276.8432922363281
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 그대로 보고하는지 재검사가 필요한지 여부",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        287.7632751464844,
        382.4396667480469,
        298.80328369140625
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        309.7232666015625,
        488.35638427734375,
        320.7632751464844
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정결과 확인 절차에 대해 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        149.52000427246094,
        331.80328369140625,
        339.6927795410156,
        342.8432922363281
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        353.7632751464844,
        488.3560485839844,
        364.80328369140625
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시하고, 정량값 판정 등의 기준을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        149.52000427246094,
        375.7232666015625,
        381.3327941894531,
        386.7632751464844
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        419.7632751464844,
        172.79965209960938,
        430.80328369140625
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<결과 판정>",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        441.7232666015625,
        208.57675170898438,
        452.7632751464844
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        463.8903503417969,
        487.9963073730469,
        473.850341796875
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ng/mL)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        149.52000427246094,
        483.8103332519531,
        183.3944854736328,
        493.77032470703125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<참고치(Expected value)>",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        503.8503112792969,
        274.2176513671875,
        513.810302734375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        523.890380859375,
        487.9963073730469,
        533.850341796875
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        543.8103637695312,
        487.99737548828125,
        553.7703247070312
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "limit)(99백분위수)는",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        563.850341796875,
        487.9958190917969,
        573.810302734375
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.16",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        563.850341796875,
        487.9958190917969,
        573.810302734375
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "㎍/L",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        563.850341796875,
        487.9958190917969,
        573.810302734375
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ng/mL)이다(95%",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        563.850341796875,
        487.9958190917969,
        573.810302734375
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신뢰구간은",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        563.850341796875,
        487.9958190917969,
        573.810302734375
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.12-0.60).",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        583.890380859375,
        203.35794067382812,
        593.850341796875
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        603.8103637695312,
        487.9963073730469,
        613.7703247070312
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "낮은 농도는 0.30 ㎍/L (ng/mL)이었다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        623.850341796875,
        330.4367370605469,
        633.810302734375
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        643.890380859375,
        484.5599670410156,
        653.850341796875
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        663.8103637695312,
        487.998291015625,
        673.7703247070312
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "infarction)을 확실히 배제하지는 않는다. 만약 심근경색이 여전히 의심된",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        683.850341796875,
        484.5599670410156,
        693.810302734375
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 31 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다면, 적절한 간격으로 시험을 반복한다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        145.55999755859375,
        155.850341796875,
        334.63720703125,
        165.8103485107422
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 증가값과 관련된 요인들(Factors associated with elevated values)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        175.89035034179688,
        472.7151184082031,
        185.85035705566406
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        195.8103485107422,
        487.9979248046875,
        205.77035522460938
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "angina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        155.51998901367188,
        215.850341796875,
        487.9963073730469,
        225.8103485107422
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "cTnI의 증가를 보였다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        155.51998901367188,
        235.8903350830078,
        268.636962890625,
        245.850341796875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.55999755859375,
        255.81033325195312,
        487.877197265625,
        265.77032470703125
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요시 자체 참고범위를 확정해야 한다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        155.51998901367188,
        275.850341796875,
        341.7171936035156,
        285.8103332519531
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 정도관리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        315.7232666015625,
        189.23965454101562,
        326.7632751464844
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        337.80328369140625,
        413.5962829589844,
        348.8432922363281
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        359.7632751464844,
        488.35638427734375,
        370.80328369140625
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준 값에 적합함을 확인하는 과정을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        149.0399932861328,
        381.7232666015625,
        395.61279296875,
        392.7632751464844
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        403.80328369140625,
        504.7951965332031,
        414.8432922363281
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        151.55999755859375,
        425.7632751464844,
        203.71664428710938,
        436.80328369140625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        497.10809326171875,
        249.12380981445312,
        511.8680725097656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용시 주의사항",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        497.10809326171875,
        249.12380981445312,
        511.8680725097656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 다음의 사항을 포함하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        543.9632568359375,
        299.2528076171875,
        555.0032958984375
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 체외진단용으로 사용해야 함을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        565.9232177734375,
        351.81280517578125,
        576.9632568359375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        587.8832397460938,
        488.3569030761719,
        598.9232788085938
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        609.9632568359375,
        446.852783203125,
        621.0032958984375
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        631.9232177734375,
        481.29278564453125,
        642.9632568359375
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        653.8832397460938,
        483.6927795410156,
        664.9232788085938
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마. 경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        675.9632568359375,
        484.67999267578125,
        687.0032958984375
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 32 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도, 습도의 영향 등)을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        155.76327514648438,
        308.372802734375,
        166.8032684326172
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        177.72328186035156,
        488.35638427734375,
        188.76327514648438
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과판정 상 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        199.80328369140625,
        316.17279052734375,
        210.84327697753906
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사. 검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        221.76327514648438,
        488.3560485839844,
        232.8032684326172
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 위음성도) 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        243.72328186035156,
        288.6927795410156,
        254.76327514648438
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아. 다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        265.80328369140625,
        484.67999267578125,
        276.8432922363281
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보를 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        287.7632751464844,
        217.1728057861328,
        298.80328369140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자. 일회용의 경우 재사용하지 않도록 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        309.7232666015625,
        428.852783203125,
        320.7632751464844
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        381.0680847167969,
        202.4438018798828,
        395.9480895996094
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장단위",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        381.0680847167969,
        202.4438018798828,
        395.9480895996094
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.92327880859375,
        488.35662841796875,
        438.9632873535156
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        449.8832702636719,
        483.2127990722656,
        460.92327880859375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        519.3080444335938,
        282.3638000488281,
        534.068115234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저장방법 및 사용기간",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        519.3080444335938,
        282.3638000488281,
        534.068115234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        566.1632690429688,
        488.35638427734375,
        577.2033081054688
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        588.1232299804688,
        488.3560485839844,
        599.1632690429688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등), 사용기간(유효기간) 등을 병기하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        610.083251953125,
        370.41278076171875,
        621.123291015625
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        632.1632690429688,
        484.6802062988281,
        643.2033081054688
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        654.1232299804688,
        462.5727844238281,
        665.1632690429688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        676.083251953125,
        488.35662841796875,
        687.123291015625
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 33 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        155.76327514648438,
        488.3572082519531,
        166.8032684326172
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        177.72328186035156,
        166.41281127929688,
        188.76327514648438
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        199.80328369140625,
        484.67999267578125,
        210.84327697753906
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기간)을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        221.76327514648438,
        233.73280334472656,
        232.8032684326172
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        243.72328186035156,
        488.3560485839844,
        254.76327514648438
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        265.80328369140625,
        476.0127868652344,
        276.8432922363281
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 5. 저장방법 및 사용기간(유효기간)작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        309.7232666015625,
        362.0400085449219,
        320.7632751464844
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        118.19999694824219,
        471.9080810546875,
        202.4438018798828,
        486.7880859375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험규격",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        118.19999694824219,
        471.9080810546875,
        202.4438018798828,
        486.7880859375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        518.7632446289062,
        488.35638427734375,
        529.8032836914062
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        540.84326171875,
        484.6796875,
        551.88330078125
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 적용할 수 있는 시험규격을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        562.80322265625,
        334.17279052734375,
        573.84326171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        606.84326171875,
        484.6796875,
        617.88330078125
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목, 시험기준, 시험방법을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        628.80322265625,
        307.5328063964844,
        639.84326171875
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험항목",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        650.7632446289062,
        189.23965454101562,
        661.8032836914062
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        672.84326171875,
        430.53277587890625,
        683.88330078125
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        694.80322265625,
        488.35638427734375,
        705.84326171875
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구성시약 개봉여부",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.36000061035156,
        349.77032470703125,
        459.9599914550781,
        359.7303161621094
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보관조건",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.36000061035156,
        349.77032470703125,
        459.9599914550781,
        359.7303161621094
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용기간",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.36000061035156,
        349.77032470703125,
        459.9599914550781,
        359.7303161621094
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.36000061035156,
        349.77032470703125,
        459.9599914550781,
        359.7303161621094
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cartridge",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        112.91999816894531,
        393.09033203125,
        155.75013732910156,
        403.0503234863281
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        166.1999969482422,
        382.17034912109375,
        398.8799743652344,
        392.1303405761719
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        166.1999969482422,
        382.17034912109375,
        398.8799743652344,
        392.1303405761719
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조일로부터 12개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        166.1999969482422,
        382.17034912109375,
        398.8799743652344,
        392.1303405761719
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.1199951171875,
        404.0103454589844,
        395.9999694824219,
        413.9703369140625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.1199951171875,
        404.0103454589844,
        395.9999694824219,
        413.9703369140625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉일로부터 1개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.1199951171875,
        404.0103454589844,
        395.9999694824219,
        413.9703369140625
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 34 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        155.76327514648438,
        460.7727966308594,
        166.8032684326172
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 시험기준",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        177.72328186035156,
        192.9160614013672,
        188.76327514648438
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        199.80328369140625,
        484.67999267578125,
        210.84327697753906
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        221.76327514648438,
        484.6796875,
        232.8032684326172
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 받는 경우에는 그 조건을 명시하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        243.72328186035156,
        391.6528015136719,
        254.76327514648438
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        265.80328369140625,
        189.23965454101562,
        276.8432922363281
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        287.7632751464844,
        488.3560485839844,
        298.80328369140625
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구체적, 개조식으로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        309.7232666015625,
        306.93280029296875,
        320.7632751464844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        331.80328369140625,
        484.6363830566406,
        342.8432922363281
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        353.7632751464844,
        488.3557434082031,
        364.80328369140625
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        375.7232666015625,
        208.39663696289062,
        386.7632751464844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        397.80328369140625,
        484.67999267578125,
        408.8432922363281
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 설정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        419.7632751464844,
        233.2528076171875,
        430.80328369140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        441.7232666015625,
        488.3560485839844,
        452.7632751464844
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        463.80328369140625,
        216.69281005859375,
        474.8432922363281
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        485.7632751464844,
        483.5727844238281,
        496.80328369140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        346.91998291015625,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 35 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 6. 시험규격 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        241.07998657226562,
        166.8032684326172
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.55999755859375,
        186.33033752441406,
        428.759521484375,
        196.29034423828125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험기준",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.55999755859375,
        186.33033752441406,
        428.759521484375,
        196.29034423828125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.55999755859375,
        186.33033752441406,
        428.759521484375,
        196.29034423828125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 외관검사",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.39999389648438,
        220.7606201171875,
        165.9595184326172,
        231.2653045654297
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라벨 유무 확인",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        204.80062866210938,
        248.63951110839844,
        215.30531311035156
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확한 바코드 및 제품명 확인",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        220.7606201171875,
        318.5999755859375,
        231.2653045654297
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확한 로트 번호 확인",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        236.8406219482422,
        283.55999755859375,
        247.34530639648438
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "육안으로 확인한다.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        220.7606201171875,
        427.84454345703125,
        231.2653045654297
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 정밀도",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.39999389648438,
        305.6006164550781,
        155.99952697753906,
        316.1053161621094
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Standard deviation (ng/mL)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        249.5606231689453,
        300.5941162109375,
        260.0653076171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Level 1 ≤ 0.05",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        265.6405944824219,
        250.4999237060547,
        276.1452941894531
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Level 2 ≤ 0.20",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        281.6006164550781,
        250.4999237060547,
        292.1053161621094
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Level 3 ≤ 0.55",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        297.56060791015625,
        250.4999237060547,
        308.0653076171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Level 4 ≤ 1.50",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        313.6405944824219,
        250.4999237060547,
        324.1452941894531
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Level 5 ≤ 2.80",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        329.6006164550781,
        250.4999237060547,
        340.1053161621094
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상기 표준물질에 대하여 제시된",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        345.56060791015625,
        328.6195373535156,
        356.0653076171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SD 기준에 적합하여야 한다.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        178.67999267578125,
        361.6405944824219,
        308.08453369140625,
        372.1452941894531
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cardiac Troponin-I",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        265.6405944824219,
        430.2601318359375,
        276.1452941894531
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Calibrator (Level 1~5)를",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        281.6006164550781,
        454.259521484375,
        292.1053161621094
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이용하여 OS-cTnI QC",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        297.56060791015625,
        444.6600036621094,
        308.0653076171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Protocol(V.2)에 따라 Level",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        313.6405944824219,
        465.7801513671875,
        324.1452941894531
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1~5의 표준물질을 5회 반복",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        329.6006164550781,
        470.1000061035156,
        340.1053161621094
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "측정 한다.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        340.1999816894531,
        345.56060791015625,
        392.82037353515625,
        356.0653076171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 재현성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.39999389648438,
        411.92059326171875,
        229.22952270507812,
        422.42529296875
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CV ≤ 10%",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.39999389648438,
        411.92059326171875,
        229.22952270507812,
        422.42529296875
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cardiac Troponin-I",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        342.1199951171875,
        374.4805908203125,
        437.2181396484375,
        384.98529052734375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Calibrator (Level 1~5)를",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        342.1199951171875,
        389.4805908203125,
        456.17999267578125,
        399.98529052734375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이용하여 OS-cTnI QC",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        342.1199951171875,
        404.4805908203125,
        446.7005310058594,
        414.98529052734375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Protocol(V.2)에 reP",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        342.1199951171875,
        419.4805908203125,
        433.6197814941406,
        429.98529052734375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "control을 5회 반복하여 CV",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        342.1199951171875,
        434.4805908203125,
        470.70050048828125,
        444.98529052734375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "값을 구한다.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        342.1199951171875,
        449.4805908203125,
        399.884521484375,
        459.98529052734375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        118.19999694824219,
        501.9080505371094,
        450.7667541503906,
        516.7880859375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조원 (수입 또는 제조공정 전부 위탁의 경우)",
      "font_size": 14.039999961853027,
      "font_name": "HYwulM",
      "bbox": [
        118.19999694824219,
        501.9080505371094,
        450.7667541503906,
        516.7880859375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<작성요령>",
      "font_size": 12.0,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        548.7792358398438,
        173.5800018310547,
        560.7792358398438
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 수입제품은 제조원을 기재하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        576.9632568359375,
        325.8927917480469,
        588.0032958984375
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        603.1232299804688,
        477.0927734375,
        614.1632690429688
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조의뢰자와 제조자의 상호와 주소를 모두 기재한다. 다만, 제조자가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        625.2032470703125,
        488.35736083984375,
        636.2432861328125
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외국회사일 경우에는 제조국을 추가로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        647.1632690429688,
        370.41278076171875,
        658.2033081054688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        669.1232299804688,
        162.83999633789062,
        680.1632690429688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        691.2032470703125,
        488.3560485839844,
        702.2432861328125
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 36 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위탁 시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        149.0399932861328,
        166.8032684326172
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조원은 다음과 같이 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        278.61279296875,
        188.76327514648438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상호 (제조사 주소)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        199.80328369140625,
        220.44000244140625,
        210.84327697753906
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․ 제조의뢰자 : A (A사 주소)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        221.76327514648438,
        269.9999694824219,
        232.8032684326172
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․ 제조자 : B (B사 주소)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        243.72328186035156,
        246.1199951171875,
        254.76327514648438
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        287.7632751464844,
        484.67999267578125,
        298.80328369140625
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.16000366210938,
        309.7232666015625,
        442.17279052734375,
        320.7632751464844
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상호 (제조국/제조사 주소)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        331.80328369140625,
        257.1600036621094,
        342.8432922363281
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․ 제조의뢰자 : C (미국 C사 주소)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        353.7632751464844,
        299.35638427734375,
        364.80328369140625
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․ 제조자 : D (아일랜드 D사 주소)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        375.7232666015625,
        311.23602294921875,
        386.7632751464844
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        327.8399963378906,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 37 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        117.23999786376953,
        160.07998657226562,
        488.11639404296875,
        188.76327514648438
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술문서 등의 심사를 위한 제출자료",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        117.23999786376953,
        160.07998657226562,
        488.11639404296875,
        188.76327514648438
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 원칙",
      "font_size": 12.0,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        223.69921875,
        150.0,
        235.69921875
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        247.68328857421875,
        488.35638427734375,
        258.7232971191406
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서식에 따라 작성하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.0,
        269.6432800292969,
        298.6528015136719,
        280.68328857421875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        291.603271484375,
        484.6796875,
        302.6432800292969
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        313.68328857421875,
        418.9966125488281,
        324.7232971191406
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        335.6432800292969,
        488.3560485839844,
        346.68328857421875
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구체적으로 기재하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        357.603271484375,
        295.7566223144531,
        368.6432800292969
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        379.68328857421875,
        484.6796875,
        390.7232971191406
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. 다만,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        401.6432800292969,
        488.2362976074219,
        412.68328857421875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        423.603271484375,
        479.372802734375,
        434.6432800292969
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)",
      "font_size": 9.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        467.6592102050781,
        481.218505859375,
        479.6592102050781
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 임상적 성능시험 자료 요건은 별도 제시",
      "font_size": 9.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        491.7303466796875,
        312.4804382324219,
        501.6903381347656
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 인정범위",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        125.5199966430664,
        531.603271484375,
        188.27964782714844,
        542.643310546875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        563.6432495117188,
        447.5560607910156,
        574.6832885742188
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        585.603271484375,
        488.3560485839844,
        596.643310546875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        607.6832275390625,
        484.67999267578125,
        618.7232666015625
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        629.6432495117188,
        484.67999267578125,
        640.6832885742188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인한 자료 또는 이를 공증한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        651.6032104492188,
        327.9599914550781,
        662.6432495117188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        673.6832275390625,
        488.3560485839844,
        684.7232666015625
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        695.6432495117188,
        484.0794677734375,
        706.6832885742188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 38 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        155.76327514648438,
        484.6796875,
        166.8032684326172
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        199.80328369140625,
        484.67999267578125,
        210.84327697753906
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        221.76327514648438,
        459.9596862792969,
        232.8032684326172
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 기재내용",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        125.5199966430664,
        265.80328369140625,
        188.27964782714844,
        276.8432922363281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 업체명 및 주소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        297.7232666015625,
        234.95999145507812,
        308.7632751464844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        319.80328369140625,
        432.8396911621094,
        330.8432922363281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 시험검사품의 모델명, 상품명(해당 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        341.7632751464844,
        403.0799865722656,
        352.80328369140625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 시험일자 및 시험성적서 발급일자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        363.7232666015625,
        328.4396667480469,
        374.7632751464844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 시험 책임자의 서명 또는 직인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        385.80328369140625,
        311.8800048828125,
        396.8432922363281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        407.7632751464844,
        483.6004333496094,
        418.80328369140625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        429.7232666015625,
        488.35638427734375,
        440.7632751464844
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전처리가 필요한 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.39999389648438,
        451.80328369140625,
        312.3599853515625,
        462.8432922363281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 시험환경요인(시험결과에 영향을 주는 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        473.7632751464844,
        421.91998291015625,
        484.80328369140625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        125.5199966430664,
        517.80322265625,
        484.67999267578125,
        528.84326171875
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 자료의 경우)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        142.55999755859375,
        539.7632446289062,
        222.69281005859375,
        550.8032836914062
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험시설개요",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        571.80322265625,
        227.59573364257812,
        582.84326171875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        592.80322265625,
        488.35662841796875,
        603.84326171875
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요설비 목록 등이 기재되어 있어야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        614.7632446289062,
        360.9599914550781,
        625.8032836914062
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 주요설비",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        636.7232666015625,
        205.6360626220703,
        647.7633056640625
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        658.80322265625,
        484.67999267578125,
        669.84326171875
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        680.7632446289062,
        448.9200134277344,
        691.8032836914062
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        327.8399963378906,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 39 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 연구인력구성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        223.9193115234375,
        188.76327514648438
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        199.80328369140625,
        488.3568115234375,
        210.84327697753906
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보가 기재되어야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        221.76327514648438,
        266.5199890136719,
        232.8032684326172
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 시험자의 연구경력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        243.72328186035156,
        255.0760498046875,
        254.76327514648438
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        265.80328369140625,
        484.67999267578125,
        276.8432922363281
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        287.7632751464844,
        484.6804504394531,
        298.80328369140625
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        309.7232666015625,
        464.28009033203125,
        320.7632751464844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        381.0680847167969,
        472.07965087890625,
        395.4351501464844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료",
      "font_size": 12.839439392089844,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        381.0680847167969,
        472.07965087890625,
        395.4351501464844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 개발경위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.92327880859375,
        169.67965698242188,
        438.9632873535156
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        449.8832702636719,
        488.35638427734375,
        460.92327880859375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함된 논문, 문헌 등의 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        471.9632873535156,
        355.29278564453125,
        483.0032958984375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 측정원리 ․ 방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        515.8832397460938,
        204.47964477539062,
        526.9232788085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        537.9632568359375,
        488.35638427734375,
        549.0032958984375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.95999145507812,
        559.9232177734375,
        191.1328125,
        570.9632568359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        581.8832397460938,
        450.8127746582031,
        592.9232788085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 국내․외에서 사용현황",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        625.9232177734375,
        232.07965087890625,
        636.9632568359375
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        647.8832397460938,
        482.1327819824219,
        658.9232788085938
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        669.9632568359375,
        483.72021484375,
        681.0032958984375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        691.9232177734375,
        488.35638427734375,
        702.9632568359375
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 40 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성 및 성능과 관련된 유해사례보고 요약",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.16000366210938,
        155.76327514648438,
        383.6400146484375,
        166.8032684326172
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 제조국에서 사용되지 않는 경우는 그 사유",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        376.036376953125,
        188.76327514648438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        227.1080780029297,
        349.0839538574219,
        241.86807250976562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원재료 및 제조방법에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        227.1080780029297,
        349.0839538574219,
        241.86807250976562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 원재료의 성분 또는 분량을 확인할 수 있는 근거자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        273.9632873535156,
        395.0396728515625,
        285.0032958984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 해당시약의 성분과 분량을 확인할 수 있는 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        295.92327880859375,
        387.1199951171875,
        306.9632873535156
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        317.8832702636719,
        488.35638427734375,
        328.92327880859375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 자료 포함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        339.9632873535156,
        222.5996551513672,
        351.0032958984375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        361.92327880859375,
        482.0396728515625,
        372.9632873535156
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 원료물질의 품질 확인 근거자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        383.8832702636719,
        304.6796875,
        394.92327880859375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제조공정의 흐름도를 포함한 제조공정에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.92327880859375,
        383.9996643066406,
        438.9632873535156
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        449.8832702636719,
        488.35638427734375,
        460.92327880859375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.8000030517578,
        471.9632873535156,
        481.5599670410156,
        483.0032958984375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        493.92327880859375,
        488.35638427734375,
        504.9632873535156
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인할 수 있는 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.3199920654297,
        515.8832397460938,
        313.5328063964844,
        526.9232788085938
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        537.9632568359375,
        488.3560485839844,
        549.0032958984375
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상호와 주소)을 확인할 수 있는 자료도 포함한다",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.59999084472656,
        559.9232177734375,
        395.0396728515625,
        570.9632568359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        609.3080444335938,
        282.36395263671875,
        624.0680541992188
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용목적에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        609.3080444335938,
        282.36395263671875,
        624.0680541992188
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        656.1632690429688,
        488.35638427734375,
        667.2033081054688
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.43999481201172,
        678.1232299804688,
        488.3554382324219,
        689.1632690429688
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        327.8399963378906,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 41 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.43999481201172,
        155.76327514648438,
        174.69281005859375,
        166.8032684326172
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 해당제품의 제품설명서(instructions for user)를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        423.0928039550781,
        188.76327514648438
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        249.06808471679688,
        418.56396484375,
        263.9480895996094
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저장방법과 사용기간(유효기간)에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        249.06808471679688,
        418.56396484375,
        263.9480895996094
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        295.92327880859375,
        488.35638427734375,
        306.9632873535156
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등에 대한 시험성적서를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        317.8832702636719,
        303.1966247558594,
        328.92327880859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 구성 제품별로 구분하여 안정성 시험 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        339.9632873535156,
        403.6528015136719,
        351.0032958984375
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        361.92327880859375,
        484.6528015136719,
        372.9632873535156
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.8832702636719,
        488.3560485839844,
        394.92327880859375
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        405.9632873535156,
        174.69281005859375,
        417.0032958984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.92327880859375,
        488.3568420410156,
        438.9632873535156
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "lot 이상의 시험성적서를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        449.8832702636719,
        303.4527893066406,
        460.92327880859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        471.9632873535156,
        484.67999267578125,
        483.0032958984375
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(on-board, reconstitution, open vial/bottle stability) 안정성 자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        493.92327880859375,
        488.3560485839844,
        504.9632873535156
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        515.8832397460938,
        174.69281005859375,
        526.9232788085938
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        537.9632568359375,
        486.1963806152344,
        549.0032958984375
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8. 저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        559.9232177734375,
        488.35638427734375,
        570.9632568359375
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인정범위내의 자료이어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        128.39999389648438,
        581.8832397460938,
        285.5727844238281,
        592.9232788085938
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 42 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        362.4039611816406,
        175.86807250976562
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 성능을 확인하기 위한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        362.4039611816406,
        175.86807250976562
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        207.96328735351562,
        442.17279052734375,
        219.00328063964844
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 분석적 성능시험에 관한 자료(시험성적서)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        225.4832763671875,
        359.6399841308594,
        236.5232696533203
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        243.12327575683594,
        467.2527770996094,
        254.16326904296875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        260.7632751464844,
        484.6796875,
        271.80328369140625
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "범위 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.36000061035156,
        278.28326416015625,
        203.39999389648438,
        289.3232727050781
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 분석적 특이도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        295.92327880859375,
        229.4396514892578,
        306.9632873535156
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정밀도(반복, 재현성 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        313.5632629394531,
        282.1199951171875,
        324.603271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 정확도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        331.0832824707031,
        190.91964721679688,
        342.123291015625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 교차반응",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        348.7232666015625,
        201.95965576171875,
        359.7632751464844
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 임상적 성능시험에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        366.36328125,
        293.6396789550781,
        377.4032897949219
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민족적 차이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        383.8832702636719,
        185.99964904785156,
        394.92327880859375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상적 민감도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        401.5232849121094,
        229.4396514892578,
        412.56329345703125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상적 특이도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        419.16326904296875,
        229.4396514892578,
        430.2032775878906
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        436.68328857421875,
        488.23638916015625,
        447.7232971191406
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 1배치 3회 이상)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        454.3232727050781,
        248.8800048828125,
        465.36328125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 완제품 품질관리 시험에 사용된 표준물질에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        471.9632873535156,
        420.1199951171875,
        483.0032958984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        489.4832763671875,
        450.8399963378906,
        500.5232849121094
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사. 국내·외 허가제품과의 상관성 시험에 대한 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        507.1232604980469,
        421.9960632324219,
        518.1632690429688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        552.0680541992188,
        448.9239501953125,
        566.8280639648438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 의료기기의 취급자 안전에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        552.0680541992188,
        448.9239501953125,
        566.8280639648438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        598.9232177734375,
        484.6793518066406,
        609.9632568359375
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스(HIV),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        620.8832397460938,
        488.35638427734375,
        631.9232788085938
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "C형간염바이러스(HCV),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        620.8832397460938,
        488.35638427734375,
        631.9232788085938
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B형간염바이러스(HBV)가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        620.8832397460938,
        488.35638427734375,
        631.9232788085938
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        642.9632568359375,
        480.7966003417969,
        654.0032958984375
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        664.9232177734375,
        488.35638427734375,
        675.9632568359375
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        686.8832397460938,
        174.69281005859375,
        697.9232788085938
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        327.8399963378906,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 43 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        402.36395263671875,
        175.86807250976562
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이미 허가·인증받은 제품과 비교한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        161.10809326171875,
        402.36395263671875,
        175.86807250976562
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        207.96328735351562,
        484.67999267578125,
        219.00328063964844
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        229.92327880859375,
        488.35662841796875,
        240.96327209472656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        251.88327026367188,
        437.2799987792969,
        262.92327880859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[별지 제3호서식]",
      "font_size": 11.039999961853027,
      "font_name": "DotumChe",
      "bbox": [
        110.5199966430664,
        278.16326904296875,
        209.52000427246094,
        289.2032775878906
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<본질적 동등품목 비교표>",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        213.72000122070312,
        301.0391540527344,
        381.7108459472656,
        319.7134704589844
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        111.47999572753906,
        666.7943725585938,
        481.86029052734375,
        675.7943725585938
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        111.47999572753906,
        681.6743774414062,
        484.67999267578125,
        690.6743774414062
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등하지 않을 경우 ‘아니오’란에 체크한다.",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        134.75999450683594,
        691.6343994140625,
        319.1399841308594,
        700.6343994140625
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        120.95999908447266,
        330.81561279296875,
        464.2799987792969,
        340.9944152832031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비교항목1)",
      "font_size": 5.759999752044678,
      "font_name": "DotumChe",
      "bbox": [
        120.95999908447266,
        330.81561279296875,
        464.2799987792969,
        340.9944152832031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기허가 제품",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        120.95999908447266,
        330.81561279296875,
        464.2799987792969,
        340.9944152832031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신청제품",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        120.95999908447266,
        330.81561279296875,
        464.2799987792969,
        340.9944152832031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동등여부2)",
      "font_size": 5.759999752044678,
      "font_name": "DotumChe",
      "bbox": [
        120.95999908447266,
        330.81561279296875,
        464.2799987792969,
        340.9944152832031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        352.514404296875,
        212.40028381347656,
        367.3944091796875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목명",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        352.514404296875,
        212.40028381347656,
        367.3944091796875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(분류번호 및 등급)",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        159.36000061035156,
        364.1544189453125,
        238.6199951171875,
        373.1544189453125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        382.3944091796875,
        226.01998901367188,
        391.3944091796875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭(모델명)",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        382.3944091796875,
        226.01998901367188,
        391.3944091796875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        404.71441650390625,
        234.95999145507812,
        413.71441650390625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조(수입)업소명",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        404.71441650390625,
        234.95999145507812,
        413.71441650390625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        426.9143981933594,
        234.95999145507812,
        435.9143981933594
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조원 및 소재지",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        426.9143981933594,
        234.95999145507812,
        435.9143981933594
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        449.2344055175781,
        216.95999145507812,
        458.2344055175781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가번호",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        449.2344055175781,
        216.95999145507812,
        458.2344055175781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        466.75439453125,
        468.1199951171875,
        482.2344055175781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용목적",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        466.75439453125,
        468.1199951171875,
        482.2344055175781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        466.75439453125,
        468.1199951171875,
        482.2344055175781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        466.75439453125,
        468.1199951171875,
        482.2344055175781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        479.5943908691406,
        468.1199951171875,
        488.5943908691406
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        479.5943908691406,
        468.1199951171875,
        488.5943908691406
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        492.4344177246094,
        468.1199951171875,
        507.7944030761719
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작용원리",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        492.4344177246094,
        468.1199951171875,
        507.7944030761719
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        492.4344177246094,
        468.1199951171875,
        507.7944030761719
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        492.4344177246094,
        468.1199951171875,
        507.7944030761719
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        505.2744140625,
        468.1199951171875,
        514.2744140625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        505.2744140625,
        468.1199951171875,
        514.2744140625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        518.1143798828125,
        468.1199951171875,
        533.4744262695312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원재료",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        518.1143798828125,
        468.1199951171875,
        533.4744262695312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        518.1143798828125,
        468.1199951171875,
        533.4744262695312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        518.1143798828125,
        468.1199951171875,
        533.4744262695312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        530.8344116210938,
        468.1199951171875,
        539.8344116210938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        530.8344116210938,
        468.1199951171875,
        539.8344116210938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        543.6743774414062,
        468.1199951171875,
        559.1544189453125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        543.6743774414062,
        468.1199951171875,
        559.1544189453125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        543.6743774414062,
        468.1199951171875,
        559.1544189453125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        127.68000030517578,
        543.6743774414062,
        468.1199951171875,
        559.1544189453125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        556.514404296875,
        468.1199951171875,
        565.514404296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        556.514404296875,
        468.1199951171875,
        565.514404296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        569.3544311523438,
        468.1199951171875,
        584.7144165039062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험규격",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        569.3544311523438,
        468.1199951171875,
        584.7144165039062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        569.3544311523438,
        468.1199951171875,
        584.7144165039062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        569.3544311523438,
        468.1199951171875,
        584.7144165039062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        582.1943969726562,
        468.1199951171875,
        591.1943969726562
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        582.1943969726562,
        468.1199951171875,
        591.1943969726562
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        595.034423828125,
        468.1199951171875,
        610.3944091796875
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용방법",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        595.034423828125,
        468.1199951171875,
        610.3944091796875
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        595.034423828125,
        468.1199951171875,
        610.3944091796875
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        125.39999389648438,
        595.034423828125,
        468.1199951171875,
        610.3944091796875
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아니오",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        607.75439453125,
        468.1199951171875,
        616.75439453125
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        409.55999755859375,
        607.75439453125,
        468.1199951171875,
        616.75439453125
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위와 같이 동등함을 확인하였음.",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        119.15999603271484,
        630.0744018554688,
        482.0993957519531,
        650.8344116210938
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년     월      일            신청자            (서명 또는 인)",
      "font_size": 9.0,
      "font_name": "DotumChe",
      "bbox": [
        119.15999603271484,
        630.0744018554688,
        482.0993957519531,
        650.8344116210938
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 44 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        117.47999572753906,
        160.07998657226562,
        365.9997253417969,
        186.43199157714844
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성능시험에 대한 상세사항",
      "font_size": 17.758378982543945,
      "font_name": "H2hdrM",
      "bbox": [
        117.47999572753906,
        160.07998657226562,
        365.9997253417969,
        186.43199157714844
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반요건",
      "font_size": 12.0,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        227.65921020507812,
        158.52000427246094,
        239.65921020507812
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 시험성적서에 다음의 항목이 포함되어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        251.64328002929688,
        361.17279052734375,
        262.68328857421875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 업체명 및 주소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        273.603271484375,
        217.5596466064453,
        284.6432800292969
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        295.68328857421875,
        432.0,
        306.7232971191406
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 시험검사품에 대한 모델명, 상품명",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        317.6432800292969,
        314.2796936035156,
        328.68328857421875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 시험일자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        339.603271484375,
        184.67965698242188,
        350.6432800292969
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 시험성적서 발급일자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        361.68328857421875,
        245.15965270996094,
        372.7232971191406
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 시험성적서에 대한 책임 있는 자의 서명 또는 직인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        383.6432800292969,
        399.0,
        394.68328857421875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 시험기준 및 시험방법. 단, 규격이 없는 경우 이에 대한 설정 사유",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        405.603271484375,
        476.8800048828125,
        416.6432800292969
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 시험검사 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        427.68328857421875,
        212.1599884033203,
        438.7232971191406
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        449.6432800292969,
        488.35638427734375,
        460.68328857421875
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요한 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.75999450683594,
        471.603271484375,
        245.16000366210938,
        482.6432800292969
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. 시험 환경요인(시험결과에 영향을 주는 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        493.68328857421875,
        416.3999938964844,
        504.7232971191406
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        537.603271484375,
        488.2360534667969,
        548.643310546875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항목이 추가로 포함되어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        559.6832275390625,
        290.1327819824219,
        570.7232666015625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 시험시설개요",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        581.6432495117188,
        206.63931274414062,
        592.6832885742188
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        603.6032104492188,
        488.35638427734375,
        614.6432495117188
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요설비 목록 등이 기재되어 있어야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        625.6832275390625,
        343.9200134277344,
        636.7232666015625
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 주요설비",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        647.6432495117188,
        184.67965698242188,
        658.6832885742188
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        669.6032104492188,
        488.35638427734375,
        680.6432495117188
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사항이 기재되고 관련 증빙자료를 함께 제출하여야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        691.6832275390625,
        415.44000244140625,
        702.7232666015625
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 45 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 연구인력구성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        155.76327514648438,
        206.63931274414062,
        166.8032684326172
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        488.3560485839844,
        188.76327514648438
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보가 기재되어야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        199.80328369140625,
        250.5599822998047,
        210.84327697753906
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 시험자의 연구경력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        221.76327514648438,
        234.11964416503906,
        232.8032684326172
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        243.72328186035156,
        488.35638427734375,
        254.76327514648438
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        265.80328369140625,
        484.67999267578125,
        276.8432922363281
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건에 적합한 시험자가 시험하였는지에 대한 자료를 제출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        287.7632751464844,
        426.4800109863281,
        298.80328369140625
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        337.1480712890625,
        329.0439758300781,
        351.9080810546875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석적 성능시험에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        337.1480712890625,
        329.0439758300781,
        351.9080810546875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        397.939208984375,
        484.67999267578125,
        409.939208984375
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "범위 등)",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        128.87998962402344,
        421.939208984375,
        180.87608337402344,
        433.939208984375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        125.5199966430664,
        445.92327880859375,
        488.35638427734375,
        456.9632873535156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한 경우, 해당 설정 값에 대한 근거를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        467.8832702636719,
        393.9163818359375,
        478.92327880859375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 최소검출한계(Limit of detection, LoD)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        511.9232482910156,
        349.63677978515625,
        522.9632568359375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        533.8832397460938,
        201.95965576171875,
        544.9232788085938
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. 호환되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        555.9632568359375,
        488.3564453125,
        567.0032958984375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.95999145507812,
        577.9232177734375,
        488.3560485839844,
        588.9632568359375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체를 낮은 농도 검체로 이용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.95999145507812,
        599.8832397460938,
        387.0928039550781,
        610.9232788085938
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        621.9632568359375,
        488.35638427734375,
        633.0032958984375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체는 최소 각 4개씩 준비할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        643.9232177734375,
        406.87628173828125,
        654.9632568359375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        665.8832397460938,
        484.67999267578125,
        676.9232788085938
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.51998901367188,
        687.9632568359375,
        237.2128143310547,
        699.0032958984375
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 46 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        155.76327514648438,
        484.6803283691406,
        166.8032684326172
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과의 동등성을 먼저 확인해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        199.80328369140625,
        352.5328063964844,
        210.84327697753906
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        221.76327514648438,
        488.35638427734375,
        232.8032684326172
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        243.72328186035156,
        484.67999267578125,
        254.76327514648438
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        265.80328369140625,
        488.35638427734375,
        276.8432922363281
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        287.7632751464844,
        221.01280212402344,
        298.80328369140625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        309.7232666015625,
        205.6360626220703,
        320.7632751464844
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        331.80328369140625,
        484.6796875,
        342.8432922363281
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.55999755859375,
        353.7632751464844,
        479.0127868652344,
        364.80328369140625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        375.7232666015625,
        488.35638427734375,
        386.7632751464844
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법을 요약 제출할 수 있다. 아래의 참고방법을 참조할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        397.80328369140625,
        488.35638427734375,
        408.8432922363281
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        419.7632751464844,
        202.6366424560547,
        430.80328369140625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다. 검출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        441.7232666015625,
        484.67999267578125,
        452.7632751464844
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        463.80328369140625,
        484.6796875,
        474.8432922363281
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        485.7632751464844,
        466.53277587890625,
        496.80328369140625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 참고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        507.7232971191406,
        194.5196533203125,
        518.7633056640625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        529.80322265625,
        488.3556823730469,
        540.84326171875
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(limit of detection), LOQ (limit of quantitation)를 확립하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        551.7632446289062,
        484.6796875,
        562.8032836914062
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        573.7232666015625,
        484.6796875,
        584.7633056640625
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(classical approach, precision profile approach, probit",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        595.80322265625,
        488.3569030761719,
        606.84326171875
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "approach)이 있다. 심혈관표지자의 LoD 측정을 위해서는 전",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        617.7632446289062,
        484.67999267578125,
        628.8032836914062
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통적인 방법 또는 정밀도 profile 방법을 이용한다. 전통적인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        639.7232666015625,
        488.3560485839844,
        650.7633056640625
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법(classical approach)은 blank 검체와 검출한계 근처의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        661.80322265625,
        488.3560485839844,
        672.84326171875
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "low level 검체의 반복 측정 수가 각각 최소 60회가 될 것을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        683.7632446289062,
        488.35638427734375,
        694.8032836914062
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 47 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.47999572753906,
        155.76327514648438,
        218.73280334472656,
        166.8032684326172
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        201.95965576171875,
        188.76327514648438
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        199.80328369140625,
        488.3560485839844,
        210.84327697753906
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종류, 검체수, 반복회수, 계산법을 함께 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.1199951171875,
        221.76327514648438,
        427.036376953125,
        232.8032684326172
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 최소정량한계(Limit of quantitation, LoQ)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        265.80328369140625,
        362.4767761230469,
        276.8432922363281
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        134.52000427246094,
        287.7632751464844,
        201.47964477539062,
        298.80328369140625
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. 호환되는 기질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        305.4032897949219,
        484.6796875,
        316.44329833984375
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        327.36328125,
        488.35638427734375,
        338.4032897949219
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "낮은 농도 검체로 이용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        349.3232727050781,
        343.17279052734375,
        360.36328125
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        371.4032897949219,
        488.35638427734375,
        382.44329833984375
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        393.36328125,
        216.69281005859375,
        404.4032897949219
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        415.3232727050781,
        484.67999267578125,
        426.36328125
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        437.4032897949219,
        484.67999267578125,
        448.44329833984375
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등성을 먼저 확인해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        459.36328125,
        310.17279052734375,
        470.4032897949219
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        481.3232727050781,
        205.6360626220703,
        492.36328125
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        503.4032897949219,
        484.6796875,
        514.4432983398438
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.55999755859375,
        525.3632202148438,
        479.0127868652344,
        536.4032592773438
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        547.3232421875,
        488.35638427734375,
        558.36328125
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법을 요약 제출할 수 있다. 아래의 참고방법을 참조할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        569.4032592773438,
        488.35638427734375,
        580.4432983398438
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        591.3632202148438,
        202.6366424560547,
        602.4032592773438
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        613.3232421875,
        488.3557434082031,
        624.36328125
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최소 농도를 제시한다. 결과에 영향을 줄 수 있는 여러 변수를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.87998962402344,
        635.4032592773438,
        488.2360534667969,
        646.4432983398438
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.87998962402344,
        657.3632202148438,
        488.35638427734375,
        668.4032592773438
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2번 이상 반복검사를 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.87998962402344,
        679.3232421875,
        331.8927917480469,
        690.36328125
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 48 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 53,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 참고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        177.72328186035156,
        197.39999389648438,
        188.76327514648438
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        160.55999755859375,
        199.80328369140625,
        487.9958190917969,
        210.84327697753906
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LoQ를 설정하는 방법을 제시하고 있다. Troponin I의 정확도 목",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        221.850341796875,
        484.5599670410156,
        231.8103485107422
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        241.8903350830078,
        484.71435546875,
        251.850341796875
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        261.8103332519531,
        484.67950439453125,
        271.77032470703125
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 산출하여 profile 그래프를 그리고 model fit process 진행하여",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        281.850341796875,
        487.9958190917969,
        291.8103332519531
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식을 도출한다. 도출된 식에 CV 10%를 대입하여 농도를 산출하",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        301.8903503417969,
        484.5599670410156,
        311.850341796875
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면 이 농도가 LoQ가 된다. CV 20%를 도출된 식에 대입하여 산출",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        321.8103332519531,
        484.5599670410156,
        331.77032470703125
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된 농도도 참고한다.",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        177.0,
        341.850341796875,
        269.9082336425781,
        351.8103332519531
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        381.7232666015625,
        201.95965576171875,
        392.7632751464844
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        403.80328369140625,
        493.7557067871094,
        414.8432922363281
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.27999877929688,
        425.7632751464844,
        488.35662841796875,
        436.80328369140625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계산법을 함께 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.27999877929688,
        447.7232666015625,
        301.1566162109375,
        458.7632751464844
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 판정기준치(cut-off value)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        491.7632751464844,
        282.360595703125,
        502.80328369140625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        513.7232666015625,
        201.95965576171875,
        524.7633056640625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        535.80322265625,
        488.35638427734375,
        546.84326171875
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의해 판정기준치의 적절성을 평가할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        557.7632446289062,
        398.1327819824219,
        568.8032836914062
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        579.7232666015625,
        488.3573913574219,
        590.7633056640625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "value)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        601.80322265625,
        488.35638427734375,
        612.84326171875
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 거칠 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        623.7632446289062,
        302.83660888671875,
        634.8032836914062
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        656.7632446289062,
        487.9963073730469,
        667.8032836914062
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        175.44000244140625,
        678.8103637695312,
        487.9958190917969,
        688.7703247070312
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 49 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 54,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        175.44000244140625,
        155.850341796875,
        466.3382873535156,
        165.8103485107422
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        185.76327514648438,
        201.95965576171875,
        196.8032684326172
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 판정기준치(농도)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        207.84327697753906,
        260.5199890136719,
        218.88327026367188
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 판정기준치에서의 임상적 민감도 및 특이도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        229.80328369140625,
        392.5199890136719,
        240.84327697753906
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 측정범위(Measurement range)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        273.7232666015625,
        302.39990234375,
        284.7632751464844
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        295.80328369140625,
        201.95965576171875,
        306.8432922363281
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        317.7632751464844,
        488.3565673828125,
        328.80328369140625
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        339.7232666015625,
        488.35638427734375,
        350.7632751464844
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        361.80328369140625,
        484.67999267578125,
        372.8432922363281
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "칠 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        383.7632751464844,
        264.93280029296875,
        394.80328369140625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        405.7232666015625,
        488.35638427734375,
        416.7632751464844
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.55999755859375,
        427.80328369140625,
        470.9727783203125,
        438.8432922363281
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        449.7632751464844,
        488.3560485839844,
        460.80328369140625
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.239990234375,
        471.7232666015625,
        287.372802734375,
        482.7632751464844
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        493.80328369140625,
        201.95965576171875,
        504.8432922363281
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        515.7632446289062,
        488.35638427734375,
        526.8032836914062
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.1199951171875,
        537.7232666015625,
        199.41281127929688,
        548.7633056640625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        559.80322265625,
        488.3560485839844,
        570.84326171875
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알고 있는 물질의 사용을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        581.7632446289062,
        353.852783203125,
        592.8032836914062
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        603.7232666015625,
        488.35638427734375,
        614.7633056640625
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도가 알려진 고농도의 임상검체를 이용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.67999267578125,
        625.80322265625,
        406.7727966308594,
        636.84326171875
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        647.7632446289062,
        488.3557434082031,
        658.8032836914062
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.51998901367188,
        669.7232666015625,
        488.35662841796875,
        680.7633056640625
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장, 전혈 등)를 사용하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.51998901367188,
        691.80322265625,
        350.372802734375,
        702.84326171875
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 50 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        201.95965576171875,
        188.76327514648438
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        199.80328369140625,
        488.35540771484375,
        210.84327697753906
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체를 단계 희석하여 시험물질을 제조한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.63999938964844,
        221.76327514648438,
        400.7566223144531,
        232.8032684326172
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        243.72328186035156,
        488.3557434082031,
        254.76327514648438
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        265.80328369140625,
        488.35638427734375,
        276.8432922363281
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        287.7632751464844,
        484.67999267578125,
        298.80328369140625
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 농도가 확립된 검체를 이용한다. 희석은 고농도와 저농도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        309.7232666015625,
        488.3560485839844,
        320.7632751464844
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        331.80328369140625,
        484.67999267578125,
        342.8432922363281
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        353.7632751464844,
        488.3560485839844,
        364.80328369140625
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수도 있다. 측정은 각 농도별로 2-4회 반복 측정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        375.7232666015625,
        452.372802734375,
        386.7632751464844
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        419.7632751464844,
        201.95965576171875,
        430.80328369140625
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 직선성 범위의 농도 구간을 제시하도록 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        441.7232666015625,
        423.0928039550781,
        452.7632751464844
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        463.80328369140625,
        484.6795654296875,
        474.8432922363281
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.95999145507812,
        485.7632751464844,
        257.9728088378906,
        496.80328369140625
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 분석적 특이도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        529.8192138671875,
        204.95999145507812,
        541.8192138671875
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        563.7632446289062,
        189.23965454101562,
        574.8032836914062
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다. 사용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        585.7232666015625,
        488.35638427734375,
        596.7633056640625
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        607.80322265625,
        479.61279296875,
        618.84326171875
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        629.7632446289062,
        484.67999267578125,
        640.8032836914062
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        651.7232666015625,
        488.3558349609375,
        662.7633056640625
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        673.80322265625,
        430.29278564453125,
        684.84326171875
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 검체 처치에 첨가된 물질(보존제, 안정제 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        695.7632446289062,
        401.15997314453125,
        706.8032836914062
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 51 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        155.76327514648438,
        488.35662841796875,
        166.8032684326172
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "rheumatoid factors, human antimouse 항체, 및 heterophile",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        177.72328186035156,
        488.3577575683594,
        188.76327514648438
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        199.80328369140625,
        213.47999572753906,
        210.84327697753906
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 7. 간섭물질 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        221.76327514648438,
        208.07998657226562,
        232.8032684326172
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        404.6432800292969,
        484.6796875,
        415.68328857421875
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 같은 4가지 형태의 세트를 준비한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        426.7232666015625,
        359.4927978515625,
        437.7632751464844
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        448.80328369140625,
        458.5199890136719,
        459.8432922363281
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        470.7632751464844,
        440.15966796875,
        481.80328369140625
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        492.7232666015625,
        458.5199890136719,
        503.7632751464844
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        514.80322265625,
        440.15966796875,
        525.84326171875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        547.6832275390625,
        192.9160614013672,
        558.7232666015625
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험할 간섭물질의 목록을 작성한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        569.6432495117188,
        342.5727844238281,
        580.6832885742188
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        591.7232666015625,
        488.35638427734375,
        602.7633056640625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.27999877929688,
        613.6832275390625,
        488.3560485839844,
        624.7232666015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.27999877929688,
        635.6432495117188,
        469.41278076171875,
        646.6832885742188
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        657.7232666015625,
        488.35638427734375,
        668.7633056640625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상이 되도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.75999450683594,
        679.6832275390625,
        260.9727783203125,
        690.7232666015625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간섭물질",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.36000061035156,
        246.09034729003906,
        396.9657287597656,
        256.05035400390625
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.36000061035156,
        246.09034729003906,
        396.9657287597656,
        256.05035400390625
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외인성 물질",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        276.09033203125,
        166.2052764892578,
        286.0503234863281
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일반의약품, 고혈압, 협심증, 심부전 등",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        295.44000244140625,
        266.0103454589844,
        478.3967590332031,
        275.9703369140625
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심장질환 치료제 등",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        295.44000244140625,
        286.05035400390625,
        385.3199768066406,
        296.0103454589844
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검체 처리 과정에 통상적으로 첨가될 수",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        301.65032958984375,
        289.2388000488281,
        311.6103210449219
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 물질",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        319.65032958984375,
        160.35838317871094,
        329.6103210449219
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보존제, 안정제 등",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        295.44000244140625,
        310.65032958984375,
        371.8857116699219,
        320.6103210449219
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "드물지 않게 볼 수 있는 특이 검체에",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        341.4903259277344,
        275.4388122558594,
        351.4503173828125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포함된 물질",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        359.4903259277344,
        166.80526733398438,
        369.4503173828125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈색소, 지질(콜레스테롤,",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        295.44000244140625,
        332.4903259277344,
        408.399169921875,
        342.4503173828125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "트리글리세리드), 빌리루빈, 이상 단백질",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        295.44000244140625,
        350.4903259277344,
        474.9988708496094,
        360.4503173828125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 펩타이드 등",
      "font_size": 9.719964981079102,
      "font_name": "Haansoft Batang",
      "bbox": [
        295.44000244140625,
        368.4903259277344,
        361.80572509765625,
        378.4503173828125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 52 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        155.76327514648438,
        488.35650634765625,
        166.8032684326172
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용범위(dmax)를 결정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.9199981689453,
        177.72328186035156,
        296.1327819824219,
        189.52252197265625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 각 검체를 3회 이상 반복 검사한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        199.80328369140625,
        337.8927917480469,
        210.84327697753906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        221.76327514648438,
        488.35638427734375,
        232.8032684326172
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과를 비교한다. 정량검사의 경우는 바이어스를 구한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.1999969482422,
        243.72328186035156,
        446.9727783203125,
        254.76327514648438
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        265.80328369140625,
        488.35638427734375,
        276.8432922363281
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.72000122070312,
        287.7632751464844,
        488.3560485839844,
        298.80328369140625
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도에 따른 영향을 보기 위해 용량-반응검사(dose-response",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.72000122070312,
        309.7232666015625,
        488.3583679199219,
        320.7632751464844
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "test)를 실시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.72000122070312,
        331.80328369140625,
        248.61280822753906,
        342.8432922363281
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        364.80328369140625,
        189.23965454101562,
        375.8432922363281
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        386.7632751464844,
        488.35638427734375,
        397.80328369140625
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.0399932861328,
        408.7232666015625,
        488.3557434082031,
        419.7632751464844
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.0399932861328,
        430.80328369140625,
        488.35638427734375,
        442.6025085449219
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.0399932861328,
        452.7632751464844,
        205.29281616210938,
        463.80328369140625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        474.7232666015625,
        488.3560485839844,
        485.7632751464844
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차이를 기술한다. 대상측정물질을 함유하지 않고 간섭 가능한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        496.80328369140625,
        488.3560485839844,
        507.8432922363281
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        518.7632446289062,
        484.6796875,
        529.8032836914062
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        540.7232666015625,
        479.61279296875,
        551.7633056640625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        562.80322265625,
        484.67999267578125,
        573.84326171875
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        584.7632446289062,
        479.7327880859375,
        595.8032836914062
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 정밀도 (반복성, 재현성 등)",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        628.8192138671875,
        280.44000244140625,
        640.8192138671875
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        664.80322265625,
        189.23965454101562,
        675.84326171875
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        686.7632446289062,
        488.35638427734375,
        697.8032836914062
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 53 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        155.76327514648438,
        243.2128143310547,
        166.8032684326172
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        488.35638427734375,
        188.76327514648438
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현성으로 구분하여 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        199.80328369140625,
        314.7327880859375,
        210.84327697753906
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        221.76327514648438,
        488.35638427734375,
        232.8032684326172
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시기를 거친 다음 평가를 수행하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        243.72328186035156,
        375.0928039550781,
        254.76327514648438
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        276.7232666015625,
        189.23965454101562,
        287.7632751464844
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 3개 이상의 농도(컷오프 근처의 검체 포함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        298.80328369140625,
        378.719970703125,
        309.8432922363281
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 환자검체 또는 정도관리검체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        320.7632751464844,
        300.9596862792969,
        331.80328369140625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 권장 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        353.7632751464844,
        220.3960723876953,
        364.80328369140625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        375.7232666015625,
        484.6796875,
        386.7632751464844
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "토콜을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        397.80328369140625,
        243.2128143310547,
        408.8432922363281
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 반복성(repeatability, within laboratory precision) 평가는 3가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        419.7632751464844,
        484.67999267578125,
        430.80328369140625
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        441.7232666015625,
        488.35614013671875,
        452.7632751464844
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "triplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        463.80328369140625,
        484.67999267578125,
        474.8432922363281
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(20일 이상 권장) 시행하기를 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        485.7632751464844,
        364.1566162109375,
        496.80328369140625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        507.7232971191406,
        488.3568115234375,
        518.7633056640625
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "precision)를 평가한다. 로트 간 정밀도 평가는 별도의 평가로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        529.80322265625,
        488.3560485839844,
        540.84326171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        551.7632446289062,
        474.0927734375,
        562.8032836914062
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        573.7232666015625,
        488.35638427734375,
        584.7633056640625
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        595.80322265625,
        488.35614013671875,
        606.84326171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "more) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        617.7632446289062,
        488.3560485839844,
        628.8032836914062
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        639.7232666015625,
        232.1728057861328,
        650.7633056640625
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        672.7232666015625,
        189.23965454101562,
        683.7633056640625
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        694.80322265625,
        488.3568115234375,
        705.84326171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 54 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "날짜 간 정밀도(between-day), 검사실 내 정밀도(within-",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        155.76327514648438,
        488.3566589355469,
        166.8032684326172
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "laboratory) 자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        177.72328186035156,
        305.9727783203125,
        188.76327514648438
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        199.80328369140625,
        488.3560485839844,
        210.84327697753906
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과를 합한 반복성 결과와 검사기관간(between-site) 결과를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        221.76327514648438,
        488.3560485839844,
        232.8032684326172
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        243.72328186035156,
        204.69281005859375,
        254.76327514648438
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        265.80328369140625,
        484.67999267578125,
        276.8432922363281
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이계수를 산출하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        287.7632751464844,
        303.6927795410156,
        298.80328369140625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 해당하는 경우 다음의 사항들을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        309.7232666015625,
        370.05279541015625,
        320.7632751464844
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 검사를 시행한 검체의 농도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        331.80328369140625,
        309.9596862792969,
        342.8432922363281
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 각각의 농도에서의 반복정밀도 표준편차",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        353.7632751464844,
        375.9596862792969,
        364.80328369140625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 각각의 농도에서의 검사실내 정밀도 표준편차",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        375.7232666015625,
        403.4396667480469,
        386.7632751464844
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        397.80328369140625,
        441.9596862792969,
        408.8432922363281
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 실제 검사일수, 검사실의 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        419.7632751464844,
        313.20001220703125,
        430.80328369140625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 총 run의 수(해당되는 경우 제시)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        441.7232666015625,
        342.9599914550781,
        452.7632751464844
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사) 총 관찰치의 수 : optional",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        463.80328369140625,
        304.0529479980469,
        474.8432922363281
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아) 시약 lot의 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        485.7632751464844,
        240.83998107910156,
        496.80328369140625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자) Calibration 시행 횟수와 calibrator lot의 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        507.7232971191406,
        392.8800048828125,
        518.7633056640625
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 정확도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        551.7792358398438,
        162.95999145507812,
        563.7792358398438
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. WHO international reference standard 물질, NIST standard",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        587.7632446289062,
        488.3559265136719,
        598.8032836914062
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "reference material 등 국제표준품 등 특성이 명시되어 있는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        149.39999389648438,
        609.7232666015625,
        484.67999267578125,
        620.7633056640625
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        149.39999389648438,
        631.80322265625,
        484.6363830566406,
        642.84326171875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회 반복 측정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        149.39999389648438,
        653.7632446289062,
        244.27664184570312,
        664.8032836914062
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        686.7632446289062,
        484.67999267578125,
        697.8032836914062
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 55 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이어스)를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        155.76327514648438,
        251.476318359375,
        166.8032684326172
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        188.76327514648438,
        471.93280029296875,
        199.8032684326172
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        221.76327514648438,
        484.67999267578125,
        232.8032684326172
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        243.72328186035156,
        178.77281188964844,
        254.76327514648438
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        276.7232666015625,
        470.4927978515625,
        287.7632751464844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 교차반응",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        320.7792053222656,
        174.95999145507812,
        332.7792053222656
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        354.7232666015625,
        189.23965454101562,
        365.7632751464844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        376.80328369140625,
        484.67999267578125,
        387.8432922363281
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.95999145507812,
        398.7632751464844,
        469.53277587890625,
        409.80328369140625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        431.7632751464844,
        189.23965454101562,
        442.80328369140625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 다양한 교차 반응 가능 물질이 포함된 검체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        453.7232666015625,
        377.8800048828125,
        464.7632751464844
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        475.80328369140625,
        488.35638427734375,
        486.8432922363281
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 물질의 예는 다음과 같다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        497.7632751464844,
        299.61279296875,
        508.80328369140625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        519.7232666015625,
        166.4399871826172,
        530.7633056640625
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.9199981689453,
        541.80322265625,
        484.6796875,
        552.84326171875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.9199981689453,
        563.7632446289062,
        370.8320007324219,
        574.8032836914062
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        607.80322265625,
        189.23965454101562,
        618.84326171875
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        629.7632446289062,
        484.67999267578125,
        640.8032836914062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        651.7232666015625,
        484.67999267578125,
        662.7633056640625
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        673.80322265625,
        484.6796875,
        684.84326171875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        695.7632446289062,
        484.67999267578125,
        706.8032836914062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 56 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 61,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로토콜을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        155.76327514648438,
        265.17279052734375,
        166.8032684326172
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        484.6796875,
        188.76327514648438
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.39999389648438,
        199.80328369140625,
        488.35662841796875,
        210.84327697753906
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "C1T1C2T2C3T3C4T4C5T5).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.39999389648438,
        221.76327514648438,
        308.85333251953125,
        232.8032684326172
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        243.72328186035156,
        488.3560485839844,
        254.76327514648438
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        265.80328369140625,
        204.69281005859375,
        276.8432922363281
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        309.7232666015625,
        189.23965454101562,
        320.7632751464844
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        331.80328369140625,
        484.67999267578125,
        342.8432922363281
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        353.7632751464844,
        232.1728057861328,
        364.80328369140625
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        375.7232666015625,
        419.4927978515625,
        386.7632751464844
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        447.0680847167969,
        329.0439758300781,
        461.9480895996094
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상적 성능시험에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        447.0680847167969,
        329.0439758300781,
        461.9480895996094
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 임상적 성능시험에 관한 자료의 작성 시 준수사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        488.8832702636719,
        377.2796630859375,
        499.92327880859375
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        510.9632873535156,
        484.6796875,
        522.0032958984375
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된 검체를 대상으로 시험한 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        532.9232177734375,
        366.0928039550781,
        543.9632568359375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        554.8832397460938,
        488.35638427734375,
        565.9232788085938
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        576.9632568359375,
        488.3560485839844,
        588.0032958984375
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상으로 한 자료를 제출하는 것을 원칙으로 한다. 이는 인종 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        598.9232177734375,
        488.2360534667969,
        609.9632568359375
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지역에 따라 유병률이 다를 수 있기 때문이다. 민족적 요인의 차이가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        620.8832397460938,
        488.35638427734375,
        631.9232788085938
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        642.9632568359375,
        488.3561706542969,
        654.0032958984375
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        664.9232177734375,
        484.67999267578125,
        675.9632568359375
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 한 자료를 추가 제출할 것을 요구 할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        686.8832397460938,
        399.0928039550781,
        697.9232788085938
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 57 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 62,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        155.76327514648438,
        488.3557434082031,
        166.8032684326172
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행한 결과를 포함하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        177.72328186035156,
        300.2127990722656,
        188.76327514648438
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        199.80328369140625,
        484.67999267578125,
        210.84327697753906
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        221.76327514648438,
        488.3560485839844,
        232.8032684326172
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자세한 실험프로토콜을 제공해야한다. 질환이 있음을 규명한 참고표",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        243.72328186035156,
        484.6796875,
        254.76327514648438
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        265.80328369140625,
        488.35638427734375,
        276.8432922363281
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        287.7632751464844,
        488.35638427734375,
        298.80328369140625
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        309.7232666015625,
        488.2360534667969,
        320.7632751464844
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수도 있다. 종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        331.80328369140625,
        482.1327819824219,
        342.8432922363281
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표7. 참고 : 진단기준",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        353.7632751464844,
        227.27964782714844,
        364.80328369140625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Third universal definition of myocardial infarction.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        375.7232666015625,
        389.3563537597656,
        386.7632751464844
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Eur Heart J 2012;33:2551-67.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        397.80328369140625,
        284.85699462890625,
        408.8432922363281
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "급성 심근경색증의 기준",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        419.7632751464844,
        241.5599822998047,
        430.80328369140625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        439.80328369140625,
        471.8399963378906,
        450.8432922363281
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다. 이러한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        457.4432678222656,
        475.3951721191406,
        468.4832763671875
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        475.0832824707031,
        475.3957214355469,
        486.123291015625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진단을 충족한다:",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        492.603271484375,
        209.59640502929688,
        503.6432800292969
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "• 적어도 한 번은 99 백분위수 참고구간 상한(upper reference",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        510.2432556152344,
        475.395263671875,
        521.2832641601562
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        527.8832397460938,
        475.51629638671875,
        538.9232788085938
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        545.4032592773438,
        475.39605712890625,
        556.4432983398438
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동반:",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        563.043212890625,
        149.1164093017578,
        574.083251953125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü 허혈 증상.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        580.23583984375,
        216.2128143310547,
        592.4887084960938
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        597.755859375,
        475.5167541503906,
        610.0087280273438
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ST–T)의 유의한 변화 또는 새로운 left bundle branch block",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        615.84326171875,
        475.39666748046875,
        626.88330078125
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(LBBB).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        633.4832153320312,
        195.57064819335938,
        644.5232543945312
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ü ECG 상에서 pathological Q waves의 발생.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        650.5558471679688,
        382.17279052734375,
        662.8087158203125
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ü 새로운 loss of viable myocardium이나 새로운 regional",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        668.1958618164062,
        475.51776123046875,
        680.44873046875
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "wall motion abnormality의 영상 상의 증거.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        686.2832641601562,
        374.61279296875,
        697.3233032226562
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 58 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 63,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        600.6032104492188,
        484.67999267578125,
        611.6432495117188
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        622.563232421875,
        413.2527770996094,
        633.603271484375
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        670.80322265625,
        488.3562316894531,
        681.84326171875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제출하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        136.0800018310547,
        692.7632446289062,
        251.85281372070312,
        703.8032836914062
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.51998901367188,
        158.07586669921875,
        457.6528015136719,
        170.32875061035156
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "• 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        176.1632843017578,
        471.8399963378906,
        187.20327758789062
      ],
      "page_num": 63,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        193.80328369140625,
        471.8396911621094,
        204.84327697753906
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        211.32327270507812,
        475.39605712890625,
        222.36326599121094
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "death).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        228.96327209472656,
        159.6924591064453,
        240.00326538085938
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "• Percutaneous coronary intervention (PCI) related MI는 정상 기",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        246.603271484375,
        471.8399963378906,
        257.6432800292969
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        264.123291015625,
        475.5169982910156,
        275.1632995605469
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        281.7632751464844,
        471.8399963378906,
        292.80328369140625
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        299.4032897949219,
        475.51605224609375,
        310.44329833984375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정의된다. 추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        316.92327880859375,
        471.8399963378906,
        327.9632873535156
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        334.5632629394531,
        471.8396911621094,
        345.603271484375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        352.2032775878906,
        471.7200012207031,
        363.2432861328125
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로운 regional wall motion abnormality가 영상으로 입증되는 것 중",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        369.7232666015625,
        475.39605712890625,
        380.7632751464844
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어느 하나가 필요하다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        387.36328125,
        236.61280822753906,
        398.4032897949219
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "• stent thrombosis associated with MI는 심근허혈의 조건에서 심",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        405.0032653808594,
        471.8399963378906,
        416.04327392578125
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        422.5232849121094,
        475.5163879394531,
        433.56329345703125
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        440.16326904296875,
        443.7327880859375,
        451.2032775878906
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "• 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        457.80328369140625,
        475.5176086425781,
        468.8432922363281
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        475.3232727050781,
        475.516845703125,
        486.36328125
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99th percentile URL)된 경우로 임의로 정의된다. 추가로, (i) 새로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        492.9632873535156,
        471.8399963378906,
        504.0032958984375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        510.6033020019531,
        475.51629638671875,
        521.643310546875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        528.1232299804688,
        471.8399963378906,
        539.1632690429688
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로운 loss of viable myocardium이나 새로운 regional wall motion",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        545.7632446289062,
        475.3964538574219,
        556.8032836914062
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "abnormality의 영상 상의 증거.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.47999572753906,
        563.4032592773438,
        279.6927795410156,
        574.4432983398438
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 59 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 64,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 4등급 체외진단용 의료기기의 시험",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        159.96328735351562,
        312.4803771972656,
        171.00328063964844
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        186.12327575683594,
        484.56036376953125,
        197.16326904296875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.83999633789062,
        208.20327758789062,
        488.197021484375,
        219.24327087402344
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.83999633789062,
        230.1632843017578,
        488.0769348144531,
        241.20327758789062
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질에 들어가는 침습적인 시험. 다만, 정맥채혈 등 피험자에게 중대한",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.83999633789062,
        252.123291015625,
        488.07733154296875,
        263.1632995605469
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.83999633789062,
        274.2032775878906,
        449.6399841308594,
        285.2432861328125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        296.16326904296875,
        484.56036376953125,
        307.2032775878906
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기로 임상적 성능시험의 결과를 확인할 수 없는 시험",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.83999633789062,
        318.123291015625,
        396.3599853515625,
        329.1632995605469
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        340.2032775878906,
        488.19769287109375,
        351.2432861328125
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.0399932861328,
        362.16326904296875,
        484.55999755859375,
        373.2032775878906
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료기기의 시험에 한함)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.0399932861328,
        384.123291015625,
        248.63999938964844,
        395.1632995605469
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        406.2032775878906,
        484.5607604980469,
        417.2432861328125
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기관의 임상시험계획승인을 받고 실시해야함)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        151.9199981689453,
        428.16326904296875,
        372.239990234375,
        439.2032775878906
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        465.36328125,
        488.235595703125,
        476.4032897949219
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        487.3232727050781,
        483.4527893066406,
        498.36328125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        513.603271484375,
        488.197021484375,
        524.643310546875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함)",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.239990234375,
        535.563232421875,
        463.91998291015625,
        546.603271484375
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.5232543945312,
        488.07745361328125,
        568.5632934570312
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리기준에 의하여 실시한 자료",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        136.8000030517578,
        579.603271484375,
        289.8003845214844,
        590.643310546875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        601.563232421875,
        492.636474609375,
        612.603271484375
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        623.5232543945312,
        422.40081787109375,
        634.5632934570312
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        645.6032104492188,
        433.4410095214844,
        656.6432495117188
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        678.6032104492188,
        488.1963806152344,
        689.6432495117188
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 60 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.0,
        155.76327514648438,
        488.196533203125,
        166.8032684326172
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것으로 인정되는 시험자료",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.0,
        177.72328186035156,
        254.27980041503906,
        188.76327514648438
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        199.80328369140625,
        488.1969299316406,
        210.84327697753906
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하나에 해당하는 자료",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        136.8000030517578,
        221.76327514648438,
        246.75730895996094,
        232.8032684326172
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        258.9632873535156,
        484.6805114746094,
        270.0032958984375
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 제출하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.47999572753906,
        280.92327880859375,
        233.97280883789062,
        291.9632873535156
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        311.4032897949219,
        454.5596618652344,
        322.44329833984375
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        341.7632751464844,
        484.56036376953125,
        352.80328369140625
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.87998962402344,
        363.7232666015625,
        488.1965637207031,
        374.7632751464844
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 이에 준하는 것으로 인정되는 시험자료",
      "font_size": 10.797332763671875,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.87998962402344,
        385.80328369140625,
        362.7596130371094,
        396.8432922363281
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        416.16326904296875,
        488.3562316894531,
        427.2032775878906
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.3199920654297,
        438.1232604980469,
        488.3565673828125,
        449.16326904296875
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.3199920654297,
        460.2032775878906,
        488.35614013671875,
        471.2432861328125
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 이를 공증한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.3199920654297,
        482.16326904296875,
        256.67974853515625,
        493.2032775878906
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 과학논문인용색인(Science Citation Index)에 등재된 전문학회지에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        512.5232543945312,
        488.3557434082031,
        523.5632934570312
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재된 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        534.603271484375,
        206.03965759277344,
        545.643310546875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 임상적 민감도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        582.7391967773438,
        204.95999145507812,
        594.7391967773438
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 실험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        617.5232543945312,
        189.23965454101562,
        628.5632934570312
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        639.4832153320312,
        461.71661376953125,
        650.5232543945312
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        661.4432373046875,
        488.3560485839844,
        672.4832763671875
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        683.5232543945312,
        208.39663696289062,
        694.5632934570312
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 61 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        150.47999572753906,
        155.76327514648438,
        188.99964904785156,
        166.8032684326172
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        177.72328186035156,
        484.67999267578125,
        188.76327514648438
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료 또는 양성임을 증명하는 임상자료 등. 평가대상 제품의 결과와 관",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        161.51998901367188,
        199.89035034179688,
        484.5599670410156,
        209.85035705566406
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계없는 기준이여야 함",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        161.51998901367188,
        219.8103485107422,
        261.47998046875,
        229.77035522460938
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        239.76327514648438,
        472.63629150390625,
        250.8032684326172
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        261.7232666015625,
        484.67999267578125,
        272.7632751464844
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        283.80328369140625,
        488.3560485839844,
        294.8432922363281
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 통계적으로 의미 있는 검체수를 산정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        305.7632751464844,
        400.75628662109375,
        316.80328369140625
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        327.7232666015625,
        487.99676513671875,
        338.7632751464844
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상을 포함하여 평가하기를 권장한다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        165.47999572753906,
        349.8903503417969,
        351.7967529296875,
        359.850341796875
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        369.7232666015625,
        488.3560485839844,
        380.7632751464844
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        391.80328369140625,
        446.61279296875,
        402.8432922363281
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 권장 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        424.80328369140625,
        216.7196502685547,
        435.8432922363281
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        446.7632751464844,
        484.67999267578125,
        457.80328369140625
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석법 등에 대한 자세한 실험프로토콜을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.9199981689453,
        468.7232666015625,
        423.1966247558594,
        479.7632751464844
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        490.80328369140625,
        484.67999267578125,
        501.8432922363281
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.239990234375,
        512.7632446289062,
        438.2127990722656,
        523.8032836914062
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        534.7232666015625,
        478.99627685546875,
        545.7633056640625
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        556.80322265625,
        488.35638427734375,
        567.84326171875
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.239990234375,
        578.7632446289062,
        459.3327941894531,
        589.8032836914062
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        600.7232666015625,
        458.0127868652344,
        611.7633056640625
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        633.7232666015625,
        192.9160614013672,
        644.7633056640625
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상적 민감도 및 95% 신뢰구간을 제시한다. 임상적 민감도란",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        655.80322265625,
        488.3561706542969,
        666.84326171875
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        677.7632446289062,
        484.6796875,
        688.8032836914062
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 62 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 67,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준치 이상)으로 나오는 환자의 비율이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        155.76327514648438,
        372.93280029296875,
        166.8032684326172
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        177.72328186035156,
        488.35638427734375,
        188.76327514648438
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 제시한다. 유병률을 구한 경우는 유병률도 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        199.80328369140625,
        449.852783203125,
        210.84327697753906
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        221.76327514648438,
        488.3560485839844,
        232.8032684326172
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.59999084472656,
        243.72328186035156,
        206.85281372070312,
        254.76327514648438
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        265.80328369140625,
        484.67999267578125,
        276.8432922363281
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.9199981689453,
        285.603271484375,
        488.35638427734375,
        296.6432800292969
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.9199981689453,
        305.4032897949219,
        488.35662841796875,
        316.44329833984375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성예측도 제시를 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.9199981689453,
        325.2032775878906,
        301.05279541015625,
        336.2432861328125
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 임상적 특이도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        366.9792175292969,
        204.95999145507812,
        378.9792175292969
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        402.0032653808594,
        189.23965454101562,
        413.04327392578125
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        423.9632873535156,
        488.3560485839844,
        435.0032958984375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        445.92327880859375,
        208.39663696289062,
        456.9632873535156
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        468.0032653808594,
        488.3568420410156,
        479.04327392578125
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가슴통증으로 응급실 내원한 환자, 입원환자 등).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        489.9632873535156,
        409.5166320800781,
        501.0032958984375
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        511.9232482910156,
        488.3560485839844,
        522.9632568359375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100개 이상 평가할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        166.44000244140625,
        534.0032348632812,
        346.3966064453125,
        545.0432739257812
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        567.0032348632812,
        189.23965454101562,
        578.0432739257812
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        588.9632568359375,
        484.67999267578125,
        600.0032958984375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자의 비율이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        610.9232177734375,
        232.1728057861328,
        621.9632568359375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        633.0032348632812,
        484.67999267578125,
        644.0432739257812
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사가 이용될 인구집단을 대상으로 산출되어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        654.9632568359375,
        419.1327819824219,
        666.0032958984375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        676.9232177734375,
        488.3560485839844,
        687.9632568359375
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 63 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진양성 유무를 확인토록 한다. 진양성인 검체는 특이도 분석에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        155.76327514648438,
        484.6796875,
        166.8032684326172
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 제외한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        177.72328186035156,
        224.8363037109375,
        188.76327514648438
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        199.80328369140625,
        484.67999267578125,
        210.84327697753906
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석법 등을 미리 확립한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        221.76327514648438,
        298.17279052734375,
        232.8032684326172
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        243.72328186035156,
        488.35638427734375,
        254.76327514648438
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        265.80328369140625,
        461.2366027832031,
        276.8432922363281
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        287.7632751464844,
        464.8363037109375,
        298.80328369140625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        309.7232666015625,
        478.99627685546875,
        320.7632751464844
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        353.7632751464844,
        189.23965454101562,
        364.80328369140625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상적 특이도 및 95% 신뢰구간을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        375.7232666015625,
        391.0362854003906,
        386.7632751464844
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        397.80328369140625,
        484.6796875,
        408.8432922363281
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서면 인정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        419.7632751464844,
        265.17279052734375,
        430.80328369140625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        441.7232666015625,
        488.35638427734375,
        452.7632751464844
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        463.80328369140625,
        232.1728057861328,
        474.8432922363281
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        485.7632751464844,
        488.3560485839844,
        496.80328369140625
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        507.7232971191406,
        208.39663696289062,
        518.7633056640625
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        579.0680541992188,
        482.2839660644531,
        593.9480590820312
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        579.0680541992188,
        482.2839660644531,
        593.9480590820312
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        625.9232177734375,
        488.3572082519531,
        636.9632568359375
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        647.8832397460938,
        429.6766052246094,
        658.9232788085938
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        691.9232177734375,
        488.3560485839844,
        702.9632568359375
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 64 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        155.76327514648438,
        488.3560485839844,
        166.8032684326172
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중복될 경우 이를 생략한다).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        177.72328186035156,
        273.6927795410156,
        188.76327514648438
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        221.76327514648438,
        484.67999267578125,
        232.8032684326172
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "밀도 등)을 설정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        243.72328186035156,
        235.1728057861328,
        254.76327514648438
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        315.0680847167969,
        482.2839660644531,
        329.9480895996094
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        315.0680847167969,
        482.2839660644531,
        329.9480895996094
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        361.92327880859375,
        488.2360534667969,
        372.9632873535156
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        383.8832702636719,
        178.39663696289062,
        394.92327880859375
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 표준품 또는 기타 사용된 표준물질의 확인서(certificate)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        405.9632873535156,
        437.11798095703125,
        417.0032958984375
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 출처 및 근거 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        427.92327880859375,
        242.3563995361328,
        438.9632873535156
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        471.9632873535156,
        456.3327941894531,
        483.0032958984375
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        493.92327880859375,
        484.67999267578125,
        504.9632873535156
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 분석 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        515.8832397460938,
        212.11605834960938,
        526.9232788085938
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 표준물질 관리방법 및 관리기록서(정도관리 포함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        537.9632568359375,
        401.8363952636719,
        549.0032958984375
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        587.22802734375,
        460.9193420410156,
        601.5951538085938
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료",
      "font_size": 12.839439392089844,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        587.22802734375,
        460.9193420410156,
        601.5951538085938
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        634.083251953125,
        488.2362976074219,
        645.123291015625
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. 이는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        656.1632690429688,
        488.3559265136719,
        667.2033081054688
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        678.1232299804688,
        484.67999267578125,
        689.1632690429688
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        368.8800048828125,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 65 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체의 사용 가능성 및 제한점 등을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        155.76327514648438,
        355.41278076171875,
        166.8032684326172
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 검체 취급 및 보관조건에 대한 시험 결과를 제시한다. 이는 제시된 시간,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        199.80328369140625,
        488.2362976074219,
        210.84327697753906
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        221.76327514648438,
        488.2360534667969,
        232.8032684326172
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대해 동일한 검사 결과를 보임을 입증해야 한다. 이 시험은 제시된 구간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        243.72328186035156,
        484.67999267578125,
        254.76327514648438
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        265.80328369140625,
        484.67999267578125,
        276.8432922363281
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        287.7632751464844,
        456.7962951660156,
        298.80328369140625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        331.80328369140625,
        488.2362976074219,
        342.8432922363281
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용기준, 결과 등을 요약하여 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.36000061035156,
        353.7632751464844,
        330.6927795410156,
        364.80328369140625
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        425.10809326171875,
        222.48397827148438,
        439.86810302734375
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상관성 평가",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        425.10809326171875,
        222.48397827148438,
        439.86810302734375
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        471.9632873535156,
        169.67965698242188,
        483.0032958984375
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        493.92327880859375,
        488.3560485839844,
        504.9632873535156
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교시험성적서를 포함하여야 한다. 다만, 측정원리 및 측정항목이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        515.8832397460938,
        488.3560485839844,
        526.9232788085938
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        537.9632568359375,
        451.05279541015625,
        549.0032958984375
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        559.9232177734375,
        488.3560485839844,
        570.9632568359375
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        581.8832397460938,
        488.35638427734375,
        592.9232788085938
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. 분석적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        603.9632568359375,
        488.35626220703125,
        615.0032958984375
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        625.9232177734375,
        484.67999267578125,
        636.9632568359375
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관성의 추가 자료로 제시할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        647.8832397460938,
        330.3327941894531,
        658.9232788085938
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        691.9232177734375,
        169.67965698242188,
        702.9632568359375
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 66 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        155.76327514648438,
        484.6796875,
        166.8032684326172
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.52000427246094,
        177.72328186035156,
        175.39630126953125,
        188.76327514648438
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        199.80328369140625,
        488.3560485839844,
        210.84327697753906
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        221.76327514648438,
        429.3327941894531,
        232.8032684326172
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        243.72328186035156,
        459.9162902832031,
        254.76327514648438
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        265.80328369140625,
        488.3560485839844,
        276.8432922363281
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100개 이상의 검체를 시험하도록 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.63999938964844,
        287.7632751464844,
        367.05279541015625,
        298.80328369140625
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 권장 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        331.80328369140625,
        197.15965270996094,
        342.8432922363281
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        353.7632751464844,
        488.2360534667969,
        364.80328369140625
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        375.7232666015625,
        484.67999267578125,
        386.7632751464844
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        397.80328369140625,
        170.73280334472656,
        408.8432922363281
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        419.7632751464844,
        451.6528015136719,
        430.80328369140625
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 비교 제품은 각 제품의 사용방법에 따라서 시험한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        441.7232666015625,
        412.29278564453125,
        452.7632751464844
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        463.80328369140625,
        451.6528015136719,
        474.8432922363281
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        485.7632751464844,
        484.67999267578125,
        496.80328369140625
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고 이에 대한 자료를 제공하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        507.7232971191406,
        356.23663330078125,
        518.7633056640625
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        551.7632446289062,
        169.67965698242188,
        562.8032836914062
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        573.7232666015625,
        472.7727966308594,
        584.7633056640625
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        595.80322265625,
        488.35638427734375,
        606.84326171875
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의학적 결정치(medical decision point)에서의 바이어스를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        617.7632446289062,
        486.7962951660156,
        628.8032836914062
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        639.7232666015625,
        484.67999267578125,
        650.7633056640625
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.87998962402344,
        661.80322265625,
        474.5727844238281,
        672.84326171875
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        683.7632446289062,
        484.41278076171875,
        694.8032836914062
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅷ. 참고문헌",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        434.3999938964844,
        117.55441284179688,
        481.44561767578125,
        126.55441284179688
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 67 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅷ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        117.23999786376953,
        160.07998657226562,
        238.55999755859375,
        186.43199157714844
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고문헌",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        117.23999786376953,
        160.07998657226562,
        238.55999755859375,
        186.43199157714844
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. CLSI. Evaluation of Stability of In Vitro Diagnostic Reagents;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        225.72328186035156,
        488.3562927246094,
        236.76327514648438
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Approved Guideline. CLSI document EP25-A. Wayne, PA: Cinical",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        247.68328857421875,
        488.3565368652344,
        258.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and Laboratory Standard Institute; 2009",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        269.7632751464844,
        339.1971435546875,
        280.80328369140625
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Precision",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Performance",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Quantitative",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.68328857421875,
        488.3594665527344,
        324.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Measurement Methods; Approved Guideline - Second Edition.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        335.7632751464844,
        488.3570556640625,
        346.80328369140625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI document EP5-A2. Wayne, PA: Cinical and Laboratory",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        357.7232666015625,
        488.35595703125,
        368.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Standard Institute; 2004",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        379.68328857421875,
        255.3171844482422,
        390.7232971191406
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "User",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Protocol",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Qualitative",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Test",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        423.7232666015625,
        488.3559265136719,
        434.7632751464844
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Performance;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Approved",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Second",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Edition.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        445.68328857421875,
        488.3562927246094,
        456.7232971191406
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "document EP12-A2. Wayne, PA: Cinical and Laboratory Standard",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        467.7632751464844,
        488.3573913574219,
        478.80328369140625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Institute; 2008",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        489.7232666015625,
        205.3971710205078,
        500.7632751464844
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. CLSI. Protocols for Determination of Limits of Detection and",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        533.7632446289062,
        488.3565368652344,
        544.8032836914062
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Limits of Quantitation; Approved Guideline. CLSI document EP17-A.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        555.7232666015625,
        488.35577392578125,
        566.7633056640625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Wayne, PA: Cinical and Laboratory Standard Institute; 2004",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        577.6832275390625,
        436.9954528808594,
        588.7232666015625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. CLSI. Evaluation of the Linearity of Quantitative Measurement",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        621.7232666015625,
        488.3557434082031,
        632.7633056640625
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Procedures: A Statistical Approach; Approved Guideline. CLSI",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        643.6832275390625,
        488.3562927246094,
        654.7232666015625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "document EP6-A. Wayne, PA: Cinical and Laboratory Standard",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        665.7632446289062,
        488.3573913574219,
        676.8032836914062
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Institute; 2003",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        687.7232666015625,
        205.3971710205078,
        698.7633056640625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 68 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. CLSI. Method Comparison and Bias Estimation Using Patient",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.84327697753906,
        488.3560485839844,
        188.88327026367188
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Samples; Approved Guideline - Second Edition (Interim Revision).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        199.80328369140625,
        488.3569030761719,
        210.84327697753906
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI document EP9-A2-IR. Wayne, PA: Cinical and Laboratory",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        221.88328552246094,
        488.3570556640625,
        232.92327880859375
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Standard Institute; 2010",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        243.84327697753906,
        255.3171844482422,
        254.88327026367188
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. CLSI. Interference Testing in Clinical Chemistry; Approved",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        287.8832702636719,
        488.3577575683594,
        298.92327880859375
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline - Second Edition. CLSI document EP7-A. Wayne, PA:",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        309.8432922363281,
        488.35614013671875,
        320.88330078125
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cinical and Laboratory Standard Institute; 2005",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        331.80328369140625,
        386.59716796875,
        342.8432922363281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        375.84326171875,
        488.3551940917969,
        386.8832702636719
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Device Studies -Frequently Asked Questions, 2010",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        397.80328369140625,
        413.1172790527344,
        408.8432922363281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. Guidance for industry and FDA staff/ Format for traditional and",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        441.84326171875,
        488.3565368652344,
        452.8832702636719
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "abbreviated 510(k)s, 2005.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        463.80328369140625,
        278.9740295410156,
        474.8432922363281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. Linnet, K and Kondratovich, M. A Partly Noparametric Approach",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        507.8432922363281,
        488.3565368652344,
        518.88330078125
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for Determination of the Llimit of Detection. Clinical Chemistry",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        529.80322265625,
        488.3568115234375,
        540.84326171875
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004:50;732-740",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        551.8832397460938,
        228.92047119140625,
        562.9232788085938
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.8399963378906,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 69 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 74,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅸ",
      "font_size": 21.959999084472656,
      "font_name": "T10",
      "bbox": [
        116.39999389648438,
        160.67999267578125,
        202.0800018310547,
        187.03199768066406
      ],
      "page_num": 74,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부록",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        116.39999389648438,
        160.67999267578125,
        202.0800018310547,
        187.03199768066406
      ],
      "page_num": 74,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 심장성 트로포닌 표준물질 현황",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        248.89920043945312,
        300.9599914550781,
        260.8992004394531
      ],
      "page_num": 74,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. NIST SRM 2921 Human Cardiac Troponin Complex",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        272.8832702636719,
        417.67669677734375,
        283.92327880859375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 심장성 트로포닌 제품 국내 제조 및 수입 현황",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        318.9792175292969,
        384.9599914550781,
        330.9792175292969
      ],
      "page_num": 74,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수입업체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.16000366210938,
        345.7232666015625,
        416.5199890136719,
        356.7632751464844
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가일자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.16000366210938,
        345.7232666015625,
        416.5199890136719,
        356.7632751464844
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시약명",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.16000366210938,
        345.7232666015625,
        416.5199890136719,
        356.7632751464844
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지멘스(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        362.4032897949219,
        493.5,
        373.44329833984375
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2012-12-26",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        362.4032897949219,
        493.5,
        373.44329833984375
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IMMULITE 1000 Turbo Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        362.4032897949219,
        493.5,
        373.44329833984375
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지멘스(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        381.84326171875,
        475.5,
        392.8832702636719
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2012-12-21",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        381.84326171875,
        475.5,
        392.8832702636719
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE 2000 Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        381.84326171875,
        475.5,
        392.8832702636719
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한국로슈진단(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        410.16326904296875,
        460.6802062988281,
        421.2032775878906
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2012-12-18",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        410.16326904296875,
        460.6802062988281,
        421.2032775878906
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Elecsys Troponin T hs",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        410.16326904296875,
        460.6802062988281,
        421.2032775878906
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한국로슈진단(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        447.2432861328125,
        450.05999755859375,
        458.2832946777344
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2012-12-18",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        447.2432861328125,
        450.05999755859375,
        458.2832946777344
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Elecsys Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        447.2432861328125,
        450.05999755859375,
        458.2832946777344
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한국로슈진단(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        484.3232727050781,
        468.7203674316406,
        495.36328125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2012-12-18",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        484.3232727050781,
        468.7203674316406,
        495.36328125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Elecsys Troponin I STAT",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        484.3232727050781,
        468.7203674316406,
        495.36328125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한국로슈진단(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        521.4032592773438,
        479.2803649902344,
        532.4432983398438
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2012-12-11",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        521.4032592773438,
        479.2803649902344,
        532.4432983398438
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Elecsys Troponin T hs STAT",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.19999694824219,
        521.4032592773438,
        479.2803649902344,
        532.4432983398438
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지멘스(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        549.603271484375,
        469.7987060546875,
        560.643310546875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2012-11-22",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        549.603271484375,
        469.7987060546875,
        560.643310546875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ADVIA Centaur TnI-Ultra",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        549.603271484375,
        469.7987060546875,
        560.643310546875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "삼성전자(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        569.1632690429688,
        501.4199523925781,
        580.2033081054688
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2013-05-23",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        569.1632690429688,
        501.4199523925781,
        580.2033081054688
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Samsung LABGEO IB Troponin I Test",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        569.1632690429688,
        501.4199523925781,
        580.2033081054688
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영인과학(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        588.603271484375,
        474.5399169921875,
        599.643310546875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2013-01-11",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        588.603271484375,
        474.5399169921875,
        599.643310546875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "AQT90 FLEX TnT Test Kit",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        588.603271484375,
        474.5399169921875,
        599.643310546875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영인과학(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        608.043212890625,
        472.4999084472656,
        619.083251953125
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2013-01-11",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        608.043212890625,
        472.4999084472656,
        619.083251953125
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "AQT90 FLEX TnI Test Kit",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        608.043212890625,
        472.4999084472656,
        619.083251953125
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한국애보트(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.5999984741211,
        627.6032104492188,
        474.30010986328125,
        638.6432495117188
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2012-12-21",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.5999984741211,
        627.6032104492188,
        474.30010986328125,
        638.6432495117188
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Architect STAT Troponin-I",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.5999984741211,
        627.6032104492188,
        474.30010986328125,
        638.6432495117188
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아산제약(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        647.043212890625,
        445.4999084472656,
        658.083251953125
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2012-11-09",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        647.043212890625,
        445.4999084472656,
        658.083251953125
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PATHFAST cTnI",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        647.043212890625,
        445.4999084472656,
        658.083251953125
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지멘스(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        666.4832153320312,
        475.5,
        677.5232543945312
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2012-12-21",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        666.4832153320312,
        475.5,
        677.5232543945312
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IMMULITE 1000 Troponin I",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        131.63999938964844,
        666.4832153320312,
        475.5,
        677.5232543945312
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 70 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 75,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.7792205810547,
        480.9599914550781,
        167.7792205810547
      ],
      "page_num": 75,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DOCUMEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        113.87999725341797,
        182.61033630371094,
        165.630126953125,
        192.57034301757812
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        136.0800018310547,
        198.69033813476562,
        146.8368682861328,
        208.6503448486328
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NUMBER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.7199935913086,
        214.6503448486328,
        161.91363525390625,
        224.6103515625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DEVICE NAME",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        198.69033813476562,
        401.9141845703125,
        208.6503448486328
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COMPANY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        198.69033813476562,
        401.9141845703125,
        208.6503448486328
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DATE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        190.6503448486328,
        466.6361083984375,
        200.6103515625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "APPROVED",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        206.61033630371094,
        488.9714050292969,
        216.57034301757812
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K000784",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        243.45034790039062,
        340.2045593261719,
        253.4103546142578
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "THE CARDIAC READER SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        243.45034790039062,
        340.2045593261719,
        253.4103546142578
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        227.49034118652344,
        388.99700927734375,
        237.45034790039062
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        243.45034790039062,
        424.8758850097656,
        253.4103546142578
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        259.53033447265625,
        380.6585388183594,
        269.4903259277344
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 18 2000",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        243.45034790039062,
        499.4873962402344,
        253.4103546142578
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K010201",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        272.6103515625,
        497.8074035644531,
        282.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER ADVIA IMS SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        272.6103515625,
        497.8074035644531,
        282.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        272.6103515625,
        497.8074035644531,
        282.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 29 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        272.6103515625,
        497.8074035644531,
        282.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K010313",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        293.850341796875,
        161.0883331298828,
        303.8103332519531
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIMENSION CTNI FLEX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        285.8103332519531,
        297.1971740722656,
        295.77032470703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "REAGENT CARTRIDGE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        301.8903503417969,
        288.15350341796875,
        311.850341796875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        285.8103332519531,
        382.75701904296875,
        295.77032470703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        301.8903503417969,
        422.89825439453125,
        311.850341796875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 20 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        293.850341796875,
        496.60736083984375,
        303.8103332519531
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K010429",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        338.6103515625,
        161.0883331298828,
        348.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCUTNI AND ACCUTNI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        314.6103515625,
        303.6759338378906,
        324.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATORS ON THE ACCESS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        330.6903381347656,
        341.11785888671875,
        340.65032958984375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOASSAY SYSTEM #",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        346.65032958984375,
        316.39703369140625,
        356.6103210449219
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "33340 33345",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        362.6103515625,
        237.16781616210938,
        372.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BECKMAN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        330.6903381347656,
        406.1571044921875,
        340.65032958984375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COULTER INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        346.65032958984375,
        425.2987365722656,
        356.6103210449219
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 05 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        338.6103515625,
        494.9273681640625,
        348.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K010562",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        383.4903259277344,
        275.0445251464844,
        393.4503173828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ALPHA DX SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        383.4903259277344,
        275.0445251464844,
        393.4503173828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FIRST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        375.4503479003906,
        384.7968444824219,
        385.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICAL INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        391.53033447265625,
        424.0982666015625,
        401.4903259277344
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 13 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        383.4903259277344,
        497.8074035644531,
        393.4503173828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K012233",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        412.29034423828125,
        161.0883331298828,
        422.2503356933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS CS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        404.2503356933594,
        311.4763488769531,
        414.2103271484375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        420.3303527832031,
        240.15345764160156,
        430.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        404.2503356933594,
        382.75701904296875,
        414.2103271484375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        420.3303527832031,
        422.89825439453125,
        430.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 11 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        412.29034423828125,
        496.48736572265625,
        422.2503356933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K012820",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        433.17034912109375,
        317.716796875,
        451.0503234863281
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AIA-PACK CTNI 2ND-GEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        433.17034912109375,
        317.716796875,
        451.0503234863281
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        449.1303405761719,
        207.99266052246094,
        459.09033203125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TOSOH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        433.17034912109375,
        389.8356018066406,
        443.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        449.1303405761719,
        416.53826904296875,
        459.09033203125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        441.09033203125,
        496.9673767089844,
        451.0503234863281
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K013062",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        477.9303283691406,
        161.0883331298828,
        487.89031982421875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOCHECK HUMAN CARDIAC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        461.9703369140625,
        324.9162292480469,
        471.9303283691406
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN-I IMMUNOASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        477.9303283691406,
        325.99713134765625,
        487.89031982421875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        493.8903503417969,
        225.5096893310547,
        503.850341796875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOCHECK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        469.8903503417969,
        406.99774169921875,
        479.850341796875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        485.9703369140625,
        371.8987121582031,
        495.9303283691406
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 08 2002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        477.9303283691406,
        494.4473571777344,
        487.89031982421875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K014024",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        514.7703857421875,
        161.0883331298828,
        524.7303466796875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODIFICATION TO ALPHA DX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        506.7303161621094,
        332.71636962890625,
        516.6903076171875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        522.8103637695312,
        216.2445068359375,
        532.7703247070312
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FIRST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        506.7303161621094,
        384.7968444824219,
        516.6903076171875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICAL INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        522.8103637695312,
        424.0982666015625,
        532.7703247070312
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 18 2001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        514.7703857421875,
        496.9673767089844,
        524.7303466796875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K014105",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        551.6103515625,
        303.4949645996094,
        561.5703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL'S TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        551.6103515625,
        303.4949645996094,
        561.5703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        535.5303955078125,
        408.1968994140625,
        545.4903564453125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        551.6103515625,
        424.8758850097656,
        561.5703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        567.5703735351562,
        371.8987121582031,
        577.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 01 2002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        551.6103515625,
        496.48736572265625,
        561.5703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K020662",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        604.4103393554688,
        161.0883331298828,
        614.3703002929688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODIFICATION TO VITROS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        580.4103393554688,
        317.2355651855469,
        590.3703002929688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNODIAGNOSTIC PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        596.370361328125,
        345.55706787109375,
        606.330322265625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I REAGENT PACK/",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        612.4503784179688,
        330.19647216796875,
        622.4103393554688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATORS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        628.4103393554688,
        246.34544372558594,
        638.3703002929688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO-CLINI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        588.4503784179688,
        423.2532958984375,
        598.4103393554688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        604.4103393554688,
        374.83685302734375,
        614.3703002929688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        620.370361328125,
        421.544189453125,
        630.330322265625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 12 2002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        604.4103393554688,
        496.60736083984375,
        614.3703002929688
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K020950",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        657.2103881835938,
        339.30029296875,
        667.1703491210938
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL'S 2 IN 1 (TNI-MYO)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        657.2103881835938,
        339.30029296875,
        667.1703491210938
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        641.2503662109375,
        408.1968994140625,
        651.2103271484375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        657.2103881835938,
        424.8758850097656,
        667.1703491210938
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        673.1703491210938,
        371.8987121582031,
        683.1303100585938
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "May 24 2002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        657.2103881835938,
        499.4873962402344,
        667.1703491210938
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K021814",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        690.4503784179688,
        496.48736572265625,
        700.4103393554688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ACCUTNI AND ACCUTNI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        690.4503784179688,
        496.48736572265625,
        700.4103393554688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BECKMAN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        690.4503784179688,
        496.48736572265625,
        700.4103393554688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Sep 27 2002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        690.4503784179688,
        496.48736572265625,
        700.4103393554688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.8399963378906,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 71 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CALIBRATORS ON THE ACCESS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        158.6103515625,
        341.11785888671875,
        168.5703582763672
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IMMUNOASSAY SYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        174.69033813476562,
        309.31768798828125,
        184.6503448486328
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL #33340 33345",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        190.6503448486328,
        286.7277526855469,
        200.6103515625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COULTER INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        174.69033813476562,
        425.2987365722656,
        184.6503448486328
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K022946",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        219.45034790039062,
        161.0883331298828,
        229.4103546142578
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LIFESIGN MI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        203.49034118652344,
        242.59669494628906,
        213.45034790039062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MYOGLOBIN/TROPONIN I RAPID",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        219.45034790039062,
        340.156005859375,
        229.4103546142578
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        235.5303497314453,
        201.7505645751953,
        245.4903564453125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRINCETON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        203.49034118652344,
        414.0773010253906,
        213.45034790039062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMEDITECH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        219.45034790039062,
        427.0362548828125,
        229.4103546142578
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        235.5303497314453,
        380.6585388183594,
        245.4903564453125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 08 2002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        219.45034790039062,
        495.287353515625,
        229.4103546142578
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K023505",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        256.29034423828125,
        161.0883331298828,
        266.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VBL SERUM TROPONIN I TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        248.25033569335938,
        338.4775085449219,
        258.2103271484375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL 1001",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        264.3303527832031,
        238.36741638183594,
        274.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VANCOUVER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        248.25033569335938,
        418.2763977050781,
        258.2103271484375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOTECH LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        264.3303527832031,
        425.7776794433594,
        274.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 31 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        256.29034423828125,
        497.8074035644531,
        266.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K024193",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        301.17034912109375,
        161.0883331298828,
        311.1303405761719
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODIFICATION TO VITROS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        277.17034912109375,
        317.2355651855469,
        287.1303405761719
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNDODIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        293.1303405761719,
        292.63568115234375,
        303.09033203125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        309.09033203125,
        299.3563537597656,
        319.0503234863281
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "REAGENT PACK/CALIBRATORS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        325.17034912109375,
        332.3837585449219,
        335.1303405761719
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO-CLINI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        285.09033203125,
        423.2532958984375,
        295.0503234863281
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        301.17034912109375,
        374.83685302734375,
        311.1303405761719
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        317.1303405761719,
        421.544189453125,
        327.09033203125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 21 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        301.17034912109375,
        496.48736572265625,
        311.1303405761719
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K030057",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        353.9703369140625,
        161.0883331298828,
        363.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL CARDIAC STATUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        337.8903503417969,
        329.3561706542969,
        347.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CK-MB/MYOGLOBIN/TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        353.9703369140625,
        345.55682373046875,
        363.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3-IN-1 TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        369.9303283691406,
        246.27005004882812,
        379.89031982421875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        337.8903503417969,
        408.1968994140625,
        347.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        353.9703369140625,
        424.8758850097656,
        363.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        369.9303283691406,
        371.8987121582031,
        379.89031982421875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 19 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        353.9703369140625,
        497.8074035644531,
        363.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K030950",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        390.8103332519531,
        161.0883331298828,
        400.77032470703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIDAS TROPONIN I (TNI)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        382.77032470703125,
        309.7961120605469,
        392.7303161621094
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL 30 445",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        398.7303466796875,
        249.16702270507812,
        408.6903381347656
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMERIEUX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        382.77032470703125,
        419.1170959472656,
        392.7303161621094
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        390.8103332519531,
        494.9273681640625,
        408.6903381347656
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 16 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        390.8103332519531,
        494.9273681640625,
        408.6903381347656
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K031031",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        435.5703430175781,
        161.0883331298828,
        445.53033447265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITROS IMMUNODIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        411.5703430175781,
        328.8755798339844,
        421.53033447265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        427.53033447265625,
        299.3563537597656,
        437.4903259277344
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "REAGENT PACK AND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        443.6103515625,
        286.8760986328125,
        453.5703430175781
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATORS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        459.5703430175781,
        246.34544372558594,
        469.53033447265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO-CLINI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        411.5703430175781,
        423.2532958984375,
        421.53033447265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        427.53033447265625,
        374.83685302734375,
        437.4903259277344
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        443.6103515625,
        424.8758850097656,
        453.5703430175781
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        459.5703430175781,
        371.8987121582031,
        469.53033447265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 29 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        435.5703430175781,
        496.48736572265625,
        445.53033447265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K031739",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        480.4503479003906,
        161.0883331298828,
        490.41033935546875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "I-STAT CARDIAC TROPONIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        472.41033935546875,
        327.3153381347656,
        482.3703308105469
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(CTNI) TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        488.3703308105469,
        242.19004821777344,
        498.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "I-STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        472.41033935546875,
        395.23590087890625,
        482.3703308105469
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORPORATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        480.4503479003906,
        496.48736572265625,
        498.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 02 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        480.4503479003906,
        496.48736572265625,
        498.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K031990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        509.2503356933594,
        306.4361572265625,
        527.1303100585938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS PRECICONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        509.2503356933594,
        306.4361572265625,
        527.1303100585938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        525.2103881835938,
        239.6699981689453,
        535.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        501.2103271484375,
        388.99700927734375,
        511.1703186035156
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        517.1703491210938,
        424.8758850097656,
        527.1303100585938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        533.2503662109375,
        380.6585388183594,
        543.2103271484375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 20 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        517.1703491210938,
        497.8074035644531,
        527.1303100585938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K033487",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        562.0503540039062,
        161.0883331298828,
        572.0103149414062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS CS ACUTE CARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        546.0903930664062,
        317.7174377441406,
        556.0503540039062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I TESTPAK MODEL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        562.0503540039062,
        334.7562255859375,
        572.0103149414062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CCTNI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        578.0103759765625,
        205.93475341796875,
        587.9703369140625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        554.0103759765625,
        382.75701904296875,
        563.9703369140625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        570.0903930664062,
        422.89825439453125,
        580.0503540039062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 24 2003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        562.0503540039062,
        496.9673767089844,
        572.0103149414062
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K033745",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        606.8103637695312,
        309.752685546875,
        616.7703247070312
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RAMP TROPONIN I ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        606.8103637695312,
        309.752685546875,
        616.7703247070312
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RESPONSE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        590.850341796875,
        407.7178039550781,
        600.810302734375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMEDICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        606.8103637695312,
        418.99652099609375,
        616.7703247070312
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        622.890380859375,
        380.6585388183594,
        632.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 17 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        606.8103637695312,
        499.4873962402344,
        616.7703247070312
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K034055",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        651.6903686523438,
        161.0883331298828,
        661.6503295898438
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE 2500 CK-MB 2500",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        635.7303466796875,
        331.0377502441406,
        645.6903076171875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MYOGLOBIN 2500 STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        651.6903686523438,
        300.5561218261719,
        661.6503295898438
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        667.650390625,
        235.93499755859375,
        677.6103515625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        635.7303466796875,
        418.6359558105469,
        645.6903076171875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        651.6903686523438,
        409.3970642089844,
        661.6503295898438
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        667.650390625,
        380.6585388183594,
        677.6103515625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 21 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        651.6903686523438,
        494.4473571777344,
        661.6503295898438
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K040733",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        687.5703735351562,
        499.4873962402344,
        697.5303344726562
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ELECSYS TROPONIN T STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        687.5703735351562,
        499.4873962402344,
        697.5303344726562
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        687.5703735351562,
        499.4873962402344,
        697.5303344726562
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "May 17 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        687.5703735351562,
        499.4873962402344,
        697.5303344726562
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 72 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        166.6503448486328,
        201.7505645751953,
        176.6103515625
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        158.6103515625,
        424.8758850097656,
        168.5703582763672
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        174.69033813476562,
        380.6585388183594,
        184.6503448486328
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K041192",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        187.5303497314453,
        341.9556579589844,
        205.4103546142578
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ARCHITECT STAT TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        187.5303497314453,
        341.9556579589844,
        205.4103546142578
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        203.49034118652344,
        252.15328979492188,
        213.45034790039062
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FISHER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        187.5303497314453,
        391.5168762207031,
        197.4903564453125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        203.49034118652344,
        421.544189453125,
        213.45034790039062
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 12 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        195.45034790039062,
        497.8074035644531,
        205.4103546142578
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K041194",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        240.33033752441406,
        161.0883331298828,
        250.29034423828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT ARCHITECT STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        216.33033752441406,
        319.51611328125,
        226.29034423828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I LIQUID ASSAYED",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        232.29034423828125,
        332.718017578125,
        242.25035095214844
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC MARKER CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        248.25033569335938,
        326.1176452636719,
        258.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LEVEL L M AND H",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        264.3303527832031,
        271.7099914550781,
        274.29034423828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        224.25033569335938,
        401.4778747558594,
        234.21034240722656
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANALYSIS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        240.33033752441406,
        406.1580810546875,
        250.29034423828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        256.29034423828125,
        425.6587219238281,
        266.2503356933594
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 16 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        240.33033752441406,
        497.8074035644531,
        250.29034423828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K041619",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        293.1303405761719,
        161.0883331298828,
        303.09033203125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIO CHECK WHOLE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        277.17034912109375,
        276.7968444824219,
        287.1303405761719
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BLOOD/PLASMA/SERMON MODEL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        293.1303405761719,
        345.4362487792969,
        303.09033203125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "#801116",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        309.09033203125,
        217.12794494628906,
        319.0503234863281
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOCHECK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        285.09033203125,
        406.99774169921875,
        295.0503234863281
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        301.17034912109375,
        371.8987121582031,
        311.1303405761719
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 17 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        293.1303405761719,
        496.9673767089844,
        303.09033203125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K041811",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        329.9703369140625,
        331.8756408691406,
        347.850341796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT AXSYM TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        329.9703369140625,
        331.8756408691406,
        347.850341796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ADV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        345.9303283691406,
        195.45095825195312,
        355.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        321.9303283691406,
        397.3972473144531,
        331.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        337.8903503417969,
        424.47259521484375,
        347.850341796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        353.9703369140625,
        357.3450012207031,
        363.9303283691406
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 10 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        337.8903503417969,
        496.48736572265625,
        347.850341796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K042227",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        382.77032470703125,
        161.0883331298828,
        392.7303161621094
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INSTANT-VIEW TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        374.7303466796875,
        327.31683349609375,
        384.6903381347656
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        390.8103332519531,
        201.7505645751953,
        400.77032470703125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ALFA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        366.8103332519531,
        381.9164123535156,
        376.77032470703125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        382.77032470703125,
        413.2366638183594,
        392.7303161621094
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DESIGNS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        398.7303466796875,
        421.5782470703125,
        408.6903381347656
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 19 2004",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        382.77032470703125,
        497.8074035644531,
        392.7303161621094
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K050644",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        427.53033447265625,
        161.0883331298828,
        437.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VANCOUVER BIOTECH HUMAN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        411.5703430175781,
        336.0762023925781,
        421.53033447265625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        427.53033447265625,
        290.2363586425781,
        437.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOASSAY TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        443.6103515625,
        308.9096984863281,
        453.5703430175781
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VANCOUVER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        419.6103515625,
        418.2763977050781,
        429.5703430175781
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOTECH LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        435.5703430175781,
        425.7776794433594,
        445.53033447265625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 17 2005",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        427.53033447265625,
        497.8074035644531,
        437.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K050975",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        488.3703308105469,
        161.0883331298828,
        498.330322265625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NANO-CHECK AMI 3 IN 1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        456.4503479003906,
        313.5166320800781,
        466.41033935546875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC DISEASE TEST FOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        472.41033935546875,
        330.1972961425781,
        482.3703308105469
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        488.3703308105469,
        290.2363586425781,
        498.330322265625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CREATINE KINASE MB AND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        504.4503479003906,
        322.3966064453125,
        514.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MYOGLOBIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        520.4103393554688,
        234.9890899658203,
        530.3703002929688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NANO-DITEC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        480.4503479003906,
        420.75250244140625,
        490.41033935546875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H CO.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        496.41033935546875,
        380.1785888671875,
        506.3703308105469
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 02 2006",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        488.3703308105469,
        497.8074035644531,
        498.330322265625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K051752",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        549.2103881835938,
        161.0883331298828,
        559.1703491210938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE ELECSYS TROPONIN T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        533.2503662109375,
        333.0768737792969,
        543.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STAT  (SHORT TURNAROUND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        549.2103881835938,
        333.55523681640625,
        559.1703491210938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TIME)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        565.1703491210938,
        205.86004638671875,
        575.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        541.1703491210938,
        388.99700927734375,
        551.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        557.2503662109375,
        421.544189453125,
        567.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 11 2005",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        549.2103881835938,
        492.4073791503906,
        559.1703491210938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K051925",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        594.0903930664062,
        161.0883331298828,
        604.0503540039062
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARESTART CARDIAC 3-IN-1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        578.0103759765625,
        335.7167053222656,
        587.9703369140625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        594.0903930664062,
        230.47628784179688,
        604.0503540039062
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1/CK-MB/MYOGLOBIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        610.0503540039062,
        285.8687438964844,
        620.0103149414062
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCESS BIO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        586.0503540039062,
        416.9564208984375,
        596.0103149414062
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCORPORATE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        594.0903930664062,
        497.8074035644531,
        611.9703369140625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 29 2005",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        594.0903930664062,
        497.8074035644531,
        611.9703369140625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K052503",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        638.850341796875,
        161.0883331298828,
        648.810302734375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I ULTRA ASSAY AND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        622.890380859375,
        346.0361022949219,
        632.850341796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATOR FOR THE ADVIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        638.850341796875,
        333.19525146484375,
        648.810302734375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMS SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        654.8103637695312,
        240.48451232910156,
        664.7703247070312
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        622.890380859375,
        388.6374816894531,
        632.850341796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        638.850341796875,
        424.9974670410156,
        648.810302734375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LLC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        654.8103637695312,
        370.2333984375,
        664.7703247070312
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14 2005",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        638.850341796875,
        496.9673767089844,
        648.810302734375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K053020",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        675.6903686523438,
        161.0883331298828,
        685.6503295898438
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TNL-ULTRA ASSAY FOR THE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        667.650390625,
        333.0765686035156,
        677.6103515625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ADVIA CENTAUR SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        683.7303466796875,
        309.3635559082031,
        693.6903076171875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        667.650390625,
        388.6374816894531,
        677.6103515625
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        683.7303466796875,
        424.9974670410156,
        693.6903076171875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 30 2005",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        675.6903686523438,
        496.9673767089844,
        685.6503295898438
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.8399963378906,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 73 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 78,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LLC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        158.6103515625,
        370.2333984375,
        168.5703582763672
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K053577",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        195.45034790039062,
        161.0883331298828,
        205.4103546142578
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIMENSION VISTA CTNI FLEX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        171.45034790039062,
        334.397705078125,
        181.4103546142578
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FLEX REAGENT CARTRIDGE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        187.5303497314453,
        322.27728271484375,
        197.4903564453125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATOR AND SDIL SAMPLE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        203.49034118652344,
        346.0366516113281,
        213.45034790039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DILUENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        219.45034790039062,
        220.1088409423828,
        229.4103546142578
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        187.5303497314453,
        382.75701904296875,
        197.4903564453125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        203.49034118652344,
        422.89825439453125,
        213.45034790039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 14 2006",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        195.45034790039062,
        496.60736083984375,
        205.4103546142578
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K060875",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        240.33033752441406,
        331.8756408691406,
        258.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT AXSYM TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        240.33033752441406,
        331.8756408691406,
        258.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ADV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        256.29034423828125,
        195.45095825195312,
        266.2503356933594
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        232.29034423828125,
        397.3972473144531,
        242.25035095214844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        248.25033569335938,
        424.47259521484375,
        258.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        264.3303527832031,
        357.3450012207031,
        274.29034423828125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 14 2006",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        248.25033569335938,
        494.9273681640625,
        258.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K062838",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        309.09033203125,
        161.0883331298828,
        319.0503234863281
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITROS TROPONIN I ES ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        277.17034912109375,
        339.79644775390625,
        287.1303405761719
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCLUDING REAGENT PACK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        293.1303405761719,
        321.91650390625,
        303.09033203125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATORS AND RANGE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        309.09033203125,
        317.35614013671875,
        319.0503234863281
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VERIFIERS MODELS 680 2301",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        325.17034912109375,
        329.23724365234375,
        335.1303405761719
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2302 AND 2303",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        341.1303405761719,
        252.64739990234375,
        351.09033203125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO-CLINI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        293.1303405761719,
        423.2532958984375,
        303.09033203125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        309.09033203125,
        374.83685302734375,
        319.0503234863281
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        325.17034912109375,
        421.544189453125,
        335.1303405761719
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 19 2006",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        309.09033203125,
        496.9673767089844,
        319.0503234863281
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K063243",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        353.9703369140625,
        316.3966064453125,
        371.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIDAS TROPONIN I ULTRA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        353.9703369140625,
        316.3966064453125,
        371.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(TNIU) ASSAY MODEL 30 448",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        369.9303283691406,
        329.6869812011719,
        379.89031982421875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMERIEUX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        353.9703369140625,
        419.1170959472656,
        363.9303283691406
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        369.9303283691406,
        371.8987121582031,
        379.89031982421875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14 2007",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        361.8903503417969,
        496.9673767089844,
        371.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K063756",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        390.8103332519531,
        161.0883331298828,
        400.77032470703125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIMENSION VISTA CTNI FLEX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        382.77032470703125,
        334.397705078125,
        392.7303161621094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "REAGENT CARTRIDGE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        398.7303466796875,
        288.15350341796875,
        408.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        382.77032470703125,
        382.75701904296875,
        392.7303161621094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        390.8103332519531,
        497.8074035644531,
        408.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 19 2007",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        390.8103332519531,
        497.8074035644531,
        408.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K070640",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        419.6103515625,
        161.0883331298828,
        429.5703430175781
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ARCHITECT STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        411.5703430175781,
        271.51611328125,
        421.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN-1; MYOGLOBIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        427.53033447265625,
        310.9501037597656,
        437.4903259277344
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FISHER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        411.5703430175781,
        391.5168762207031,
        421.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        419.6103515625,
        496.48736572265625,
        437.4903259277344
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 13 2007",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        419.6103515625,
        496.48736572265625,
        437.4903259277344
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K081643",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        464.3703308105469,
        161.0883331298828,
        474.330322265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIMENSION TNI FLEX REAGENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        440.3703308105469,
        345.1962890625,
        450.330322265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARTRIDGE AND CTNI SAMPLE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        456.4503479003906,
        341.4786376953125,
        466.41033935546875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DILUENT WITH MODELS RF621",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        472.41033935546875,
        339.79833984375,
        482.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KD692",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        488.3703308105469,
        205.8462371826172,
        498.330322265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIEMENS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        448.41033935546875,
        400.63726806640625,
        458.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        464.3703308105469,
        424.9974670410156,
        474.330322265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        480.4503479003906,
        421.544189453125,
        490.41033935546875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 03 2008",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        464.3703308105469,
        492.4073791503906,
        474.330322265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K081683",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        509.2503356933594,
        318.91680908203125,
        527.1303100585938
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LOCI CARDIAC TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        509.2503356933594,
        318.91680908203125,
        527.1303100585938
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATOR MODEL RC621",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        525.2103881835938,
        317.20751953125,
        535.1703491210938
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIEMENS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        501.2103271484375,
        400.63726806640625,
        511.1703186035156
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        517.1703491210938,
        424.9974670410156,
        527.1303100585938
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        533.2503662109375,
        421.544189453125,
        543.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 07 2008",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        517.1703491210938,
        492.4073791503906,
        527.1303100585938
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K082699",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        562.0503540039062,
        161.0883331298828,
        572.0103149414062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS TROPONIN I AND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        546.0903930664062,
        316.8766174316406,
        556.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I STAT TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        562.0503540039062,
        306.0765075683594,
        572.0103149414062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        578.0103759765625,
        222.58587646484375,
        587.9703369140625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        554.0103759765625,
        388.99700927734375,
        563.9703369140625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        570.0903930664062,
        421.544189453125,
        580.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 19 2009",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        562.0503540039062,
        497.8074035644531,
        572.0103149414062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K092848",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        598.890380859375,
        293.4764099121094,
        616.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS TROPONIN T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        598.890380859375,
        293.4764099121094,
        616.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALCHECK 5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        614.850341796875,
        240.16676330566406,
        624.810302734375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        590.850341796875,
        388.99700927734375,
        600.810302734375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        606.8103637695312,
        424.8758850097656,
        616.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        622.890380859375,
        380.6585388183594,
        632.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 19 2010",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        606.8103637695312,
        497.8074035644531,
        616.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K100130",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        651.6903686523438,
        161.0883331298828,
        661.6503295898438
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PATHFAST CTNI-II TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        635.7303466796875,
        312.677490234375,
        645.6903076171875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PATHFAST CTNI CALIBRATORS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        651.6903686523438,
        341.4772644042969,
        661.6503295898438
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PATHFAST SAMPLE DILUENT 2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        667.650390625,
        339.2867431640625,
        677.6103515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MITSUBISHI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        635.7303466796875,
        416.59716796875,
        645.6903076171875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CHEMICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        651.6903686523438,
        408.6780090332031,
        661.6503295898438
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDIENCE CO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        667.650390625,
        424.0517883300781,
        677.6103515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 16 2011",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        651.6903686523438,
        499.4873962402344,
        661.6503295898438
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K100594",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        680.850341796875,
        496.60736083984375,
        690.810302734375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        680.850341796875,
        496.60736083984375,
        690.810302734375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ROCHE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        680.850341796875,
        496.60736083984375,
        690.810302734375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 01 2010",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        680.850341796875,
        496.60736083984375,
        690.810302734375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 74 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 79,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CALCHECK 5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        158.6103515625,
        421.544189453125,
        168.5703582763672
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        158.6103515625,
        421.544189453125,
        168.5703582763672
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K102131",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        187.5303497314453,
        161.0883331298828,
        197.4903564453125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NANO-CHECK AMI CTNI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        179.49034118652344,
        306.0766296386719,
        189.45034790039062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC MARKER TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        195.45034790039062,
        301.830078125,
        205.4103546142578
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NANO-DITEC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        171.45034790039062,
        420.75250244140625,
        181.4103546142578
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "H",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        187.5303497314453,
        361.87689208984375,
        197.4903564453125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORPORATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        203.49034118652344,
        424.8290100097656,
        213.45034790039062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 20 2010",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        187.5303497314453,
        495.287353515625,
        197.4903564453125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K102441",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        232.29034423828125,
        161.0883331298828,
        242.25035095214844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NANO-CHECK AMI 2 IN 1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        216.33033752441406,
        313.5166320800781,
        226.29034423828125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC MARKER CTNL AND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        232.29034423828125,
        332.3560791015625,
        242.25035095214844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MYOGLOBIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        248.25033569335938,
        234.9890899658203,
        258.2103271484375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NANO-DITEC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        216.33033752441406,
        420.75250244140625,
        226.29034423828125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        232.29034423828125,
        361.87689208984375,
        242.25035095214844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORPORATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        248.25033569335938,
        424.8290100097656,
        258.2103271484375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 20 2010",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        232.29034423828125,
        495.287353515625,
        242.25035095214844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K121084",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        277.17034912109375,
        322.2756652832031,
        295.0503234863281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LOCI CARDIAC TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        277.17034912109375,
        322.2756652832031,
        295.0503234863281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTROL (LOW) LCTNI CON L",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        293.1303405761719,
        334.7850036621094,
        303.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIEMENS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        261.09033203125,
        400.63726806640625,
        271.0503234863281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        277.17034912109375,
        424.9974670410156,
        287.1303405761719
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        293.1303405761719,
        424.8758850097656,
        303.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        309.09033203125,
        371.8987121582031,
        319.0503234863281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 09 2012",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        285.09033203125,
        499.4873962402344,
        295.0503234863281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K121214",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        353.9703369140625,
        161.0883331298828,
        363.9303283691406
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCESS ACCUTNI+3 REAGENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        321.9303283691406,
        338.2373046875,
        331.89031982421875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AND ACCESS ACCUTN1+3",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        337.8903503417969,
        312.67633056640625,
        347.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATORS FOR USE ON THE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        353.9703369140625,
        346.5165710449219,
        363.9303283691406
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCESS 2 IMMUNOASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        369.9303283691406,
        311.3560791015625,
        379.89031982421875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        385.8903503417969,
        216.2445068359375,
        395.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BECKMAN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        345.9303283691406,
        406.1571044921875,
        355.89031982421875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COULTER INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        353.9703369140625,
        494.9273681640625,
        371.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 14 2013",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        353.9703369140625,
        494.9273681640625,
        371.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K924392",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        414.8103332519531,
        341.9098205566406,
        424.77032470703125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC T ELISA TROPONIN-T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        414.8103332519531,
        341.9098205566406,
        424.77032470703125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        398.7303466796875,
        420.79632568359375,
        408.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        414.8103332519531,
        413.2366638183594,
        424.77032470703125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        430.77032470703125,
        380.6585388183594,
        440.7303161621094
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 26 1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        414.8103332519531,
        496.60736083984375,
        424.77032470703125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K942632",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        459.5703430175781,
        267.2699890136719,
        469.53033447265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TNT TROPONIN T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        459.5703430175781,
        267.2699890136719,
        469.53033447265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRECK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        443.6103515625,
        395.717041015625,
        453.5703430175781
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        459.5703430175781,
        424.47259521484375,
        469.53033447265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        475.53033447265625,
        383.1782531738281,
        485.4903259277344
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 09 1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        459.5703430175781,
        496.48736572265625,
        469.53033447265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K951888",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        496.41033935546875,
        161.0883331298828,
        506.3703308105469
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE STRATUS TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        488.3703308105469,
        330.1956481933594,
        498.330322265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        504.4503479003906,
        222.5839080810547,
        514.4103393554688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        488.3703308105469,
        415.7565002441406,
        498.330322265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        504.4503479003906,
        371.8987121582031,
        514.4103393554688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 13 1995",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        496.41033935546875,
        492.4073791503906,
        506.3703308105469
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K951890",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        549.2103881835938,
        161.0883331298828,
        559.1703491210938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS CARDIAC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        517.1703491210938,
        277.27618408203125,
        527.1303100585938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN-I FLUOROMETRIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        533.2503662109375,
        328.8775634765625,
        543.2103271484375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYME IMMUNMNOASSAY &",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        549.2103881835938,
        333.4364929199219,
        559.1703491210938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS CARDIAC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        565.1703491210938,
        277.27618408203125,
        575.1303100585938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN-I CALIBRATORS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        581.2503662109375,
        316.7850341796875,
        591.2103271484375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        541.1703491210938,
        415.7565002441406,
        551.1303100585938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        557.2503662109375,
        371.8987121582031,
        567.2103271484375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 13 1995",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        549.2103881835938,
        492.4073791503906,
        559.1703491210938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K952478",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        610.0503540039062,
        161.0883331298828,
        620.0103149414062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        594.0903930664062,
        307.27667236328125,
        604.0503540039062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC T TROPONIN T RAPID",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        610.0503540039062,
        342.7969970703125,
        620.0103149414062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        626.0103759765625,
        207.99266052246094,
        635.9703369140625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        594.0903930664062,
        420.79632568359375,
        604.0503540039062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        610.0503540039062,
        413.2366638183594,
        620.0103149414062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        626.0103759765625,
        380.6585388183594,
        635.9703369140625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 09 1995",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        610.0503540039062,
        497.8074035644531,
        620.0103149414062
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K955284",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        654.8103637695312,
        267.9749755859375,
        664.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        654.8103637695312,
        267.9749755859375,
        664.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        638.850341796875,
        400.2767028808594,
        648.810302734375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        654.8103637695312,
        424.8758850097656,
        664.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        670.890380859375,
        371.8987121582031,
        680.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 25 1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        654.8103637695312,
        494.4473571777344,
        664.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K955868",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        689.2503662109375,
        496.48736572265625,
        699.2103271484375
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BOEHRINGER MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        689.2503662109375,
        496.48736572265625,
        699.2103271484375
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        689.2503662109375,
        496.48736572265625,
        699.2103271484375
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Feb 14 1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        689.2503662109375,
        496.48736572265625,
        699.2103271484375
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.8399963378906,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 75 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 80,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CARDIAC T TROPNIN T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        166.6503448486328,
        296.07000732421875,
        176.6103515625
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        158.6103515625,
        413.2366638183594,
        168.5703582763672
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        174.69033813476562,
        380.6585388183594,
        184.6503448486328
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K961500",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        203.49034118652344,
        290.07000732421875,
        213.45034790039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS TROPONIN T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        203.49034118652344,
        290.07000732421875,
        213.45034790039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        187.5303497314453,
        420.79632568359375,
        197.4903564453125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        203.49034118652344,
        413.2366638183594,
        213.45034790039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        219.45034790039062,
        380.6585388183594,
        229.4103546142578
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 11 1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        203.49034118652344,
        494.9273681640625,
        213.45034790039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K963143",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        240.33033752441406,
        341.475341796875,
        258.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS CALCHECK TROPONIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        240.33033752441406,
        341.475341796875,
        258.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        256.29034423828125,
        181.22999572753906,
        266.2503356933594
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        232.29034423828125,
        420.79632568359375,
        242.25035095214844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        248.25033569335938,
        413.2366638183594,
        258.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        264.3303527832031,
        380.6585388183594,
        274.29034423828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 23 1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        248.25033569335938,
        497.8074035644531,
        258.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K963513",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        293.1303405761719,
        334.4549865722656,
        303.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC STATUS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        293.1303405761719,
        334.4549865722656,
        303.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRINCETON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        277.17034912109375,
        414.0773010253906,
        287.1303405761719
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMEDITECH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        293.1303405761719,
        427.0362548828125,
        303.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        309.09033203125,
        380.6585388183594,
        319.0503234863281
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 07 1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        293.1303405761719,
        497.8074035644531,
        303.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K963934",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        353.9703369140625,
        161.0883331298828,
        363.9303283691406
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCESS TROPONIN I REAGENTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        321.9303283691406,
        345.19622802734375,
        331.89031982421875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ON THE ACCESS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        337.8903503417969,
        263.476806640625,
        347.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOASSAY ANALYZER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        353.9703369140625,
        315.5566101074219,
        363.9303283691406
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL NUMBERS: 33320 33325",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        369.9303283691406,
        340.5176086425781,
        379.89031982421875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AND 33329",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        385.8903503417969,
        230.0878143310547,
        395.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIO-RAD",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        337.8903503417969,
        401.4768371582031,
        347.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        353.9703369140625,
        424.47259521484375,
        363.9303283691406
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        369.9303283691406,
        383.1782531738281,
        379.89031982421875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 16 1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        353.9703369140625,
        496.9673767089844,
        363.9303283691406
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K964372",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        414.8103332519531,
        161.0883331298828,
        424.77032470703125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC T TROPONIN T RAPID",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        406.77032470703125,
        342.7969970703125,
        416.7303161621094
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        422.7303466796875,
        207.99266052246094,
        432.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        398.7303466796875,
        420.79632568359375,
        408.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        414.8103332519531,
        413.2366638183594,
        424.77032470703125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        430.77032470703125,
        380.6585388183594,
        440.7303161621094
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 10 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        414.8103332519531,
        496.48736572265625,
        424.77032470703125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K964862",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        443.6103515625,
        415.7565002441406,
        461.4903259277344
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN-I TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        443.6103515625,
        415.7565002441406,
        461.4903259277344
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        443.6103515625,
        415.7565002441406,
        461.4903259277344
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        459.5703430175781,
        371.8987121582031,
        469.53033447265625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 10 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        451.53033447265625,
        496.48736572265625,
        461.4903259277344
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K972094",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        480.4503479003906,
        338.2363586425781,
        498.330322265625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TARGET CARDIAC TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        480.4503479003906,
        338.2363586425781,
        498.330322265625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        496.41033935546875,
        201.7505645751953,
        506.3703308105469
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEXAS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        472.41033935546875,
        388.99700927734375,
        482.3703308105469
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOLOGY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        488.3703308105469,
        425.7155456542969,
        498.330322265625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        504.4503479003906,
        371.8987121582031,
        514.4103393554688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 23 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        488.3703308105469,
        492.4073791503906,
        498.330322265625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K972687",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        533.2503662109375,
        161.0883331298828,
        543.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC STATUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        525.2103881835938,
        270.5561828613281,
        535.1703491210938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTROLS/TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        541.1703491210938,
        294.2549743652344,
        551.1303100585938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        517.1703491210938,
        408.1968994140625,
        527.1303100585938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        533.2503662109375,
        424.8758850097656,
        543.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        549.2103881835938,
        371.8987121582031,
        559.1703491210938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 28 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        533.2503662109375,
        492.4073791503906,
        543.2103271484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K973126",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        594.0903930664062,
        161.0883331298828,
        604.0503540039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE CARDIAC PANEL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        562.0503540039062,
        306.43743896484375,
        572.0103149414062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE TROPONIN-I TRIAGE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        578.0103759765625,
        331.0372009277344,
        587.9703369140625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CK-MB TRIAGE MYOGLOBIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        594.0903930664062,
        325.99554443359375,
        604.0503540039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE TROPONIN-I AND",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        610.0503540039062,
        313.9966125488281,
        620.0103149414062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CK-MB TRIAGE TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        626.0103759765625,
        326.7742614746094,
        635.9703369140625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOSITE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        578.0103759765625,
        396.0765686035156,
        587.9703369140625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCORPORATE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        594.0903930664062,
        424.47259521484375,
        604.0503540039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        610.0503540039062,
        358.1717529296875,
        620.0103149414062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 06 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        594.0903930664062,
        495.287353515625,
        604.0503540039062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K973616",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        646.890380859375,
        161.0883331298828,
        656.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I ASSAY FOR THE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        638.850341796875,
        330.1965637207031,
        648.810302734375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER IMMUNO 1 SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        646.890380859375,
        496.9673767089844,
        664.7703247070312
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        646.890380859375,
        496.9673767089844,
        664.7703247070312
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 05 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        646.890380859375,
        496.9673767089844,
        664.7703247070312
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K973650",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        675.6903686523438,
        319.6514892578125,
        685.6503295898438
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN (TROP) METHOD",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        675.6903686523438,
        319.6514892578125,
        685.6503295898438
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        667.650390625,
        382.75701904296875,
        677.6103515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CHEMISTRY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        683.7303466796875,
        415.2774963378906,
        693.6903076171875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 20 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        675.6903686523438,
        495.287353515625,
        685.6503295898438
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 76 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 81,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        158.6103515625,
        425.6587219238281,
        168.5703582763672
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K973668",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        179.49034118652344,
        161.0883331298828,
        189.45034790039062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC TROPONIN-I (TROP)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        171.45034790039062,
        336.0759582519531,
        181.4103546142578
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        187.5303497314453,
        240.15345764160156,
        197.4903564453125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        171.45034790039062,
        415.7565002441406,
        181.4103546142578
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        187.5303497314453,
        371.8987121582031,
        197.4903564453125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 20 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        179.49034118652344,
        495.287353515625,
        189.45034790039062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974075",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        216.33033752441406,
        161.0883331298828,
        226.29034423828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCESS TROPONIN I REAGENTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        200.25033569335938,
        345.19622802734375,
        210.21034240722656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ON THE ACCESS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        216.33033752441406,
        263.476806640625,
        226.29034423828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOASSAY ANALYZER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        232.29034423828125,
        312.2728576660156,
        242.25035095214844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BECKMAN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        200.25033569335938,
        406.1571044921875,
        210.21034240722656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INSTRUMENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        216.33033752441406,
        421.1109619140625,
        226.29034423828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        232.29034423828125,
        383.1782531738281,
        242.25035095214844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 10 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        216.33033752441406,
        497.8074035644531,
        226.29034423828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974103",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        261.09033203125,
        328.45428466796875,
        271.0503234863281
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT AXSYM TROPONIN-I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        261.09033203125,
        328.45428466796875,
        271.0503234863281
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        245.13034057617188,
        397.3972473144531,
        255.09034729003906
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        261.09033203125,
        424.47259521484375,
        271.0503234863281
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        277.17034912109375,
        357.3450012207031,
        287.1303405761719
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 25 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        261.09033203125,
        497.8074035644531,
        271.0503234863281
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974461",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        313.8903503417969,
        161.0883331298828,
        323.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE CARDIAC CONTROLS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        289.8903503417969,
        327.3155822753906,
        299.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE TROPONIN-I CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        305.9703369140625,
        340.6356506347656,
        315.9303283691406
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE CK-MB CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        321.9303283691406,
        313.5156555175781,
        331.89031982421875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRIAGE MYOGLOBIN CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        337.8903503417969,
        333.10394287109375,
        347.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOSITE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        297.9303283691406,
        396.0765686035156,
        307.89031982421875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCORPORATE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        313.8903503417969,
        424.47259521484375,
        323.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        329.9703369140625,
        358.1717529296875,
        339.9303283691406
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 10 1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        313.8903503417969,
        496.9673767089844,
        323.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974818",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        366.8103332519531,
        161.0883331298828,
        376.77032470703125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABL555 BLOOD GAS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        350.7303466796875,
        280.036376953125,
        360.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECTROLYTE & METABOLITE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        366.8103332519531,
        338.9562072753906,
        376.77032470703125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        382.77032470703125,
        216.2445068359375,
        392.7303161621094
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RADIOMETER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        358.77032470703125,
        423.1966857910156,
        368.7303161621094
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AMERICA INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        366.8103332519531,
        494.4473571777344,
        384.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 16 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        366.8103332519531,
        494.4473571777344,
        384.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974839",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        427.53033447265625,
        161.0883331298828,
        437.4903259277344
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ALPHA DX ANALYZER 01-0100",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        395.6103515625,
        339.3177185058594,
        405.5703430175781
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ALPHA DX MYO/CK/CK-MB/TNI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        411.5703430175781,
        340.156005859375,
        421.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC PANEL TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        427.53033447265625,
        319.0361328125,
        437.4903259277344
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "03-0001 ALPHA DX CK/CK-MB",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        443.6103515625,
        340.1572265625,
        453.5703430175781
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PANEL TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        459.5703430175781,
        264.74969482421875,
        469.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FIRST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        419.6103515625,
        384.7968444824219,
        429.5703430175781
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICAL INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        435.5703430175781,
        424.0982666015625,
        445.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 04 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        427.53033447265625,
        496.48736572265625,
        437.4903259277344
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K980528",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        480.4503479003906,
        338.1169738769531,
        498.330322265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CHIRON DIAGNOSTICS ACS:180",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        480.4503479003906,
        338.1169738769531,
        498.330322265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I ASSAY (CTNI)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        496.41033935546875,
        315.6596374511719,
        506.3703308105469
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CHIRON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        472.41033935546875,
        393.67620849609375,
        482.3703308105469
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        488.3703308105469,
        424.8758850097656,
        498.330322265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        504.4503479003906,
        380.6585388183594,
        514.4103393554688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 03 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        488.3703308105469,
        497.8074035644531,
        498.330322265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K981098",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        525.2103881835938,
        161.0883331298828,
        535.1703491210938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS CS CARDIAC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        517.1703491210938,
        295.1567077636719,
        527.1303100585938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I TESTPAK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        533.2503662109375,
        290.1893310546875,
        543.2103271484375
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        517.1703491210938,
        382.75701904296875,
        527.1303100585938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        533.2503662109375,
        422.89825439453125,
        543.2103271484375
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 27 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        525.2103881835938,
        496.60736083984375,
        535.1703491210938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K981474",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        562.0503540039062,
        161.0883331298828,
        572.0103149414062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC STATUS CONTROLS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        546.0903930664062,
        330.6775817871094,
        556.0503540039062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(CK-MB/MYOGLOBIN/TROPONIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        562.0503540039062,
        341.8341064453125,
        572.0103149414062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "I)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        578.0103759765625,
        182.46005249023438,
        587.9703369140625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        546.0903930664062,
        408.1968994140625,
        556.0503540039062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        562.0503540039062,
        424.8758850097656,
        572.0103149414062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        578.0103759765625,
        371.8987121582031,
        587.9703369140625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 07 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        562.0503540039062,
        499.4873962402344,
        572.0103149414062
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K981882",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        606.8103637695312,
        161.0883331298828,
        616.7703247070312
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIAC STATUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        590.850341796875,
        270.5561828613281,
        600.810302734375
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CK-MB/MYOGLOBIN/TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        606.8103637695312,
        345.55682373046875,
        616.7703247070312
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RAPID TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        622.890380859375,
        237.99005126953125,
        632.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRINCETON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        590.850341796875,
        414.0773010253906,
        600.810302734375
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMEDITECH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        606.8103637695312,
        427.0362548828125,
        616.7703247070312
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        622.890380859375,
        380.6585388183594,
        632.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 06 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        606.8103637695312,
        492.4073791503906,
        616.7703247070312
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K983693",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        635.7303466796875,
        339.31671142578125,
        653.6103515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIMENSIONS (R) RXL CARDIAC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        635.7303466796875,
        339.31671142578125,
        653.6103515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I CALIBRATOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        651.6903686523438,
        307.2330322265625,
        661.6503295898438
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        635.7303466796875,
        382.75701904296875,
        645.6903076171875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        651.6903686523438,
        422.89825439453125,
        661.6503295898438
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 04 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        643.650390625,
        497.8074035644531,
        653.6103515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K983722",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        664.5303344726562,
        311.4763488769531,
        682.4103393554688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS CS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        664.5303344726562,
        311.4763488769531,
        682.4103393554688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CALIBRATOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        680.4903564453125,
        240.15345764160156,
        690.4503173828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        664.5303344726562,
        382.75701904296875,
        674.4902954101562
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        680.4903564453125,
        422.89825439453125,
        690.4503173828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 04 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        672.4503784179688,
        497.8074035644531,
        682.4103393554688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K983972",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        694.0503540039062,
        496.9673767089844,
        704.0103149414062
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IMMULITE TROPONIN I MODEL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        694.0503540039062,
        496.9673767089844,
        704.0103149414062
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        694.0503540039062,
        496.9673767089844,
        704.0103149414062
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Dec 07 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        694.0503540039062,
        496.9673767089844,
        704.0103149414062
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.8399963378906,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 77 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LKTI1 AND LKT15",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        166.6503448486328,
        269.807373046875,
        176.6103515625
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        158.6103515625,
        409.3970642089844,
        168.5703582763672
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        174.69033813476562,
        380.6585388183594,
        184.6503448486328
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K984093",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        187.5303497314453,
        316.8762512207031,
        205.4103546142578
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STRATUS (R) CS CARDIAC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        187.5303497314453,
        316.8762512207031,
        205.4103546142578
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I (TROP) TESTPAK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        203.49034118652344,
        332.6703186035156,
        213.45034790039062
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        187.5303497314453,
        382.75701904296875,
        197.4903564453125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        203.49034118652344,
        422.89825439453125,
        213.45034790039062
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        195.45034790039062,
        496.9673767089844,
        205.4103546142578
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K984105",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        232.29034423828125,
        161.0883331298828,
        242.25035095214844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS TROPONIN T STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        224.25033569335938,
        327.3161315917969,
        234.21034240722656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        240.33033752441406,
        201.7505645751953,
        250.29034423828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        216.33033752441406,
        420.79632568359375,
        226.29034423828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        232.29034423828125,
        413.2366638183594,
        242.25035095214844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        248.25033569335938,
        380.6585388183594,
        258.2103271484375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 08 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        232.29034423828125,
        496.9673767089844,
        242.25035095214844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K984359",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        269.1303405761719,
        335.1931457519531,
        279.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AIA-PACK TROPONIN I ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        269.1303405761719,
        335.1931457519531,
        279.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TOSOH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        261.09033203125,
        389.8356018066406,
        271.0503234863281
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        277.17034912109375,
        416.53826904296875,
        287.1303405761719
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 23 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        269.1303405761719,
        496.9673767089844,
        279.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K984372",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        305.9703369140625,
        161.0883331298828,
        315.9303283691406
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECSYS CALCHECK TROPONIN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        297.9303283691406,
        341.475341796875,
        307.89031982421875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        313.8903503417969,
        181.22999572753906,
        323.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOEHRINGER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        289.8903503417969,
        420.79632568359375,
        299.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MANNHEIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        305.9703369140625,
        413.2366638183594,
        315.9303283691406
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        321.9303283691406,
        380.6585388183594,
        331.89031982421875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14 1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        305.9703369140625,
        496.9673767089844,
        315.9303283691406
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K991176",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        342.8103332519531,
        339.3935546875,
        352.77032470703125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS TROPONIN I CALIBRATOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        342.8103332519531,
        339.3935546875,
        352.77032470703125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        334.7703552246094,
        382.75701904296875,
        344.7303466796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        342.8103332519531,
        492.4073791503906,
        360.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 01 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        342.8103332519531,
        492.4073791503906,
        360.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K991177",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        371.6103515625,
        161.0883331298828,
        381.5703430175781
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS TROPONIN I (CTN) TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        363.5703430175781,
        340.99749755859375,
        373.53033447265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODULES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        379.53033447265625,
        223.78509521484375,
        389.4903259277344
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DADE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        363.5703430175781,
        382.75701904296875,
        373.53033447265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        371.6103515625,
        492.4073791503906,
        389.4903259277344
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 01 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        371.6103515625,
        492.4073791503906,
        389.4903259277344
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K991795",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        408.4503479003906,
        161.0883331298828,
        418.41033935546875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE TURBO TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        400.41033935546875,
        338.5963439941406,
        410.3703308105469
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODELS LSKTI1 LSKTI5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        416.3703308105469,
        300.5260009765625,
        426.330322265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        392.3703308105469,
        418.6359558105469,
        402.330322265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        408.4503479003906,
        409.3970642089844,
        418.41033935546875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        424.41033935546875,
        380.6585388183594,
        434.3703308105469
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 09 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        408.4503479003906,
        494.9273681640625,
        418.41033935546875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K992127",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        453.2103271484375,
        161.0883331298828,
        463.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CARDIOQUANT TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        445.17034912109375,
        320.23681640625,
        455.1303405761719
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        461.2503356933594,
        201.7505645751953,
        471.2103271484375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPECTRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        437.2503356933594,
        408.1968994140625,
        447.2103271484375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        453.2103271484375,
        424.8758850097656,
        463.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        469.17034912109375,
        371.8987121582031,
        479.1303405761719
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 04 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        453.2103271484375,
        495.287353515625,
        463.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K992349",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        506.0103454589844,
        161.0883331298828,
        515.9703369140625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITROS IMMUNODIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        490.0503234863281,
        328.8755798339844,
        500.01031494140625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS TROPONIN I RANGE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        506.0103454589844,
        339.796142578125,
        515.9703369140625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VERIFIERS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        522.0903930664062,
        227.62562561035156,
        532.0503540039062
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO-CLINI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        482.0103454589844,
        423.2532958984375,
        491.9703369140625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        498.09033203125,
        374.83685302734375,
        508.0503234863281
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        514.0503540039062,
        424.8758850097656,
        524.0103149414062
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        530.0103759765625,
        371.8987121582031,
        539.9703369140625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 24 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        506.0103454589844,
        497.8074035644531,
        515.9703369140625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K992366",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        566.850341796875,
        161.0883331298828,
        576.810302734375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITROS IMMUNODIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        550.890380859375,
        328.8755798339844,
        560.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS TROPONIN I",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        566.850341796875,
        299.3563537597656,
        576.810302734375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "REAGENT PACK",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        582.8103637695312,
        256.4695739746094,
        592.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO-CLINI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        542.850341796875,
        423.2532958984375,
        552.810302734375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        558.8103637695312,
        374.83685302734375,
        568.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        574.890380859375,
        424.8758850097656,
        584.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        590.850341796875,
        371.8987121582031,
        600.810302734375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 08 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.5199890136719,
        566.850341796875,
        495.287353515625,
        576.810302734375
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K993309",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        619.650390625,
        161.0883331298828,
        629.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER DIAGNOSTICS ACS:180",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        603.6903686523438,
        333.07696533203125,
        613.6503295898438
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AND ADVIA CENTAUR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        619.650390625,
        292.2768249511719,
        629.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        635.7303466796875,
        275.07415771484375,
        645.6903076171875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        619.650390625,
        496.9673767089844,
        629.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 06 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        619.650390625,
        496.9673767089844,
        629.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K993353",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.55999755859375,
        664.5303344726562,
        161.0883331298828,
        674.4902954101562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TROPONIN I ASSAY FOR THE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        648.4503784179688,
        330.1965637207031,
        658.4103393554688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER IMMUNO 1 SYSTEM ( IN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        664.5303344726562,
        345.19647216796875,
        674.4902954101562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITRO DIAGNOSTIC SYSTEM)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        680.4903564453125,
        327.66143798828125,
        690.4503173828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAYER CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        664.5303344726562,
        496.9673767089844,
        674.4902954101562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 06 1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        351.1199951171875,
        664.5303344726562,
        496.9673767089844,
        674.4902954101562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        119.59441375732422,
        435.96533203125,
        128.59442138671875
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 의료기기 중 심근혈관표지자",
      "font_size": 15.718777656555176,
      "font_name": "T4",
      "bbox": [
        159.95999145507812,
        385.20001220703125,
        439.5625915527344,
        404.35198974609375
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심장성 트로포닌 검사제품의 허가․심사 가이드라인",
      "font_size": 15.718777656555176,
      "font_name": "T4",
      "bbox": [
        118.43999481201172,
        410.760009765625,
        481.0823974609375,
        429.9119873046875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        435.1997375488281,
        279.1190490722656,
        448.4472961425781
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        435.1997375488281,
        279.1190490722656,
        448.4472961425781
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처 식품의약품안전처",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        435.1997375488281,
        279.1190490722656,
        448.4472961425781
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        459.43975830078125,
        251.75999450683594,
        472.68731689453125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        459.43975830078125,
        251.75999450683594,
        472.68731689453125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일 2014년 5월",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        459.43975830078125,
        251.75999450683594,
        472.68731689453125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        483.55975341796875,
        229.0800018310547,
        496.80731201171875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        483.55975341796875,
        229.0800018310547,
        496.80731201171875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        483.55975341796875,
        229.0800018310547,
        496.80731201171875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "왕진호",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        483.55975341796875,
        229.0800018310547,
        496.80731201171875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장 정희교",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        507.6797180175781,
        229.0800018310547,
        520.9273071289062
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "편 집 위 원",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        535.5197143554688,
        442.68084716796875,
        548.767333984375
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        535.5197143554688,
        442.68084716796875,
        548.767333984375
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        573.3197021484375,
        481.7017822265625,
        587.6473388671875
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        573.3197021484375,
        481.7017822265625,
        587.6473388671875
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        117.0,
        573.3197021484375,
        481.7017822265625,
        587.6473388671875
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        573.3197021484375,
        481.7017822265625,
        587.6473388671875
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오송보건의료행정타운 식품의약품안전평가원",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        199.1999969482422,
        595.7597045898438,
        407.66015625,
        609.00732421875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기심사부 체외진단기기과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        199.1999969482422,
        613.0397338867188,
        344.1590576171875,
        626.287353515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화: 043-719-4652~4665",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        199.1999969482422,
        630.3197021484375,
        318.8033447265625,
        643.5673217773438
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팩스: 043-719-4650",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        199.1999969482422,
        647.5997314453125,
        289.76397705078125,
        660.8473510742188
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.8399963378906,
        117.55441284179688,
        481.4460144042969,
        126.55441284179688
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 79 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 84,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        124.91999816894531,
        539.0594482421875,
        470.2649841308594,
        555.0203857421875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의료기기심사부 체외진단기기과",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        147.59999084472656,
        558.2594604492188,
        447.5999755859375,
        574.2203979492188
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEL : 043-719-4652~4665  FAX : 043-719-4650",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        164.0399932861328,
        577.4594116210938,
        431.16937255859375,
        593.4203491210938
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://www.mfds.go.kr",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        237.36000061035156,
        596.659423828125,
        357.8821716308594,
        612.620361328125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“내가 지킨 청렴실천 모아지면 청렴사회”",
      "font_size": 12.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        184.3199920654297,
        625.939453125,
        410.5401611328125,
        641.900390625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    }
  ],
  "markdown_content": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018. 7.\n발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction. | ❍ 제조방법 | 구해진다. | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. | 제시하고, 정량값 판정 등의 기준을 제시한다. | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다. | INSTANT-VIEW TROPONIN I | 수도 있다. 측정은 각 농도별로 2-4회 반복 측정한다. | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다. | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다. | Ⅴ. 제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2. | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다. | 라. 원료물질의 품질 확인 근거자료 | 민족적 차이 | 6. 시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다. | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다. | 또는 이에 준하는 것으로 인정되는 시험자료 | 7. 이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다. | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다. | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다. | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC. | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다. | ALPHA DX ANALYZER 01-0100 | 내용입니까? | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67. | 가. 시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다. | 한다. | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1. 명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다. | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC. | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다. 검사항목 | 7. 시험기준 및 시험방법. 단, 규격이 없는 경우 이에 대한 설정 사유 | 가. 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다. | 참고한다. | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ. 성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나. 가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다. | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다. | 여 설정한다. | 있다. | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC. | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나. 권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. | 기술한다. | 2. 모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다. | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다. | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP. | □ 예 | ■ 아니오 |\n| 나. 검사 전 준비사항 | 8. 시험검사 결과 | 나. 시험물질 | 나. 출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다. | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다. 다음의 | 산출되었다. | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP. | CORP. |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD. | MEDICAL INC. | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다. | ❍ 사용 시 주의사항 | 다. 비교 제품은 각 제품의 사용방법에 따라서 시험한다. | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다. | <결과 판정> | Troponin I 농도에 대해 정비례한다. | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다. | 바) 총 run의 수(해당되는 경우 제시) | 1. 분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까? |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3. 원재료 | 22 | 평가한다. | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다. | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다. | ASSAY | Sens. | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다. | MEDICS INC. | SIEMENS | Speci. |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다. 이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다. | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5. | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2. 임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다. | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi. | INC. | LABORATORIE | INC. | % | N | confi. |\n| 라. 정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다. | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005. | 사) 총 관찰치의 수 : optional | 4. 제조방법 | 24 | 등을 제시한다. | 설정한다. | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라. 측정원리 : 측정에 사용된 검사 원리 | 마. 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다. | 기구 및 조건 등을 기재한다. | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다. | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다. | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다. | H u m a n | Mouse monoclonal | 기재한다. | BIOCHECK | I-STAT | TEXAS | CHIRON | INC. |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter. | S INC. | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함. | ng/mL) | 아) 시약 lot의 수 | 3. 완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다. | 자료를 제시한다. | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다. | serum 3 | INC. | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바. 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다. 판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5. 사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등). | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL. | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다. 추가로, (i) 새로 | 라. 분량 | 10. 시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까? (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO. |\n| 있는 물질의 예는 다음과 같다. | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사. 국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4. 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC. | INC. | CORP. | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다. | 가. 최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다. | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다. | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6. 사용방법 | 29 | 제시한다. | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음. 또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다. | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다. | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5. 검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다. 비혈관 | MEDICAL INC. |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가. 인정범위 | -02 | 2018.7. | 7. 사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC. | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다. | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. | 량, 반정량 검사용 등을 명확하게 기재한다. | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다. | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP. | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC. |\n| 3 | R | 나. 표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다. | 한다. | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. | 체외진단용 시약을 중심으로 사용방법을 기술한다. | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다. | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC. | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP. | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다. 시험방법 | 나. 기재내용 | 나. 최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. | 져야 한다. | 어떻게 처리해야 하는지에 대한 지침을 제시한다. | 권장한다. | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까? | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD. | S | CORP. |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다. | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다. | 특이도(specificity)는 아래 표와 같다. | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가. 검체준비 및 저장방법 | 1. 업체명 및 주소 | 라. 측정범위(Measurement range) | 나. 시험물질 | 마. 대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다. | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ. 관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다. | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC. |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다. | 분석적 | 2. 원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다. 다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다. | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다. | 보를 제공한다. | 100개 이상의 검체를 시험하도록 권장한다. | 이계수를 산출하여 기재한다. | 사용한다. | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가. 해당시약의 성분과 분량을 확인할 수 있는 자료 | 2. 시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다. | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3. 사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC. | CAL | INC. | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ. 신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다. | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자. 일회용의 경우 재사용하지 않도록 주의사항을 기재한다. | 라. 결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다. | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다. | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. | 용될 수 있다. | 구체적, 개조식으로 기재한다. | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens. | 보존제, 안정제 등 | ng/mL | CAL | INC. | CORP. | Speci. |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다. 추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마. 정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다. | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx. | DIAGNOSTICS | INCORPORATE |\n| 3. 시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다. | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi. | ABBOTT | CORP. | % | N | confi. |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4. 저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다. | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다. | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가. 상품명이 없는 경우, 생략 가능 | 수 있다. | Cinical and Laboratory Standard Institute; 2005 | 수도 있다. 종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다. | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다. | 가) 검사를 시행한 검체의 농도 | 1. 제조․수입허가신청서 | test)를 실시한다. | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter. | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가. 검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. | 4. 시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다. | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5. 제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다. | COULTER INC. | BECKMAN |\n| 사항이 아님을 알려드립니다. 또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나. 상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2. 기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다. | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다. | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까? | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7. 참고 : 진단기준 | 등록대상 | 다. 권장 시험방법 | 가. 일반사항 | 다. 결과제시 | 허용기준, 결과 등을 요약하여 제시한다. | 1 | 품목명 | 와 ISO에서 사용되고 있다. | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다. | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나. 검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다. | 다. 원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5. 시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다. | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다. | RADIOMETER | 0.12 |\n| K974818 | 다. 임상적 성능시험에 관한 자료 | 다. 결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6. 체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다. | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC. | INC. | S INC. | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.**\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다. | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL. |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다. | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다. | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187. | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. | CONTROLS/TROPONIN I | ROCHE | DADE INTL. |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나. 시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다. | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC. | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8. 포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC. | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다. | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다. | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다. | 의해 판정기준치의 적절성을 평가할 수 있다. | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까? | 산출에서 배제하였다. 환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거. | 가. 체외진단용으로 사용해야 함을 명시한다. | 가. 시험물질 | 나. 시험방법 | 여 적용할 수 있는 시험규격을 명시한다. | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다. | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다. | 라고 정의한다. | 조절하여 근육 수축에서 매우 중요한 역할을 한다. | 6. 상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC. | BEHRING INC. | DIAGNOSTICS |\n| 가. 전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n상기 사항에 대하여 확인하였음.\n\n2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n<!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ. 개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ. 용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9. 저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10. 시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11. 제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ. 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1. 개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ. 참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ. 부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1. 목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ. 개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2. 적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다. 급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다. TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다. TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다. 또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\nⅡ. 용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\nb) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n사용 시 안정성 (in–use stability)\n\nⅡ. 용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\nb) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ. 용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\nⅡ. 용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다. 정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ. 용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다. 첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n<!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ. 신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1. 제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n- 다. 동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1. 품목명 : 심질환표지자검사시약\n- 2. 모델명 : OS-Troponin I\n- 3. 품목분류번호 : D04030.01\n- 4. 등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1. 모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n- 가. 임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다. 트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다. 트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다. 복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다. 그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나. 작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다. 시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다. 첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다. 두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다. 검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다. 첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다. 복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다. 결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2. 모양 및 구조 - 외형\n- 가. 외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n- 나. 외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n- 다. 구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1. 외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1. 구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2. 외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2. 구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1. 원재료는 다음 양식의 표를 사용하여 기재한다.\n※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n- 가. 명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다. 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나. 배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다. 원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마. 규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n- 바. 비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3. 원재료 작성의 예\n\n- 1. 체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다. | 결과판정 상 주의사항을 기재한다. | 재현성으로 구분하여 평가한다. | 등을 제시한다. 유병률을 구한 경우는 유병률도 제시한다. | 항체 등) | 과의 동등성을 먼저 확인해야 한다. | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다. 헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC. | CORPORATION | MANNHEIM | BEHRING INC. |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx. | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4. 시험자의 연구경력 | 해석을 제시한다. | 하나에 해당하는 자료 | 기간)을 기재한다. | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다. | C1T1C2T2C3T3C4T4C5T5). | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다. | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다. | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다. | BIOMEDITECH | CORP. | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가. 분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다. ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death). | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC. | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다. | TEST | 정확한 로트 번호 확인 | CORP. | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다. | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나. 분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다. | 다. 다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다. | 밀도 등)을 설정한다. | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다. | 술한다. | 을 받는 경우에는 그 조건을 명시하여야 한다. | 시기를 거친 다음 평가를 수행하도록 한다. | 제시한다. | 제시한다. | 결과를 비교한다. 정량검사의 경우는 바이어스를 구한다. | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP. | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2. 별도판매구성품 : OS-Troponin I CalSet\n- 1. '제조원의 제조방법에 따른다.’라고 기재한다. 다만, 다음 각 호에 해당\n- 가. 멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n**[표 시작]**\n\n| 일련 | K973668 | 나. 시험기준 | 중복될 경우 이를 생략한다). | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다. | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다. | 한다. | 않는 성능 배제하고 구체적 근거 자료로 제시한다. | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다. | 서 제외한다. | 허용범위(dmax)를 결정한다. | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다. 시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC. | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1. 사용목적은 성능을 포함하여 다음에 따라 기재한다.\n- 2. 사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마. 정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n- 3. 성능\n- 가. 근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4. 성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\ninfarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다. 69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다. ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98). 급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1. 검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n- 다. 검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다. 환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라. 결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\ncTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다. 만약 심근경색이 여전히 의심된\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n- - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1. 다음의 사항을 포함하여 기재한다.\n- 나. 일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n- 다. 구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n- 라. 사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n- 마. 경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n- 바. 임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사. 검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아. 다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1. 체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1. 저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n- 가. 키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n- 나. 일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다. 시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라. 전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5. 저장방법 및 사용기간(유효기간)작성의 예\n\n- 1. 시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2. 시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n- 가. 시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6. 시험규격 작성의 예\n\n**[표 시작]**\n\n**1. 외관검사**\n**2. 정밀도**\n\n**[표 끝]**\n\n- 3. 재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가. 수입제품은 제조원을 기재하여야 한다.\n- 나. 제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n제조의뢰자와 제조자의 상호와 주소를 모두 기재한다. 다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1. 원칙\n\n- 가. 기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나. 첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다. 해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라. 외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. 다만,\n\n- 2. 시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다. 추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1. 개발경위\n- 가. 측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2. 측정원리 ․ 방법\n- 가. 검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나. 제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n- 3. 국내․외에서 사용현황\n- 가. 국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1. 원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나. 원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2. 제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가. 제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나. 원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다. 일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1. 허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n- 2. 해당제품의 제품설명서(instructions for user)를 제출한다.\n- 1. 완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2. 구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n- 3. 시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n- 4. 안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5. 저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6. 일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7. 수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n- 8. 저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1. 제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라. 완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1. 구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n- 2. 유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1. 이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n- 9. 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1. 시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2. 주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 45 -\n- 3. 연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1. 분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. 호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. 아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다. 검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다. 심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다. 전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. 호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. 아래의 참고방법을 참조할 수\n\n있다.\n\n다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다. 결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다. Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다. 도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다. CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다. 희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2. 분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다. 사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7. 간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다. 대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n<!-- PAGE_57 -->\n###### 3. 정밀도 (반복성, 재현성 등)\n\n- 가. 일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다. 로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n- 다. 결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4. 정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n- 나. 표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ. 성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n- 라. 보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5. 교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다. 시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다. 이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다. 민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다. 질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\nü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\nü ECG 상에서 pathological Q waves의 발생.\n\nü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\nü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n- • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ. 성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험. 다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가. 식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나. 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다. 해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라. 과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1. 임상적 민감도\n\n- 가. 실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등. 평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n- 다. 결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다. 임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2. 임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다. 진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1. 3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n- 2. 시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3. 시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1. 표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2. 자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n- 가. 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1. 시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. 이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n- 2. 검체 취급 및 보관조건에 대한 시험 결과를 제시한다. 이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다. 이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3. 시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1. 일반사항\n- 가. 국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다. 다만, 측정원리 및 측정항목이\n\n- 나. 임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. 분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n- 2. 시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가. 통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나. 임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라. 임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3. 권장 시험방법\n- 가. 해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마. 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4. 결과제시\n- 나. 정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n- 다. 판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n- 라. 결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\nⅧ. 참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1. CLSI. Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline. CLSI document EP25-A. Wayne, PA: Cinical\n\n- 2.\nCLSI.\n\nEvaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\nCLSI document EP5-A2. Wayne, PA: Cinical and Laboratory\n\n- 3.\nCLSI.\n\nUser\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\nCLSI\n\ndocument EP12-A2. Wayne, PA: Cinical and Laboratory Standard\n\n- 4. CLSI. Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline. CLSI document EP17-A.\n\nWayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5. CLSI. Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline. CLSI\n\ndocument EP6-A. Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6. CLSI. Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\nCLSI document EP9-A2-IR. Wayne, PA: Cinical and Laboratory\n\n- 7. CLSI. Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition. CLSI document EP7-A. Wayne, PA:\n\n- 8. Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9. Guidance for industry and FDA staff/ Format for traditional and\n- 10. Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection. Clinical Chemistry\n\nⅨ. 부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1. 심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2. 심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3. 미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP. | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC. | Jul 01 1999 |\n| COULTER INC. | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC. | Jan 16 1998 |\n| BEHRING INC. | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC. | Jun 16 2003 | BEHRING INC. | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC. |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC. |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP. | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP. | BAYER | CORP. | CORP. | CORP. |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP. | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC. | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\nK021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ. 부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC. | CORP. | CORP. | CORP. |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP. | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP. | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC. | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC. |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ. 부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ. 부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n**[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL. |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ. 부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\nⅨ. 부록\n\n- - 79 -",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 130,
        "word_count": 26,
        "page_number": 1,
        "window_text": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction.  | ❍ 제조방법 | 구해진다. ",
        "original_sentence": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018. "
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "7.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 1,
        "window_text": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction.  | ❍ 제조방법 | 구해진다.  | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. ",
        "original_sentence": "7.\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 353,
        "word_count": 60,
        "page_number": 2,
        "window_text": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction.  | ❍ 제조방법 | 구해진다.  | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. ",
        "original_sentence": "발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction. "
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "| ❍ 제조방법 | 구해진다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 15,
        "window_text": "체외진단용 의료기기\n\n<!-- PAGE_1 -->\n## 체외진단용 의료기기 중 심장성\n\n<!-- PAGE_1 -->\n## 트로포닌 검사제품의 허가․심사\n\n<!-- PAGE_1 -->\n## 가이드라인 [민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction.  | ❍ 제조방법 | 구해진다.  | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  | 제시하고, 정량값 판정 등의 기준을 제시한다. ",
        "original_sentence": "| ❍ 제조방법 | 구해진다. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "| 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 21,
        "window_text": "7.\n 발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction.  | ❍ 제조방법 | 구해진다.  | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  | 제시하고, 정량값 판정 등의 기준을 제시한다.  | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다. ",
        "original_sentence": "| 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "| 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 5,
        "window_text": "발간등록번호\n\n안내서-0637-02\n\n제·개정 이력서\n\n<!-- PAGE_2 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_2 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n<!-- PAGE_2 -->\n###### 제․개정\n\n<!-- PAGE_2 -->\n###### 번호\n\n<!-- PAGE_2 -->\n###### 승인일자\n\n<!-- PAGE_2 -->\n###### 주요 내용\n\n심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n제정\n\n**[표 시작]**\n\n| B1-2016-5- | Third universal definition of myocardial infarction.  | ❍ 제조방법 | 구해진다.  | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  | 제시하고, 정량값 판정 등의 기준을 제시한다.  | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다.  | INSTANT-VIEW TROPONIN I | 수도 있다. ",
        "original_sentence": "| 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "| 제시하고, 정량값 판정 등의 기준을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 24,
        "window_text": "| ❍ 제조방법 | 구해진다.  | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  | 제시하고, 정량값 판정 등의 기준을 제시한다.  | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다.  | INSTANT-VIEW TROPONIN I | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다. ",
        "original_sentence": "| 제시하고, 정량값 판정 등의 기준을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "| 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 62,
        "word_count": 21,
        "page_number": 13,
        "window_text": "| 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  | 제시하고, 정량값 판정 등의 기준을 제시한다.  | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다.  | INSTANT-VIEW TROPONIN I | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다. ",
        "original_sentence": "| 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "| INSTANT-VIEW TROPONIN I | 수도 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 35,
        "word_count": 7,
        "page_number": 13,
        "window_text": "| 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  | 제시하고, 정량값 판정 등의 기준을 제시한다.  | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다.  | INSTANT-VIEW TROPONIN I | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.  | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다. ",
        "original_sentence": "| INSTANT-VIEW TROPONIN I | 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "측정은 각 농도별로 2-4회 반복 측정한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 제시하고, 정량값 판정 등의 기준을 제시한다.  | 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다.  | INSTANT-VIEW TROPONIN I | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.  | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다.  | Ⅴ. ",
        "original_sentence": "측정은 각 농도별로 2-4회 반복 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "| 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 439,
        "word_count": 120,
        "page_number": 1,
        "window_text": "| 다) 각각의 농도에서의 검사실내 정밀도 표준편차 | 전체 | a + c | b + d | n | 기재한다.  | INSTANT-VIEW TROPONIN I | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.  | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다.  | Ⅴ.  제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2. ",
        "original_sentence": "| 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "| 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 18,
        "window_text": "| INSTANT-VIEW TROPONIN I | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.  | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다.  | Ⅴ.  제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2.  | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다. ",
        "original_sentence": "| 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "| Ⅴ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 22,
        "window_text": "측정은 각 농도별로 2-4회 반복 측정한다.  | 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.  | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다.  | Ⅴ.  제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2.  | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다.  | 라. ",
        "original_sentence": "| Ⅴ. "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 113,
        "word_count": 27,
        "page_number": 3,
        "window_text": "| 트로포닌-I(사람골격근) | 2 | 8 | 0 | 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | ㎍/L | Cardiac Troponin-I | FIRST | 2 | 8 | 0 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 8 | 포장단위 | 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | Standard Institute; 2004 | 2 | 명칭(모델명) | 지멘스(주) | 2012-12-21 | IMMULITE 2000 Troponin I | 사람의 혈청, 혈장, 전혈(정맥, 모세관) 등을 포함한다.  | 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다.  | Ⅴ.  제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2.  | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다.  | 라.  원료물질의 품질 확인 근거자료 | 민족적 차이 | 6. ",
        "original_sentence": "제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2. "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "| 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 60,
        "word_count": 14,
        "page_number": 13,
        "window_text": "| 3) 결과제시 | 기준 값에 적합함을 확인하는 과정을 제공한다.  | Ⅴ.  제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2.  | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다.  | 라.  원료물질의 품질 확인 근거자료 | 민족적 차이 | 6.  시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다. ",
        "original_sentence": "| 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "| 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| Ⅴ.  제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2.  | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다.  | 라.  원료물질의 품질 확인 근거자료 | 민족적 차이 | 6.  시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다.  | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다. ",
        "original_sentence": "| 라. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "원료물질의 품질 확인 근거자료 | 민족적 차이 | 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 6,
        "window_text": "제조․수입허가 신청서 기재항목 | 17 | 미개봉 | 2~8℃ | 제조일로부터 12개월 | 보조성분 | HEPES | 적량 자사규격 | MODULES | 보조성분 | Phosphate | 2015.2.  | 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다.  | 라.  원료물질의 품질 확인 근거자료 | 민족적 차이 | 6.  시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다.  | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다.  | 또는 이에 준하는 것으로 인정되는 시험자료 | 7. ",
        "original_sentence": "원료물질의 품질 확인 근거자료 | 민족적 차이 | 6. "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 24,
        "window_text": "| 동시에 측정한 상용화된 심장 트로포닌 I (cardiac troponin |\n| 어느 하나가 필요하다.  | 라.  원료물질의 품질 확인 근거자료 | 민족적 차이 | 6.  시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다.  | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다.  | 또는 이에 준하는 것으로 인정되는 시험자료 | 7.  이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다. ",
        "original_sentence": "시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "| 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 83,
        "word_count": 26,
        "page_number": 30,
        "window_text": "| 라.  원료물질의 품질 확인 근거자료 | 민족적 차이 | 6.  시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다.  | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다.  | 또는 이에 준하는 것으로 인정되는 시험자료 | 7.  이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다.  | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다. ",
        "original_sentence": "| 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "| 또는 이에 준하는 것으로 인정되는 시험자료 | 7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 12,
        "window_text": "원료물질의 품질 확인 근거자료 | 민족적 차이 | 6.  시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다.  | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다.  | 또는 이에 준하는 것으로 인정되는 시험자료 | 7.  이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다.  | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다.  | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다. ",
        "original_sentence": "| 또는 이에 준하는 것으로 인정되는 시험자료 | 7. "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 114,
        "word_count": 24,
        "page_number": 5,
        "window_text": "시험성적서에 대한 책임 있는 자의 서명 또는 직인 | 제출한다.  | 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다.  | 또는 이에 준하는 것으로 인정되는 시험자료 | 7.  이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다.  | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다.  | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.  | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC. ",
        "original_sentence": "이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "| VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 109,
        "word_count": 23,
        "page_number": 13,
        "window_text": "| 료기기의 시험에 한함) | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 5) 시험 책임자의 서명 또는 직인 | 등을 기재할 수 있다.  | 또는 이에 준하는 것으로 인정되는 시험자료 | 7.  이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다.  | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다.  | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.  | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC.  | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다. ",
        "original_sentence": "| VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "| 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 133,
        "word_count": 37,
        "page_number": 13,
        "window_text": "| 또는 이에 준하는 것으로 인정되는 시험자료 | 7.  이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다.  | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다.  | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.  | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC.  | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다.  | ALPHA DX ANALYZER 01-0100 | 내용입니까? ",
        "original_sentence": "| 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "| TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 64,
        "word_count": 13,
        "page_number": 5,
        "window_text": "이미 허가·인증받은 제품과 비교한 자료..................43 | 체외진단용 의료기기 중 심근혈관표지자 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | 칠 것을 권장한다.  | VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다.  | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.  | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC.  | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다.  | ALPHA DX ANALYZER 01-0100 | 내용입니까?  | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67. ",
        "original_sentence": "| TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC. "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "| DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 139,
        "word_count": 39,
        "page_number": 2,
        "window_text": "| VIDAS TROPONIN I (TNI) | DIMENSION VISTA CTNI FLEX | SYSTEM | AND 33329 | SYSTEM | 하는 경우에는 세트별로 구분하여 기재한다.  | 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.  | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC.  | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다.  | ALPHA DX ANALYZER 01-0100 | 내용입니까?  | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67.  | 가. ",
        "original_sentence": "| DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "| ALPHA DX ANALYZER 01-0100 | 내용입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 37,
        "word_count": 7,
        "page_number": 2,
        "window_text": "| 검체 | buffer | 적량 | 자사규격 | ㎍/L | BIOMERIEUX | SCIENTIFIC | DADE | ㎍/L | □ 예 | ■ 아니오 | 0.13 |\n| 157 | 안정성을 보장한다면 냉동검체를 일부 이용할 수도 있다.  | TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC.  | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다.  | ALPHA DX ANALYZER 01-0100 | 내용입니까?  | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67.  | 가.  시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다. ",
        "original_sentence": "| ALPHA DX ANALYZER 01-0100 | 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 87,
        "word_count": 18,
        "page_number": 13,
        "window_text": "| TEST | (ng/m | ng/mL | Calibrator (Level 1~5)를 | MEDICAL INC.  | DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다.  | ALPHA DX ANALYZER 01-0100 | 내용입니까?  | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67.  | 가.  시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.  | 한다. ",
        "original_sentence": "| I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "| 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| DIAGNOSTIC | 개정 | % | µg/L | % |\n| ❍ 사용목적(성능) | 법의 평가 또는 물질에 값을 할당하기 위해서 사용되는 물질 | (수출용 의료기기 제외) 불가 | 보조성분 | Mouse IgG | 적량 자사규격 | 제시한다.  | ALPHA DX ANALYZER 01-0100 | 내용입니까?  | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67.  | 가.  시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.  | 한다.  | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1. ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 106,
        "word_count": 21,
        "page_number": 13,
        "window_text": "| ALPHA DX ANALYZER 01-0100 | 내용입니까?  | I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67.  | 가.  시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.  | 한다.  | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1.  명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다. ",
        "original_sentence": "시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "| 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| I) 검사에서는 결과의 최고값으로부터 ROC 분석에 의해 | (ng/mL) | (ng/mL) |\n| Eur Heart J 2012;33:2551-67.  | 가.  시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.  | 한다.  | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1.  명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다.  | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| 가.  시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.  | 한다.  | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1.  명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다.  | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC.  | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다. ",
        "original_sentence": "| 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1. "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 3,
        "window_text": "시험물질 | Device Studies -Frequently Asked Questions, 2010 | 1) 임상적 민감도 | 차반응을 시험하여 검사의 특이도에 대한 자료를 제공해야 한다.  | 한다.  | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1.  명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다.  | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC.  | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다.  검사항목 | 7. ",
        "original_sentence": "명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "| MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 78,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| 한다.  | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1.  명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다.  | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC.  | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다.  검사항목 | 7.  시험기준 및 시험방법. ",
        "original_sentence": "| MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC. "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "| BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 87,
        "word_count": 17,
        "page_number": 13,
        "window_text": "| 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 1.  명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다.  | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC.  | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다.  검사항목 | 7.  시험기준 및 시험방법.  단, 규격이 없는 경우 이에 대한 설정 사유 | 가. ",
        "original_sentence": "| BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "검사항목 | 7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 3,
        "window_text": "명칭(제품명, 품목명, 모델명) | 17 | 토콜을 제시한다.  | MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC.  | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다.  검사항목 | 7.  시험기준 및 시험방법.  단, 규격이 없는 경우 이에 대한 설정 사유 | 가.  표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다. ",
        "original_sentence": "검사항목 | 7. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "시험기준 및 시험방법. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 40,
        "window_text": "| MODEL 30 445 | REAGENT CARTRIDGE | IMMULITE TURBO TROPONIN I | DESIGNS INC.  | BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다.  검사항목 | 7.  시험기준 및 시험방법.  단, 규격이 없는 경우 이에 대한 설정 사유 | 가.  표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다.  | 참고한다. ",
        "original_sentence": "시험기준 및 시험방법. "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "단, 규격이 없는 경우 이에 대한 설정 사유 | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 30,
        "word_count": 10,
        "page_number": 27,
        "window_text": "| BOEHRINGER | BOEHRINGER |\n| • stent thrombosis associated with MI는 심근허혈의 조건에서 심 | 다.  검사항목 | 7.  시험기준 및 시험방법.  단, 규격이 없는 경우 이에 대한 설정 사유 | 가.  표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다.  | 참고한다.  | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "단, 규격이 없는 경우 이에 대한 설정 사유 | 가. "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 63,
        "word_count": 10,
        "page_number": 13,
        "window_text": "검사항목 | 7.  시험기준 및 시험방법.  단, 규격이 없는 경우 이에 대한 설정 사유 | 가.  표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다.  | 참고한다.  | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ. ",
        "original_sentence": "표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "| 참고한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "시험기준 및 시험방법.  단, 규격이 없는 경우 이에 대한 설정 사유 | 가.  표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다.  | 참고한다.  | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ.  성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나. ",
        "original_sentence": "| 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "| 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 108,
        "word_count": 30,
        "page_number": 23,
        "window_text": "단, 규격이 없는 경우 이에 대한 설정 사유 | 가.  표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다.  | 참고한다.  | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ.  성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다. ",
        "original_sentence": "| 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "| □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 282,
        "word_count": 55,
        "page_number": 3,
        "window_text": "표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 로 면역원(immunogen)과 결합한다.  | 참고한다.  | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ.  성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.  | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 151,
        "word_count": 39,
        "page_number": 3,
        "window_text": "| 참고한다.  | 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ.  성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.  | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다.  | 여 설정한다. ",
        "original_sentence": "성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나. "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 21,
        "window_text": "| 3 | 제조(수입)업소명 | ※ 예시 | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 개봉 | 2~8℃ | 개봉일로부터 1개월 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ.  성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.  | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다.  | 여 설정한다.  | 있다. ",
        "original_sentence": "가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "| 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 67,
        "word_count": 21,
        "page_number": 5,
        "window_text": "| □ 예 | ■ 아니오 | STRATUS CS TROPONIN I | CARDIAC T TROPONIN T RAPID | L) | 이용하여 OS-cTnI QC | DADE |\n| VITROS IMMUNODIAGNOSTIC | VANCOUVER BIOTECH HUMAN | ARCHITECT STAT | ALPHA DX MYO/CK/CK-MB/TNI | 적정 기준(optimized cut-off)이 0.50 ㎍/L(ng/mL)로 | ORTHO-CLINI | FISHER | PRODUCTS |\n| Ⅶ.  성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.  | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다.  | 여 설정한다.  | 있다.  | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC. ",
        "original_sentence": "| 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| 여 설정한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 24,
        "window_text": "성능시험에 대한 상세사항 | 44 | MODELS LSKTI1 LSKTI5 | 응급실에서 흉통 환자에 대한 후향적 연구(prospective | H u m a n | MANNHEIM | MANNHEIM |\n| ※ 예시 | 급성 심근경색증의 기준 | ❍ 사용방법 | 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.  | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다.  | 여 설정한다.  | 있다.  | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC.  | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나. ",
        "original_sentence": "| 여 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "| 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 51,
        "window_text": "가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.  | 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다.  | 여 설정한다.  | 있다.  | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC.  | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나.  권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. ",
        "original_sentence": "| 있다. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "| CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 49,
        "word_count": 8,
        "page_number": 13,
        "window_text": "| 범위 등) | 2) 임상적 특이도 | 4) 결과제시 | 마) 실제 검사일수, 검사실의 수 | 서면 인정할 수 있다.  | 여 설정한다.  | 있다.  | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC.  | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나.  권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.  | 기술한다. ",
        "original_sentence": "| CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "| VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 82,
        "word_count": 24,
        "page_number": 13,
        "window_text": "| 여 설정한다.  | 있다.  | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC.  | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나.  권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.  | 기술한다.  | 2. ",
        "original_sentence": "| VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나. "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 79,
        "word_count": 23,
        "page_number": 5,
        "window_text": "| 있다.  | CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC.  | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나.  권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.  | 기술한다.  | 2.  모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다. ",
        "original_sentence": "권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "| 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| CALIBRATOR | Protocol(V.2)에 reP | BEHRING INC.  | VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나.  권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.  | 기술한다.  | 2.  모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다. ",
        "original_sentence": "| 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "| 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "| VANCOUVER | FIRST |\n| 6 | 상관성 평가 | 장 표지자 값이 적어도 한 번은 99th 백분위수 URL 이상으로 상승 | 나.  권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.  | 기술한다.  | 2.  모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다.  | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 38,
        "word_count": 12,
        "page_number": 5,
        "window_text": "권장 시험방법 | 4 | 제조원 및 소재지 | 1) 검출대상이 되는 물질 | 영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.  | 기술한다.  | 2.  모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다.  | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP.  | □ 예 | ■ 아니오 |\n| 나. ",
        "original_sentence": "모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 51,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 기술한다.  | 2.  모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다.  | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP.  | □ 예 | ■ 아니오 |\n| 나.  검사 전 준비사항 | 8. ",
        "original_sentence": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "| 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 46,
        "word_count": 12,
        "page_number": 5,
        "window_text": "| 2.  모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다.  | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP.  | □ 예 | ■ 아니오 |\n| 나.  검사 전 준비사항 | 8.  시험검사 결과 | 나. ",
        "original_sentence": "| 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "| □ 예 | ■ 아니오 |\n| 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 21,
        "word_count": 9,
        "page_number": 3,
        "window_text": "모양 및 구조 | 18 | 과 같은 4가지 형태의 세트를 준비한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다.  | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP.  | □ 예 | ■ 아니오 |\n| 나.  검사 전 준비사항 | 8.  시험검사 결과 | 나.  시험물질 | 나. ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 나. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "검사 전 준비사항 | 8. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | ASSAY | 기재한다.  | 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP.  | □ 예 | ■ 아니오 |\n| 나.  검사 전 준비사항 | 8.  시험검사 결과 | 나.  시험물질 | 나.  출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다. ",
        "original_sentence": "검사 전 준비사항 | 8. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "시험검사 결과 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 1,
        "window_text": "| 0.180 | 0.026 | 14.2 | 0.029 | 15.9 | CORP.  | □ 예 | ■ 아니오 |\n| 나.  검사 전 준비사항 | 8.  시험검사 결과 | 나.  시험물질 | 나.  출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.  | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다. ",
        "original_sentence": "시험검사 결과 | 나. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "시험물질 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 1,
        "window_text": "| □ 예 | ■ 아니오 |\n| 나.  검사 전 준비사항 | 8.  시험검사 결과 | 나.  시험물질 | 나.  출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.  | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다.  다음의 | 산출되었다. ",
        "original_sentence": "시험물질 | 나. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 74,
        "word_count": 19,
        "page_number": 64,
        "window_text": "검사 전 준비사항 | 8.  시험검사 결과 | 나.  시험물질 | 나.  출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.  | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다.  다음의 | 산출되었다.  | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP. ",
        "original_sentence": "출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "| PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 127,
        "word_count": 25,
        "page_number": 13,
        "window_text": "시험검사 결과 | 나.  시험물질 | 나.  출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.  | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다.  다음의 | 산출되었다.  | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP.  | CORP. ",
        "original_sentence": "| PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "다음의 | 산출되었다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 33,
        "window_text": "시험물질 | 나.  출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.  | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다.  다음의 | 산출되었다.  | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP.  | CORP.  |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD. ",
        "original_sentence": "다음의 | 산출되었다. "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "| serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 53,
        "word_count": 14,
        "page_number": 2,
        "window_text": "출처 및 근거 자료 | 기관의 임상시험계획승인을 받고 실시해야함) | 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야 한다.  | PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다.  다음의 | 산출되었다.  | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP.  | CORP.  |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD.  | MEDICAL INC. ",
        "original_sentence": "| serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "| PRODUCTS TROPONIN I | CARDIAC TROPONIN I | TROPONIN-1; MYOGLOBIN | CARDIAC PANEL TEST KIT | study)에 독일 1개 및 미국 1개 병원이 참여하였다.  다음의 | 산출되었다.  | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP.  | CORP.  |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD.  | MEDICAL INC.  | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "|\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 90,
        "word_count": 23,
        "page_number": 5,
        "window_text": "다음의 | 산출되었다.  | serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP.  | CORP.  |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD.  | MEDICAL INC.  | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.  | ❍ 사용 시 주의사항 | 다. ",
        "original_sentence": "|\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD. "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| MEDICAL INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| serum 1 | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | CAL | CORP.  | CORP.  |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD.  | MEDICAL INC.  | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.  | ❍ 사용 시 주의사항 | 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다. ",
        "original_sentence": "| MEDICAL INC. "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "| SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 99,
        "word_count": 22,
        "page_number": 5,
        "window_text": "| CORP.  |\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD.  | MEDICAL INC.  | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.  | ❍ 사용 시 주의사항 | 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.  | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다. ",
        "original_sentence": "| SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다. "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "| ❍ 사용 시 주의사항 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 19,
        "word_count": 7,
        "page_number": 3,
        "window_text": "|\n| 1 | 정밀도 | 보조성분 | Dextran T-500 | 적량 자사규격 | control을 5회 반복하여 CV | TOSOH | BIOTECH LTD.  | MEDICAL INC.  | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.  | ❍ 사용 시 주의사항 | 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.  | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.  | <결과 판정> | Troponin I 농도에 대해 정비례한다. ",
        "original_sentence": "| ❍ 사용 시 주의사항 | 다. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "비교 제품은 각 제품의 사용방법에 따라서 시험한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 24,
        "window_text": "| MEDICAL INC.  | SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.  | ❍ 사용 시 주의사항 | 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.  | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.  | <결과 판정> | Troponin I 농도에 대해 정비례한다.  | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다. ",
        "original_sentence": "비교 제품은 각 제품의 사용방법에 따라서 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "| 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 13,
        "window_text": "| SPECTRAL |\n| 4 | 제조방법 | 급성 심근경색증(MI)이라는 용어는 급성 심근허혈에 부합되는 임상 | 및/또는 하강하며 관상동맥조영술이나 부검에서 발견될 때이다.  | ❍ 사용 시 주의사항 | 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.  | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.  | <결과 판정> | Troponin I 농도에 대해 정비례한다.  | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다.  | 바) 총 run의 수(해당되는 경우 제시) | 1. ",
        "original_sentence": "| 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "| <결과 판정> | Troponin I 농도에 대해 정비례한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 13,
        "window_text": "| ❍ 사용 시 주의사항 | 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.  | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.  | <결과 판정> | Troponin I 농도에 대해 정비례한다.  | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다.  | 바) 총 run의 수(해당되는 경우 제시) | 1.  분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까? ",
        "original_sentence": "| <결과 판정> | Troponin I 농도에 대해 정비례한다. "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "| 가) 직선성 범위의 농도 구간을 제시하도록 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 24,
        "window_text": "비교 제품은 각 제품의 사용방법에 따라서 시험한다.  | 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.  | <결과 판정> | Troponin I 농도에 대해 정비례한다.  | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다.  | 바) 총 run의 수(해당되는 경우 제시) | 1.  분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까?  |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3. ",
        "original_sentence": "| 가) 직선성 범위의 농도 구간을 제시하도록 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "| 바) 총 run의 수(해당되는 경우 제시) | 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 5,
        "window_text": "| 변경은 반드시 분해능(resolution)에 비하여 큰 차이여야 한다.  | <결과 판정> | Troponin I 농도에 대해 정비례한다.  | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다.  | 바) 총 run의 수(해당되는 경우 제시) | 1.  분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까?  |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3.  원재료 | 22 | 평가한다. ",
        "original_sentence": "| 바) 총 run의 수(해당되는 경우 제시) | 1. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 5,
        "window_text": "| <결과 판정> | Troponin I 농도에 대해 정비례한다.  | 가) 직선성 범위의 농도 구간을 제시하도록 권장한다.  | 바) 총 run의 수(해당되는 경우 제시) | 1.  분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까?  |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3.  원재료 | 22 | 평가한다.  | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다. ",
        "original_sentence": "분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "|\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 68,
        "word_count": 19,
        "page_number": 2,
        "window_text": "| 가) 직선성 범위의 농도 구간을 제시하도록 권장한다.  | 바) 총 run의 수(해당되는 경우 제시) | 1.  분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까?  |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3.  원재료 | 22 | 평가한다.  | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다.  | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다. ",
        "original_sentence": "|\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3. "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "원재료 | 22 | 평가한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 바) 총 run의 수(해당되는 경우 제시) | 1.  분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까?  |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3.  원재료 | 22 | 평가한다.  | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다.  | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다.  | ASSAY | Sens. ",
        "original_sentence": "원재료 | 22 | 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "| REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 244,
        "word_count": 55,
        "page_number": 13,
        "window_text": "분석적 성능시험에 관한 자료 | 45 | DIMENSION TNI FLEX REAGENT | 정리한 자료입니까?  |\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3.  원재료 | 22 | 평가한다.  | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다.  | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다.  | ASSAY | Sens.  | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다. ",
        "original_sentence": "| REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "| 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 82,
        "word_count": 20,
        "page_number": 2,
        "window_text": "|\n| 안내서-0637 | 2 | 임상적 성능시험에 관한 자료 | ※ 예시 : cardiac Troponin I | 3.  원재료 | 22 | 평가한다.  | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다.  | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다.  | ASSAY | Sens.  | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다.  | MEDICS INC. ",
        "original_sentence": "| 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "| ASSAY | Sens. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 13,
        "window_text": "원재료 | 22 | 평가한다.  | REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다.  | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다.  | ASSAY | Sens.  | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다.  | MEDICS INC.  | SIEMENS | Speci. ",
        "original_sentence": "| ASSAY | Sens. "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "| 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| REAGENT PACK AND | IMMUNOASSAY TEST KIT | 03-0001 ALPHA DX CK/CK-MB | CARDIOQUANT TROPONIN I | 기준에 의해 선택된 358명의 피험자의 민감도와 특이도를 | H u m a n | Cut-off | 허가․심사 가이드라인 [민원인 안내서]｣ 명칭 변경 및 | 95% | DIAGNOSTICS | STRECK | 95% |\n| lot 이상의 시험성적서를 제출한다.  | 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다.  | ASSAY | Sens.  | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다.  | MEDICS INC.  | SIEMENS | Speci.  |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다. ",
        "original_sentence": "| 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다. "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "| MEDICS INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| 5 | 허가번호 | 가) 분석물질 양성(판정기준치 이상)인 검체(간섭물질 없음) | 전처리가 필요한 경우에 한함) | 계산법을 함께 제시한다.  | ASSAY | Sens.  | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다.  | MEDICS INC.  | SIEMENS | Speci.  |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다.  이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다. ",
        "original_sentence": "| MEDICS INC. "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "| SIEMENS | Speci. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 13,
        "window_text": "| ASSAY | Sens.  | 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다.  | MEDICS INC.  | SIEMENS | Speci.  |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다.  이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
        "original_sentence": "| SIEMENS | Speci. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "|\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 24,
        "window_text": "| 0.197 | 0.020 | 10.0 | 0.026 | 13.4 | 값을 구한다.  | MEDICS INC.  | SIEMENS | Speci.  |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다.  이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "|\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 57,
        "word_count": 17,
        "page_number": 5,
        "window_text": "| MEDICS INC.  | SIEMENS | Speci.  |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다.  이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5. ",
        "original_sentence": "이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다. "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| SIEMENS | Speci.  |\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다.  이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5.  | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2. ",
        "original_sentence": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 2,
        "window_text": "|\n| 조건에서 심근괴사의 증거가 있을 때에 사용되어야 한다.  이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5.  | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2.  임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다. ",
        "original_sentence": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "| NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 5,
        "window_text": "이러한 | 1) 다양한 교차 반응 가능 물질이 포함된 검체 | 또는 1배치 3회 이상) | 판단한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5.  | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2.  임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다.  | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi. ",
        "original_sentence": "| NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5. "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "| serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 118,
        "word_count": 30,
        "page_number": 13,
        "window_text": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5.  | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2.  임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다.  | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi.  | INC. ",
        "original_sentence": "| serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 6,
        "window_text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5.  | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2.  임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다.  | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi.  | INC.  | LABORATORIE | INC. ",
        "original_sentence": "임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "| BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 121,
        "word_count": 27,
        "page_number": 13,
        "window_text": "| NANO-CHECK AMI 3 IN 1 | CARTRIDGE AND CTNI SAMPLE | 2017.5.  | serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2.  임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다.  | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi.  | INC.  | LABORATORIE | INC.  | % | N | confi. ",
        "original_sentence": "| BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi. "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 13,
        "window_text": "| serum 2 | DIAGNOSTICS |\n| • 관상동맥우회술(CABG) related MI는 정상 cTn 기저 값(≤99th | ❍ 포장단위 | 나 또는 그 이상의 값을 갖는 참고물질 | -01 | 2.  임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다.  | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi.  | INC.  | LABORATORIE | INC.  | % | N | confi.  |\n| 라. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "| LABORATORIE | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 13,
        "window_text": "임상적 성능시험에 관한 자료 | 56 | 등성을 먼저 확인해야 한다.  | BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi.  | INC.  | LABORATORIE | INC.  | % | N | confi.  |\n| 라.  정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다. ",
        "original_sentence": "| LABORATORIE | INC. "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "| % | N | confi. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 17,
        "word_count": 6,
        "page_number": 13,
        "window_text": "| BIOCHECK HUMAN CARDIAC | CALIBRATORS | PANEL TEST KIT | TEST | ㎍/L(ng/ | 제·개정 점검표 등 추가 [근거: ｢식품의약품안전처 | % | N | confi.  | INC.  | LABORATORIE | INC.  | % | N | confi.  |\n| 라.  정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.  | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005. ",
        "original_sentence": "| % | N | confi. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "|\n| 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 7,
        "word_count": 3,
        "page_number": 1,
        "window_text": "| INC.  | LABORATORIE | INC.  | % | N | confi.  |\n| 라.  정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.  | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005.  | 사) 총 관찰치의 수 : optional | 4. ",
        "original_sentence": "|\n| 라. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 21,
        "window_text": "| LABORATORIE | INC.  | % | N | confi.  |\n| 라.  정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.  | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005.  | 사) 총 관찰치의 수 : optional | 4.  제조방법 | 24 | 등을 제시한다. ",
        "original_sentence": "정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "| 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 5,
        "window_text": "| % | N | confi.  |\n| 라.  정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.  | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005.  | 사) 총 관찰치의 수 : optional | 4.  제조방법 | 24 | 등을 제시한다.  | 설정한다. ",
        "original_sentence": "| 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "| 사) 총 관찰치의 수 : optional | 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 30,
        "word_count": 9,
        "page_number": 5,
        "window_text": "|\n| 라.  정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.  | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005.  | 사) 총 관찰치의 수 : optional | 4.  제조방법 | 24 | 등을 제시한다.  | 설정한다.  | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라. ",
        "original_sentence": "| 사) 총 관찰치의 수 : optional | 4. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "제조방법 | 24 | 등을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 21,
        "word_count": 6,
        "page_number": 5,
        "window_text": "정량검사의 경우 각 검사를 2회 이상 반복 측정을 권장한다.  | 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005.  | 사) 총 관찰치의 수 : optional | 4.  제조방법 | 24 | 등을 제시한다.  | 설정한다.  | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라.  측정원리 : 측정에 사용된 검사 원리 | 마. ",
        "original_sentence": "제조방법 | 24 | 등을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "| 설정한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| 6 | 사용목적 | 예 | □ | abbreviated 510(k)s, 2005.  | 사) 총 관찰치의 수 : optional | 4.  제조방법 | 24 | 등을 제시한다.  | 설정한다.  | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라.  측정원리 : 측정에 사용된 검사 원리 | 마.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다. ",
        "original_sentence": "| 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "| 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 56,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| 사) 총 관찰치의 수 : optional | 4.  제조방법 | 24 | 등을 제시한다.  | 설정한다.  | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라.  측정원리 : 측정에 사용된 검사 원리 | 마.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다.  | 기구 및 조건 등을 기재한다. ",
        "original_sentence": "| 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "측정원리 : 측정에 사용된 검사 원리 | 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 1,
        "window_text": "제조방법 | 24 | 등을 제시한다.  | 설정한다.  | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라.  측정원리 : 측정에 사용된 검사 원리 | 마.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다.  | 기구 및 조건 등을 기재한다.  | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다. ",
        "original_sentence": "측정원리 : 측정에 사용된 검사 원리 | 마. "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 61,
        "word_count": 16,
        "page_number": 6,
        "window_text": "| 설정한다.  | 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라.  측정원리 : 측정에 사용된 검사 원리 | 마.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다.  | 기구 및 조건 등을 기재한다.  | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다.  | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다. ",
        "original_sentence": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "| 기구 및 조건 등을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 24,
        "window_text": "| 산출하였다: 내원 전 24시간 이내 흉통 시작, 20분 넘는 | HEALTHCARE |\n| 라.  측정원리 : 측정에 사용된 검사 원리 | 마.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다.  | 기구 및 조건 등을 기재한다.  | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다.  | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다.  | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다. ",
        "original_sentence": "| 기구 및 조건 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "| 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 40,
        "word_count": 11,
        "page_number": 24,
        "window_text": "측정원리 : 측정에 사용된 검사 원리 | 마.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다.  | 기구 및 조건 등을 기재한다.  | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다.  | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다.  | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다.  | H u m a n | Mouse monoclonal | 기재한다. ",
        "original_sentence": "| 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "| 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 64,
        "word_count": 15,
        "page_number": 13,
        "window_text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 기재한 경우, 해당 설정 값에 대한 근거를 제시한다.  | 기구 및 조건 등을 기재한다.  | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다.  | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다.  | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다.  | H u m a n | Mouse monoclonal | 기재한다.  | BIOCHECK | I-STAT | TEXAS | CHIRON | INC. ",
        "original_sentence": "| 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "| I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 96,
        "word_count": 18,
        "page_number": 13,
        "window_text": "| 기구 및 조건 등을 기재한다.  | 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다.  | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다.  | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다.  | H u m a n | Mouse monoclonal | 기재한다.  | BIOCHECK | I-STAT | TEXAS | CHIRON | INC.  |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter. ",
        "original_sentence": "| I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "| H u m a n | Mouse monoclonal | 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 13,
        "window_text": "| 필요한 경우에 한함) | 포함된 논문, 문헌 등의 자료를 제출한다.  | 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다.  | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다.  | H u m a n | Mouse monoclonal | 기재한다.  | BIOCHECK | I-STAT | TEXAS | CHIRON | INC.  |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter.  | S INC. ",
        "original_sentence": "| H u m a n | Mouse monoclonal | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "| BIOCHECK | I-STAT | TEXAS | CHIRON | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 13,
        "window_text": "| 나) 분석물질 양성(판정기준치 이상)인 검체 + 간섭물질 | 분석법 등에 대한 자세한 실험프로토콜을 제공한다.  | I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다.  | H u m a n | Mouse monoclonal | 기재한다.  | BIOCHECK | I-STAT | TEXAS | CHIRON | INC.  |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter.  | S INC.  | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함. ",
        "original_sentence": "| BIOCHECK | I-STAT | TEXAS | CHIRON | INC. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "|\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 201,
        "word_count": 48,
        "page_number": 13,
        "window_text": "| I-STAT CARDIAC TROPONIN | CARDIAC DISEASE TEST FOR | DILUENT WITH MODELS RF621 | 포함할 것을 권장한다.  | H u m a n | Mouse monoclonal | 기재한다.  | BIOCHECK | I-STAT | TEXAS | CHIRON | INC.  |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter.  | S INC.  | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함.  | ng/mL) | 아) 시약 lot의 수 | 3. ",
        "original_sentence": "|\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter. "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "| S INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| H u m a n | Mouse monoclonal | 기재한다.  | BIOCHECK | I-STAT | TEXAS | CHIRON | INC.  |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter.  | S INC.  | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함.  | ng/mL) | 아) 시약 lot의 수 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다. ",
        "original_sentence": "| S INC. "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "| inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 182,
        "word_count": 45,
        "page_number": 13,
        "window_text": "| BIOCHECK | I-STAT | TEXAS | CHIRON | INC.  |\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter.  | S INC.  | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함.  | ng/mL) | 아) 시약 lot의 수 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다.  | 자료를 제시한다. ",
        "original_sentence": "| inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "| ng/mL) | 아) 시약 lot의 수 | 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 13,
        "window_text": "|\n| 조건들 하에서 다음의 기준들 중 어느 하나만 있어도 심근경색증의 | percentile URL)을 가진 환자에서 심장표지자 값이 증가(>10 x | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | mL) | 지침서등의 관리에 관한 규정｣ 개정, ‘17.5.1] | 0.322 | 0.017 | 5.3 | 0.028 | 8.7 | inter.  | S INC.  | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함.  | ng/mL) | 아) 시약 lot의 수 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다.  | 자료를 제시한다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다. ",
        "original_sentence": "| ng/mL) | 아) 시약 lot의 수 | 3. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 60,
        "word_count": 15,
        "page_number": 6,
        "window_text": "| S INC.  | inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함.  | ng/mL) | 아) 시약 lot의 수 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다.  | 자료를 제시한다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.  | serum 3 | INC. ",
        "original_sentence": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "| 자료를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 24,
        "window_text": "| inte |\n| 2) 시험방법 | 또는 이를 공증한 자료 | TROPONIN-I IMMUNOASSAY | 흉통, ECG 기준에 의해 평가, 20세 초과, 임신하지 않은 | NANO-DITEC | DIAGNOSTICS | ORTHO-CLINI | 아니오 | □ |\n| ❍ 저장방법 및 사용기간 | 사 제품에 한하여 가능함.  | ng/mL) | 아) 시약 lot의 수 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다.  | 자료를 제시한다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.  | serum 3 | INC.  | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바. ",
        "original_sentence": "| 자료를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| ng/mL) | 아) 시약 lot의 수 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다.  | 자료를 제시한다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.  | serum 3 | INC.  | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바.  검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다. ",
        "original_sentence": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "| serum 3 | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 13,
        "window_text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료 | 63 | (20일 이상 권장) 시행하기를 권장한다.  | 자료를 제시한다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.  | serum 3 | INC.  | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바.  검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다.  판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5. ",
        "original_sentence": "| serum 3 | INC. "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "| □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 47,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 자료를 제시한다.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.  | serum 3 | INC.  | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바.  검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다.  판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5.  사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등). ",
        "original_sentence": "| □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 40,
        "word_count": 12,
        "page_number": 31,
        "window_text": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사무 | 일은 3-5일 이상, 측정시 2번 이상 반복검사를 권장한다.  | serum 3 | INC.  | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바.  검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다.  판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5.  사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등).  | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL. ",
        "original_sentence": "검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 63,
        "word_count": 15,
        "page_number": 13,
        "window_text": "| serum 3 | INC.  | □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바.  검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다.  판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5.  사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등).  | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL.  | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다. ",
        "original_sentence": "판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5. "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등). ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| □ 예(☞지침서) | ■ 아니오 |\n| ※ 예시 : 화학발광 면역측정법 | 바.  검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다.  판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5.  사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등).  | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL.  | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다.  추가로, (i) 새로 | 라. ",
        "original_sentence": "사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등). "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "| 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 138,
        "word_count": 24,
        "page_number": 6,
        "window_text": "검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 다.  판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5.  사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등).  | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL.  | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다.  추가로, (i) 새로 | 라.  분량 | 10. ",
        "original_sentence": "| 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "| IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 105,
        "word_count": 24,
        "page_number": 13,
        "window_text": "판정기준치(cut-off value) | Institute; 2008 | 7 | 작용원리 | 예 | □ | 5.  사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등).  | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL.  | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다.  추가로, (i) 새로 | 라.  분량 | 10.  시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. ",
        "original_sentence": "| IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다. "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "추가로, (i) 새로 | 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 1,
        "window_text": "사용목적(성능) | 25 | 가슴통증으로 응급실 내원한 환자, 입원환자 등).  | 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL.  | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다.  추가로, (i) 새로 | 라.  분량 | 10.  시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "추가로, (i) 새로 | 라. "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "분량 | 10. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 5,
        "window_text": "| 주성분 | (CTNI) TEST | CARDIAC TROPONIN I | KD692 | DADE STRATUS TROPONIN-I | VITROS IMMUNODIAGNOSTIC | cardiac    troponin-I | DADE INTL.  | IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다.  추가로, (i) 새로 | 라.  분량 | 10.  시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO. ",
        "original_sentence": "분량 | 10. "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 81,
        "word_count": 17,
        "page_number": 5,
        "window_text": "| IMMUNOLOGY | DIAGNOSTICS | 2 | 자사규격 |\n| 7 | 사용시 주의사항 | 진단을 충족한다: | 99th percentile URL)된 경우로 임의로 정의된다.  추가로, (i) 새로 | 라.  분량 | 10.  시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO.  |\n| 있는 물질의 예는 다음과 같다. ",
        "original_sentence": "시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "| 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 116,
        "word_count": 26,
        "page_number": 13,
        "window_text": "추가로, (i) 새로 | 라.  분량 | 10.  시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO.  |\n| 있는 물질의 예는 다음과 같다.  | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사. ",
        "original_sentence": "| 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "(공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 62,
        "word_count": 22,
        "page_number": 21,
        "window_text": "분량 | 10.  시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO.  |\n| 있는 물질의 예는 다음과 같다.  | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사.  국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4. ",
        "original_sentence": "(공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO. "
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "|\n| 있는 물질의 예는 다음과 같다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 48,
        "window_text": "시험 환경요인(시험결과에 영향을 주는 경우에 한함) | of agreement) | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO.  |\n| 있는 물질의 예는 다음과 같다.  | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사.  국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC. ",
        "original_sentence": "|\n| 있는 물질의 예는 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "| 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 76,
        "word_count": 22,
        "page_number": 5,
        "window_text": "| 2) 시험물질 | 다) 분석물질 음성(판정기준치 이하)인 검체(간섭물질 없음) | TEST KIT | TEST | TROPONIN I ASSAY (CTNI) | 의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO.  |\n| 있는 물질의 예는 다음과 같다.  | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사.  국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC.  | INC. ",
        "original_sentence": "| 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사. "
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 58,
        "word_count": 11,
        "page_number": 13,
        "window_text": "(공무원용) | 사람, 내원 전 및 최소 2회 채혈 전 3주 이내 심근경색 | H u m a n | H CO.  |\n| 있는 물질의 예는 다음과 같다.  | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사.  국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC.  | INC.  | CORP. ",
        "original_sentence": "국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4. "
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 159,
        "word_count": 33,
        "page_number": 5,
        "window_text": "|\n| 있는 물질의 예는 다음과 같다.  | 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사.  국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC.  | INC.  | CORP.  | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다. ",
        "original_sentence": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 13,
        "window_text": "| 0.425 | 0.022 | 5.2 | 0.031 | 7.3 | ROCHE | SIEMENS | CAL |\n| ❍ 시험규격 | 사.  국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC.  | INC.  | CORP.  | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다.  | 가. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "국내·외 허가제품과의 상관성 시험에 대한 시험성적서 | <참고치(Expected value)> | 4.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC.  | INC.  | CORP.  | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다.  | 가.  최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "| 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 141,
        "word_count": 33,
        "page_number": 32,
        "window_text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 64 | MODIFICATION TO ALPHA DX | CREATINE KINASE MB AND | CONTROL | PRODUCTS TROPONIN I RANGE | antibody fragment | FIRST | INC.  | INC.  | CORP.  | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다.  | 가.  최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다.  | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다. ",
        "original_sentence": "| 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "| 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| INC.  | CORP.  | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다.  | 가.  최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다.  | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다.  | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6. ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 59,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| CORP.  | 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다.  | 가.  최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다.  | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다.  | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6.  사용방법 | 29 | 제시한다. ",
        "original_sentence": "최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "| (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 78,
        "word_count": 13,
        "page_number": 13,
        "window_text": "| 아니오 | □ |\n| • 적어도 한 번은 99 백분위수 참고구간 상한(upper reference | 운 pathological Q waves나 새로운 LBBB, 또는 (ii) graft나 native | 사망 위험을 예측하기 위한 값을 보여준다.  | 가.  최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다.  | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다.  | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6.  사용방법 | 29 | 제시한다.  | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음. ",
        "original_sentence": "| (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "| 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 55,
        "word_count": 13,
        "page_number": 13,
        "window_text": "| 가.  최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다.  | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다.  | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6.  사용방법 | 29 | 제시한다.  | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음.  또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다. ",
        "original_sentence": "| 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6. "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "사용방법 | 29 | 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 5,
        "window_text": "최소검출한계(Limit of detection, LoD) | 하는 경우에는 해당사항을 부가하여 기재한다.  | (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다.  | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6.  사용방법 | 29 | 제시한다.  | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음.  또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다.  | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. ",
        "original_sentence": "사용방법 | 29 | 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "| □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 47,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| (주)오송진단         심질환표지자검사시약      OS-Troponin I Test | 하고 이에 대한 자료를 제공하여야 한다.  | 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6.  사용방법 | 29 | 제시한다.  | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음.  또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다.  | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다. ",
        "original_sentence": "| □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 53,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| 라) 참고 | 자) Calibration 시행 횟수와 calibrator lot의 수 | 6.  사용방법 | 29 | 제시한다.  | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음.  또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다.  | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다.  | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. ",
        "original_sentence": "또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "| 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 3,
        "window_text": "사용방법 | 29 | 제시한다.  | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음.  또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다.  | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다.  | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? ",
        "original_sentence": "| 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "| 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 41,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | 없음.  또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다.  | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다.  | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5. ",
        "original_sentence": "| 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "| 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 67,
        "word_count": 17,
        "page_number": 13,
        "window_text": "또 다른 기준으로는 동시에 측정된 상용화된 troponin | serum 4 |\n| 포함한다.  | 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다.  | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5.  검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. ",
        "original_sentence": "| 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "| STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 302,
        "word_count": 71,
        "page_number": 25,
        "window_text": "| 구분 | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다.  | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5.  검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다. ",
        "original_sentence": "| STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "(민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 123,
        "word_count": 24,
        "page_number": 32,
        "window_text": "| 1) 일반사항 | 과 분석 자료 | 확인할 수 있는 자료를 제출한다.  | 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5.  검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다.  비혈관 | MEDICAL INC. ",
        "original_sentence": "(민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 65,
        "word_count": 16,
        "page_number": 18,
        "window_text": "| 라) 분석물질 음성(판정기준치 이하)인 검체 + 간섭물질 | 사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5.  검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다.  비혈관 | MEDICAL INC.  |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가. ",
        "original_sentence": "검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "| SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 101,
        "word_count": 18,
        "page_number": 5,
        "window_text": "| STRATUS CARDIAC | STRATUS CS CARDIAC | ｢체외진단용 시약 중 심장성 트로포닌 검사제품의 | DIAGNOSTICS | HEALTHCARE | SPECTRAL | DADE | DIAGNOSTICS | ■ 예(☞안내서) | □ 아니오 |\n| 9 | 저장방법 및 사용기간 | 8 | 원재료 | 예 | □ | ※ 예시 | 보조성분 | Bovine serum albumin | 적량 자사규격 | MYOGLOBIN | VERIFIERS | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5.  검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다.  비혈관 | MEDICAL INC.  |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가.  인정범위 | -02 | 2018.7. ",
        "original_sentence": "| SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다. "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "비혈관 | MEDICAL INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 13,
        "window_text": "(민원인용) | 본 제품과 자사 기허가 제품(제 수허 00-0000호)과의 | H u m a n |\n| 안내서-0637 | ↓                     ↓                        ↓ | 5.  검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다.  비혈관 | MEDICAL INC.  |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가.  인정범위 | -02 | 2018.7.  | 7. ",
        "original_sentence": "비혈관 | MEDICAL INC. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "|\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 130,
        "word_count": 29,
        "page_number": 13,
        "window_text": "검체보관 및 취급상(온도, 습도 등)의 조건 설정 | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다.  비혈관 | MEDICAL INC.  |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가.  인정범위 | -02 | 2018.7.  | 7.  사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC. ",
        "original_sentence": "|\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가. "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "인정범위 | -02 | 2018.7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| SYSTEM | TROPONIN T | CALIBRATOR MODEL RC621 | CARDIAC STATUS | I 검사 결과의 유효성(availability)이 사용되었다.  비혈관 | MEDICAL INC.  |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가.  인정범위 | -02 | 2018.7.  | 7.  사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC.  | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다. ",
        "original_sentence": "인정범위 | -02 | 2018.7. "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "| 7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 36,
        "window_text": "비혈관 | MEDICAL INC.  |\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가.  인정범위 | -02 | 2018.7.  | 7.  사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC.  | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. ",
        "original_sentence": "| 7. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 94,
        "word_count": 25,
        "page_number": 3,
        "window_text": "|\n| limit, URL)을 넘는 심장 표지자[가급적이면 심장성 troponin | coronary artery의 새로운 폐색이 혈관조영술로 입증, 또는 (iii) 새 | ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우) | 가.  인정범위 | -02 | 2018.7.  | 7.  사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC.  | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 량, 반정량 검사용 등을 명확하게 기재한다. ",
        "original_sentence": "사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "| 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 46,
        "word_count": 14,
        "page_number": 5,
        "window_text": "인정범위 | -02 | 2018.7.  | 7.  사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC.  | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 량, 반정량 검사용 등을 명확하게 기재한다.  | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다. ",
        "original_sentence": "| 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "| 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 49,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| 7.  사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC.  | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 량, 반정량 검사용 등을 명확하게 기재한다.  | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다.  | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP. ",
        "original_sentence": "| 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "| 량, 반정량 검사용 등을 명확하게 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 24,
        "window_text": "사용시 주의사항 | 31 | serum 5 | 17.6 | 0.479 | 2.7 | 0.823 | 4.7 | 허가․심사 가이드라인 [민원인 안내서]｣ 개정 | INC.  | 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 량, 반정량 검사용 등을 명확하게 기재한다.  | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다.  | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC. ",
        "original_sentence": "| 량, 반정량 검사용 등을 명확하게 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "| 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 84,
        "word_count": 21,
        "page_number": 32,
        "window_text": "| 아니오 | □ | 1x10 |\n| 된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 량, 반정량 검사용 등을 명확하게 기재한다.  | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다.  | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC.  |\n| 3 | R | 나. ",
        "original_sentence": "| 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "| ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 93,
        "word_count": 16,
        "page_number": 13,
        "window_text": "| 1) 시험물질 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 량, 반정량 검사용 등을 명확하게 기재한다.  | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다.  | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC.  |\n| 3 | R | 나.  표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다. ",
        "original_sentence": "| ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP. "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "| DIAGNOSTICS | DIAGNOSTICS | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 43,
        "word_count": 7,
        "page_number": 13,
        "window_text": "| 량, 반정량 검사용 등을 명확하게 기재한다.  | 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다.  | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC.  |\n| 3 | R | 나.  표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.  | 한다. ",
        "original_sentence": "| DIAGNOSTICS | DIAGNOSTICS | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "|\n| 3 | R | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 15,
        "word_count": 7,
        "page_number": 25,
        "window_text": "| 게재된 자료 | 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | 역가를 기재 | 임상적 | 100개 이상 평가할 것을 권장한다.  | ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC.  |\n| 3 | R | 나.  표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.  | 한다.  | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
        "original_sentence": "|\n| 3 | R | 나. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 62,
        "word_count": 14,
        "page_number": 32,
        "window_text": "| ROCHE ELECSYS TROPONIN T | TROPONIN-I FLUOROMETRIC | TROPONIN I TESTPAK | SPECTRAL | CORP.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING INC.  |\n| 3 | R | 나.  표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.  | 한다.  | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. ",
        "original_sentence": "표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "| 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| DIAGNOSTICS | DIAGNOSTICS | BEHRING INC.  |\n| 3 | R | 나.  표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.  | 한다.  | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 체외진단용 시약을 중심으로 사용방법을 기술한다. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "| 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 231,
        "word_count": 45,
        "page_number": 3,
        "window_text": "|\n| 3 | R | 나.  표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.  | 한다.  | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 체외진단용 시약을 중심으로 사용방법을 기술한다.  | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다. ",
        "original_sentence": "| 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "**[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 24,
        "window_text": "표준물질 관리방법 및 관리기록서(정도관리 포함) | 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.  | 한다.  | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 체외진단용 시약을 중심으로 사용방법을 기술한다.  | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다.  | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC. ",
        "original_sentence": "**[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "| 체외진단용 시약을 중심으로 사용방법을 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 24,
        "window_text": "| 한다.  | 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 체외진단용 시약을 중심으로 사용방법을 기술한다.  | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다.  | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC.  | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP. ",
        "original_sentence": "| 체외진단용 시약을 중심으로 사용방법을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "| 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 303,
        "word_count": 86,
        "page_number": 25,
        "window_text": "| 상관성을 (CLSI EP9-A2 실험 결과치) 121[0.165 ~ |\n\n**[표 끝]**\n\n(현재 적용중인 의료기기 허가규정의 개정내용을 반영)\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 체외진단용 시약 중 심장성 트로포닌 검사제품\n\n<!-- PAGE_3 -->\n###### 허가․심사 가이드라인 [민원인 안내서]\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 체외진단용 시약을 중심으로 사용방법을 기술한다.  | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다.  | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC.  | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP.  | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다. ",
        "original_sentence": "| 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다. "
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "| ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 55,
        "word_count": 8,
        "page_number": 13,
        "window_text": "**[표 시작]**\n\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 체외진단용 시약을 중심으로 사용방법을 기술한다.  | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다.  | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC.  | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP.  | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다.  시험방법 | 나. ",
        "original_sentence": "| ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "| x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 86,
        "word_count": 20,
        "page_number": 5,
        "window_text": "| 체외진단용 시약을 중심으로 사용방법을 기술한다.  | 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다.  | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC.  | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP.  | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다.  시험방법 | 나.  기재내용 | 나. ",
        "original_sentence": "| x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP. "
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "| SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 89,
        "word_count": 19,
        "page_number": 13,
        "window_text": "| 성능, 시험규격, 사용방법을 비교한 별제 제3호서식의 비교표 | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- |\n| 번호 | 성능항목 | 방법 및 결과 | Troponin T, TnT) 검사 제품의 허가․심사 시에 요구되는 신청서 | K023505 | 1 | 명칭 (제품명, 품목명, 모델명) | Cal1 | ADV | T | 보조성분 | Human serum | 적량 | 자사규격 | 농도에서 의미 있는 교차 반응이 나타나지 않았다.  | ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC.  | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP.  | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다.  시험방법 | 나.  기재내용 | 나.  최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. ",
        "original_sentence": "| SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다. "
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "시험방법 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 40,
        "window_text": "| ㎍/L(ng/mL))에 대해 산출한 민감도(sensitivity)와 | SYSTEMS INC.  | x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP.  | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다.  시험방법 | 나.  기재내용 | 나.  최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.  | 져야 한다. ",
        "original_sentence": "시험방법 | 나. "
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "기재내용 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 1,
        "window_text": "| x1 |\n| K974103 | ABBOTT AXSYM TROPONIN-I | 관한 자료 | 39 | Troponin I antibody | CORP.  | SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다.  시험방법 | 나.  기재내용 | 나.  최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.  | 져야 한다.  | 어떻게 처리해야 하는지에 대한 지침을 제시한다. ",
        "original_sentence": "기재내용 | 나. "
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 74,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| SIEMENS | LABORATORIE | TOSOH |\n| 저 값(≤99th percentile URL)을 가진 환자에서 cTn 값이 상승(>5 | 다.  시험방법 | 나.  기재내용 | 나.  최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.  | 져야 한다.  | 어떻게 처리해야 하는지에 대한 지침을 제시한다.  | 권장한다. ",
        "original_sentence": "최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "| 져야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 11,
        "window_text": "시험방법 | 나.  기재내용 | 나.  최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.  | 져야 한다.  | 어떻게 처리해야 하는지에 대한 지침을 제시한다.  | 권장한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. ",
        "original_sentence": "| 져야 한다. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "| 어떻게 처리해야 하는지에 대한 지침을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 24,
        "window_text": "기재내용 | 나.  최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.  | 져야 한다.  | 어떻게 처리해야 하는지에 대한 지침을 제시한다.  | 권장한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까? ",
        "original_sentence": "| 어떻게 처리해야 하는지에 대한 지침을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "| 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "최소정량한계(Limit of quantitation, LoQ) | ‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.  | 져야 한다.  | 어떻게 처리해야 하는지에 대한 지침을 제시한다.  | 권장한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까?  | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD. ",
        "original_sentence": "| 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "| 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 24,
        "window_text": "| 져야 한다.  | 어떻게 처리해야 하는지에 대한 지침을 제시한다.  | 권장한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까?  | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD.  | S | CORP. ",
        "original_sentence": "| 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "| MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 65,
        "word_count": 17,
        "page_number": 5,
        "window_text": "| 어떻게 처리해야 하는지에 대한 지침을 제시한다.  | 권장한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까?  | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD.  | S | CORP.  |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다. ",
        "original_sentence": "| MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "| 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 61,
        "word_count": 12,
        "page_number": 13,
        "window_text": "| 권장한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까?  | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD.  | S | CORP.  |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다.  | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다. ",
        "original_sentence": "| 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD. "
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "| S | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 25,
        "window_text": "| 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까?  | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD.  | S | CORP.  |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다.  | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다.  | 특이도(specificity)는 아래 표와 같다. ",
        "original_sentence": "| S | CORP. "
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "|\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 66,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| MODEL 1001 | LEVEL L M AND H | Level 1 ≤ 0.05 | 지침서ㆍ안내서가 있습니까?  | 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD.  | S | CORP.  |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다.  | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다.  | 특이도(specificity)는 아래 표와 같다.  | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가. ",
        "original_sentence": "|\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다. "
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "| and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 61,
        "word_count": 11,
        "page_number": 13,
        "window_text": "| 일반의약품, 고혈압, 협심증, 심부전 등 | Cardiac Troponin-I | BIOTECH LTD.  | S | CORP.  |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다.  | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다.  | 특이도(specificity)는 아래 표와 같다.  | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가.  검체준비 및 저장방법 | 1. ",
        "original_sentence": "| and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "| 특이도(specificity)는 아래 표와 같다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 13,
        "window_text": "| S | CORP.  |\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다.  | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다.  | 특이도(specificity)는 아래 표와 같다.  | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가.  검체준비 및 저장방법 | 1.  업체명 및 주소 | 라. ",
        "original_sentence": "| 특이도(specificity)는 아래 표와 같다. "
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "| 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 93,
        "word_count": 24,
        "page_number": 28,
        "window_text": "|\n| K984359 | AIA-PACK TROPONIN I ASSAY | 식품의약품안전처의 입장을 기술한 것입니다.  | and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다.  | 특이도(specificity)는 아래 표와 같다.  | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가.  검체준비 및 저장방법 | 1.  업체명 및 주소 | 라.  측정범위(Measurement range) | 나. ",
        "original_sentence": "| 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가. "
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "검체준비 및 저장방법 | 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| and Laboratory Standard Institute; 2009 | 서식에 따라 작성하여야 한다.  | 특이도(specificity)는 아래 표와 같다.  | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가.  검체준비 및 저장방법 | 1.  업체명 및 주소 | 라.  측정범위(Measurement range) | 나.  시험물질 | 마. ",
        "original_sentence": "검체준비 및 저장방법 | 1. "
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "업체명 및 주소 | 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 1,
        "window_text": "| 특이도(specificity)는 아래 표와 같다.  | 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가.  검체준비 및 저장방법 | 1.  업체명 및 주소 | 라.  측정범위(Measurement range) | 나.  시험물질 | 마.  대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다. ",
        "original_sentence": "업체명 및 주소 | 라. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "측정범위(Measurement range) | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 29,
        "word_count": 4,
        "page_number": 13,
        "window_text": "| 교차반응 | mL |\n| 작성 방법 및 제출자료 요건을 예시를 들어 구체적이고 알기 쉽게 | K121084 | LOCI CARDIAC TROPONIN-I | 가.  검체준비 및 저장방법 | 1.  업체명 및 주소 | 라.  측정범위(Measurement range) | 나.  시험물질 | 마.  대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.  | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ. ",
        "original_sentence": "측정범위(Measurement range) | 나. "
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "시험물질 | 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 1,
        "window_text": "검체준비 및 저장방법 | 1.  업체명 및 주소 | 라.  측정범위(Measurement range) | 나.  시험물질 | 마.  대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.  | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ.  관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다. ",
        "original_sentence": "시험물질 | 마. "
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 24,
        "window_text": "업체명 및 주소 | 라.  측정범위(Measurement range) | 나.  시험물질 | 마.  대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.  | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ.  관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다.  | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC. ",
        "original_sentence": "대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "| 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 101,
        "word_count": 25,
        "page_number": 5,
        "window_text": "측정범위(Measurement range) | 나.  시험물질 | 마.  대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.  | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ.  관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다.  | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC.  |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다. ",
        "original_sentence": "| 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ. "
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 5,
        "window_text": "시험물질 | 마.  대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.  | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ.  관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다.  | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC.  |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다.  | 분석적 | 2. ",
        "original_sentence": "관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "| MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 157,
        "word_count": 32,
        "page_number": 13,
        "window_text": "대조물질의 제조방법, 설정 농도 및 반복 측정 결과를 기술한다.  | 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ.  관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다.  | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC.  |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다.  | 분석적 | 2.  원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다. ",
        "original_sentence": "| MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC. "
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "|\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 64,
        "word_count": 15,
        "page_number": 13,
        "window_text": "| 가. NIST SRM 2921 Human Cardiac Troponin Complex | ※ 예시 : | 위험을 미치지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | Ⅲ.  관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다.  | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC.  |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다.  | 분석적 | 2.  원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다.  다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다. ",
        "original_sentence": "|\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "| 분석적 | 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 11,
        "word_count": 4,
        "page_number": 21,
        "window_text": "관련 규정 | 14 | 필요시 자체 참고범위를 확정해야 한다.  | MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC.  |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다.  | 분석적 | 2.  원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다.  다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.  | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다. ",
        "original_sentence": "| 분석적 | 2. "
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 309,
        "word_count": 73,
        "page_number": 5,
        "window_text": "| MODIFICATION TO VITROS | BIO CHECK WHOLE | VITROS TROPONIN I ES ASSAY | 보조성분 | Phosphate | (CLSI EP5-A2 실험 결과치) | HEALTHCARE | PRINCETON | S | MEDICS INC.  |\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다.  | 분석적 | 2.  원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다.  다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.  | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.  | 보를 제공한다. ",
        "original_sentence": "원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다. "
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 70,
        "word_count": 17,
        "page_number": 3,
        "window_text": "|\n| x 99th percentile URL)하거나 기저 값이 증가되어 있으면서 유지 | 으로 제출하여야 한다.  | 분석적 | 2.  원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다.  다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.  | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.  | 보를 제공한다.  | 100개 이상의 검체를 시험하도록 권장한다. ",
        "original_sentence": "다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "| 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 108,
        "word_count": 27,
        "page_number": 3,
        "window_text": "| 분석적 | 2.  원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다.  다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.  | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.  | 보를 제공한다.  | 100개 이상의 검체를 시험하도록 권장한다.  | 이계수를 산출하여 기재한다. ",
        "original_sentence": "| 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "| 보를 제공한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 24,
        "window_text": "원재료 및 제조방법에 관한 자료 | 40 | 범위 등) | Level 2 ≤ 0.20 | concentrate (Biotinylated | 교차 반응물질 | 농도 | SI단위 | Calibrator (Level 1~5)를 |\n| ❍ 명칭(제품명, 품목명, 모델명) | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로 | DIMENSION CTNI FLEX | buffer | 적량 | 자사규격 | 심장질환 치료제 등 | 비교방법 | DADE | ORTHO-CLINI | BIOCHECK | (%) |\n| 설명하였습니다.  다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.  | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.  | 보를 제공한다.  | 100개 이상의 검체를 시험하도록 권장한다.  | 이계수를 산출하여 기재한다.  | 사용한다. ",
        "original_sentence": "| 보를 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "| 100개 이상의 검체를 시험하도록 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 5,
        "window_text": "다만, 가이드라인에 기술한 사항은 현재까지의 경험과 | 4 | 과의 변화를 제시하고 평가에 사용된 만족기준을 함께 기록한다.  | 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.  | 보를 제공한다.  | 100개 이상의 검체를 시험하도록 권장한다.  | 이계수를 산출하여 기재한다.  | 사용한다.  | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가. ",
        "original_sentence": "| 100개 이상의 검체를 시험하도록 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "| 이계수를 산출하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 24,
        "window_text": "| 1) 시험물질 | 가) 그대로 보고하는지 재검사가 필요한지 여부 | 건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | 6) 선택한 비교평가 방법을 명시하고, 선택한 사유를 기술한다.  | 보를 제공한다.  | 100개 이상의 검체를 시험하도록 권장한다.  | 이계수를 산출하여 기재한다.  | 사용한다.  | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 2. ",
        "original_sentence": "| 이계수를 산출하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "| 사용한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| 보를 제공한다.  | 100개 이상의 검체를 시험하도록 권장한다.  | 이계수를 산출하여 기재한다.  | 사용한다.  | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 2.  시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다. ",
        "original_sentence": "| 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": "| TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 104,
        "word_count": 20,
        "page_number": 5,
        "window_text": "| 100개 이상의 검체를 시험하도록 권장한다.  | 이계수를 산출하여 기재한다.  | 사용한다.  | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 2.  시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다. ",
        "original_sentence": "| TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가. "
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "해당시약의 성분과 분량을 확인할 수 있는 자료 | 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 18,
        "window_text": "| 이계수를 산출하여 기재한다.  | 사용한다.  | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 2.  시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다.  | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3. ",
        "original_sentence": "해당시약의 성분과 분량을 확인할 수 있는 자료 | 2. "
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 188,
        "word_count": 39,
        "page_number": 2,
        "window_text": "| 사용한다.  | TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 2.  시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다.  | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3.  사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC. ",
        "original_sentence": "시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 59,
        "word_count": 15,
        "page_number": 2,
        "window_text": "| TRIAGE CARDIAC CONTROLS | BOEHRINGER |\n| K010313 | K041619 | K963513 | CARDIAC STATUS TROPONIN I | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 2.  시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다.  | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3.  사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC.  | CAL | INC. ",
        "original_sentence": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "| 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 193,
        "word_count": 43,
        "page_number": 13,
        "window_text": "해당시약의 성분과 분량을 확인할 수 있는 자료 | 2.  시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다.  | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3.  사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC.  | CAL | INC.  | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ. ",
        "original_sentence": "| 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3. "
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 167,
        "word_count": 38,
        "page_number": 5,
        "window_text": "시험성적서의 일련번호 및 각 페이지와 전체 페이지 번호 | 1) 검체대상 및 채취방법 등 | 2) 분석적 특이도 | 1) 일반사항 | IMMUNDODIAGNOSTIC | BLOOD/PLASMA/SERMON MODEL | INCLUDING REAGENT PACK | CONTROL (LOW) LCTNI CON L | 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다.  | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3.  사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC.  | CAL | INC.  | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다. ",
        "original_sentence": "사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "| CAL | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 13,
        "window_text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한 경 | 우 그 사유를 아래에 기재해 주시기 바랍니다.  | 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3.  사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC.  | CAL | INC.  | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다.  | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자. ",
        "original_sentence": "| CAL | INC. "
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "| BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 95,
        "word_count": 28,
        "page_number": 5,
        "window_text": "| 혈청풀(pooled human sera) 및 관리물질 (controls)을 | ORTHO-CLINI | DIAGNOSTICS | BIOMEDITECH |\n| K024193 | 되거나 하강할 경우에는 cTn 값이 >20% 상승하는 것으로 임의로 | 1) 업체명 및 주소 | 1) 3개 이상의 농도(컷오프 근처의 검체 포함) | 특이도 | 3.  사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC.  | CAL | INC.  | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다.  | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다. ",
        "original_sentence": "| BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ. "
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 55,
        "word_count": 15,
        "page_number": 3,
        "window_text": "사용목적에 관한 자료 | 40 | 주성분 | REAGENT CARTRIDGE | ELECSYS CALCHECK TROPONIN | Level 3 ≤ 0.55 | <본질적 동등품목 비교표> | mouse monoclonal | 1 0 0 0 | 이용하여 OS-cTnI QC | BEHRING INC.  | CAL | INC.  | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다.  | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | 라. ",
        "original_sentence": "신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "| TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 173,
        "word_count": 42,
        "page_number": 13,
        "window_text": "| CAL | INC.  | BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다.  | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | 라.  결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다. ",
        "original_sentence": "| TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자. "
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "일회용의 경우 재사용하지 않도록 주의사항을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 3,
        "window_text": "| BIOSITE | 0.5 자사규격 | 1 0 0 0 |\n| K984372 | 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식 | 1 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다.  | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | 라.  결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.  | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다. ",
        "original_sentence": "일회용의 경우 재사용하지 않도록 주의사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "| 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "신청서 기재 항목 및 기술문서 제출자료 | 15 | 따라 통계적으로 의미 있는 검체수를 산정한다.  | TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | 라.  결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.  | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다.  | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. ",
        "original_sentence": "| 라. "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 63,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| TRIAGE TROPONIN-I CONTROL | 트로포닌-C(심장) | Cut-off | 양성 | 음성 | 전체 | 95% | MANNHEIM | µg/L | 0.005 | 95% |\n| 과학적 사실을 근거로 작성된 바, 새로운 과학적 사실이 밝혀지거나 | K062838 | ❍ 분류번호(등급) | 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | 라.  결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.  | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다.  | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 용될 수 있다. ",
        "original_sentence": "결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "| 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 3,
        "window_text": "일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | 라.  결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.  | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다.  | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 용될 수 있다.  | 구체적, 개조식으로 기재한다. ",
        "original_sentence": "| 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "| 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 21,
        "window_text": "| 라.  결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.  | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다.  | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 용될 수 있다.  | 구체적, 개조식으로 기재한다.  | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens. ",
        "original_sentence": "| 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "| 용될 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 11,
        "word_count": 4,
        "page_number": 10,
        "window_text": "결과제시 | 로분자의 항원결정기와의 친화력 함수 | 사시약 제조를 전면 위탁 시 제조원은 다음과 같이 기재한다.  | 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다.  | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 용될 수 있다.  | 구체적, 개조식으로 기재한다.  | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens.  | 보존제, 안정제 등 | ng/mL | CAL | INC. ",
        "original_sentence": "| 용될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "| 구체적, 개조식으로 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 24,
        "window_text": "| 2) 시험방법 | 4) 해당하는 경우 다음의 사항들을 기술한다.  | 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 용될 수 있다.  | 구체적, 개조식으로 기재한다.  | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens.  | 보존제, 안정제 등 | ng/mL | CAL | INC.  | CORP. ",
        "original_sentence": "| 구체적, 개조식으로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "| 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 144,
        "word_count": 33,
        "page_number": 25,
        "window_text": "| 7) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 용될 수 있다.  | 구체적, 개조식으로 기재한다.  | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens.  | 보존제, 안정제 등 | ng/mL | CAL | INC.  | CORP.  | Speci. ",
        "original_sentence": "| 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens. "
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "| 보존제, 안정제 등 | ng/mL | CAL | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 34,
        "word_count": 10,
        "page_number": 13,
        "window_text": "| 용될 수 있다.  | 구체적, 개조식으로 기재한다.  | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens.  | 보존제, 안정제 등 | ng/mL | CAL | INC.  | CORP.  | Speci.  |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다. ",
        "original_sentence": "| 보존제, 안정제 등 | ng/mL | CAL | INC. "
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "| 구체적, 개조식으로 기재한다.  | 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens.  | 보존제, 안정제 등 | ng/mL | CAL | INC.  | CORP.  | Speci.  |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다.  추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "| Speci. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 9,
        "word_count": 2,
        "page_number": 13,
        "window_text": "| 한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | PRODUCTS TROPONIN I | #801116 | CALIBRATORS AND RANGE | 교차 | 사용하여 21일 동안 1일 2회로 42회를 2번 반복 (n=84); | Sens.  | 보존제, 안정제 등 | ng/mL | CAL | INC.  | CORP.  | Speci.  |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다.  추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마.  정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. ",
        "original_sentence": "| Speci. "
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "|\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 55,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| 보존제, 안정제 등 | ng/mL | CAL | INC.  | CORP.  | Speci.  |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다.  추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마.  정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다. ",
        "original_sentence": "|\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다. "
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 1,
        "window_text": "| CORP.  | Speci.  |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다.  추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마.  정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.  | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx. ",
        "original_sentence": "추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마. "
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 25,
        "window_text": "| Speci.  |\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다.  추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마.  정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.  | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx.  | DIAGNOSTICS | INCORPORATE |\n| 3. ",
        "original_sentence": "정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "| 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 13,
        "window_text": "|\n| K974461 | 4 | 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 정의된다.  추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마.  정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.  | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx.  | DIAGNOSTICS | INCORPORATE |\n| 3.  시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다. ",
        "original_sentence": "| 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다. "
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "| ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 113,
        "word_count": 23,
        "page_number": 5,
        "window_text": "추가로, (i) 심근허혈을 시사하는 증상이나 (ii) 새로운 허 | 마.  정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.  | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx.  | DIAGNOSTICS | INCORPORATE |\n| 3.  시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다.  | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi. ",
        "original_sentence": "| ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx. "
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "| DIAGNOSTICS | INCORPORATE |\n| 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 35,
        "word_count": 7,
        "page_number": 13,
        "window_text": "정도관리 | 3) 정밀도(반복, 재현성 등) | 된 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.  | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx.  | DIAGNOSTICS | INCORPORATE |\n| 3.  시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다.  | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi.  | ABBOTT | CORP. ",
        "original_sentence": "| DIAGNOSTICS | INCORPORATE |\n| 3. "
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 24,
        "window_text": "| 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용 시약이다.  | ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx.  | DIAGNOSTICS | INCORPORATE |\n| 3.  시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다.  | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi.  | ABBOTT | CORP.  | % | N | confi. ",
        "original_sentence": "시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "| 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 273,
        "word_count": 55,
        "page_number": 18,
        "window_text": "| ACCUTNI AND ACCUTNI | T | Level 4 ≤ 1.50 | cardiac Troponin-I | Troponin I | Protocol(V.2)에 따라 Level | approx.  | DIAGNOSTICS | INCORPORATE |\n| 3.  시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다.  | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi.  | ABBOTT | CORP.  | % | N | confi.  |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4. ",
        "original_sentence": "| 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi. "
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "| ABBOTT | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 25,
        "window_text": "| DIAGNOSTICS | INCORPORATE |\n| 3.  시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다.  | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi.  | ABBOTT | CORP.  | % | N | confi.  |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다. ",
        "original_sentence": "| ABBOTT | CORP. "
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "| % | N | confi. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 17,
        "word_count": 6,
        "page_number": 13,
        "window_text": "시험검사품에 대한 모델명, 상품명 | 등에 대한 시험성적서를 제출한다.  | 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi.  | ABBOTT | CORP.  | % | N | confi.  |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다.  | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다. ",
        "original_sentence": "| % | N | confi. "
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "|\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 53,
        "word_count": 13,
        "page_number": 4,
        "window_text": "| 기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 2) 검체 종류별 사용 가능한 항응고제 | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 2) 환자검체 또는 정도관리검체 | (사유 :                                                 ) | ACCESS ACCUTNI+3 REAGENT | ACCESS TROPONIN I REAGENTS | TRIAGE CK-MB CONTROL | ㎍/L(ng/ | % | N | confi.  | ABBOTT | CORP.  | % | N | confi.  |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다.  | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다.  | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가. ",
        "original_sentence": "|\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4. "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 5,
        "window_text": "| ABBOTT | CORP.  | % | N | confi.  |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다.  | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다.  | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가.  상품명이 없는 경우, 생략 가능 | 수 있다. ",
        "original_sentence": "저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "| REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 161,
        "word_count": 40,
        "page_number": 13,
        "window_text": "| % | N | confi.  |\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다.  | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다.  | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가.  상품명이 없는 경우, 생략 가능 | 수 있다.  | Cinical and Laboratory Standard Institute; 2005 | 수도 있다. ",
        "original_sentence": "| REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다. "
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "| K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 92,
        "word_count": 24,
        "page_number": 2,
        "window_text": "|\n| (‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다.  | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다.  | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가.  상품명이 없는 경우, 생략 가능 | 수 있다.  | Cinical and Laboratory Standard Institute; 2005 | 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다. ",
        "original_sentence": "| K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가. "
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "상품명이 없는 경우, 생략 가능 | 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 10,
        "window_text": "저장방법 및 사용기간(유효기간)에 관한 자료 | 41 | 음성예측도 제시를 권장한다.  | REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다.  | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가.  상품명이 없는 경우, 생략 가능 | 수 있다.  | Cinical and Laboratory Standard Institute; 2005 | 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.  | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다. ",
        "original_sentence": "상품명이 없는 경우, 생략 가능 | 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "| Cinical and Laboratory Standard Institute; 2005 | 수도 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 59,
        "word_count": 10,
        "page_number": 13,
        "window_text": "| REAGENT PACK/CALIBRATORS | VERIFIERS MODELS 680 2301 | 반응 | 보정물질 | 트로포닌-T(사람심장) | 1 0 0 0 | DIAGNOSTICS | 40 | 자사규격 | 1 0 0 0 |\n| 관련 규정이 개정될 경우 추후 변경될 수 있습니다.  | K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가.  상품명이 없는 경우, 생략 가능 | 수 있다.  | Cinical and Laboratory Standard Institute; 2005 | 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.  | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다.  | 가) 검사를 시행한 검체의 농도 | 1. ",
        "original_sentence": "| Cinical and Laboratory Standard Institute; 2005 | 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 32,
        "word_count": 7,
        "page_number": 24,
        "window_text": "| K041811 | ABBOTT AXSYM TROPONIN-I | 번호 | 비교항목1) | 기허가 제품 | 신청제품 | 동등여부2) | ❍ 모양 및 구조 | 가.  상품명이 없는 경우, 생략 가능 | 수 있다.  | Cinical and Laboratory Standard Institute; 2005 | 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.  | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다.  | 가) 검사를 시행한 검체의 농도 | 1.  제조․수입허가신청서 | test)를 실시한다. ",
        "original_sentence": "종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "| 4) 정확도 | 보정결과 확인 절차에 대해 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 32,
        "word_count": 9,
        "page_number": 5,
        "window_text": "상품명이 없는 경우, 생략 가능 | 수 있다.  | Cinical and Laboratory Standard Institute; 2005 | 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.  | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다.  | 가) 검사를 시행한 검체의 농도 | 1.  제조․수입허가신청서 | test)를 실시한다.  | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter. ",
        "original_sentence": "| 4) 정확도 | 보정결과 확인 절차에 대해 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "| 가) 검사를 시행한 검체의 농도 | 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| Cinical and Laboratory Standard Institute; 2005 | 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.  | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다.  | 가) 검사를 시행한 검체의 농도 | 1.  제조․수입허가신청서 | test)를 실시한다.  | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter.  | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가. ",
        "original_sentence": "| 가) 검사를 시행한 검체의 농도 | 1. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "제조․수입허가신청서 | test)를 실시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 26,
        "word_count": 4,
        "page_number": 20,
        "window_text": "종합한 방법일 경우 참값으로 규정한 알고리즘을 기술한다.  | 4) 정확도 | 보정결과 확인 절차에 대해 제시한다.  | 가) 검사를 시행한 검체의 농도 | 1.  제조․수입허가신청서 | test)를 실시한다.  | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter.  | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가.  검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. ",
        "original_sentence": "제조․수입허가신청서 | test)를 실시한다. "
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "| CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 98,
        "word_count": 27,
        "page_number": 13,
        "window_text": "| 4) 정확도 | 보정결과 확인 절차에 대해 제시한다.  | 가) 검사를 시행한 검체의 농도 | 1.  제조․수입허가신청서 | test)를 실시한다.  | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter.  | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가.  검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 4. ",
        "original_sentence": "| CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter. "
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "| 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 129,
        "word_count": 32,
        "page_number": 5,
        "window_text": "| 가) 검사를 시행한 검체의 농도 | 1.  제조․수입허가신청서 | test)를 실시한다.  | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter.  | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가.  검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 4.  시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다. ",
        "original_sentence": "| 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 131,
        "word_count": 27,
        "page_number": 13,
        "window_text": "제조․수입허가신청서 | test)를 실시한다.  | CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter.  | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가.  검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 4.  시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다.  | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5. ",
        "original_sentence": "검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "| 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| CALIBRATORS ON THE ACCESS | Level 5 ≤ 2.80 | 양성 | a | b | a + b | mL) | 혈색소, 지질(콜레스테롤, | inter.  | 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가.  검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 4.  시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다.  | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5.  제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다. ",
        "original_sentence": "| 4. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 232,
        "word_count": 48,
        "page_number": 25,
        "window_text": "| 1~5의 표준물질을 5회 반복 | BECKMAN | D | 0.06 | inte |\n| 1 | 분석적 성능시험에 관한 자료 | 혈성 ECG 변화나 (iii) procedural complication에 부합되는 혈관조 | 가.  검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 4.  시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다.  | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5.  제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다.  | COULTER INC. ",
        "original_sentence": "시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "| ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 136,
        "word_count": 34,
        "page_number": 13,
        "window_text": "검사대상 | 후보 | antibody fragment) | (recombinant) | Repeatability | DADE | Intermediate |\n| K010429 | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 4.  시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다.  | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5.  제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다.  | COULTER INC.  | BECKMAN |\n| 사항이 아님을 알려드립니다. ",
        "original_sentence": "| ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5. "
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 132,
        "word_count": 35,
        "page_number": 5,
        "window_text": "| 4.  시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다.  | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5.  제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다.  | COULTER INC.  | BECKMAN |\n| 사항이 아님을 알려드립니다.  또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나. ",
        "original_sentence": "제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다. "
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "| COULTER INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 13,
        "window_text": "시험일자 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 있는 자료 포함 | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예규)의 | SPECTRAL CARDIAC STATUS | 2302 AND 2303 | AND ACCESS ACCUTN1+3 | ON THE ACCESS | TRIAGE MYOGLOBIN CONTROL | 된 농도도 참고한다.  | ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5.  제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다.  | COULTER INC.  | BECKMAN |\n| 사항이 아님을 알려드립니다.  또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나.  상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2. ",
        "original_sentence": "| COULTER INC. "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "| BECKMAN |\n| 사항이 아님을 알려드립니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| ng/mL | SPECTRAL | LABORATORIE | BIO-RAD | µg/L | □ 예 | ■ 아니오 | 2.5 |\n| K991176 | OPUS TROPONIN I CALIBRATOR | 수입업체 | 허가일자 | 시약명 | 5.  제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다.  | COULTER INC.  | BECKMAN |\n| 사항이 아님을 알려드립니다.  또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나.  상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2.  기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다. ",
        "original_sentence": "| BECKMAN |\n| 사항이 아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 92,
        "word_count": 23,
        "page_number": 83,
        "window_text": "제품의 성능을 확인하기 위한 자료 | 42 | IMMUNOASSAY SYSTEM # | ADV | 상기 표준물질에 대하여 제시된 | 0.30 | 84 | 58/69 | 74-91 | 94 | 272/289 | 91-96 | 측정 한다.  | COULTER INC.  | BECKMAN |\n| 사항이 아님을 알려드립니다.  또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나.  상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2.  기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다.  | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다. ",
        "original_sentence": "또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 59,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| COULTER INC.  | BECKMAN |\n| 사항이 아님을 알려드립니다.  또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나.  상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2.  기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다.  | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다.  | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까? ",
        "original_sentence": "상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2. "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| BECKMAN |\n| 사항이 아님을 알려드립니다.  또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나.  상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2.  기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다.  | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다.  | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까?  | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7. ",
        "original_sentence": "기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "| 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 62,
        "word_count": 16,
        "page_number": 13,
        "window_text": "또한, 본 안내서는 현재 과학적ㆍ기술적 사실 및 | 영술 상의 소견이나 (iv) 새로운 loss of viable myocardium이나 새 | ❍ 원재료 | 나.  상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2.  기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다.  | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다.  | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까?  | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7.  참고 : 진단기준 | 등록대상 | 다. ",
        "original_sentence": "| 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "| ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 3,
        "window_text": "상품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨 | 검사법 | 5) 교차반응 | 2.  기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다.  | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다.  | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까?  | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7.  참고 : 진단기준 | 등록대상 | 다.  권장 시험방법 | 가. ",
        "original_sentence": "| ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "| 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 168,
        "word_count": 40,
        "page_number": 5,
        "window_text": "기술문서에 관한 자료 | 16 | 이상을 포함하여 평가하기를 권장한다.  | 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다.  | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까?  | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7.  참고 : 진단기준 | 등록대상 | 다.  권장 시험방법 | 가.  일반사항 | 다. ",
        "original_sentence": "| 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "참고 : 진단기준 | 등록대상 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 보조성분 | Bovine serum albumin | 적량 자사규격 | 낮은 농도 검체로 이용할 수 있다.  | ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까?  | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7.  참고 : 진단기준 | 등록대상 | 다.  권장 시험방법 | 가.  일반사항 | 다.  결과제시 | 허용기준, 결과 등을 요약하여 제시한다. ",
        "original_sentence": "참고 : 진단기준 | 등록대상 | 다. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "권장 시험방법 | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 40,
        "window_text": "| ABL555 BLOOD GAS | 내용을 단순 편집 또는 나열한 것입니까?  | 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7.  참고 : 진단기준 | 등록대상 | 다.  권장 시험방법 | 가.  일반사항 | 다.  결과제시 | 허용기준, 결과 등을 요약하여 제시한다.  | 1 | 품목명 | 와 ISO에서 사용되고 있다. ",
        "original_sentence": "권장 시험방법 | 가. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "일반사항 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 3,
        "window_text": "| 트로포닌-I(사람골격근) | 1 0 0 0 | 트리글리세리드), 빌리루빈, 이상 단백질 | (within run) | 1 0 0 0 | precision | 1x10 |\n| K030057 | K063243 | VIDAS TROPONIN I ULTRA | K121214 | K963934 | 표7.  참고 : 진단기준 | 등록대상 | 다.  권장 시험방법 | 가.  일반사항 | 다.  결과제시 | 허용기준, 결과 등을 요약하여 제시한다.  | 1 | 품목명 | 와 ISO에서 사용되고 있다.  | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다. ",
        "original_sentence": "일반사항 | 다. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "결과제시 | 허용기준, 결과 등을 요약하여 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 24,
        "window_text": "참고 : 진단기준 | 등록대상 | 다.  권장 시험방법 | 가.  일반사항 | 다.  결과제시 | 허용기준, 결과 등을 요약하여 제시한다.  | 1 | 품목명 | 와 ISO에서 사용되고 있다.  | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다.  | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. ",
        "original_sentence": "결과제시 | 허용기준, 결과 등을 요약하여 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "| 1 | 품목명 | 와 ISO에서 사용되고 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 5,
        "window_text": "권장 시험방법 | 가.  일반사항 | 다.  결과제시 | 허용기준, 결과 등을 요약하여 제시한다.  | 1 | 품목명 | 와 ISO에서 사용되고 있다.  | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다.  | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나. ",
        "original_sentence": "| 1 | 품목명 | 와 ISO에서 사용되고 있다. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "| 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 13,
        "window_text": "일반사항 | 다.  결과제시 | 허용기준, 결과 등을 요약하여 제시한다.  | 1 | 품목명 | 와 ISO에서 사용되고 있다.  | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다.  | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나.  검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다. ",
        "original_sentence": "| 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "| 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 18,
        "window_text": "결과제시 | 허용기준, 결과 등을 요약하여 제시한다.  | 1 | 품목명 | 와 ISO에서 사용되고 있다.  | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다.  | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나.  검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.  | 다. ",
        "original_sentence": "| 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "| CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 240,
        "word_count": 58,
        "page_number": 13,
        "window_text": "| 1 | 품목명 | 와 ISO에서 사용되고 있다.  | 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다.  | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나.  검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.  | 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5. ",
        "original_sentence": "| CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나. "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 24,
        "window_text": "| 나) 각각의 농도에서의 반복정밀도 표준편차 | Cal2 | 료를 제시한다.  | 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나.  검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.  | 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5.  시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다. ",
        "original_sentence": "검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "| 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| 횟수, 분석물질의 농도, 농도를 확인한 방법 등)을 기술한다.  | CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나.  검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.  | 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5.  시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다.  | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 2,
        "window_text": "| CK-MB/MYOGLOBIN/TROPONIN I | CALIBRATORS FOR USE ON THE | IMMUNOASSAY ANALYZER | 보조성분 | Human serum | 적량 | 자사규격 | 음성 | c | d | c + d | DIAGNOSTICS | S | BIOMERIEUX | LABORATORIE | x1 |\n| 2 | Q | 또한 본 가이드라인은 트로포닌 검사 제품의 허가․심사 시에 요구되는 | 나.  검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.  | 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5.  시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다.  | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다. ",
        "original_sentence": "원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5. "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 5,
        "window_text": "검체종류 : 해당 제품의 적용이 가능한 검체의 종류를 기술한다.  | 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5.  시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다.  | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다.  | RADIOMETER | 0.12 |\n| K974818 | 다. ",
        "original_sentence": "시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "| □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5.  시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다.  | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다.  | RADIOMETER | 0.12 |\n| K974818 | 다.  임상적 성능시험에 관한 자료 | 다. ",
        "original_sentence": "| □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "| □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 33,
        "word_count": 11,
        "page_number": 3,
        "window_text": "원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 5.  시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다.  | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다.  | RADIOMETER | 0.12 |\n| K974818 | 다.  임상적 성능시험에 관한 자료 | 다.  결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6. ",
        "original_sentence": "| □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "| RADIOMETER | 0.12 |\n| K974818 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 5,
        "window_text": "시험성적서 발급일자 | 4) 검체 보관조건, 방법 및 사용기간 등 | 구체적으로 기재하여야 한다.  | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다.  | RADIOMETER | 0.12 |\n| K974818 | 다.  임상적 성능시험에 관한 자료 | 다.  결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다. ",
        "original_sentence": "| RADIOMETER | 0.12 |\n| K974818 | 다. "
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "임상적 성능시험에 관한 자료 | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 21,
        "word_count": 6,
        "page_number": 6,
        "window_text": "| □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다.  | RADIOMETER | 0.12 |\n| K974818 | 다.  임상적 성능시험에 관한 자료 | 다.  결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다.  | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC. ",
        "original_sentence": "임상적 성능시험에 관한 자료 | 다. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 38,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 | SD 기준에 적합하여야 한다.  | RADIOMETER | 0.12 |\n| K974818 | 다.  임상적 성능시험에 관한 자료 | 다.  결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다.  | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC.  | INC. ",
        "original_sentence": "결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6. "
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 282,
        "word_count": 68,
        "page_number": 1,
        "window_text": "| RADIOMETER | 0.12 |\n| K974818 | 다.  임상적 성능시험에 관한 자료 | 다.  결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다.  | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC.  | INC.  | S INC. ",
        "original_sentence": "체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다. "
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "| 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 112,
        "word_count": 24,
        "page_number": 5,
        "window_text": "임상적 성능시험에 관한 자료 | 다.  결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다.  | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC.  | INC.  | S INC.  | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
        "original_sentence": "| 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 13,
        "window_text": "결과제시 | 여부 | 4) 시험일자 및 시험성적서 발급일자 | 6.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다.  | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC.  | INC.  | S INC.  | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. **\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "| S INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 13,
        "window_text": "체외진단용 의료기기의 취급자 안전에 관한 자료 | 42 | (분류번호 및 등급) | 보조성분 | Bovine IgG | 적량 자사규격 | 33340 33345 | ELECTROLYTE & METABOLITE | OPUS TROPONIN I (CTN) TEST | Mean | SD | CV | SD | CV | ng/mL | ALFA | DADE | µg/L |\n| K991177 | 로운 regional wall motion abnormality가 영상으로 입증되는 것 중 | 원인에 기인하기도 한다.  | 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC.  | INC.  | S INC.  | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. **\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다.  | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL. ",
        "original_sentence": "| S INC. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "| mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 193,
        "word_count": 49,
        "page_number": 2,
        "window_text": "| 3-IN-1 TEST | (TNIU) ASSAY MODEL 30 448 | ACCESS 2 IMMUNOASSAY | MODEL NUMBERS: 33320 33325 | 및 펩타이드 등 | INC.  | INC.  | S INC.  | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. **\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다.  | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL.  |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다. ",
        "original_sentence": "| mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다."
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "**\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 146,
        "word_count": 37,
        "page_number": 3,
        "window_text": "| INC.  | S INC.  | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. **\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다.  | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL.  |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.  | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다. ",
        "original_sentence": "**\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "| K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 219,
        "word_count": 43,
        "page_number": 5,
        "window_text": "| S INC.  | mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. **\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다.  | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL.  |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.  | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. ",
        "original_sentence": "| K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "|\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 46,
        "word_count": 9,
        "page_number": 24,
        "window_text": "| mL |\n| 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 | mL |\n**사항에 대한 일반적인 해석을 기술하고 있는 것으로서 법적 효력이**\n| K010562 | ALPHA DX SYSTEM | K042227 |\n| K030950 | K063756 |\n**사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. **\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다.  | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL.  |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.  | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187. ",
        "original_sentence": "|\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "| 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 396,
        "word_count": 91,
        "page_number": 4,
        "window_text": "**\n**있는 사항이 아니며, 개별 사항에 따라 다르게 해석할 수 있음을**\n| 심장성 트로포닌 검사제품의 허가․심사 가이드라인 | K012233 | K991795 | 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유 |\n| 알려드립니다.  | K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL.  |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.  | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.  | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. ",
        "original_sentence": "| 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "| 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 24,
        "window_text": "| K924392 | CARDIAC T ELISA TROPONIN-T | K964372 |\n**K070640**\n| K050644 | K974839 |\n| K012820 | AIA-PACK CTNI 2ND-GEN | K031031 | ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 |\n| K964862 | TROPONIN-I TEST SYSTEM | DADE INTL.  |\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.  | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.  | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | CONTROLS/TROPONIN I | ROCHE | DADE INTL. ",
        "original_sentence": "| 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "|\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 263,
        "word_count": 58,
        "page_number": 5,
        "window_text": "|\n| 제조의 경우 “자사포장단위”, 수입의 경우는 “제조원포장단위”로 기재한다.  | 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.  | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | CONTROLS/TROPONIN I | ROCHE | DADE INTL.  |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나. ",
        "original_sentence": "|\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "| 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 96,
        "word_count": 18,
        "page_number": 22,
        "window_text": "| 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처 | 의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 | 규정 제2조) |\n**K992127**\n| K942632 | TNT TROPONIN T |\n**K081643**\n| 10 | 시험규격 | 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료) |\n| K013062 | K031739 | K972094 | TARGET CARDIAC TROPONIN I | K980528 | CHIRON DIAGNOSTICS ACS:180 | 0.50 | 61 | 42/69 | 49-72 | 100 | 289/289 | 99-100 |\n| 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자료로 제출하여야 한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.  | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | CONTROLS/TROPONIN I | ROCHE | DADE INTL.  |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나.  시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다. ",
        "original_sentence": "| 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "| CONTROLS/TROPONIN I | ROCHE | DADE INTL. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 43,
        "word_count": 8,
        "page_number": 13,
        "window_text": "| 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.  | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | CONTROLS/TROPONIN I | ROCHE | DADE INTL.  |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나.  시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC. ",
        "original_sentence": "| CONTROLS/TROPONIN I | ROCHE | DADE INTL. "
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "|\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 424,
        "word_count": 97,
        "page_number": 13,
        "window_text": "|\n**K050975**\n**K951888**\n| 11 | 제조원 (수입 또는 제조공정 전부 위탁의 경우) |\n| 지침서ㆍ안내서 | K992349 |\n| K031990 | ELECSYS PRECICONTROL | K081683 | LOCI CARDIAC TROPONIN I |\n**K014024**\n| K981098 | 일련번호 | 명 칭 | 세부 구성 | 외관상 특징 |\n**K972687**\n| (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.  | 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | CONTROLS/TROPONIN I | ROCHE | DADE INTL.  |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나.  시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC.  | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8. ",
        "original_sentence": "|\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나. "
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 116,
        "word_count": 22,
        "page_number": 5,
        "window_text": "| 제조수입업소명           품목류명                   모델명 | 한 자료의 경우) | 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | CONTROLS/TROPONIN I | ROCHE | DADE INTL.  |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나.  시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC.  | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8.  포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC. ",
        "original_sentence": "시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 131,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| CONTROLS/TROPONIN I | ROCHE | DADE INTL.  |\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나.  시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC.  | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8.  포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC.  | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다. ",
        "original_sentence": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC. "
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "| □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 43,
        "word_count": 18,
        "page_number": 3,
        "window_text": "|\n| (cTn)] 값의 상승 및/또는 하강의 발견과 다음 중 적어도 한 개가 | 로운 loss of viable myocardium이나 새로운 regional wall motion | 9 | 성능 | 예 | □ | 보조성분 | Bovine IgG | 적량 자사규격 | 근거자료 | 64 | STRATUS CS ACUTE CARE | ELECSYS TROPONIN I AND | CARDIAC STATUS CONTROLS | 심장병(non-vascular cardiac disease) 환자는 결과 | OS -Control | SPECTRAL | ORTHO-CLINI |\n| K014105 | SPECTRAL'S TROPONIN I | K051752 | K951890 | 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | ❍ 허가조건 | 5 | 나.  시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC.  | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8.  포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC.  | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다.  | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8. "
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 133,
        "word_count": 34,
        "page_number": 5,
        "window_text": "시험방법 | 지멘스(주) | 2012-11-22 | ADVIA Centaur TnI-Ultra | 2004:50;732-740 | 특이도/민감 | 계획되거나 반복성이나 재현성 평가의 일부로 계획될 수 있다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC.  | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8.  포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC.  | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다.  | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다.  | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다. ",
        "original_sentence": "포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC. "
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "| 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 71,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | STAT  (SHORT TURNAROUND | ENZYME IMMUNMNOASSAY & | VITROS IMMUNODIAGNOSTIC | DIAGNOSTICS | INC.  | □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8.  포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC.  | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다.  | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다.  | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다.  | 의해 판정기준치의 적절성을 평가할 수 있다. ",
        "original_sentence": "| 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "| 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 35,
        "word_count": 12,
        "page_number": 5,
        "window_text": "| □ 예 | ■ 아니오 | mL |\n| 6 | 상관성 | ※ 예시 | 8.  포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC.  | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다.  | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다.  | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다.  | 의해 판정기준치의 적절성을 평가할 수 있다.  | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "| 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "| 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 85,
        "word_count": 18,
        "page_number": 18,
        "window_text": "포장단위 | 32 | 24.6 ug/L(ng/mL)] 검체로 확인한 결과 | ① Cal 1 | 동결건조 시약 | 0.340 | 0.024 | 7.0 | 0.027 | 8.0 | DADE | DIAGNOSTICS | ROCHE | INC.  | 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다.  | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다.  | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다.  | 의해 판정기준치의 적절성을 평가할 수 있다.  | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까?  | 산출에서 배제하였다. ",
        "original_sentence": "| 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "| 의해 판정기준치의 적절성을 평가할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 10,
        "window_text": "| 아니오 | □ |\n| 기타 확인사 | K033487 | K082699 | K981474 | 항목이 추가로 포함되어야 한다.  | 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다.  | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다.  | 의해 판정기준치의 적절성을 평가할 수 있다.  | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까?  | 산출에서 배제하였다.  환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거. ",
        "original_sentence": "| 의해 판정기준치의 적절성을 평가할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "| TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 123,
        "word_count": 21,
        "page_number": 13,
        "window_text": "| 1 | P | 단일구성 | 투명한 액상 시약 | 제출한다.  | 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다.  | 의해 판정기준치의 적절성을 평가할 수 있다.  | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까?  | 산출에서 배제하였다.  환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거.  | 가. ",
        "original_sentence": "| TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "| 산출에서 배제하였다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 1,
        "window_text": "| 상호와 주소)을 확인할 수 있는 자료도 포함한다 | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | 소프트웨어의 회사명, 모델명 등을 기재한다.  | 의해 판정기준치의 적절성을 평가할 수 있다.  | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까?  | 산출에서 배제하였다.  환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거.  | 가.  체외진단용으로 사용해야 함을 명시한다. ",
        "original_sentence": "| 산출에서 배제하였다. "
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 93,
        "word_count": 20,
        "page_number": 5,
        "window_text": "| 의해 판정기준치의 적절성을 평가할 수 있다.  | TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까?  | 산출에서 배제하였다.  환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거.  | 가.  체외진단용으로 사용해야 함을 명시한다.  | 가. ",
        "original_sentence": "환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거. "
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "| 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| TROPONIN I TESTPAK MODEL | TROPONIN I STAT TEST | TRIAGE CARDIAC PANEL | (CK-MB/MYOGLOBIN/TROPONIN | 민원인을 구속하는 내용이 있습니까?  | 산출에서 배제하였다.  환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거.  | 가.  체외진단용으로 사용해야 함을 명시한다.  | 가.  시험물질 | 나. ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "체외진단용으로 사용해야 함을 명시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 24,
        "window_text": "| 산출에서 배제하였다.  환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거.  | 가.  체외진단용으로 사용해야 함을 명시한다.  | 가.  시험물질 | 나.  시험방법 | 여 적용할 수 있는 시험규격을 명시한다. ",
        "original_sentence": "체외진단용으로 사용해야 함을 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "| 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "환자는 일반적인 troponin 검사법들에 | Tn1 | DIAGNOSTICS | CAL |\n| K992366 | 동반: | abnormality의 영상 상의 증거.  | 가.  체외진단용으로 사용해야 함을 명시한다.  | 가.  시험물질 | 나.  시험방법 | 여 적용할 수 있는 시험규격을 명시한다.  | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다. ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "시험물질 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 1,
        "window_text": "| 가.  체외진단용으로 사용해야 함을 명시한다.  | 가.  시험물질 | 나.  시험방법 | 여 적용할 수 있는 시험규격을 명시한다.  | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다.  | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다. ",
        "original_sentence": "시험물질 | 나. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "시험방법 | 여 적용할 수 있는 시험규격을 명시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 24,
        "window_text": "체외진단용으로 사용해야 함을 명시한다.  | 가.  시험물질 | 나.  시험방법 | 여 적용할 수 있는 시험규격을 명시한다.  | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다.  | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다.  | 라고 정의한다. ",
        "original_sentence": "시험방법 | 여 적용할 수 있는 시험규격을 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "| 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 193,
        "word_count": 47,
        "page_number": 5,
        "window_text": "| 가.  시험물질 | 나.  시험방법 | 여 적용할 수 있는 시험규격을 명시한다.  | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다.  | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다.  | 라고 정의한다.  | 조절하여 근육 수축에서 매우 중요한 역할을 한다. ",
        "original_sentence": "| 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다. "
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "| 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 5,
        "window_text": "시험물질 | 나.  시험방법 | 여 적용할 수 있는 시험규격을 명시한다.  | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다.  | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다.  | 라고 정의한다.  | 조절하여 근육 수축에서 매우 중요한 역할을 한다.  | 6. ",
        "original_sentence": "| 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "| 라고 정의한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 16,
        "window_text": "시험방법 | 여 적용할 수 있는 시험규격을 명시한다.  | 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다.  | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다.  | 라고 정의한다.  | 조절하여 근육 수축에서 매우 중요한 역할을 한다.  | 6.  상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC. ",
        "original_sentence": "| 라고 정의한다. "
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "| 조절하여 근육 수축에서 매우 중요한 역할을 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 23,
        "window_text": "| 오신, 액틴, 미오신경쇄, 미오글로빈, CK-MB | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 도 | 보조성분 | Phosphate buffer | 적량 자사규격 | TIME) | STRATUS CARDIAC | PRODUCTS TROPONIN I |\n| ❍ 비고 | 10 | 시험규격 | 예 | □ | 형곡선을 갖는다.  | 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다.  | 라고 정의한다.  | 조절하여 근육 수축에서 매우 중요한 역할을 한다.  | 6.  상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC.  | BEHRING INC. ",
        "original_sentence": "| 조절하여 근육 수축에서 매우 중요한 역할을 한다. "
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "| 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 33,
        "window_text": "| 1) 시험시설개요 | 1) 시험할 간섭물질의 목록을 작성한다.  | 라고 정의한다.  | 조절하여 근육 수축에서 매우 중요한 역할을 한다.  | 6.  상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC.  | BEHRING INC.  | DIAGNOSTICS |\n| 가. ",
        "original_sentence": "| 6. "
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 6,
        "window_text": "| 라고 정의한다.  | 조절하여 근육 수축에서 매우 중요한 역할을 한다.  | 6.  상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC.  | BEHRING INC.  | DIAGNOSTICS |\n| 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. ",
        "original_sentence": "상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC. "
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "| BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| 조절하여 근육 수축에서 매우 중요한 역할을 한다.  | 6.  상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC.  | BEHRING INC.  | DIAGNOSTICS |\n| 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n",
        "original_sentence": "| BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "| DIAGNOSTICS |\n| 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 13,
        "window_text": "| 6.  상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC.  | BEHRING INC.  | DIAGNOSTICS |\n| 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n",
        "original_sentence": "| DIAGNOSTICS |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 13,
        "window_text": "상관성 평가 | 65 | Passing/Bablok : y = 0.982x - 0.003 (T = 0.974) | INC.  | BEHRING INC.  | DIAGNOSTICS |\n| 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n",
        "original_sentence": "전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "| 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 157,
        "word_count": 33,
        "page_number": 3,
        "window_text": "| BEHRING INC.  | DIAGNOSTICS |\n| 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ. ",
        "original_sentence": "| 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "상기 사항에 대하여 확인하였음.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| DIAGNOSTICS |\n| 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ. ",
        "original_sentence": "상기 사항에 대하여 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 175,
        "word_count": 38,
        "page_number": 4,
        "window_text": "전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ.  용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9. ",
        "original_sentence": "2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "<!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 231,
        "word_count": 48,
        "page_number": 4,
        "window_text": "| 항 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내서 | 의한 결과를 포함하여 급성 심근경색(acute myocardial | OS -Control | DIAGNOSTICS |\n\n**[표 끝]**\n\n제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ.  용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9.  저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10. ",
        "original_sentence": "<!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ. "
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 56,
        "word_count": 11,
        "page_number": 5,
        "window_text": "상기 사항에 대하여 확인하였음.\n\n 2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ.  용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9.  저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10.  시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11. ",
        "original_sentence": "개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 60,
        "word_count": 12,
        "page_number": 5,
        "window_text": "2018 년    7 월   31  일\n\n담당자\n\n확  인(부서장)\n\n우 승 민\n\n이 원 규\n\n<!-- PAGE_4 -->\n###### ※ 본 민원인 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품\n\n<!-- PAGE_4 -->\n###### 안전평가원 의료기기심사부 체외진단기기과에 문의하시기 바랍니다.\n\n <!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ.  용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9.  저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10.  시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11.  제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ. ",
        "original_sentence": "용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9. "
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 67,
        "word_count": 13,
        "page_number": 5,
        "window_text": "<!-- PAGE_4 -->\n###### - 전화번호 : 043-719-4652~4665\n\n<!-- PAGE_4 -->\n###### - 팩스번호 : 043-719-4650\n\n이 안내서는 체외진단용 시약 중 심장성 트로포닌 검사제품  허가심사 시\n\n요구되는 신청서 작성 방법 및 제출자료 요건에 대하여 알기 쉽게 설명하거나\n\n<!-- PAGE_5 -->\n# 목  차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ.  용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9.  저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10.  시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11.  제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1. ",
        "original_sentence": "저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10. "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 60,
        "word_count": 11,
        "page_number": 5,
        "window_text": "개요\n\n<!-- PAGE_5 -->\n###### 1\n\n<!-- PAGE_5 -->\n###### Ⅱ.  용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9.  저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10.  시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11.  제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ. ",
        "original_sentence": "시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11. "
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 58,
        "word_count": 11,
        "page_number": 5,
        "window_text": "용어의 정의\n\n<!-- PAGE_5 -->\n###### 4\n\n<!-- PAGE_5 -->\n###### 9.  저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10.  시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11.  제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ.  참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ. ",
        "original_sentence": "제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 74,
        "word_count": 15,
        "page_number": 6,
        "window_text": "저장방법 및 사용기간\n\n<!-- PAGE_5 -->\n###### 32\n\n<!-- PAGE_5 -->\n###### 10.  시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11.  제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ.  참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ.  부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 54,
        "word_count": 10,
        "page_number": 6,
        "window_text": "시험규격\n\n<!-- PAGE_5 -->\n###### 33\n\n<!-- PAGE_5 -->\n###### 11.  제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ.  참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ.  부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n",
        "original_sentence": "개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ. "
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 59,
        "word_count": 11,
        "page_number": 6,
        "window_text": "제조원\n\n<!-- PAGE_5 -->\n###### 35\n\n<!-- PAGE_6 -->\n###### Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ.  참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ.  부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n ※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n",
        "original_sentence": "참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ. "
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 159,
        "word_count": 35,
        "page_number": 6,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_6 -->\n###### 37\n\n<!-- PAGE_6 -->\n###### 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ.  참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ.  부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n ※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n 본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ. ",
        "original_sentence": "부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 130,
        "word_count": 28,
        "page_number": 7,
        "window_text": "개발경위, 측정원리·방법 및 국내․외 사용현황에\n\n<!-- PAGE_6 -->\n###### Ⅷ.  참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ.  부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n ※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n 본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ.  개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2. ",
        "original_sentence": "목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 92,
        "word_count": 22,
        "page_number": 7,
        "window_text": "참고문헌\n\n<!-- PAGE_6 -->\n###### 67\n\n<!-- PAGE_6 -->\n###### Ⅸ.  부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n ※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n 본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ.  개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2.  적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n",
        "original_sentence": "※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 44,
        "word_count": 7,
        "page_number": 7,
        "window_text": "부록\n\n<!-- PAGE_6 -->\n###### 69\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 2 -\n<!-- PAGE_7 -->\n# Ⅰ\n\n<!-- PAGE_7 -->\n#### 개  요\n\n<!-- PAGE_7 -->\n###### 1.  목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n ※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n 본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ.  개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2.  적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n 심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다. ",
        "original_sentence": "본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ. "
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 8,
        "window_text": "목적\n\n본 가이드라인은 허혈성 심장질환 진단에 도움을 주는 심장성 트로포닌\n\n(Troponin I, Troponin T) 측정시약의 허가․심사 시 요구되는 신청서 및\n\n제출자료 준비를 위한 참고자료로 활용하는 것을 목적으로 한다.\n\n ※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n 본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ.  개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2.  적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n 심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다.  급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다. ",
        "original_sentence": "개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 116,
        "word_count": 21,
        "page_number": 8,
        "window_text": "※ 알림 : 본 가이드라인에 따라 정상적인 서류와 첨부자료를 제대로\n\n갖추어 접수한 민원에 대하여 신속처리가 진행될 수 있으니 민원 신청시\n\n참고하시기 바랍니다.\n\n 본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ.  개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2.  적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n 심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다.  급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다.  TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다. ",
        "original_sentence": "적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 150,
        "word_count": 30,
        "page_number": 8,
        "window_text": "본 가이드라인은 심근혈관표지자인 트로포닌(Troponin I, TnI;\n\nⅠ.  개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2.  적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n 심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다.  급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다.  TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다.  TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다. ",
        "original_sentence": "심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다. "
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 126,
        "word_count": 25,
        "page_number": 13,
        "window_text": "개 요\n\n- - 3 -\n<!-- PAGE_8 -->\n###### 2.  적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n 심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다.  급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다.  TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다.  TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다.  또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n",
        "original_sentence": "급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다. "
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 128,
        "word_count": 27,
        "page_number": 13,
        "window_text": "적용범위\n\n본 가이드라인은 인체에서 유래하는 시료를 검체로 심장성 트로포닌\n\n(Troponin I, TnI; Troponin T, TnT)을 측정하는 체외진단용 시약에\n\n적용되는 허가․심사 가이드라인이다.\n\n 심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다.  급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다.  TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다.  TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다.  또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n Ⅱ. ",
        "original_sentence": "TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 59,
        "word_count": 15,
        "page_number": 13,
        "window_text": "심장성 트로포닌은 일반적으로 흉통, 심전도 변화, 심근 손상 표지자의\n\n상승에 근거하는 급성심근경색증(acute myocardial infarction, AMI)의\n\n진단 및 비ST 분절 상승 급성 관상동맥 증후군 환자의 위험 분류를\n\n위한 보조 수단으로서 사용된다.  급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다.  TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다.  TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다.  또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n Ⅱ.  용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n",
        "original_sentence": "TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다. "
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 698,
        "word_count": 150,
        "page_number": 9,
        "window_text": "급성심근경색증 발생 시 심장성 TnI와\n\nTnT가 분비되는데 줄무늬 근육섬유의 가는 필라멘트인 액틴(actin)에\n\n결합하여 세포 내의 칼슘과 반응 후 굵은 필라멘트인 미오신(myosin)와\n\n결합하여 근육 수축을 조절한다.  TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다.  TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다.  또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n Ⅱ.  용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n",
        "original_sentence": "또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "Ⅱ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "TnI과 TnT는 급성심근경색증 환자의\n\n경우 초기에 상승하고 기저 값과 명백하게 구별되는 농도에 도달하므로\n\n급성심근경색 발생 후 7시간이 경과하여 TnI 검사를 실시하면 급성심\n\n근경색증이 확인되는 환자의 95%를 검출한다.  TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다.  또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n Ⅱ.  용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n 비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n",
        "original_sentence": "Ⅱ. "
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 884,
        "word_count": 182,
        "page_number": 9,
        "window_text": "TnI의 혈장 농도는 며칠\n\n동안 상승 상태를 유지하여 심장 손상 검사를 위한 충분한 시간을\n\n제공한다.  또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n Ⅱ.  용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n 비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n 사용 시 안정성 (in–use stability)\n\nⅡ. ",
        "original_sentence": "용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 333,
        "word_count": 69,
        "page_number": 11,
        "window_text": "또한 TnI과 TnT는 불안정 협심증과 비-Q파 심근 경색 시의\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 4 -\n<!-- PAGE_9 -->\n# Ⅱ\n\n<!-- PAGE_9 -->\n#### 용어의 정의\n\n※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n돕기 위해 사용되는 것이므로 단순 참고용임\n\n간섭 (Interference)\n\n분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이적\n\n으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억제,\n\n분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의 다른\n\n검출한계 (Limit of detection, LoD)\n\n검출될 수 있는 분석 물질의 최소량\n\n공란한계 (Limit of blank, LoB)\n\nblank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n교차반응 (Cross-reactivity)\n\n항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원과\n\n항체가 반응하는 현상\n\n기질효과 (Matrix effect)\n\n측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향을\n\n미치는 경우\n\n☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n요인이다.\n\n Ⅱ.  용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n 비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n 사용 시 안정성 (in–use stability)\n\nⅡ.  용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n",
        "original_sentence": "b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 124,
        "word_count": 24,
        "page_number": 3,
        "window_text": "Ⅱ.  용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n 비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n 사용 시 안정성 (in–use stability)\n\nⅡ.  용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n 신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n",
        "original_sentence": "비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "사용 시 안정성 (in–use stability)\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 32,
        "word_count": 6,
        "page_number": 9,
        "window_text": "용어의 정의\n\n- - 5 -\n대조물질 (Control / Control material)\n\n정도 관리를 위해 이용되는 물질\n\n면역분석법, 면역측정법 (Immunoassay)\n\n분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또는\n\n비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표지\n\n또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법일\n\n바이어스 (Bias)\n\n검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n간섭물질 (Interfering substances)\n\n임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n할 수 있는 물질\n\n보관 시 안정성 (Storage stability)\n\n최종 디자인(포장) 상태에서 시약의 유효기간\n\n보정 (Calibration)\n\n특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n확립하는 일련의 조작\n\n보정물질 (Calibrator / Calibration material)\n\n측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 6 -\n알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n설정하는데 사용될 수 있다.\n\n b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n 비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n 사용 시 안정성 (in–use stability)\n\nⅡ.  용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n 신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n",
        "original_sentence": "사용 시 안정성 (in–use stability)\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 275,
        "word_count": 56,
        "page_number": 9,
        "window_text": "b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을 가\n\nc) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데 사\n\nd) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n분석물질 (Analyte)\n\n검사실이 수행하는 검사의 물질 또는 구성요소\n\n분석적 특이도 (Analytical specificity)\n\n정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n되지 않는 분석법의 능력\n\n비정밀도 (Imprecision)\n\n특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n 비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n 사용 시 안정성 (in–use stability)\n\nⅡ.  용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n 신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 354,
        "word_count": 74,
        "page_number": 12,
        "window_text": "비특이도 (Nonspecificity)\n\n분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n효소, ionophore, 시약에 의해 발생한다.\n\n 사용 시 안정성 (in–use stability)\n\nⅡ.  용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n 신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n 위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ. ",
        "original_sentence": "신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 73,
        "word_count": 8,
        "page_number": 5,
        "window_text": "사용 시 안정성 (in–use stability)\n\nⅡ.  용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n 신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n 위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ.  용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n",
        "original_sentence": "b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 355,
        "word_count": 57,
        "page_number": 1,
        "window_text": "용어의 정의\n\n- - 7 -\n제조사에서 제공한 용기를 개봉한 이후에 사용자의 작동 조건에서 시약의\n\n유효기간내의 검사수행능\n\n상관계수 (Correlation coefficient, r)\n\n측정된 데이터에 대한 두개의 무작위 변수의 공분산(covariance)과 그들의\n\n표준편차의 곱의 비(ratio)\n\n수송 안정성 실험 (Transport stability test)\n\n제품 운송 도중 발생 가능한 환경변화가 제품 성능에 미치는 영향을 평가\n\n하는 것\n\n☞ 최악의 상황을 시험해야 한다.\n\n 신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n 위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ.  용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n 1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 271,
        "word_count": 65,
        "page_number": 13,
        "window_text": "신뢰구간 (Confidence interval)\n\n평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n것으로 예상되는 계산된 구간\n\n실시간 안정성 실험 (Real time stability)\n\n시약을 추천하는 정상적인 보관과 사용 환경에 두고 그 안정성을 평가하는\n\n실험\n\n양성 예측도 (Predictive value of positive result, PPV)\n\n표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n양성 결과를 보이는 비율(100을 곱한 값)\n\n☞ a) 양성 예측도(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n해 결정되는)의 유병률에 맞추어 해석해야 한다.\n\n b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n 위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ.  용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n 1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n Ⅱ. ",
        "original_sentence": "위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 700,
        "word_count": 142,
        "page_number": 9,
        "window_text": "b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n은 100xTP/(TP+FP)로 계산된다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n 위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ.  용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n 1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n Ⅱ.  용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 707,
        "word_count": 146,
        "page_number": 5,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 8 -\n양성 일치율(Percent positive agreement, PPA)  = 100×a/(a+c)\n\n음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n음성 예측도 (Predictive value of negative result, NPV)\n\n표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을\n\n곱한 값)\n\n☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n 위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ.  용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n 1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n Ⅱ.  용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n 참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n",
        "original_sentence": "1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "Ⅱ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "위양성 (False positive, FP)\n\n질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n위음성 (False negative, FN)\n\n양성 환자나 양성 검체에서의 음성검사 결과\n\n진단정확도기준\n\n양성\n\n음성\n\n전체\n\n방법 X\n\n양성\n\n# 진양성 TP\n\n# 위양성 FP\n\n진양성+ 위양성\n\n음성\n\n# 위음성 FN\n\n# 진음성 TN\n\n위음성 + 진음성\n\n전체\n\n진양성 + 위음성\n\n위양성 + 진음성\n\nN\n\nⅡ.  용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n 1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n Ⅱ.  용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n 참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n",
        "original_sentence": "Ⅱ. "
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": "용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 211,
        "word_count": 47,
        "page_number": 5,
        "window_text": "용어의 정의\n\n- - 9 -\n임상적 민감도 (Clinical sensitivity)\n\n특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n임상적 보고가능범위 (Clinically reportable range, CCR)\n\n분석측정범위를 연장하기 위해 검체에 대한 희석, 농축, 또는 기타 전처\n\n리를 하여 정량 결과 값으로 보고할 수 있는 분석물질 값의 범위\n\n임상적 특이도 (Clinical specificity)\n\n특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n재현성 조건 (Reproducibility condition)\n\n동일한 방법과 동일한 검사 품목으로 다른 검사실에서 다른 사용자가 다\n\n른 장비를 사용하여 검사 결과를 얻는 조건\n\n재현성 (Reproducibility)\n\n다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n정규분포 (Normal distribution)\n\n가우스 분포라고 표현되며 측정값을 곡선의 x축에, 관측치의 빈도를 곡선\n\n의 y축에 표시\n\n☞ 관측치가 평균의 양측에 균일하게 분포하면 결과그래프는 전형적인 종\n\n정량분석 (Quantitative assay)\n\n검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n보간법(Interpolation)1)을 통해 이루어진다.\n\n 1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n Ⅱ.  용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n 참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n 측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다. ",
        "original_sentence": "용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": "참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 461,
        "word_count": 95,
        "page_number": 13,
        "window_text": "1) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 10 -\n정밀도 (Precision)\n\n규정된 조건 하에서 얻어진 독립적인 검사결과들 가운데 일치도의 근접성\n\n☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현\n\n정성분석 (Qualitative assay)\n\n분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n시스템\n\n☞ 양성 검사 결과는 검사신호가 분석 역치를 넘는 것만을 의미하고 판단\n\n기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에 의해\n\n정확도 (Accuracy)\n\n측정치와 참값 사이의 일치도\n\n☞ 평가대상 검사법에 의한 다수의 연속적인 결과값들에서 얻은 평균값과\n\n공인된 참고값(accepted reference value)사이의 일치 근접도(closeness\n\n직선성 (Linearity)\n\n실험 검체에 있는 분석물질의 농도[양]에 정비례하는 결과를 제공할 수\n\n있는 능력\n\n진단검사 (Diagnostic test)\n\n특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n손상 정도를 평가하기 위한 목적\n\n☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n Ⅱ.  용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n 참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n 측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ. ",
        "original_sentence": "참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 190,
        "word_count": 40,
        "page_number": 1,
        "window_text": "Ⅱ.  용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n 참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n 측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ.  용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 385,
        "word_count": 83,
        "page_number": 13,
        "window_text": "용어의 정의\n\n- - 11 -\n진양성 (True positive, TP)\n\n환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n진음성 (True negative, TN)\n\n환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n참고구간 (Reference interval)\n\n상하 두 개의 참고 한계치 내의 간격\n\n☞ 하한 참고치와 상한 참고치 간의 간격으로 명시되어 있다.\n\n 참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n 측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ.  용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다.  첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n",
        "original_sentence": "측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 153,
        "word_count": 34,
        "page_number": 13,
        "window_text": "참고물질 / 참고제작 (Reference material / Reference preparation, RM)\n\n1) 하나 또는 그 이상의 특성값이 충분히 균일하고 기구의 보정, 측정방\n\n2) 인증참고물질(CRM) – 기술적으로 입증된 과정에 의해 공인되었고 인\n\n증서나 다른 인증기관에 의해 발행된 서류가 있거나 추적 가능한 하\n\n☞ a) 인증참고물질(CRM)은 “인증서가 있는 참고물질로서 하나 또는 그\n\n이상의 특성값이 절차에 따라 공인되며, 그 절차는 특성값이 표현\n\n되는 단위의 정확한 구현에 대한 추적을 할 수 있고, 그것에 대해\n\n각 공인된 값은 신뢰의 명시된 수준에서의 불확실성과 함께 한다”\n\nb) 표준참고물질(SRM)은 인증참고물질(CRM)의 한 이름으로서 과거\n\n에 국립표준원(NBS)으로 알려졌던 미국정부기관으로, 국립표준기\n\n술연구소(NIST)에 의해 인증되고 배포되는 인증참고물질의 상품명\n\n이다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n 측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ.  용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다.  첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n ☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n",
        "original_sentence": "정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 679,
        "word_count": 156,
        "page_number": 3,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 12 -\n참고치 (Reference value)\n\n개체에서 관측 또는 측정으로 얻은 특정 형태의 정량값\n\n총 분석 오차 (Total analytical error)\n\n특정 구성요소들로 구성되어 있으며 90% 또는 95% 신뢰구간으로 정량\n\n화된다.\n\n 측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ.  용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다.  첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n ☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n <!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ. ",
        "original_sentence": "용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다. "
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 53,
        "word_count": 12,
        "page_number": 5,
        "window_text": "측정가능범위 (Analytical measurement range, AMR)\n\n일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이 어떤\n\n검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n측정 시스템의 민감도 (Sensitivity of a measuring system)\n\n측정 시스템 표시 도수의 변화 및 측정된 양의 값의 변화계수\n\n☞ 측정시스템의 민감도는 측정된 양의 크기에 의존하며 측정된 양의 값\n\n친화력, 친화성 (Affinity)\n\n면역학에서 한 개의 항원결정기 부위와 한 개의 항체 사이에 작용하는 힘\n\n판정기준치 (Cut-off value)\n\n정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ.  용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다.  첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n ☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n <!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ. ",
        "original_sentence": "첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 19,
        "window_text": "정량검사에서는 측정 결과가 임상적 또는 분석\n\n적 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n하는데 사용되는 측정물질의 정량값\n\n항원 (Antigen)\n\n생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\nⅡ.  용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다.  첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n ☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n <!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1. ",
        "original_sentence": "☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "<!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 546,
        "word_count": 101,
        "page_number": 19,
        "window_text": "용어의 정의\n\n- - 13 -\n항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n결정하는 부위의 화학적 구조\n\n항원항체결합력 (Avidity)\n\n항혈청 또는 항체의 복합적인 반응 강도\n\n☞ 항원항체결합력은 항혈청 내 모든 항체의 항체결합부위와 가용한 마크\n\n항체 (Antibody)\n\n면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으\n\n허용 오차 (Allowable error)\n\n모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n만족시킬 수 있는 변이의 정도\n\n후크효과 (Hook effect)\n\n항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이하\n\n로 나타나는 현상\n\n회복, 회수 (Recovery)\n\n동일 물질의 검체에 알고 있는 양을 첨가한 후 분석물질 농도의 증가를\n\n확인\n\n☞ 분석물질이 첨가되지 않은 혈청 검체와 첨가된 혈청 검체로 분석물질\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 14 -\n의 증가가 첨가된 양과 동등한 지 분석한다.  첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n ☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n <!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1.  제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n",
        "original_sentence": "<!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ. "
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 439,
        "word_count": 97,
        "page_number": 20,
        "window_text": "첨가된 물질의 양을 확인\n\n하는 정확도는 회수 실험에 필수적이며 100% 회수가 이상적이다.\n\n ☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n <!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1.  제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n - 다. ",
        "original_sentence": "신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 94,
        "word_count": 22,
        "page_number": 22,
        "window_text": "☞ 회수실험의 다른 형태는 희석-회수분석이다.\n\n <!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1.  제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n - 다.  동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 35,
        "word_count": 5,
        "page_number": 22,
        "window_text": "<!-- PAGE_19 -->\n# Ⅲ\n\n<!-- PAGE_19 -->\n#### 관련규정\n\n■ 「의료기기법」제3조 (제조업의 허가의 신청절차)\n\n■ 「의료기기법」제10조 (임상시험계획의 승인 등)\n\n■ 「의료기기법」제29조 (수입업 허가신청 등)\n\n■ 「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n■ 「의료기기법 시행규칙」제6조 (제조인증의 절차)\n\n■ 「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n■ 「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n■ 「의료기기법 시행규칙」제20조 (임상시험계획의 승인 등)\n\n■ 「의료기기법 시행규칙」제21조 (임상시험기관 지정기준 및 절차 등)\n\n■ 「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n■ 「의료기기법 시행규칙」제42조 (용기 등의 기재사항)\n\n■ 「의료기기법 시행규칙」제43조 (첨부문서의 기재사항)\n\n■ 「의료기기법 시행규칙」제44조 (기재사항의 표시방법)\n\n■ 「의료기기 허가․신고․심사 등에 관한 규정」\n\n■ 「의료기기 품목 및 품목별 등급에 관한 규정」\n\n■ 「의료기기 안정성시험 기준」\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1.  제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n - 다.  동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1.  품목명 : 심질환표지자검사시약\n- 2. ",
        "original_sentence": "제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n# Ⅳ\n\n신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_20 -->\n###### 1\n\n<!-- PAGE_20 -->\n###### 제조․수입허가신청서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 16 -\n<!-- PAGE_21 -->\n###### 2\n\n<!-- PAGE_21 -->\n###### 기술문서에 관한 자료\n\n❍ 개발경위, 측정원리․방법 및 국내·외 사용현황에 관한 자료\n\n❍ 원재료 및 제조방법에 관한 자료\n\n❍ 사용목적에 관한 자료\n\n❍ 저장방법과 사용기간(유효기간)에 관한 자료\n\n❍ 성능시험에 관한 자료\n\n❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n❍ 이미 허가·인증받은 제품과 비교한 자료(별지제3호서식)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1.  제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n - 다.  동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1.  품목명 : 심질환표지자검사시약\n- 2.  모델명 : OS-Troponin I\n- 3. ",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 139,
        "word_count": 35,
        "page_number": 48,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n# Ⅴ\n\n<!-- PAGE_22 -->\n### 제조․수입허가 신청서 기재항목\n\n- 1.  제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n - 다.  동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1.  품목명 : 심질환표지자검사시약\n- 2.  모델명 : OS-Troponin I\n- 3.  품목분류번호 : D04030.01\n- 4. ",
        "original_sentence": "동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "품목명 : 심질환표지자검사시약\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 21,
        "window_text": "제조(수입)업소명·상품명, 품목류명, 모델명을 각각 기재한다.\n - 다.  동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1.  품목명 : 심질환표지자검사시약\n- 2.  모델명 : OS-Troponin I\n- 3.  품목분류번호 : D04030.01\n- 4.  등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1. ",
        "original_sentence": "품목명 : 심질환표지자검사시약\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "모델명 : OS-Troponin I\n- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 13,
        "window_text": "- 다.  동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1.  품목명 : 심질환표지자검사시약\n- 2.  모델명 : OS-Troponin I\n- 3.  품목분류번호 : D04030.01\n- 4.  등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1.  모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n",
        "original_sentence": "모델명 : OS-Troponin I\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": "품목분류번호 : D04030.01\n- 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 24,
        "word_count": 5,
        "page_number": 2,
        "window_text": "동일제품에 대하여 두개 이상의 다른 상품명(또는 모델명) 부여는\n※ 다만, 기허가 제품과 사용목적이 유사하여 허가받은 제품의 상품명\n\n에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동일 제조\n\n※ 별첨 기재시의 예\n\n<제품명>\n\n- 1.  품목명 : 심질환표지자검사시약\n- 2.  모델명 : OS-Troponin I\n- 3.  품목분류번호 : D04030.01\n- 4.  등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1.  모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n - 가. ",
        "original_sentence": "품목분류번호 : D04030.01\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 129,
        "word_count": 30,
        "page_number": 23,
        "window_text": "품목명 : 심질환표지자검사시약\n- 2.  모델명 : OS-Troponin I\n- 3.  품목분류번호 : D04030.01\n- 4.  등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1.  모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n - 가.  임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다. ",
        "original_sentence": "등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 113,
        "word_count": 27,
        "page_number": 23,
        "window_text": "모델명 : OS-Troponin I\n- 3.  품목분류번호 : D04030.01\n- 4.  등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1.  모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n - 가.  임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다.  트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다. ",
        "original_sentence": "모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "품목분류번호 : D04030.01\n- 4.  등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1.  모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n - 가.  임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다.  트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다.  트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다. ",
        "original_sentence": "- 가. "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 77,
        "word_count": 16,
        "page_number": 13,
        "window_text": "등급 : 3등급\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 2\n\n<!-- PAGE_23 -->\n###### 모양 및 구조\n\n- 1.  모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n - 가.  임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다.  트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다.  트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다.  복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다. ",
        "original_sentence": "임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다. "
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 107,
        "word_count": 18,
        "page_number": 23,
        "window_text": "모양 및 구조 - 작용원리\n제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상적\n\n의의 등을 포함하여 기재한다.\n\n - 가.  임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다.  트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다.  트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다.  복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다.  그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n",
        "original_sentence": "트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다. "
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 124,
        "word_count": 21,
        "page_number": 13,
        "window_text": "- 가.  임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다.  트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다.  트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다.  복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다.  그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n Ⅴ. ",
        "original_sentence": "트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 137,
        "word_count": 32,
        "page_number": 13,
        "window_text": "임상적 의의(배경) : 필요에 따라 해당 검사의 임상적 의의(배경)\n본 Troponin-I 검사는 심장 트로포닌-I를 측정하는 검사이다.  트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다.  트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다.  복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다.  그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n Ⅴ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나. ",
        "original_sentence": "복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다. "
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 137,
        "word_count": 33,
        "page_number": 83,
        "window_text": "트로포닌\n\n은 가로무늬근의 수축 조절 단백질 복합체로, 단백질 트로포미오신\n\n(tropomyosin)과 함께 근원섬유의 가는 필라멘트(thin filament)를 따라\n\n주기적으로 발견된다.  트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다.  복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다.  그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n Ⅴ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n",
        "original_sentence": "그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": "Ⅴ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "트로포닌 복합체는 트로포닌-C(칼슘 결합 성분),\n\n트로포닌-I(액티노미오신(actinomyosin) ATPase 억제 성분), 트로포닌\n\n- -T(트로포미오신 결합 성분)로 구분되는 세 가지 폴리펩티드로 구성된\n- 다.  복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다.  그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n Ⅴ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n ※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다. ",
        "original_sentence": "Ⅴ. "
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 33,
        "word_count": 10,
        "page_number": 3,
        "window_text": "복합체는 미오신(myosin)과 액틴(actin)의 칼슘 의존성 상호 작용을\n심장 트로포닌-I 농도의 측정을 통해 광범위한 진단 기간 전반에 걸쳐\n\n심근 손상에 대한 민감도 및 특이성을 알 수 있으며, 심근 경색증과 심근\n\n괴사의 지표가 된다.  그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n Ⅴ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n ※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다.  시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 24,
        "window_text": "그 외에 트로포닌 수치의 상승을 일으키는 상태로는\n\n흉부 외상, 심장 및 비심장 수술, 울혈성 심부전, 신부전, 약물 심장독성,\n\n염증성 질환 (예: 심근염), 폐색전증, 침윤성 질환 및 급성 신경계 질환을\n\n포함하나 이에 국한되지는 않는다.\n\n Ⅴ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n ※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다.  시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다.  첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다. ",
        "original_sentence": "작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n"
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 16,
        "window_text": "Ⅴ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n ※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다.  시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다.  첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다.  두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다. ",
        "original_sentence": "※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다. "
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 69,
        "word_count": 15,
        "page_number": 13,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 19 -\n- 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n ※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다.  시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다.  첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다.  두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다.  검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다. ",
        "original_sentence": "시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다. "
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 51,
        "window_text": "작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n ※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다.  시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다.  첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다.  두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다.  검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다.  첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다. ",
        "original_sentence": "첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 71,
        "word_count": 17,
        "page_number": 3,
        "window_text": "※ 예시\n\n측정원리는 동종 샌드위치 화학발광 면역측정법이다.  시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다.  첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다.  두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다.  검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다.  첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다.  복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다. ",
        "original_sentence": "두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 78,
        "word_count": 16,
        "page_number": 3,
        "window_text": "시약에는 두 개의\n\n합성 비드시약과 비오틴이 결합된 Cardiac Troponin I 억제 단클론 항\n\n체가 포함되어있다.  첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다.  두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다.  검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다.  첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다.  복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다.  결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2. ",
        "original_sentence": "검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다. "
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 24,
        "window_text": "첫 번째 비드 시약은 스트렙타비딘으로 코팅되어 있\n\n고 감광제 염료가 포함되어 있다.  두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다.  검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다.  첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다.  복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다.  결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2.  모양 및 구조 - 외형\n- 가. ",
        "original_sentence": "첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다. "
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 86,
        "word_count": 23,
        "page_number": 3,
        "window_text": "두 번째 비드 시약은 Cardiac\n\nTroponin I 억제 단클론 항체로 코팅되어 있고 화학발광 염료가 포함되\n\n어 있다.  검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다.  첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다.  복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다.  결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2.  모양 및 구조 - 외형\n- 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n",
        "original_sentence": "복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다. "
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 5,
        "window_text": "검체는 비드 시약 및 비오틴이 결합된 항체와 함께 배양되어\n\n비드-Cardiac Troponin I-비오틴 결합 항체 샌드위치를 형성한다.  첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다.  복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다.  결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2.  모양 및 구조 - 외형\n- 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n - 나. ",
        "original_sentence": "결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "모양 및 구조 - 외형\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 18,
        "word_count": 7,
        "page_number": 23,
        "window_text": "첫\n\n번째 비드 시약이 추가되고 비오틴과 결합되어 비드 쌍 면역 복합체를\n\n형성한다.  복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다.  결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2.  모양 및 구조 - 외형\n- 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n - 나.  외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n",
        "original_sentence": "모양 및 구조 - 외형\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 66,
        "word_count": 17,
        "page_number": 13,
        "window_text": "복합체에 680 nm의 빛을 가하면 첫 번째 비드는 일중항 산소\n\n를 생성하고, 이 일중항 산소가 두 번째 비드로 발산되어 화학발광 반응\n\n을 일으킨다.  결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2.  모양 및 구조 - 외형\n- 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n - 나.  외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n - 다. ",
        "original_sentence": "외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "결과 신호는 612 nm에서 측정되며, 이는 검체의 Cardiac\n\n- 2.  모양 및 구조 - 외형\n- 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n - 나.  외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n - 다.  구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": "외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 80,
        "word_count": 19,
        "page_number": 83,
        "window_text": "모양 및 구조 - 외형\n- 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n - 나.  외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n - 다.  구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1. ",
        "original_sentence": "외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및\n구성하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n - 나.  외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n - 다.  구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1.  외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1. ",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 78,
        "word_count": 19,
        "page_number": 32,
        "window_text": "- 나.  외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n - 다.  구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1.  외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1.  구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ. ",
        "original_sentence": "구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 1,
        "window_text": "외관설명 : 고형의 구성제품에 대해서는 모양․구조․중량 등을, 액상\n또는 분말의 시약에 대해서는 색, 성상, 액성, 냄새 등\n\n을 기재한다.\n\n - 다.  구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1.  외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1.  구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1. "
      }
    },
    {
      "chunk_id": "chunk_391",
      "text": "외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 390,
        "window_size": 3,
        "char_count": 41,
        "word_count": 9,
        "page_number": 5,
        "window_text": "- 다.  구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1.  외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1.  구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2.  외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2. ",
        "original_sentence": "외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1. "
      }
    },
    {
      "chunk_id": "chunk_392",
      "text": "구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 391,
        "window_size": 3,
        "char_count": 56,
        "word_count": 15,
        "page_number": 21,
        "window_text": "구성 : 만일 체외진단용 시약과 별도의 구성품을 포함하고자 할 경우,\n별도판매 구성품에 대하여 추가로 외관사진 및 구성표를 제시\n\n한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1.  외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1.  구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2.  외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2.  구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1. ",
        "original_sentence": "구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_393",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 392,
        "window_size": 3,
        "char_count": 34,
        "word_count": 10,
        "page_number": 3,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 20 -\n그림 1.  외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1.  구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2.  외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2.  구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2. "
      }
    },
    {
      "chunk_id": "chunk_394",
      "text": "외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 393,
        "window_size": 3,
        "char_count": 74,
        "word_count": 14,
        "page_number": 13,
        "window_text": "외관사진 첨부 예\n\n체외진단용 시약: OS-Troponin I\n\n표 1.  구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2.  외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2.  구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n ※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n",
        "original_sentence": "외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2. "
      }
    },
    {
      "chunk_id": "chunk_395",
      "text": "구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 394,
        "window_size": 3,
        "char_count": 254,
        "word_count": 59,
        "page_number": 27,
        "window_text": "구성의 예\n\n2\n\nQ\n\n단일구성\n\n투명한 액상 시약\n\n3\n\nR\n\n단일구성\n\n투명한 액상 시약\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2.  외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2.  구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n ※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n - 가. ",
        "original_sentence": "구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_396",
      "text": "원재료는 다음 양식의 표를 사용하여 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 395,
        "window_size": 3,
        "char_count": 26,
        "word_count": 6,
        "page_number": 24,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 21 -\n그림 2.  외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2.  구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n ※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n - 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다. ",
        "original_sentence": "원재료는 다음 양식의 표를 사용하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_397",
      "text": "※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 396,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 27,
        "window_text": "외관사진 첨부 예\n\n별도판매구성품: OS-Troponin I Calibrator\n\n< Troponin I CalSet >\n\n표 2.  구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n ※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n - 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다.  두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나. ",
        "original_sentence": "※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_398",
      "text": "- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 397,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "구성의 예\n\n일련\n\n번호\n\n명 칭\n\n세부 구성\n\n외관상 특징\n\n1\n\nOS-Troponin I\n\nCalSet\n\n- ② Cal 2\n동결건조 시약\n\n- ③ Snap-cap bottle\n소분용 빈 병\n\n- ④ Snap-cap bottle\n소분용 빈 병\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 3\n\n<!-- PAGE_27 -->\n###### 원재료\n\n- 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n ※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n - 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다.  두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나.  배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다. ",
        "original_sentence": "- 가. "
      }
    },
    {
      "chunk_id": "chunk_399",
      "text": "명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 398,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 3,
        "window_text": "원재료는 다음 양식의 표를 사용하여 기재한다.\n ※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n - 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다.  두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나.  배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마. ",
        "original_sentence": "명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_400",
      "text": "두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 399,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 48,
        "window_text": "※ 별도판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n - 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다.  두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나.  배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n",
        "original_sentence": "두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_401",
      "text": "배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 400,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 27,
        "window_text": "- 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다.  두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나.  배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n - 바. ",
        "original_sentence": "배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_402",
      "text": "원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 401,
        "window_size": 3,
        "char_count": 194,
        "word_count": 47,
        "page_number": 5,
        "window_text": "명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한\n- 다.  두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나.  배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n - 바.  비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n",
        "original_sentence": "원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마. "
      }
    },
    {
      "chunk_id": "chunk_403",
      "text": "규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 402,
        "window_size": 3,
        "char_count": 72,
        "word_count": 19,
        "page_number": 25,
        "window_text": "두 세트 이상이 함께 사용되어 하나의 사용목적을 달성\n- 나.  배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n - 바.  비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n 일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ. ",
        "original_sentence": "규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_404",
      "text": "- 바. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 403,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "배합목적 : 체외진단용 시약의 특성에 맞게 각 성분의 배합목적을\n- 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n - 바.  비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n 일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3. ",
        "original_sentence": "- 바. "
      }
    },
    {
      "chunk_id": "chunk_405",
      "text": "비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 404,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 24,
        "window_text": "원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n1) 반응주성분에 대하여 해당 분량을 명시하고 항체의 경우 가급적\n\n2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n반응정지제, 희석액 등) 성분은 적량으로 표시 가능\n\n3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n- 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n - 바.  비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n 일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3.  원재료 작성의 예\n\n- 1. ",
        "original_sentence": "비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_406",
      "text": "일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 405,
        "window_size": 3,
        "char_count": 47,
        "word_count": 11,
        "page_number": 2,
        "window_text": "규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)\n을 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n - 바.  비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n 일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3.  원재료 작성의 예\n\n- 1.  체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다. ",
        "original_sentence": "일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_407",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 406,
        "window_size": 3,
        "char_count": 33,
        "word_count": 10,
        "page_number": 3,
        "window_text": "- 바.  비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n 일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3.  원재료 작성의 예\n\n- 1.  체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다.  | 결과판정 상 주의사항을 기재한다. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3. "
      }
    },
    {
      "chunk_id": "chunk_408",
      "text": "원재료 작성의 예\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 407,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 5,
        "window_text": "비고 : 비고란에는 각 구성 시약의 총량 및 수량 등을 기재한다.\n 일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3.  원재료 작성의 예\n\n- 1.  체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다.  | 결과판정 상 주의사항을 기재한다.  | 재현성으로 구분하여 평가한다. ",
        "original_sentence": "원재료 작성의 예\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_409",
      "text": "체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 408,
        "window_size": 3,
        "char_count": 125,
        "word_count": 25,
        "page_number": 5,
        "window_text": "일련\n\n번호\n\n명칭\n\n배합목적\n\n원재료명 또는\n\n성분명\n\n분량\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3.  원재료 작성의 예\n\n- 1.  체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다.  | 결과판정 상 주의사항을 기재한다.  | 재현성으로 구분하여 평가한다.  | 등을 제시한다. ",
        "original_sentence": "체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다. "
      }
    },
    {
      "chunk_id": "chunk_410",
      "text": "| 결과판정 상 주의사항을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 409,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 3,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 23 -\n표 3.  원재료 작성의 예\n\n- 1.  체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다.  | 결과판정 상 주의사항을 기재한다.  | 재현성으로 구분하여 평가한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다. ",
        "original_sentence": "| 결과판정 상 주의사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_411",
      "text": "| 재현성으로 구분하여 평가한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 410,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 3,
        "window_text": "원재료 작성의 예\n\n- 1.  체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다.  | 결과판정 상 주의사항을 기재한다.  | 재현성으로 구분하여 평가한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 항체 등) | 과의 동등성을 먼저 확인해야 한다. ",
        "original_sentence": "| 재현성으로 구분하여 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_412",
      "text": "| 등을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 411,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 24,
        "window_text": "체외진단용 시약 : OS-Troponin I\n1) oxypyrion : 1-hydroxy-2(1H)-pyridinone\n\n**[표 시작]**\n\n| 일련 | 정보가 기재되어야 함 | 5) 각 검체를 3회 이상 반복 검사한다.  | 결과판정 상 주의사항을 기재한다.  | 재현성으로 구분하여 평가한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 항체 등) | 과의 동등성을 먼저 확인해야 한다.  | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다. ",
        "original_sentence": "| 등을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_413",
      "text": "유병률을 구한 경우는 유병률도 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 412,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 24,
        "window_text": "| 결과판정 상 주의사항을 기재한다.  | 재현성으로 구분하여 평가한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 항체 등) | 과의 동등성을 먼저 확인해야 한다.  | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다.  헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC. ",
        "original_sentence": "유병률을 구한 경우는 유병률도 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_414",
      "text": "| 항체 등) | 과의 동등성을 먼저 확인해야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 413,
        "window_size": 3,
        "char_count": 30,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 재현성으로 구분하여 평가한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 항체 등) | 과의 동등성을 먼저 확인해야 한다.  | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다.  헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC.  | CORPORATION | MANNHEIM | BEHRING INC. ",
        "original_sentence": "| 항체 등) | 과의 동등성을 먼저 확인해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_415",
      "text": "| ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 414,
        "window_size": 3,
        "char_count": 265,
        "word_count": 64,
        "page_number": 13,
        "window_text": "| 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 항체 등) | 과의 동등성을 먼저 확인해야 한다.  | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다.  헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC.  | CORPORATION | MANNHEIM | BEHRING INC.  |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx. ",
        "original_sentence": "| ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다. "
      }
    },
    {
      "chunk_id": "chunk_416",
      "text": "헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 415,
        "window_size": 3,
        "char_count": 94,
        "word_count": 15,
        "page_number": 13,
        "window_text": "유병률을 구한 경우는 유병률도 제시한다.  | 항체 등) | 과의 동등성을 먼저 확인해야 한다.  | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다.  헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC.  | CORPORATION | MANNHEIM | BEHRING INC.  |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx.  | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4. ",
        "original_sentence": "헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_417",
      "text": "| CORPORATION | MANNHEIM | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 416,
        "window_size": 3,
        "char_count": 40,
        "word_count": 7,
        "page_number": 13,
        "window_text": "| 항체 등) | 과의 동등성을 먼저 확인해야 한다.  | ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다.  헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC.  | CORPORATION | MANNHEIM | BEHRING INC.  |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx.  | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4.  시험자의 연구경력 | 해석을 제시한다. ",
        "original_sentence": "| CORPORATION | MANNHEIM | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_418",
      "text": "|\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 417,
        "window_size": 3,
        "char_count": 219,
        "word_count": 55,
        "page_number": 2,
        "window_text": "| ACCESS TROPONIN I REAGENTS | BECKMAN | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| K961500 | ELECSYS TROPONIN T | LIFESIGN MI | IMMUNOASSAY | CALIBRATOR AND SDIL SAMPLE | TROPONIN I (TROP) TESTPAK | 라벨 유무 확인 | 농도에서 간섭 반응이 나타나지 않았다.  헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC.  | CORPORATION | MANNHEIM | BEHRING INC.  |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx.  | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4.  시험자의 연구경력 | 해석을 제시한다.  | 하나에 해당하는 자료 | 기간)을 기재한다. ",
        "original_sentence": "|\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx. "
      }
    },
    {
      "chunk_id": "chunk_419",
      "text": "| NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 418,
        "window_size": 3,
        "char_count": 56,
        "word_count": 11,
        "page_number": 5,
        "window_text": "헤모글로빈: | 적정 기준(optimal cut-off)은 troponin I의 최고값으로부터 | PRINCETON | DIAGNOSTICS | BEHRING INC.  | CORPORATION | MANNHEIM | BEHRING INC.  |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx.  | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4.  시험자의 연구경력 | 해석을 제시한다.  | 하나에 해당하는 자료 | 기간)을 기재한다.  | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. ",
        "original_sentence": "| NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4. "
      }
    },
    {
      "chunk_id": "chunk_420",
      "text": "시험자의 연구경력 | 해석을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 419,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 24,
        "window_text": "| CORPORATION | MANNHEIM | BEHRING INC.  |\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx.  | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4.  시험자의 연구경력 | 해석을 제시한다.  | 하나에 해당하는 자료 | 기간)을 기재한다.  | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다. ",
        "original_sentence": "시험자의 연구경력 | 해석을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_421",
      "text": "| 하나에 해당하는 자료 | 기간)을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 420,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 24,
        "window_text": "|\n| 번호 명칭 배합목적 | 원재료명 또는 성분명 | 거나 심장 표지자 값이 증가하기 전에 사망한 심장사(cardiac | 가) 판정기준치(농도) | w/v | 규격 | 비고 |\n| NUMBER | K974075 | ABBOTT ARCHITECT STAT | NANO-CHECK AMI 2 IN 1 | ON THE ACCESS | 반응 | 보정물질 | Troponin I | approx.  | NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4.  시험자의 연구경력 | 해석을 제시한다.  | 하나에 해당하는 자료 | 기간)을 기재한다.  | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다.  | C1T1C2T2C3T3C4T4C5T5). ",
        "original_sentence": "| 하나에 해당하는 자료 | 기간)을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_422",
      "text": "| 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 421,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 24,
        "window_text": "| NANO-DITEC | INSTRUMENT | BOEHRINGER |\n| K022946 | 4.  시험자의 연구경력 | 해석을 제시한다.  | 하나에 해당하는 자료 | 기간)을 기재한다.  | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다.  | C1T1C2T2C3T3C4T4C5T5).  | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다. ",
        "original_sentence": "| 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_423",
      "text": "| 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 422,
        "window_size": 3,
        "char_count": 66,
        "word_count": 17,
        "page_number": 43,
        "window_text": "시험자의 연구경력 | 해석을 제시한다.  | 하나에 해당하는 자료 | 기간)을 기재한다.  | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다.  | C1T1C2T2C3T3C4T4C5T5).  | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다.  | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다. ",
        "original_sentence": "| 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다. "
      }
    },
    {
      "chunk_id": "chunk_424",
      "text": "| C1T1C2T2C3T3C4T4C5T5). ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 423,
        "window_size": 3,
        "char_count": 25,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| 하나에 해당하는 자료 | 기간)을 기재한다.  | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다.  | C1T1C2T2C3T3C4T4C5T5).  | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다.  | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다.  | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다. ",
        "original_sentence": "| C1T1C2T2C3T3C4T4C5T5). "
      }
    },
    {
      "chunk_id": "chunk_425",
      "text": "| 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 424,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 24,
        "window_text": "| 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다.  | C1T1C2T2C3T3C4T4C5T5).  | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다.  | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다.  | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다.  | BIOMEDITECH | CORP. ",
        "original_sentence": "| 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다. "
      }
    },
    {
      "chunk_id": "chunk_426",
      "text": "| MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 425,
        "window_size": 3,
        "char_count": 70,
        "word_count": 13,
        "page_number": 13,
        "window_text": "| 함한다)을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 정보가 기재되어야 함 | 분석법 등을 미리 확립한다.  | C1T1C2T2C3T3C4T4C5T5).  | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다.  | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다.  | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다.  | BIOMEDITECH | CORP.  | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가. ",
        "original_sentence": "| MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_427",
      "text": "| 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 426,
        "window_size": 3,
        "char_count": 75,
        "word_count": 16,
        "page_number": 5,
        "window_text": "| C1T1C2T2C3T3C4T4C5T5).  | 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다.  | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다.  | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다.  | BIOMEDITECH | CORP.  | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가.  분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다. ",
        "original_sentence": "| 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_428",
      "text": "| BIOMEDITECH | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 427,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 25,
        "window_text": "| 계없는 기준이여야 함 | 검체를 단계 희석하여 시험물질을 제조한다.  | MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다.  | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다.  | BIOMEDITECH | CORP.  | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가.  분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다.  ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death). ",
        "original_sentence": "| BIOMEDITECH | CORP. "
      }
    },
    {
      "chunk_id": "chunk_429",
      "text": "| 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 428,
        "window_size": 3,
        "char_count": 38,
        "word_count": 13,
        "page_number": 6,
        "window_text": "| MYOGLOBIN/TROPONIN I RAPID | DILUENT | 종류, 검체수, 반복회수, 계산법을 함께 제시한다.  | 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다.  | BIOMEDITECH | CORP.  | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가.  분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다.  ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death).  | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC. ",
        "original_sentence": "| 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가. "
      }
    },
    {
      "chunk_id": "chunk_430",
      "text": "분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 429,
        "window_size": 3,
        "char_count": 86,
        "word_count": 16,
        "page_number": 6,
        "window_text": "| 정확한 바코드 및 제품명 확인 | 1000mg/dL, 인지질: 300mg/dL, 빌리루빈: 40 mg/dL | 육안으로 확인한다.  | BIOMEDITECH | CORP.  | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가.  분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다.  ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death).  | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC.  | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다. ",
        "original_sentence": "분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다. "
      }
    },
    {
      "chunk_id": "chunk_431",
      "text": "ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death). ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 430,
        "window_size": 3,
        "char_count": 90,
        "word_count": 20,
        "page_number": 5,
        "window_text": "| BIOMEDITECH | CORP.  | 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가.  분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다.  ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death).  | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC.  | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다.  | TEST | 정확한 로트 번호 확인 | CORP. ",
        "original_sentence": "ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death). "
      }
    },
    {
      "chunk_id": "chunk_432",
      "text": "| 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 431,
        "window_size": 3,
        "char_count": 156,
        "word_count": 31,
        "page_number": 13,
        "window_text": "| 자사규격 |\n| 2 | 원재료 및 제조방법에 관한 자료 | 가.  분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다.  ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death).  | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC.  | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다.  | TEST | 정확한 로트 번호 확인 | CORP.  | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다. ",
        "original_sentence": "| 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC. "
      }
    },
    {
      "chunk_id": "chunk_433",
      "text": "| MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 432,
        "window_size": 3,
        "char_count": 55,
        "word_count": 15,
        "page_number": 5,
        "window_text": "분석적 성능시험에 관한 자료(시험성적서) | ELECSYS TROPONIN T STAT | ROC 분석에 의해 0.30 ㎍/L(ng/mL)로 산출되었다.  ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death).  | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC.  | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다.  | TEST | 정확한 로트 번호 확인 | CORP.  | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.  | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나. ",
        "original_sentence": "| MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다. "
      }
    },
    {
      "chunk_id": "chunk_434",
      "text": "| TEST | 정확한 로트 번호 확인 | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 433,
        "window_size": 3,
        "char_count": 30,
        "word_count": 9,
        "page_number": 2,
        "window_text": "ROC | ROCHE | MEDICAL |\n| K102441 | K984105 | 1 | P | 주성분 | Streptavidin-coated | death).  | 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC.  | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다.  | TEST | 정확한 로트 번호 확인 | CORP.  | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.  | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나.  분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다. ",
        "original_sentence": "| TEST | 정확한 로트 번호 확인 | CORP. "
      }
    },
    {
      "chunk_id": "chunk_435",
      "text": "| 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 434,
        "window_size": 3,
        "char_count": 130,
        "word_count": 27,
        "page_number": 5,
        "window_text": "| 나) 판정기준치에서의 임상적 민감도 및 특이도 | TROPONIN I LIQUID ASSAYED | CARDIAC MARKER CTNL AND | IMMUNOASSAY ANALYZER | (recombinant) | ABBOTT | H | BOEHRINGER | S INC.  | MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다.  | TEST | 정확한 로트 번호 확인 | CORP.  | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.  | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나.  분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.  | 다. ",
        "original_sentence": "| 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_436",
      "text": "| TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 435,
        "window_size": 3,
        "char_count": 207,
        "word_count": 42,
        "page_number": 5,
        "window_text": "| MANNHEIM | 0.6 | 2 | 자사규격 | 1x6.5 |\n| cTnI의 증가를 보였다.  | TEST | 정확한 로트 번호 확인 | CORP.  | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.  | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나.  분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.  | 다.  다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다. ",
        "original_sentence": "| TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나. "
      }
    },
    {
      "chunk_id": "chunk_437",
      "text": "분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 436,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| TEST | 정확한 로트 번호 확인 | CORP.  | 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.  | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나.  분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.  | 다.  다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.  | 밀도 등)을 설정한다. ",
        "original_sentence": "분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_438",
      "text": "| 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 437,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| 2.5 |\n| K041194 | K060875 | ABBOTT AXSYM TROPONIN-I | K963143 | ELECSYS CALCHECK TROPONIN | 3) 양성 검체는 각 질환의 다양한 임상단계가 포함되도록 한다.  | TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나.  분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.  | 다.  다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.  | 밀도 등)을 설정한다.  | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_439",
      "text": "다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 438,
        "window_size": 3,
        "char_count": 33,
        "word_count": 7,
        "page_number": 24,
        "window_text": "| TEST | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 분석에 의한 적정 기준(optimized cut-off) (0.30 | ANALYSIS |\n| K000784 | THE CARDIAC READER SYSTEM | • Percutaneous coronary intervention (PCI) related MI는 정상 기 | 나.  분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.  | 다.  다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.  | 밀도 등)을 설정한다.  | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다.  | 술한다. ",
        "original_sentence": "다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_440",
      "text": "| 밀도 등)을 설정한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 439,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 24,
        "window_text": "분석적 성능시험에 관한 자료에는 다음의 평가항목을 포함한다.  | 다.  다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.  | 밀도 등)을 설정한다.  | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다.  | 술한다.  | 을 받는 경우에는 그 조건을 명시하여야 한다. ",
        "original_sentence": "| 밀도 등)을 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_441",
      "text": "| Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 440,
        "window_size": 3,
        "char_count": 61,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| 다.  다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.  | 밀도 등)을 설정한다.  | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다.  | 술한다.  | 을 받는 경우에는 그 조건을 명시하여야 한다.  | 시기를 거친 다음 평가를 수행하도록 한다. ",
        "original_sentence": "| Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_442",
      "text": "| 술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 441,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 24,
        "window_text": "다양한 임상상을 포함하는 검체를 포함하여 비교하도록 한다.  | 밀도 등)을 설정한다.  | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다.  | 술한다.  | 을 받는 경우에는 그 조건을 명시하여야 한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 제시한다. ",
        "original_sentence": "| 술한다. "
      }
    },
    {
      "chunk_id": "chunk_443",
      "text": "| 을 받는 경우에는 그 조건을 명시하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 442,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 24,
        "window_text": "| 밀도 등)을 설정한다.  | Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다.  | 술한다.  | 을 받는 경우에는 그 조건을 명시하여야 한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 제시한다.  | 제시한다. ",
        "original_sentence": "| 을 받는 경우에는 그 조건을 명시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_444",
      "text": "| 시기를 거친 다음 평가를 수행하도록 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 443,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 24,
        "window_text": "| Standard Institute; 2010 | 4) 시험자의 연구경력 | 및 위음성도) 등을 기재한다.  | 술한다.  | 을 받는 경우에는 그 조건을 명시하여야 한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 제시한다.  | 제시한다.  | 결과를 비교한다. ",
        "original_sentence": "| 시기를 거친 다음 평가를 수행하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_445",
      "text": "| 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 444,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| 술한다.  | 을 받는 경우에는 그 조건을 명시하여야 한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 제시한다.  | 제시한다.  | 결과를 비교한다.  정량검사의 경우는 바이어스를 구한다. ",
        "original_sentence": "| 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_446",
      "text": "| 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 445,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| 을 받는 경우에는 그 조건을 명시하여야 한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 제시한다.  | 제시한다.  | 결과를 비교한다.  정량검사의 경우는 바이어스를 구한다.  | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP. ",
        "original_sentence": "| 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_447",
      "text": "| 결과를 비교한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 446,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 24,
        "window_text": "| 시기를 거친 다음 평가를 수행하도록 한다.  | 제시한다.  | 제시한다.  | 결과를 비교한다.  정량검사의 경우는 바이어스를 구한다.  | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP.  | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2. ",
        "original_sentence": "| 결과를 비교한다. "
      }
    },
    {
      "chunk_id": "chunk_448",
      "text": "정량검사의 경우는 바이어스를 구한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 447,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 24,
        "window_text": "| 제시한다.  | 제시한다.  | 결과를 비교한다.  정량검사의 경우는 바이어스를 구한다.  | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP.  | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2.  별도판매구성품 : OS-Troponin I CalSet\n- 1. ",
        "original_sentence": "정량검사의 경우는 바이어스를 구한다. "
      }
    },
    {
      "chunk_id": "chunk_449",
      "text": "| 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 448,
        "window_size": 3,
        "char_count": 237,
        "word_count": 44,
        "page_number": 5,
        "window_text": "| 제시한다.  | 결과를 비교한다.  정량검사의 경우는 바이어스를 구한다.  | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP.  | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2.  별도판매구성품 : OS-Troponin I CalSet\n- 1.  '제조원의 제조방법에 따른다.’라고 기재한다. ",
        "original_sentence": "| 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP. "
      }
    },
    {
      "chunk_id": "chunk_450",
      "text": "| mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 449,
        "window_size": 3,
        "char_count": 472,
        "word_count": 112,
        "page_number": 28,
        "window_text": "| 결과를 비교한다.  정량검사의 경우는 바이어스를 구한다.  | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP.  | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2.  별도판매구성품 : OS-Troponin I CalSet\n- 1.  '제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n- 가. ",
        "original_sentence": "| mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_451",
      "text": "별도판매구성품 : OS-Troponin I CalSet\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 450,
        "window_size": 3,
        "char_count": 36,
        "word_count": 7,
        "page_number": 5,
        "window_text": "정량검사의 경우는 바이어스를 구한다.  | 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP.  | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2.  별도판매구성품 : OS-Troponin I CalSet\n- 1.  '제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n- 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n",
        "original_sentence": "별도판매구성품 : OS-Troponin I CalSet\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_452",
      "text": "'제조원의 제조방법에 따른다.’라고 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 451,
        "window_size": 3,
        "char_count": 26,
        "word_count": 4,
        "page_number": 24,
        "window_text": "| 간섭물질 | 예시 | DIAGNOSTICS | ABBOTT |\n| 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | VBL SERUM TROPONIN I TEST | CARDIAC MARKER CONTROL | MYOGLOBIN | Standard deviation (ng/mL) | microparticles | VANCOUVER | LABORATORIE | CORPORATION | MANNHEIM | CORP.  | mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2.  별도판매구성품 : OS-Troponin I CalSet\n- 1.  '제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n- 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n **[표 시작]**\n\n| 일련 | K973668 | 나. ",
        "original_sentence": "'제조원의 제조방법에 따른다.’라고 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_453",
      "text": "다만, 다음 각 호에 해당\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 452,
        "window_size": 3,
        "char_count": 20,
        "word_count": 7,
        "page_number": 72,
        "window_text": "| mL |\n**외인성 물질**\n**검체 처리 과정에 통상적으로 첨가될 수**\n**있는 물질**\n**드물지 않게 볼 수 있는 특이 검체에**\n| 구성시약 개봉여부 | 보관조건 | 사용기간 | 비고 |\n**포함된 물질**\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin T hs |\n| 발 | 행 | 처 식품의약품안전처 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I |\n| 발 | 행 | 일 2014년 5월 |\n| 한국로슈진단(주) | 2012-12-18 | Elecsys Troponin I STAT | 발 | 행 | 인 | 왕진호 |\n\n**[표 끝]**\n\n보조성분\n\nNeomycin sulfate\n\n적량 자사규격\n\n보조성분\n\nOxypyrion1)\n\n적량 자사규격\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 24 -\n- 2.  별도판매구성품 : OS-Troponin I CalSet\n- 1.  '제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n- 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n **[표 시작]**\n\n| 일련 | K973668 | 나.  시험기준 | 중복될 경우 이를 생략한다). ",
        "original_sentence": "다만, 다음 각 호에 해당\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_454",
      "text": "멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 453,
        "window_size": 3,
        "char_count": 105,
        "word_count": 21,
        "page_number": 29,
        "window_text": "별도판매구성품 : OS-Troponin I CalSet\n- 1.  '제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n- 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n **[표 시작]**\n\n| 일련 | K973668 | 나.  시험기준 | 중복될 경우 이를 생략한다).  | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다. ",
        "original_sentence": "멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_455",
      "text": "**[표 시작]**\n\n| 일련 | K973668 | 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 454,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 25,
        "window_text": "'제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n- 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n **[표 시작]**\n\n| 일련 | K973668 | 나.  시험기준 | 중복될 경우 이를 생략한다).  | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다.  | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다. ",
        "original_sentence": "**[표 시작]**\n\n| 일련 | K973668 | 나. "
      }
    },
    {
      "chunk_id": "chunk_456",
      "text": "시험기준 | 중복될 경우 이를 생략한다). ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 455,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 40,
        "window_text": "다만, 다음 각 호에 해당\n- 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n **[표 시작]**\n\n| 일련 | K973668 | 나.  시험기준 | 중복될 경우 이를 생략한다).  | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다.  | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다.  | 한다. ",
        "original_sentence": "시험기준 | 중복될 경우 이를 생략한다). "
      }
    },
    {
      "chunk_id": "chunk_457",
      "text": "| 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 456,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 24,
        "window_text": "멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n멸균의료기기의 멸균방법 [의료기기 허가신고심사 등에 관한 규정,\n\n별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.\n\n **[표 시작]**\n\n| 일련 | K973668 | 나.  시험기준 | 중복될 경우 이를 생략한다).  | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다.  | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다.  | 한다.  | 않는 성능 배제하고 구체적 근거 자료로 제시한다. ",
        "original_sentence": "| 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_458",
      "text": "| 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 457,
        "window_size": 3,
        "char_count": 66,
        "word_count": 19,
        "page_number": 25,
        "window_text": "**[표 시작]**\n\n| 일련 | K973668 | 나.  시험기준 | 중복될 경우 이를 생략한다).  | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다.  | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다.  | 한다.  | 않는 성능 배제하고 구체적 근거 자료로 제시한다.  | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다. ",
        "original_sentence": "| 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_459",
      "text": "| 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 458,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 24,
        "window_text": "시험기준 | 중복될 경우 이를 생략한다).  | 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다.  | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다.  | 한다.  | 않는 성능 배제하고 구체적 근거 자료로 제시한다.  | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다.  | 서 제외한다. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_460",
      "text": "| 않는 성능 배제하고 구체적 근거 자료로 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 459,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 24,
        "window_text": "| 것으로 인정되는 시험자료 | 수행한 결과를 포함하여야 한다.  | 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다.  | 한다.  | 않는 성능 배제하고 구체적 근거 자료로 제시한다.  | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다.  | 서 제외한다.  | 허용범위(dmax)를 결정한다. ",
        "original_sentence": "| 않는 성능 배제하고 구체적 근거 자료로 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_461",
      "text": "| ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 460,
        "window_size": 3,
        "char_count": 53,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 3) 연구인력구성 | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 결과제시 | 3) 시험방법 | 한다.  | 한다.  | 않는 성능 배제하고 구체적 근거 자료로 제시한다.  | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다.  | 서 제외한다.  | 허용범위(dmax)를 결정한다.  | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다. ",
        "original_sentence": "| ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_462",
      "text": "| 서 제외한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 461,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 24,
        "window_text": "| 한다.  | 않는 성능 배제하고 구체적 근거 자료로 제시한다.  | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다.  | 서 제외한다.  | 허용범위(dmax)를 결정한다.  | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. ",
        "original_sentence": "| 서 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_463",
      "text": "| 허용범위(dmax)를 결정한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 462,
        "window_size": 3,
        "char_count": 20,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| 않는 성능 배제하고 구체적 근거 자료로 제시한다.  | ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다.  | 서 제외한다.  | 허용범위(dmax)를 결정한다.  | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC. ",
        "original_sentence": "| 허용범위(dmax)를 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_464",
      "text": "| NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 463,
        "window_size": 3,
        "char_count": 284,
        "word_count": 79,
        "page_number": 13,
        "window_text": "| ※ 참고 | 명칭 | 배합목적 | 원재료명 또는 | laboratory) 자료를 제시한다.  | 서 제외한다.  | 허용범위(dmax)를 결정한다.  | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC.  | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ. ",
        "original_sentence": "| NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다. "
      }
    },
    {
      "chunk_id": "chunk_465",
      "text": "시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 464,
        "window_size": 3,
        "char_count": 43,
        "word_count": 6,
        "page_number": 13,
        "window_text": "| 서 제외한다.  | 허용범위(dmax)를 결정한다.  | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC.  | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1. ",
        "original_sentence": "시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_466",
      "text": "| MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 465,
        "window_size": 3,
        "char_count": 186,
        "word_count": 37,
        "page_number": 5,
        "window_text": "| 허용범위(dmax)를 결정한다.  | NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC.  | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n",
        "original_sentence": "| MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC. "
      }
    },
    {
      "chunk_id": "chunk_467",
      "text": "| DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 466,
        "window_size": 3,
        "char_count": 166,
        "word_count": 44,
        "page_number": 2,
        "window_text": "| NANO-CHECK AMI CTNI | 분량 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 시험항목 | 시험기준 | 시험방법 | 2) 결과제시 |\n| K041192 | ARCHITECT STAT TROPONIN-I | K102131 | K984093 | STRATUS (R) CS CARDIAC | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC.  | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n - 2. ",
        "original_sentence": "| DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_468",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 467,
        "window_size": 3,
        "char_count": 94,
        "word_count": 20,
        "page_number": 30,
        "window_text": "시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC.  | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n - 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_469",
      "text": "사용목적은 성능을 포함하여 다음에 따라 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 468,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 24,
        "window_text": "| MODEL #33340 33345 | FLEX REAGENT CARTRIDGE | CALIBRATOR | 본 제품은 약 0.4 ng/mL 및 4 ng/mL의 troponin I | 심근경색(acute myocardial infarction)을 평가하기 위한 | FISHER | DADE | H | BOEHRINGER | INC.  | DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n - 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마.  정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n",
        "original_sentence": "사용목적은 성능을 포함하여 다음에 따라 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_470",
      "text": "- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 469,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "| DADE | DATE |\n| 번호 | K053577 | 혈성 ECG 변화나 새로운 LBBB가 있지만 심장 표지자 값을 확보하 | CARDIAC MARKER TEST | 성분명 | ㎍/L |\n| T | DEVICE NAME | COMPANY | 간섭 |\n\n**[표 끝]**\n\n규격\n\n비고\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n - 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마.  정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n - 3. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_471",
      "text": "사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 470,
        "window_size": 3,
        "char_count": 81,
        "word_count": 18,
        "page_number": 3,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 5\n\n<!-- PAGE_30 -->\n###### 사용목적(성능)\n\n- 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n - 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마.  정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n - 3.  성능\n- 가. ",
        "original_sentence": "사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마. "
      }
    },
    {
      "chunk_id": "chunk_472",
      "text": "정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 471,
        "window_size": 3,
        "char_count": 122,
        "word_count": 31,
        "page_number": 83,
        "window_text": "사용목적은 성능을 포함하여 다음에 따라 기재한다.\n - 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마.  정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n - 3.  성능\n- 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4. ",
        "original_sentence": "정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_473",
      "text": "- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 472,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 25,
        "window_text": "- 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마.  정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n - 3.  성능\n- 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4.  성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ. ",
        "original_sentence": "- 3. "
      }
    },
    {
      "chunk_id": "chunk_474",
      "text": "성능\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 473,
        "window_size": 3,
        "char_count": 8,
        "word_count": 3,
        "page_number": 48,
        "window_text": "사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n본 시약은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용하여\n\n- 마.  정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n - 3.  성능\n- 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4.  성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n",
        "original_sentence": "성능\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_475",
      "text": "근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 474,
        "window_size": 3,
        "char_count": 162,
        "word_count": 36,
        "page_number": 6,
        "window_text": "정성 또는 정량 : 검사 목적 및 해당 제품의 특성에 따라 정성, 정\n본 제품은 사람 혈청 또는 혈장에서 화학발광 면역측정법을 사용\n\n하여 심장성 Troponin I을 정량적으로 측정하기 위한 체외진단용\n\n시약이다.\n\n - 3.  성능\n- 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4.  성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다. ",
        "original_sentence": "근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4. "
      }
    },
    {
      "chunk_id": "chunk_476",
      "text": "성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 475,
        "window_size": 3,
        "char_count": 274,
        "word_count": 54,
        "page_number": 5,
        "window_text": "- 3.  성능\n- 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4.  성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다.  69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n",
        "original_sentence": "성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_477",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 476,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 3,
        "window_text": "성능\n- 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4.  성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다.  69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n 수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_478",
      "text": "infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 477,
        "window_size": 3,
        "char_count": 49,
        "word_count": 7,
        "page_number": 13,
        "window_text": "근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n치적으로 제시된 성능 기재\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 26 -\n❍ 당 해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 명확하지\n\n표 4.  성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다.  69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n 수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다.  ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98). ",
        "original_sentence": "infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다. "
      }
    },
    {
      "chunk_id": "chunk_479",
      "text": "69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 478,
        "window_size": 3,
        "char_count": 137,
        "word_count": 19,
        "page_number": 6,
        "window_text": "성능 작성의 예\n\nTn2\n\n- 18.0\n- 0.475\n- 2.6\n- 0.783\n- 4.4\n2\n\n분석적\n\n민감도\n\n공란한계(LoB) : 0.10 ng/mL [μg/L] (CLSI EP17-A\n\n실험 결과치)\n\n검출 한계(LoD) : 0.15 ng/mL [μg/L]\n\n정량 한계(LoB) : 0.28 ng/mL [μg/L]\n\n측정범위(Measuring range)는 0.15-28 ng/mL [μg/L]\n\n3\n\n후크 효과\n\n최대 1000 μg/L (ng/mL)까지 후크 효과를 나타내지\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다.  69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n 수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다.  ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98).  급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ. ",
        "original_sentence": "69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_480",
      "text": "수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 479,
        "window_size": 3,
        "char_count": 82,
        "word_count": 8,
        "page_number": 32,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 27 -\n않는다.\n\n infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다.  69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n 수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다.  ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98).  급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1. ",
        "original_sentence": "수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다. "
      }
    },
    {
      "chunk_id": "chunk_481",
      "text": "ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98). ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 480,
        "window_size": 3,
        "char_count": 194,
        "word_count": 41,
        "page_number": 1,
        "window_text": "infarction)의 평가에 대한 현재 지침(guideline)에 따라\n\n진단되었다.  69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n 수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다.  ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98).  급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n",
        "original_sentence": "ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98). "
      }
    },
    {
      "chunk_id": "chunk_482",
      "text": "급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 481,
        "window_size": 3,
        "char_count": 59,
        "word_count": 13,
        "page_number": 5,
        "window_text": "69명의 환자는 심근경색으로 진단받았고,\n\n80명의 환자는 불안정협심증(unstable angina pectoris)으로,\n\n209명의 환자는 심장 손상(cardiac injury) 원인이 아닌\n\n가슴통증(chest pain)으로 발전되었다.\n\n 수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다.  ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98).  급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n - 다. ",
        "original_sentence": "급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_483",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 482,
        "window_size": 3,
        "char_count": 90,
        "word_count": 20,
        "page_number": 34,
        "window_text": "수신자조작특성곡선(Receiver operating characteristic(ROC)\n\ncurve)은 troponin 값 최고점에서 계산되었다.  ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98).  급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n - 다.  검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_484",
      "text": "검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 483,
        "window_size": 3,
        "char_count": 200,
        "word_count": 53,
        "page_number": 3,
        "window_text": "ROC 곡선은\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 28 -\n※ 상기 성능은 예시(참고용)에 해당되므로 제품의 특성에 따라 일부\n\n해당 성능 항목을 가감할 수 있음\n\n- 0.96의 곡선아래 면적(area under the curve, AUC)을\n나타낸다(95% 신뢰구간은 0.91-0.98).  급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n - 다.  검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다.  환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n",
        "original_sentence": "검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_485",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 484,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "급성\n\nLinear regression : y = 0.991x - 0.045 (r = 0.996)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n - 다.  검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다.  환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라. ",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_486",
      "text": "검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 485,
        "window_size": 3,
        "char_count": 47,
        "word_count": 10,
        "page_number": 24,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 6\n\n<!-- PAGE_34 -->\n###### 사용방법\n\n- 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n - 다.  검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다.  환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라.  결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n",
        "original_sentence": "검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다. "
      }
    },
    {
      "chunk_id": "chunk_487",
      "text": "환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 486,
        "window_size": 3,
        "char_count": 114,
        "word_count": 25,
        "page_number": 12,
        "window_text": "검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n관리, 장비(해당 장비의 제조사, 모델명) 등을 아래와 같이 포함하여\n\n시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.\n\n - 다.  검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다.  환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라.  결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n 본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n",
        "original_sentence": "환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_488",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 487,
        "window_size": 3,
        "char_count": 60,
        "word_count": 15,
        "page_number": 1,
        "window_text": "- 다.  검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다.  환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라.  결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n 본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_489",
      "text": "결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 488,
        "window_size": 3,
        "char_count": 434,
        "word_count": 74,
        "page_number": 13,
        "window_text": "검사과정\n체외진단 의료기기 장비의 매뉴얼 및 사용방법에 대하여 상세하게\n\n기재한다.  환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라.  결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n 본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다.  만약 심근경색이 여전히 의심된\n\nⅤ. ",
        "original_sentence": "결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n"
      }
    },
    {
      "chunk_id": "chunk_490",
      "text": "본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 489,
        "window_size": 3,
        "char_count": 73,
        "word_count": 13,
        "page_number": 5,
        "window_text": "환자의 검체를 첨가하는 과정(검체 전처리, 반응시간,\n\n실험실 온도 조건 등), 시험검사 단계(장비의 운용 방법 및 반응시간\n\n등) 및 결과판독과정(판독시간, 결과 출력 방법 등)을 상세하게 기재한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라.  결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n 본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다.  만약 심근경색이 여전히 의심된\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n",
        "original_sentence": "본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_491",
      "text": "cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 490,
        "window_size": 3,
        "char_count": 130,
        "word_count": 21,
        "page_number": 35,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 30 -\n- 라.  결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n 본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다.  만약 심근경색이 여전히 의심된\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n - - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1. ",
        "original_sentence": "cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다. "
      }
    },
    {
      "chunk_id": "chunk_492",
      "text": "만약 심근경색이 여전히 의심된\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 491,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 22,
        "window_text": "결과판정\n양성,\n\n음성,\n\n경계값(equivocal),\n\n미확정(indeterminate),\n\n무효\n\n(invalid) 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과\n\n1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid) 결과를\n\n2) 환자 검체의 검사 결과를 판독하기 전에 확인해야 할 대조물질 및\n\n3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n각 검체의 분석물 농도는 분석장비에서 자동으로 계산된다(㎍/L 또는\n\n본 검사법으로 미국의 4개 site, 프랑스의 2개 site에서 839명의 건강한\n\n피험자가 참여한 연구에서, cTnI에 대한 상한참고치(upper reference\n\nlimit)(99백분위수)는\n\n- 0.16\n㎍/L\n\n(ng/mL)이다(95%\n\n신뢰구간은\n\n- 0.12-0.60).\n 본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다.  만약 심근경색이 여전히 의심된\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n - - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1.  다음의 사항을 포함하여 기재한다.\n",
        "original_sentence": "만약 심근경색이 여전히 의심된\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_493",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 492,
        "window_size": 3,
        "char_count": 52,
        "word_count": 13,
        "page_number": 3,
        "window_text": "본 검사법에서 변동계수(CV)보다 작거나 또는 10%(LoQ)와 동일한 가장\n\n낮은 농도는 0.30 ㎍/L (ng/mL)이었다.\n\n cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다.  만약 심근경색이 여전히 의심된\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n - - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1.  다음의 사항을 포함하여 기재한다.\n - 나. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_494",
      "text": "- - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 493,
        "window_size": 3,
        "char_count": 274,
        "word_count": 56,
        "page_number": 13,
        "window_text": "cTnI의 유출속도론(release kinetics) 때문에, 증상 발발 후 처음 몇 시\n\n간 이내 결정한계(decision limit) 이하의 결과는 심근경색(myocardial\n\ninfarction)을 확실히 배제하지는 않는다.  만약 심근경색이 여전히 의심된\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n - - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1.  다음의 사항을 포함하여 기재한다.\n - 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n",
        "original_sentence": "- - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_495",
      "text": "다음의 사항을 포함하여 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 494,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 3,
        "window_text": "만약 심근경색이 여전히 의심된\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n - - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1.  다음의 사항을 포함하여 기재한다.\n - 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n - 다. ",
        "original_sentence": "다음의 사항을 포함하여 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_496",
      "text": "- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 495,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 31 -\n다면, 적절한 간격으로 시험을 반복한다.\n\n - - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1.  다음의 사항을 포함하여 기재한다.\n - 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n - 다.  구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_497",
      "text": "일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 496,
        "window_size": 3,
        "char_count": 73,
        "word_count": 18,
        "page_number": 12,
        "window_text": "- - 증가값과 관련된 요인들(Factors associated with elevated values)\n임상 연구에서 심근 손상이 있는 환자는 불안정한 협심증(unstable\n\nangina pectoris), 심타박상(cardiac contusions) 및 심장 이식에서\n\n각 실험실은 자체 환자 인구에 대한 참고치의 변동성을 조사해야 하며,\n\n2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n3) 정도 관리 결과가 적합하지 않을 때 제시할 수 있는 대책을\n\n- 1.  다음의 사항을 포함하여 기재한다.\n - 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n - 다.  구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n - 라. ",
        "original_sentence": "일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_498",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 497,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "다음의 사항을 포함하여 기재한다.\n - 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n - 다.  구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n - 라.  사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_499",
      "text": "구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 498,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 3,
        "window_text": "- 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n - 다.  구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n - 라.  사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n - 마. ",
        "original_sentence": "구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_500",
      "text": "- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 499,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.\n\n - 다.  구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n - 라.  사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n - 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n",
        "original_sentence": "- 라. "
      }
    },
    {
      "chunk_id": "chunk_501",
      "text": "사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 500,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 3,
        "window_text": "- 다.  구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n - 라.  사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n - 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n - 바. ",
        "original_sentence": "사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_502",
      "text": "- 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 501,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "구성시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재한다.\n - 라.  사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n - 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n - 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사. ",
        "original_sentence": "- 마. "
      }
    },
    {
      "chunk_id": "chunk_503",
      "text": "경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 502,
        "window_size": 3,
        "char_count": 112,
        "word_count": 27,
        "page_number": 3,
        "window_text": "- 라.  사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n - 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n - 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사.  검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아. ",
        "original_sentence": "경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_504",
      "text": "- 바. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 503,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "사용한 검체 및 키트의 처리 및 폐기방법 및 주의사항을 기재한다.\n - 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n - 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사.  검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1. ",
        "original_sentence": "- 바. "
      }
    },
    {
      "chunk_id": "chunk_505",
      "text": "임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 504,
        "window_size": 3,
        "char_count": 41,
        "word_count": 12,
        "page_number": 3,
        "window_text": "- 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n - 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사.  검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1.  체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1. ",
        "original_sentence": "임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사. "
      }
    },
    {
      "chunk_id": "chunk_506",
      "text": "검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 505,
        "window_size": 3,
        "char_count": 42,
        "word_count": 12,
        "page_number": 13,
        "window_text": "경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항(온\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 32 -\n도, 습도의 영향 등)을 명시한다.\n\n - 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사.  검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1.  체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1.  저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n",
        "original_sentence": "검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아. "
      }
    },
    {
      "chunk_id": "chunk_507",
      "text": "다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 506,
        "window_size": 3,
        "char_count": 40,
        "word_count": 11,
        "page_number": 5,
        "window_text": "- 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사.  검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1.  체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1.  저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n - 가. ",
        "original_sentence": "다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_508",
      "text": "체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 507,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 5,
        "window_text": "임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n- 사.  검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1.  체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1.  저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n - 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n",
        "original_sentence": "체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_509",
      "text": "저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 508,
        "window_size": 3,
        "char_count": 106,
        "word_count": 22,
        "page_number": 32,
        "window_text": "검사에 영향을 미치는 내용(예 : 간섭 및 교차반응 물질, 위양성\n- 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1.  체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1.  저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n - 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n - 나. ",
        "original_sentence": "저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_510",
      "text": "- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 509,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한 정\n- 1.  체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1.  저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n - 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n - 나.  일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ. ",
        "original_sentence": "- 가. "
      }
    },
    {
      "chunk_id": "chunk_511",
      "text": "키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 510,
        "window_size": 3,
        "char_count": 76,
        "word_count": 17,
        "page_number": 38,
        "window_text": "체외진단용 시약의 포장단위는 취급상 용이한 최소 단위로 기재하되,\n- 1.  저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n - 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n - 나.  일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다. ",
        "original_sentence": "키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_512",
      "text": "- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 511,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "저장방법은 체외진단용 시약의 특성을 고려하여 안정성이 보장될 수\n있도록 검증된 자료에 의한 구체적인 보관조건(온도, 습도, 차광, 밀폐\n\n등), 사용기간(유효기간) 등을 병기하여야 한다.\n\n - 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n - 나.  일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다.  시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_513",
      "text": "일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 512,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 22,
        "window_text": "- 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n - 나.  일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다.  시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5. ",
        "original_sentence": "일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_514",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 513,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 3,
        "window_text": "키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고, 사용\n기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n - 나.  일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다.  시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5.  저장방법 및 사용기간(유효기간)작성의 예\n\n- 1. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_515",
      "text": "시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 514,
        "window_size": 3,
        "char_count": 41,
        "word_count": 12,
        "page_number": 38,
        "window_text": "- 나.  일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다.  시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5.  저장방법 및 사용기간(유효기간)작성의 예\n\n- 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2. ",
        "original_sentence": "시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_516",
      "text": "전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 515,
        "window_size": 3,
        "char_count": 42,
        "word_count": 9,
        "page_number": 3,
        "window_text": "일회용 체외진단용 시약이 아닐 경우, 개봉 후 시약의 저장방법(온도,\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다.  시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5.  저장방법 및 사용기간(유효기간)작성의 예\n\n- 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n",
        "original_sentence": "전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5. "
      }
    },
    {
      "chunk_id": "chunk_517",
      "text": "저장방법 및 사용기간(유효기간)작성의 예\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 516,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 5,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 33 -\n습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)등이 포함되도록\n\n- 다.  시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5.  저장방법 및 사용기간(유효기간)작성의 예\n\n- 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n - 가. ",
        "original_sentence": "저장방법 및 사용기간(유효기간)작성의 예\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_518",
      "text": "시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 517,
        "window_size": 3,
        "char_count": 81,
        "word_count": 18,
        "page_number": 32,
        "window_text": "시약의 조제가 필요할 경우 조제 후 보관 조건 및 사용기간(유효\n- 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5.  저장방법 및 사용기간(유효기간)작성의 예\n\n- 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n - 가.  시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n",
        "original_sentence": "시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_519",
      "text": "시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 518,
        "window_size": 3,
        "char_count": 59,
        "word_count": 12,
        "page_number": 3,
        "window_text": "전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n표 5.  저장방법 및 사용기간(유효기간)작성의 예\n\n- 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n - 가.  시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n 2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n",
        "original_sentence": "시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_520",
      "text": "- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 519,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "저장방법 및 사용기간(유효기간)작성의 예\n\n- 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n - 가.  시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n 2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ. ",
        "original_sentence": "- 가. "
      }
    },
    {
      "chunk_id": "chunk_521",
      "text": "시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 520,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 3,
        "window_text": "시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하\n\n- 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n - 가.  시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n 2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6. ",
        "original_sentence": "시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_522",
      "text": "2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 521,
        "window_size": 3,
        "char_count": 140,
        "word_count": 31,
        "page_number": 12,
        "window_text": "시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험항\n목, 시험기준, 시험방법을 기재한다.\n\n - 가.  시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n 2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6.  시험규격 작성의 예\n\n**[표 시작]**\n\n**1. ",
        "original_sentence": "2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_523",
      "text": "1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 522,
        "window_size": 3,
        "char_count": 265,
        "word_count": 63,
        "page_number": 5,
        "window_text": "- 가.  시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n 2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6.  시험규격 작성의 예\n\n**[표 시작]**\n\n**1.  외관검사**\n**2. ",
        "original_sentence": "1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_524",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 523,
        "window_size": 3,
        "char_count": 33,
        "word_count": 10,
        "page_number": 3,
        "window_text": "시험항목\n1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.\n\n 2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6.  시험규격 작성의 예\n\n**[표 시작]**\n\n**1.  외관검사**\n**2.  정밀도**\n\n**[표 끝]**\n\n- 3. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6. "
      }
    },
    {
      "chunk_id": "chunk_525",
      "text": "시험규격 작성의 예\n\n**[표 시작]**\n\n**1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 524,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 5,
        "window_text": "2) 분석적 성능시험(민감도, 특이도, 재현성 등)을 포함하는 것을\n\nCartridge\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 34 -\n권장하고, 그 외 자사가 설정한 시험항목을 설정할 수 있다.\n\n 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6.  시험규격 작성의 예\n\n**[표 시작]**\n\n**1.  외관검사**\n**2.  정밀도**\n\n**[표 끝]**\n\n- 3.  재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가. ",
        "original_sentence": "시험규격 작성의 예\n\n**[표 시작]**\n\n**1. "
      }
    },
    {
      "chunk_id": "chunk_526",
      "text": "외관검사**\n**2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 525,
        "window_size": 3,
        "char_count": 12,
        "word_count": 2,
        "page_number": 21,
        "window_text": "1) 시험결과의 적부판정의 기준이 되는 기준치의 허용범위를 명확\n\n히 기재하여야 하며, 시험결과가 온도, 습도 등 주위조건에 영향\n\n1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3\n\n개 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\n가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로 하\n\n나) 표준물질의 농도는 재현성, 직선성, 최소검출한계를 고려하여\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6.  시험규격 작성의 예\n\n**[표 시작]**\n\n**1.  외관검사**\n**2.  정밀도**\n\n**[표 끝]**\n\n- 3.  재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가.  수입제품은 제조원을 기재하여야 한다.\n",
        "original_sentence": "외관검사**\n**2. "
      }
    },
    {
      "chunk_id": "chunk_527",
      "text": "정밀도**\n\n**[표 끝]**\n\n- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 526,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 25,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 35 -\n표 6.  시험규격 작성의 예\n\n**[표 시작]**\n\n**1.  외관검사**\n**2.  정밀도**\n\n**[표 끝]**\n\n- 3.  재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가.  수입제품은 제조원을 기재하여야 한다.\n - 나. ",
        "original_sentence": "정밀도**\n\n**[표 끝]**\n\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_528",
      "text": "재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 527,
        "window_size": 3,
        "char_count": 51,
        "word_count": 11,
        "page_number": 40,
        "window_text": "시험규격 작성의 예\n\n**[표 시작]**\n\n**1.  외관검사**\n**2.  정밀도**\n\n**[표 끝]**\n\n- 3.  재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가.  수입제품은 제조원을 기재하여야 한다.\n - 나.  제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n",
        "original_sentence": "재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_529",
      "text": "수입제품은 제조원을 기재하여야 한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 528,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 24,
        "window_text": "외관검사**\n**2.  정밀도**\n\n**[표 끝]**\n\n- 3.  재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가.  수입제품은 제조원을 기재하여야 한다.\n - 나.  제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n 제조의뢰자와 제조자의 상호와 주소를 모두 기재한다. ",
        "original_sentence": "수입제품은 제조원을 기재하여야 한다.\n"
      }
    },
    {
      "chunk_id": "chunk_530",
      "text": "- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 529,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "정밀도**\n\n**[표 끝]**\n\n- 3.  재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가.  수입제품은 제조원을 기재하여야 한다.\n - 나.  제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n 제조의뢰자와 제조자의 상호와 주소를 모두 기재한다.  다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_531",
      "text": "제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 530,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 24,
        "window_text": "재현성\nCV ≤ 10%\n\n<!-- PAGE_40 -->\n###### <작성요령>\n\n- 가.  수입제품은 제조원을 기재하여야 한다.\n - 나.  제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n 제조의뢰자와 제조자의 상호와 주소를 모두 기재한다.  다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n ※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n",
        "original_sentence": "제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n"
      }
    },
    {
      "chunk_id": "chunk_532",
      "text": "제조의뢰자와 제조자의 상호와 주소를 모두 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 531,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 24,
        "window_text": "수입제품은 제조원을 기재하여야 한다.\n - 나.  제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n 제조의뢰자와 제조자의 상호와 주소를 모두 기재한다.  다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n ※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n 상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ. ",
        "original_sentence": "제조의뢰자와 제조자의 상호와 주소를 모두 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_533",
      "text": "다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 532,
        "window_size": 3,
        "char_count": 37,
        "word_count": 7,
        "page_number": 24,
        "window_text": "- 나.  제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n 제조의뢰자와 제조자의 상호와 주소를 모두 기재한다.  다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n ※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n 상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1. ",
        "original_sentence": "다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_534",
      "text": "※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 533,
        "window_size": 3,
        "char_count": 126,
        "word_count": 31,
        "page_number": 23,
        "window_text": "제조제품 중 제조공정을 전부 위탁하는 경우 해당 제조소를 기재한다.\n 제조의뢰자와 제조자의 상호와 주소를 모두 기재한다.  다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n ※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n 상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1.  원칙\n\n- 가. ",
        "original_sentence": "※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_535",
      "text": "상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 534,
        "window_size": 3,
        "char_count": 164,
        "word_count": 44,
        "page_number": 41,
        "window_text": "제조의뢰자와 제조자의 상호와 주소를 모두 기재한다.  다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n ※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n 상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1.  원칙\n\n- 가.  기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나. ",
        "original_sentence": "상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_536",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 535,
        "window_size": 3,
        "char_count": 121,
        "word_count": 28,
        "page_number": 42,
        "window_text": "다만, 제조자가\n\n외국회사일 경우에는 제조국을 추가로 기재한다.\n\n ※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n 상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1.  원칙\n\n- 가.  기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_537",
      "text": "원칙\n\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 536,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 72,
        "window_text": "※ 예시\n\n- - 국내 A 제조업체가 B 제조업체에게 유전질환검사시약 제조를 전면\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 36 -\n위탁 시\n\n제조원은 다음과 같이 기재한다.\n\n 상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1.  원칙\n\n- 가.  기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라. ",
        "original_sentence": "원칙\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_538",
      "text": "기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 537,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 36,
        "window_text": "상호 (제조사 주소)\n\n․ 제조의뢰자 : A (A사 주소)\n\n․ 제조자 : B (B사 주소)\n\n- - 수입제품의 경우, 미국에 있는 C사가 아일랜드에 있는 D사에 OOO검\n상호 (제조국/제조사 주소)\n\n․ 제조의뢰자 : C (미국 C사 주소)\n\n․ 제조자 : D (아일랜드 D사 주소)\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1.  원칙\n\n- 가.  기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. ",
        "original_sentence": "기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_539",
      "text": "첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 538,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 72,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n# Ⅵ\n\n<!-- PAGE_42 -->\n### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_42 -->\n###### 1.  원칙\n\n- 가.  기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n- 2. ",
        "original_sentence": "첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_540",
      "text": "해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 539,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 72,
        "window_text": "원칙\n\n- 가.  기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n- 2.  시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다. ",
        "original_sentence": "해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_541",
      "text": "외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 540,
        "window_size": 3,
        "char_count": 69,
        "word_count": 18,
        "page_number": 3,
        "window_text": "기술문서 등의 심사를 받고자 하는 자는 시행규칙 별지 제7호\n- 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n- 2.  시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다.  추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ. ",
        "original_sentence": "외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_542",
      "text": "다만,\n\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 541,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 21,
        "window_text": "첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성\n- 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n- 2.  시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다.  추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1. ",
        "original_sentence": "다만,\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_543",
      "text": "시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 542,
        "window_size": 3,
        "char_count": 478,
        "word_count": 115,
        "page_number": 31,
        "window_text": "해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n- 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n- 2.  시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다.  추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1.  개발경위\n- 가. ",
        "original_sentence": "시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_544",
      "text": "추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 543,
        "window_size": 3,
        "char_count": 178,
        "word_count": 41,
        "page_number": 3,
        "window_text": "외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n- 2.  시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다.  추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1.  개발경위\n- 가.  측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2. ",
        "original_sentence": "추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_545",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 544,
        "window_size": 3,
        "char_count": 144,
        "word_count": 36,
        "page_number": 6,
        "window_text": "다만,\n\n- 2.  시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다.  추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1.  개발경위\n- 가.  측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2.  측정원리 ․ 방법\n- 가. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_546",
      "text": "개발경위\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 545,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 72,
        "window_text": "시험 자료의 요건 (분석적 성능, 품질관리 시험성적서, 검체 조건 설정 자료)\n※ 임상적 성능시험 자료 요건은 별도 제시\n\n2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는 정\n\n부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확\n\n인한 자료 또는 이를 공증한 자료\n\n3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적서\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 38 -\n4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로\n\n서 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시\n\n설 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포\n\n7) 시험 검사품 채취 및 방법에 대한 사항(시험을 위한 별도의\n\n- 다.  추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1.  개발경위\n- 가.  측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2.  측정원리 ․ 방법\n- 가.  검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나. ",
        "original_sentence": "개발경위\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_547",
      "text": "측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 546,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 21,
        "window_text": "추가 기재내용 (대학 또는 연구기관 등 국내외 전문기관에서 시험\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n2) 주요설비\n\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대\n\n한 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1.  개발경위\n- 가.  측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2.  측정원리 ․ 방법\n- 가.  검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나.  제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n",
        "original_sentence": "측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_548",
      "text": "측정원리 ․ 방법\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 547,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 72,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경\n\n력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정\n\n- 1.  개발경위\n- 가.  측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2.  측정원리 ․ 방법\n- 가.  검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나.  제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n - 3. ",
        "original_sentence": "측정원리 ․ 방법\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_549",
      "text": "검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 548,
        "window_size": 3,
        "char_count": 42,
        "word_count": 11,
        "page_number": 72,
        "window_text": "개발경위\n- 가.  측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2.  측정원리 ․ 방법\n- 가.  검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나.  제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n - 3.  국내․외에서 사용현황\n- 가. ",
        "original_sentence": "검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_550",
      "text": "제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 549,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 24,
        "window_text": "측정하고자 하는 대상 또는 질병이나 증후군의 설명 및 개발배경이\n- 2.  측정원리 ․ 방법\n- 가.  검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나.  제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n - 3.  국내․외에서 사용현황\n- 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n",
        "original_sentence": "제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n"
      }
    },
    {
      "chunk_id": "chunk_551",
      "text": "- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 550,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 25,
        "window_text": "측정원리 ․ 방법\n- 가.  검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나.  제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n - 3.  국내․외에서 사용현황\n- 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n 1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1. ",
        "original_sentence": "- 3. "
      }
    },
    {
      "chunk_id": "chunk_552",
      "text": "국내․외에서 사용현황\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 551,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 72,
        "window_text": "검출 대상을 검출하는데 사용한 방법 및 측정원리를 설명하는 자료를\n- 나.  제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n - 3.  국내․외에서 사용현황\n- 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n 1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나. ",
        "original_sentence": "국내․외에서 사용현황\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_553",
      "text": "국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 552,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 3,
        "window_text": "제품개발 및 자사제품 성능에 관련된 문헌 자료를 제출한다.\n - 3.  국내․외에서 사용현황\n- 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n 1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2. ",
        "original_sentence": "국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_554",
      "text": "1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 553,
        "window_size": 3,
        "char_count": 168,
        "word_count": 44,
        "page_number": 5,
        "window_text": "- 3.  국내․외에서 사용현황\n- 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n 1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가. ",
        "original_sentence": "1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_555",
      "text": "원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 554,
        "window_size": 3,
        "char_count": 34,
        "word_count": 10,
        "page_number": 6,
        "window_text": "국내․외에서 사용현황\n- 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n 1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나. ",
        "original_sentence": "원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_556",
      "text": "원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 555,
        "window_size": 3,
        "char_count": 42,
        "word_count": 9,
        "page_number": 3,
        "window_text": "국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.\n 1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나.  원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다. ",
        "original_sentence": "원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_557",
      "text": "제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 556,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 6,
        "window_text": "1) 외국의 판매 또는 허가현황 및 제조품목허가 경위 등과 관련된 자료\n\n2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우, 제품\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 40 -\n안전성 및 성능과 관련된 유해사례보고 요약\n\n- 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나.  원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1. ",
        "original_sentence": "제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_558",
      "text": "제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 557,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 72,
        "window_text": "원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n- 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나.  원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ. ",
        "original_sentence": "제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_559",
      "text": "원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 558,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 29,
        "window_text": "원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n- 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나.  원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n",
        "original_sentence": "원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_560",
      "text": "일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 559,
        "window_size": 3,
        "char_count": 104,
        "word_count": 20,
        "page_number": 45,
        "window_text": "제조공정의 흐름도를 포함한 제조공정에 관한 자료\n- 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나.  원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n - 2. ",
        "original_sentence": "일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_561",
      "text": "허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 560,
        "window_size": 3,
        "char_count": 81,
        "word_count": 18,
        "page_number": 3,
        "window_text": "제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n- 나.  원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n - 2.  해당제품의 제품설명서(instructions for user)를 제출한다.\n",
        "original_sentence": "허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_562",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 561,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 5,
        "window_text": "원료물질의 제조방법을 간략하게 기술하고, 이를 구매한 경우, 이를\n- 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n - 2.  해당제품의 제품설명서(instructions for user)를 제출한다.\n - 1. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_563",
      "text": "- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 562,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의\n<!-- PAGE_45 -->\n###### 3\n\n<!-- PAGE_45 -->\n###### 사용목적에 관한 자료\n\n- 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n - 2.  해당제품의 제품설명서(instructions for user)를 제출한다.\n - 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_564",
      "text": "해당제품의 제품설명서(instructions for user)를 제출한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 563,
        "window_size": 3,
        "char_count": 42,
        "word_count": 5,
        "page_number": 13,
        "window_text": "허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상,\n검체종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n - 2.  해당제품의 제품설명서(instructions for user)를 제출한다.\n - 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n",
        "original_sentence": "해당제품의 제품설명서(instructions for user)를 제출한다.\n"
      }
    },
    {
      "chunk_id": "chunk_565",
      "text": "- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 564,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 41 -\n제출한다.\n\n - 2.  해당제품의 제품설명서(instructions for user)를 제출한다.\n - 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n - 3. ",
        "original_sentence": "- 1. "
      }
    },
    {
      "chunk_id": "chunk_566",
      "text": "완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 565,
        "window_size": 3,
        "char_count": 44,
        "word_count": 12,
        "page_number": 6,
        "window_text": "- 2.  해당제품의 제품설명서(instructions for user)를 제출한다.\n - 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n - 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n",
        "original_sentence": "완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_567",
      "text": "구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 566,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 3,
        "window_text": "해당제품의 제품설명서(instructions for user)를 제출한다.\n - 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n - 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n - 4. ",
        "original_sentence": "구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n"
      }
    },
    {
      "chunk_id": "chunk_568",
      "text": "- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 567,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 25,
        "window_text": "- 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n - 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n - 4.  안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5. ",
        "original_sentence": "- 3. "
      }
    },
    {
      "chunk_id": "chunk_569",
      "text": "시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 568,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 24,
        "window_text": "완제품 및 개봉 후 시약의 안정성에 관한 자료로서 저장방법, 사용기간\n- 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n - 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n - 4.  안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6. ",
        "original_sentence": "시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_570",
      "text": "- 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 569,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n - 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n - 4.  안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6.  일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7. ",
        "original_sentence": "- 4. "
      }
    },
    {
      "chunk_id": "chunk_571",
      "text": "안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 570,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 30,
        "window_text": "- 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n - 4.  안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6.  일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7.  수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n",
        "original_sentence": "안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5. "
      }
    },
    {
      "chunk_id": "chunk_572",
      "text": "저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 571,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한다.\n - 4.  안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6.  일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7.  수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n - 8. ",
        "original_sentence": "저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6. "
      }
    },
    {
      "chunk_id": "chunk_573",
      "text": "일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 572,
        "window_size": 3,
        "char_count": 107,
        "word_count": 18,
        "page_number": 13,
        "window_text": "- 4.  안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6.  일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7.  수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n - 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n",
        "original_sentence": "일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_574",
      "text": "수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 573,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 24,
        "window_text": "안정성 시험 시에는 식약처「의료기기의 안정성 시험 기준」의 내용을\n- 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6.  일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7.  수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n - 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1. ",
        "original_sentence": "수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n"
      }
    },
    {
      "chunk_id": "chunk_575",
      "text": "- 8. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 574,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 32,
        "window_text": "저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 lots, 개봉 후 1\n- 6.  일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7.  수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n - 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n",
        "original_sentence": "- 8. "
      }
    },
    {
      "chunk_id": "chunk_576",
      "text": "저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 575,
        "window_size": 3,
        "char_count": 53,
        "word_count": 9,
        "page_number": 37,
        "window_text": "일회용으로 낱개 포장되어 있는 체외진단용 시약을 제외하고, 개봉 후\n(on-board, reconstitution, open vial/bottle stability) 안정성 자료를\n\n- 7.  수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n - 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라. ",
        "original_sentence": "저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_577",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 576,
        "window_size": 3,
        "char_count": 131,
        "word_count": 29,
        "page_number": 47,
        "window_text": "수송 조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권장한다.\n - 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_578",
      "text": "제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 577,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 18,
        "window_text": "- 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n",
        "original_sentence": "제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n"
      }
    },
    {
      "chunk_id": "chunk_579",
      "text": "1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 578,
        "window_size": 3,
        "char_count": 50,
        "word_count": 8,
        "page_number": 5,
        "window_text": "저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n인정범위내의 자료이어야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n - 2. ",
        "original_sentence": "1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_580",
      "text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 579,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 5,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 5\n\n<!-- PAGE_47 -->\n###### 제품의 성능을 확인하기 위한 자료\n\n- 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n - 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n",
        "original_sentence": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_581",
      "text": "구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 580,
        "window_size": 3,
        "char_count": 118,
        "word_count": 18,
        "page_number": 47,
        "window_text": "제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n - 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n Ⅵ. ",
        "original_sentence": "구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_582",
      "text": "- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 581,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n- 라.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n - 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_583",
      "text": "유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 582,
        "window_size": 3,
        "char_count": 47,
        "word_count": 11,
        "page_number": 18,
        "window_text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이상\n- 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n - 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1.  이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n",
        "original_sentence": "유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_584",
      "text": "Ⅵ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 583,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 6,
        "window_text": "구성시약 중 인간혈액 유래물질이 포함되었을 경우에는 사람면역결핍\n바이러스(HIV),\n\nC형간염바이러스(HCV),\n\nB형간염바이러스(HBV)가\n\n음성 또는 불활성화하여 감염력이 없음을 입증하는 자료를 제출한다.\n\n - 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1.  이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n 2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n",
        "original_sentence": "Ⅵ. "
      }
    },
    {
      "chunk_id": "chunk_585",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 584,
        "window_size": 3,
        "char_count": 109,
        "word_count": 25,
        "page_number": 48,
        "window_text": "- 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1.  이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n 2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n 아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_586",
      "text": "이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 585,
        "window_size": 3,
        "char_count": 145,
        "word_count": 27,
        "page_number": 3,
        "window_text": "유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료를\n제출한다.\n\n Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1.  이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n 2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n 아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n 년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n",
        "original_sentence": "이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_587",
      "text": "2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 586,
        "window_size": 3,
        "char_count": 74,
        "word_count": 18,
        "page_number": 3,
        "window_text": "Ⅵ.  기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1.  이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n 2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n 아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n 년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n - 9. ",
        "original_sentence": "2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_588",
      "text": "아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 587,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 5,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 7\n\n<!-- PAGE_48 -->\n###### 이미 허가·인증받은 제품과 비교한 자료\n\n- 1.  이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n 2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n 아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n 년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n - 9.  시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1. ",
        "original_sentence": "아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_589",
      "text": "년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 588,
        "window_size": 3,
        "char_count": 224,
        "word_count": 43,
        "page_number": 49,
        "window_text": "이미 허가·인증받은 제품과 명칭(제품명, 품목명, 모델명), 제조(수입)업\n소명, 제조원 및 소재지, 허가(인증)번호, 사용목적, 작용원리, 원재료,\n\n[별지 제3호서식]\n\n1) 기허가된 의료기기와의 차이가 명확하게 입증도록 필요한 항목을 기재하여야 한다.\n\n 2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n 아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n 년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n - 9.  시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1.  시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2. ",
        "original_sentence": "년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_590",
      "text": "- 9. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 589,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 37,
        "window_text": "2) 각 항목에 대한 정보가 기 허가된 의료기기와 동등한 경우 ‘예’에 체크하고, 동\n\n등하지 않을 경우 ‘아니오’란에 체크한다.\n\n 아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n 년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n - 9.  시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1.  시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2.  주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ. ",
        "original_sentence": "- 9. "
      }
    },
    {
      "chunk_id": "chunk_591",
      "text": "시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 590,
        "window_size": 3,
        "char_count": 82,
        "word_count": 21,
        "page_number": 3,
        "window_text": "아니오\n\n□\n\n11\n\n사용방법\n\n예\n\n□\n\n아니오\n\n□\n\n위와 같이 동등함을 확인하였음.\n\n 년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n - 9.  시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1.  시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2.  주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n- 3. ",
        "original_sentence": "시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_592",
      "text": "시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 591,
        "window_size": 3,
        "char_count": 73,
        "word_count": 16,
        "page_number": 3,
        "window_text": "년     월      일            신청자            (서명 또는 인)\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 44 -\n<!-- PAGE_49 -->\n# Ⅶ\n\n<!-- PAGE_49 -->\n#### 성능시험에 대한 상세사항\n\n<!-- PAGE_49 -->\n###### 일반요건\n\n❍ 시험성적서에 다음의 항목이 포함되어야 한다.\n\n - 9.  시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1.  시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2.  주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n- 3.  연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1. ",
        "original_sentence": "시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_593",
      "text": "주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 592,
        "window_size": 3,
        "char_count": 76,
        "word_count": 17,
        "page_number": 3,
        "window_text": "- 9.  시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1.  시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2.  주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n- 3.  연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1.  분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. ",
        "original_sentence": "주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_594",
      "text": "성능시험에 대한 상세사항\n\n- - 45 -\n- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 593,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 3,
        "window_text": "시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도의 전처리가\n❍ 대학 또는 연구기관 등 국내․외 전문기관에서 시험한 자료는 다음의\n\n- 1.  시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2.  주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n- 3.  연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1.  분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 45 -\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_595",
      "text": "연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 594,
        "window_size": 3,
        "char_count": 145,
        "word_count": 31,
        "page_number": 50,
        "window_text": "시험시설개요\n전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n주요설비 목록 등이 기재되어 있어야 함\n\n- 2.  주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n- 3.  연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1.  분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n 나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n",
        "original_sentence": "연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_596",
      "text": "분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 595,
        "window_size": 3,
        "char_count": 107,
        "word_count": 20,
        "page_number": 31,
        "window_text": "주요설비\n시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n사항이 기재되고 관련 증빙자료를 함께 제출하여야 함\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n- 3.  연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1.  분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n 나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n 다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n",
        "original_sentence": "분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_597",
      "text": "호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 596,
        "window_size": 3,
        "char_count": 68,
        "word_count": 15,
        "page_number": 13,
        "window_text": "성능시험에 대한 상세사항\n\n- - 45 -\n- 3.  연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1.  분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n 나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n 다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. ",
        "original_sentence": "호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_598",
      "text": "나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 597,
        "window_size": 3,
        "char_count": 64,
        "word_count": 16,
        "page_number": 5,
        "window_text": "연구인력구성\n시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공, 경력\n\n등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서 규정한 요\n\n<!-- PAGE_50 -->\n###### 1.  분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n 나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n 다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다. ",
        "original_sentence": "나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_599",
      "text": "다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 598,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 24,
        "window_text": "분석적 민감도 (최소검출한계, 최소정량한계, 컷오프농도, 측정\n\n분석적 성능으로 최소검출한계, 최소정량한계 및 측정범위를 심사의뢰서에\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n 나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n 다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다.  검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다. ",
        "original_sentence": "다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_600",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 599,
        "window_size": 3,
        "char_count": 328,
        "word_count": 78,
        "page_number": 1,
        "window_text": "호환되는\n\n기질(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한\n\n검체를 낮은 농도 검체로 이용할 수 있다.\n\n 나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n 다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다.  검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다.  심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_601",
      "text": "아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 600,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 24,
        "window_text": "나) 공란한계 설정을 위한 검체와 추정되는 검출한계 농도 근처의\n\n검체는 최소 각 4개씩 준비할 것을 권장한다.\n\n 다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다.  검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다.  심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다.  전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ. ",
        "original_sentence": "아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_602",
      "text": "검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 601,
        "window_size": 3,
        "char_count": 248,
        "word_count": 43,
        "page_number": 5,
        "window_text": "다) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과\n\n를 제시한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다.  검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다.  심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다.  전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n",
        "original_sentence": "검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다. "
      }
    },
    {
      "chunk_id": "chunk_603",
      "text": "심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 602,
        "window_size": 3,
        "char_count": 56,
        "word_count": 12,
        "page_number": 31,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 46 -\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 제품\n\n설명서에 이를 권장한다면 적절한 수의 시험물질로 자연기질\n\n마) 희석을 위해 분석대상물질이 포함되어 있지 않은 사람 유래\n\n검체를 찾는 것이 어려울 경우에는 제조사에서 제시 또는 권장\n\n하는 물질로 희석할 수도 있으나 되도록이면 사람 유래 검체를\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다.  검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다.  심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다.  전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n 가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. ",
        "original_sentence": "심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다. "
      }
    },
    {
      "chunk_id": "chunk_604",
      "text": "전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 603,
        "window_size": 3,
        "char_count": 93,
        "word_count": 19,
        "page_number": 13,
        "window_text": "아래의 참고방법을 참조할 수\n\n다) 검체에서 검출될 수 있는 최소 검출한계치를 제시한다.  검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다.  심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다.  전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n 가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. ",
        "original_sentence": "전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_605",
      "text": "성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 604,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 3,
        "window_text": "검출\n\n한계에 영향을 줄 수 있는 여러 변수를 고려하기 위해 검사\n\nCLSI 지침(EP17-A2)에서는 LOB (limit of blank), LoD\n\n(limit of detection), LOQ (limit of quantitation)를 확립하\n\n기 위한 방법이 기술되어 있으며, LoD 측정에 3가지 방법\n\n(classical approach, precision profile approach, probit\n\napproach)이 있다.  심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다.  전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n 가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n있다.\n\n",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_606",
      "text": "가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 605,
        "window_size": 3,
        "char_count": 66,
        "word_count": 14,
        "page_number": 31,
        "window_text": "심혈관표지자의 LoD 측정을 위해서는 전\n\n통적인 방법 또는 정밀도 profile 방법을 이용한다.  전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n 가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n있다.\n\n 다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다. ",
        "original_sentence": "가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_607",
      "text": "호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 606,
        "window_size": 3,
        "char_count": 258,
        "word_count": 59,
        "page_number": 13,
        "window_text": "전통적인\n\n방법(classical approach)은 blank 검체와 검출한계 근처의\n\nlow level 검체의 반복 측정 수가 각각 최소 60회가 될 것을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n 가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n있다.\n\n 다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다.  결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n",
        "original_sentence": "호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_608",
      "text": "아래의 참고방법을 참조할 수\n\n있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 607,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 51,
        "window_text": "성능시험에 대한 상세사항\n\n- - 47 -\n권장한다.\n\n 가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n있다.\n\n 다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다.  결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다. ",
        "original_sentence": "아래의 참고방법을 참조할 수\n\n있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_609",
      "text": "다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 608,
        "window_size": 3,
        "char_count": 52,
        "word_count": 12,
        "page_number": 5,
        "window_text": "가) 통계적으로 유효한 최소검출한계치와 설정에 사용된 검체의\n\n가) 사람의 검체(혈청, 혈장, 전혈 등)를 사용한다.  호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n있다.\n\n 다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다.  결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다.  Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다. ",
        "original_sentence": "다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_610",
      "text": "결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 609,
        "window_size": 3,
        "char_count": 82,
        "word_count": 20,
        "page_number": 21,
        "window_text": "호환되는 기질\n\n(matrix)로 희석하거나 분석 대상 물질을 일정량 첨가한 검체를\n\n나) 측정 가능한 검체(혈청, 혈장, 전혈 등)의 종류별 시험 결과를\n\n라) 희석을 위해 만약 인공(simulated)기질을 사용하거나 사용방법\n\n에 이를 권장한다면 적절한 수의 시험물질로 자연기질과의 동\n\n가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체의 수, 측정\n\n나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실험\n\n방법을 요약 제출할 수 있다.  아래의 참고방법을 참조할 수\n\n있다.\n\n 다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다.  결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다.  Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다.  도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다. ",
        "original_sentence": "결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_611",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 610,
        "window_size": 3,
        "char_count": 117,
        "word_count": 24,
        "page_number": 1,
        "window_text": "아래의 참고방법을 참조할 수\n\n있다.\n\n 다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다.  결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다.  Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다.  도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다.  CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_612",
      "text": "Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 611,
        "window_size": 3,
        "char_count": 156,
        "word_count": 32,
        "page_number": 5,
        "window_text": "다) CV 10%를 만족시키는 최소 농도와 CV 20%를 만족시키는\n\n최소 농도를 제시한다.  결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다.  Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다.  도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다.  CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n ※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ. ",
        "original_sentence": "Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다. "
      }
    },
    {
      "chunk_id": "chunk_613",
      "text": "도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 612,
        "window_size": 3,
        "char_count": 46,
        "word_count": 12,
        "page_number": 5,
        "window_text": "결과에 영향을 줄 수 있는 여러 변수를\n\n고려하기 위해 검사일은 20일, 하루에 2번 측정(run), 측정 시\n\n2번 이상 반복검사를 권장한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다.  Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다.  도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다.  CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n ※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n",
        "original_sentence": "도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다. "
      }
    },
    {
      "chunk_id": "chunk_614",
      "text": "CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 613,
        "window_size": 3,
        "char_count": 232,
        "word_count": 50,
        "page_number": 21,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 48 -\nCLSI 지침(EP17-A2)에서는 정확도 목표에 정밀도만 포함시켜\n\nLoQ를 설정하는 방법을 제시하고 있다.  Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다.  도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다.  CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n ※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n 가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n",
        "original_sentence": "CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_615",
      "text": "※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 614,
        "window_size": 3,
        "char_count": 83,
        "word_count": 15,
        "page_number": 13,
        "window_text": "Troponin I의 정확도 목\n\n표는 검사실내정밀도 CV 10%이므로 20일간 CLSI 지침(EP05A2)\n\n따라 정밀도 평가 시행 한 후 평균과 검사실내정밀도 및 표준편차\n\n를 산출하여 profile 그래프를 그리고 model fit process 진행하여\n\n식을 도출한다.  도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다.  CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n ※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n 가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n 다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n",
        "original_sentence": "※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_616",
      "text": "성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 615,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 3,
        "window_text": "도출된 식에 CV 10%를 대입하여 농도를 산출하\n\n면 이 농도가 LoQ가 된다.  CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n ※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n 가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n 다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n 라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n"
      }
    },
    {
      "chunk_id": "chunk_617",
      "text": "가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 616,
        "window_size": 3,
        "char_count": 281,
        "word_count": 63,
        "page_number": 3,
        "window_text": "CV 20%를 도출된 식에 대입하여 산출\n\n가) 통계적으로 유효한 최소정량한계치와 CV 20%를 만족시키는\n\n최소 농도, LoQ 설정에 사용된 검체의 종류, 검체수, 반복회수,\n\n가) 임상적 성능시험(임상적 진단, 추적관찰에 따른 진단 등)에\n\n나) 측정항목, 측정원리, 판독방법 등에 따라 판정기준치(cut-off\n\nvalue)의 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문\n\n등을 거칠 것을 권장한다.\n\n ※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n 가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n 다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n 라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다. ",
        "original_sentence": "가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_618",
      "text": "다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 617,
        "window_size": 3,
        "char_count": 64,
        "word_count": 15,
        "page_number": 32,
        "window_text": "※ 판정기준치 혹은 판정기준치와 연계된 기대값(Expected Value)의\n\n설정이 임상적 성능(임상적 민감도와 임상적 특이도)을 바탕으로\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n 가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n 다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n 라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2. ",
        "original_sentence": "다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_619",
      "text": "라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 618,
        "window_size": 3,
        "char_count": 92,
        "word_count": 20,
        "page_number": 13,
        "window_text": "성능시험에 대한 상세사항\n\n- - 49 -\n한 경우, 타당한 임상적 근거를 제시한다(임상적 민감도 참고).\n\n 가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n 다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n 라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2.  분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다. ",
        "original_sentence": "라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_620",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 619,
        "window_size": 3,
        "char_count": 212,
        "word_count": 47,
        "page_number": 1,
        "window_text": "가) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거\n\n나) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희석에\n\n다) 고역가 검체에 의한 후크효과(hook effect) 등에 대한 자료를\n\n가) 시험물질은 측정법에 적합한 기질(matrix)을 가진 물질이어야\n\n나) 표준품에 비교된 참고물질로 적합한 기질 성상과 목표치를\n\n알고 있는 물질의 사용을 권장한다.\n\n 다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n 라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2.  분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.  사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다. "
      }
    },
    {
      "chunk_id": "chunk_621",
      "text": "희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 620,
        "window_size": 3,
        "char_count": 149,
        "word_count": 32,
        "page_number": 55,
        "window_text": "다) 참고물질을 구할 수 없는 경우, 측정하고자 하는 물질에 대한\n\n농도가 알려진 고농도의 임상검체를 이용한다.\n\n 라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2.  분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.  사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n",
        "original_sentence": "희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_622",
      "text": "분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 621,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 5,
        "window_text": "라) 희석에 사용하는 음성 검체나 혼합할 음성검체는 기질효과를\n\n고려하여, 해당 제품의 대상이 되는 사람의 음성검체(혈청,\n\n혈장, 전혈 등)를 사용하여야 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2.  분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.  사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n 가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ. ",
        "original_sentence": "분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다. "
      }
    },
    {
      "chunk_id": "chunk_623",
      "text": "사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 622,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 24,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 50 -\n가) 고농도검체와 음성검체를 혼합하여 제조하거나, 고농도의\n\n나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 5개\n\n이상의 알려진 농도를 가지는 검체를 이용하거나 희석을 통\n\n해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2.  분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.  사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n 가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7. ",
        "original_sentence": "사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_624",
      "text": "2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 623,
        "window_size": 3,
        "char_count": 104,
        "word_count": 27,
        "page_number": 13,
        "window_text": "희석은 고농도와 저농도\n\n검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의 검\n\n체를 만드는 것이 권장되나  농도간의 간격이 일정하지 않을\n\n나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_55 -->\n###### 2.  분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.  사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n 가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7.  간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n",
        "original_sentence": "2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_625",
      "text": "가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 624,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 31,
        "window_text": "분석적 특이도\n\n1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.  사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n 가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7.  간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n",
        "original_sentence": "가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_626",
      "text": "성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 625,
        "window_size": 3,
        "char_count": 119,
        "word_count": 24,
        "page_number": 3,
        "window_text": "사용\n\n검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.\n\n 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n 가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7.  간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7. "
      }
    },
    {
      "chunk_id": "chunk_627",
      "text": "간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 626,
        "window_size": 3,
        "char_count": 160,
        "word_count": 37,
        "page_number": 21,
        "window_text": "2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n다음과 같은 물질에 대한 간섭 평가 시험을 고려한다.\n\n 가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7.  간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n",
        "original_sentence": "간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_628",
      "text": "3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 627,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 24,
        "window_text": "가) 검체 처치에 첨가된 물질(보존제, 안정제 등)\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7.  간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n <!-- PAGE_57 -->\n###### 3. ",
        "original_sentence": "3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_629",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 628,
        "window_size": 3,
        "char_count": 400,
        "word_count": 90,
        "page_number": 1,
        "window_text": "성능시험에 대한 상세사항\n\n- - 51 -\n나) 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈,\n\nrheumatoid factors, human antimouse 항체, 및 heterophile\n\n표 7.  간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n <!-- PAGE_57 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n- 가. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_630",
      "text": "대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 629,
        "window_size": 3,
        "char_count": 134,
        "word_count": 31,
        "page_number": 31,
        "window_text": "간섭물질 예\n\n3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n검체의 제조 방법(예: 간섭물질을 혼합한 검체, 자연적으로 높은\n\n간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.\n\n 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n <!-- PAGE_57 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n- 가.  일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ. ",
        "original_sentence": "대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n"
      }
    },
    {
      "chunk_id": "chunk_631",
      "text": "<!-- PAGE_57 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 630,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 57,
        "window_text": "3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n이상이 되도록 한다.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n <!-- PAGE_57 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n- 가.  일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n",
        "original_sentence": "<!-- PAGE_57 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_632",
      "text": "정밀도 (반복성, 재현성 등)\n\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 631,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 31,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 52 -\n4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n농도에 따른 영향을 보기 위해 용량-반응검사(dose-response\n\n1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의 결과\n\n값을 제시하고, 정량검사의 경우는 결과를 비교하여 바이어스가\n\n있는지 확인하고 두 값의 차이가 허용범위(dmax)보다 작은지\n\n2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n <!-- PAGE_57 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n- 가.  일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다. ",
        "original_sentence": "정밀도 (반복성, 재현성 등)\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_633",
      "text": "일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 632,
        "window_size": 3,
        "char_count": 47,
        "word_count": 12,
        "page_number": 3,
        "window_text": "대상측정물질을 함유하지 않고 간섭 가능한\n\n물질만 포함된 검체의 실측한 자료를 바탕으로 배경한계와 검출\n\n3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n한다(예 : 높은 농도의 물질 X는 분석물질의 결과를 감소시킴).\n\n <!-- PAGE_57 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n- 가.  일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다.  로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n",
        "original_sentence": "일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_634",
      "text": "성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 633,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 3,
        "window_text": "<!-- PAGE_57 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n- 가.  일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다.  로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n - 다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_635",
      "text": "2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 634,
        "window_size": 3,
        "char_count": 329,
        "word_count": 61,
        "page_number": 21,
        "window_text": "정밀도 (반복성, 재현성 등)\n\n- 가.  일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다.  로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n - 다.  결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4. ",
        "original_sentence": "2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_636",
      "text": "로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 635,
        "window_size": 3,
        "char_count": 165,
        "word_count": 32,
        "page_number": 5,
        "window_text": "일반사항\n1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다.  로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n - 다.  결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4.  정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n",
        "original_sentence": "로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_637",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 636,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "성능시험에 대한 상세사항\n\n- - 53 -\n자료를 제시한다.\n\n 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다.  로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n - 다.  결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4.  정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n - 나. ",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_638",
      "text": "결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 637,
        "window_size": 3,
        "char_count": 302,
        "word_count": 61,
        "page_number": 59,
        "window_text": "2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n1) 검체의 종류, 검체 수, 측정방법, 측정횟수 등에 대한 실험프로\n\n2) 반복성(repeatability, within laboratory precision) 평가는 3가\n\n지 농도 이상의 검체를 1회(run)마다 2~3회 반복(duplicate or\n\ntriplicate) 측정하기를, 1일에 2회(run) 이상, 최소 10일 동안\n\n3) 최소 3개의 시약 로트를 이용하여 로트 간 정밀도(lot-to-lot\n\nprecision)를 평가한다.  로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n - 다.  결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4.  정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n - 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ. ",
        "original_sentence": "결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_639",
      "text": "정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 638,
        "window_size": 3,
        "char_count": 159,
        "word_count": 32,
        "page_number": 13,
        "window_text": "로트 간 정밀도 평가는 별도의 평가로\n\n4) 재현성(reproducibility) 평가는 2곳 이상의 검사실에서 3가지\n\n농도 이상의 검체를 1회(run)마다 2회 이상 반복(duplicate or\n\nmore) 측정하기를, 1일에 2회(run) 이상, 5일 이상 동안 실시할\n\n것을 권장한다.\n\n - 다.  결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4.  정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n - 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n",
        "original_sentence": "정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_640",
      "text": "- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 639,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "- 다.  결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4.  정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n - 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n - 라. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_641",
      "text": "표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 640,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 49,
        "window_text": "결과제시\n1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도(between-run),\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 54 -\n날짜 간 정밀도(between-day), 검사실 내 정밀도(within-\n\n2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n결과를 합한 반복성 결과와 검사기관간(between-site) 결과를\n\n3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는 변\n\n<!-- PAGE_59 -->\n###### 4.  정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n - 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n - 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5. ",
        "original_sentence": "표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_642",
      "text": "성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 641,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 3,
        "window_text": "정확도\n\n- 가. WHO international reference standard 물질, NIST standard\nreference material 등 국제표준품 등 특성이 명시되어 있는 물질\n\n이 존재할 경우에는 이를 사용하여 평가할 것을 권장하며 최소 2\n\n회 반복 측정한다.\n\n - 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n - 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5.  교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_643",
      "text": "- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 642,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "- 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n - 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5.  교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다.  시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n",
        "original_sentence": "- 라. "
      }
    },
    {
      "chunk_id": "chunk_644",
      "text": "보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 643,
        "window_size": 3,
        "char_count": 75,
        "word_count": 10,
        "page_number": 60,
        "window_text": "표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과 값과 바\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n - 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5.  교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다.  시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n 3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다. ",
        "original_sentence": "보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_645",
      "text": "교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 644,
        "window_size": 3,
        "char_count": 130,
        "word_count": 32,
        "page_number": 21,
        "window_text": "성능시험에 대한 상세사항\n\n- - 55 -\n이어스)를 제시한다.\n\n - 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5.  교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다.  시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n 3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다. ",
        "original_sentence": "교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_646",
      "text": "시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 645,
        "window_size": 3,
        "char_count": 224,
        "word_count": 53,
        "page_number": 5,
        "window_text": "- 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5.  교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다.  시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n 3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다.  민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n",
        "original_sentence": "시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_647",
      "text": "3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 646,
        "window_size": 3,
        "char_count": 323,
        "word_count": 77,
        "page_number": 25,
        "window_text": "보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해 기\n<!-- PAGE_60 -->\n###### 5.  교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다.  시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n 3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다.  민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n Ⅶ. ",
        "original_sentence": "3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_648",
      "text": "이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 647,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 16,
        "window_text": "교차반응\n\n사람 근육 조직에서 발견되는 다른 근원섬유 단백질 등에 대한 교\n\n2) 심장성 Troponin 항원과의 교차반응을 위한 평가에 이용될 수\n\n골격근 트로포닌 I, 심장 트로포닌 T, 심장 트로포닌 C, 트로포마이\n\n- 다.  시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n 3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다.  민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다. ",
        "original_sentence": "이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다. "
      }
    },
    {
      "chunk_id": "chunk_649",
      "text": "민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 648,
        "window_size": 3,
        "char_count": 118,
        "word_count": 29,
        "page_number": 32,
        "window_text": "시험방법\n1) 교차반응물질의 종류, 교차반응물질의 농도, 검체종류(예 : 교차\n\n반응 예상 물질을 인위적으로 첨가한 검체, 자연적으로 높은 교\n\n차 반응 예상물질을 함유한 검체 등), 비교검체(예 : 교차반응물\n\n질이 없는 검체 등), 분석물질의 농도 및 결과 등에 대한 실험\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 56 -\n프로토콜을 제공한다.\n\n 3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다.  민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n",
        "original_sentence": "민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_650",
      "text": "Ⅶ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 649,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 6,
        "window_text": "3) 최소 5회 이상 교차 반응 예상물질을 함유한 검체(T)와 교차반\n\n응물질을 함유하지 않은 비교검체(C)를 교대로 검사한다(예,\n\n4) 교차반응평가를 위해 준비된 검체는 최소 3회 반복 측정하기를\n\n1) 교차반응 평가에 사용된 물질의 종류, 농도등이 포함된 시험 자\n\n※ 임상적 성능시험에 관한 자료의 작성 시 준수사항\n\n❍ 체외진단용 시약의 성능 및 유효성을 증명하기 위하여 사람에서 유래\n\n❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다.  민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n",
        "original_sentence": "Ⅶ. "
      }
    },
    {
      "chunk_id": "chunk_651",
      "text": "성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 650,
        "window_size": 3,
        "char_count": 166,
        "word_count": 35,
        "page_number": 3,
        "window_text": "이는 인종 및\n\n지역에 따라 유병률이 다를 수 있기 때문이다.  민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n ü ECG 상에서 pathological Q waves의 발생.\n\n",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다. "
      }
    },
    {
      "chunk_id": "chunk_652",
      "text": "질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 651,
        "window_size": 3,
        "char_count": 144,
        "word_count": 36,
        "page_number": 83,
        "window_text": "민족적 요인의 차이가\n\n있어 외국 임상적 성능시험을 그대로 적용하기가 어렵다고 판단되는\n\n경우, 처장은 국내에 거주하는 한국인으로부터 유래한 검체를 대상\n\n으로 한 자료를 추가 제출할 것을 요구 할 수 있다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n ü ECG 상에서 pathological Q waves의 발생.\n\n ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n",
        "original_sentence": "질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n"
      }
    },
    {
      "chunk_id": "chunk_653",
      "text": "ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 652,
        "window_size": 3,
        "char_count": 96,
        "word_count": 17,
        "page_number": 13,
        "window_text": "Ⅶ.  성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n ü ECG 상에서 pathological Q waves의 발생.\n\n ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n",
        "original_sentence": "ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n"
      }
    },
    {
      "chunk_id": "chunk_654",
      "text": "ü ECG 상에서 pathological Q waves의 발생.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 653,
        "window_size": 3,
        "char_count": 37,
        "word_count": 7,
        "page_number": 62,
        "window_text": "성능시험에 대한 상세사항\n\n- - 57 -\n❍ 임상기관에서 임상시험이 수행되어야 하며, 임상시험 수행기관에서\n\n❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선택\n\n기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대한\n\n자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n ü ECG 상에서 pathological Q waves의 발생.\n\n ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n ❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n",
        "original_sentence": "ü ECG 상에서 pathological Q waves의 발생.\n\n"
      }
    },
    {
      "chunk_id": "chunk_655",
      "text": "ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 654,
        "window_size": 3,
        "char_count": 84,
        "word_count": 14,
        "page_number": 13,
        "window_text": "질환이 있음을 규명한 참고표\n\n준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일 수도\n\n있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사, 임상\n\n소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한 방법일\n\nü 허혈 증상.\n\n ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n ü ECG 상에서 pathological Q waves의 발생.\n\n ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n ❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n",
        "original_sentence": "ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n"
      }
    },
    {
      "chunk_id": "chunk_656",
      "text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 655,
        "window_size": 3,
        "char_count": 127,
        "word_count": 32,
        "page_number": 1,
        "window_text": "ü 새롭거나 새로운 것으로 추정되는 ST-segment–T wave\n\n(ST–T)의 유의한 변화 또는 새로운 left bundle branch block\n\n(LBBB).\n\n ü ECG 상에서 pathological Q waves의 발생.\n\n ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n ❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n - • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ. ",
        "original_sentence": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_657",
      "text": "❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 656,
        "window_size": 3,
        "char_count": 60,
        "word_count": 14,
        "page_number": 5,
        "window_text": "ü ECG 상에서 pathological Q waves의 발생.\n\n ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n ❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n - • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험. ",
        "original_sentence": "❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_658",
      "text": "ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 657,
        "window_size": 3,
        "char_count": 44,
        "word_count": 6,
        "page_number": 63,
        "window_text": "ü 새로운 loss of viable myocardium이나 새로운 regional\n\nwall motion abnormality의 영상 상의 증거.\n\n 체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n ❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n - • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가. ",
        "original_sentence": "ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n"
      }
    },
    {
      "chunk_id": "chunk_659",
      "text": "- • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 658,
        "window_size": 3,
        "char_count": 42,
        "word_count": 11,
        "page_number": 49,
        "window_text": "체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 58 -\n❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체\n\n를 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.\n\n ❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n - • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가.  식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나. ",
        "original_sentence": "- • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_660",
      "text": "성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 659,
        "window_size": 3,
        "char_count": 189,
        "word_count": 46,
        "page_number": 1,
        "window_text": "❍ 아래의 1)부터 4)중 어느 하나에 해당하는 경우, 임상적 성능시험에 관한\n\n자료를 제출하여야 한다.\n\n ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n - • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가.  식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험. "
      }
    },
    {
      "chunk_id": "chunk_661",
      "text": "다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 660,
        "window_size": 3,
        "char_count": 673,
        "word_count": 151,
        "page_number": 25,
        "window_text": "ü 혈관조영술이나 부검에서 intracoronary thrombus를 확인.\n\n - • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가.  식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라. ",
        "original_sentence": "다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_662",
      "text": "식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 661,
        "window_size": 3,
        "char_count": 36,
        "word_count": 7,
        "page_number": 72,
        "window_text": "- • 심근허혈을 시사하는 증상을 가지면서 새로운 것으로 추정되는 허\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가.  식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라.  과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1. ",
        "original_sentence": "식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_663",
      "text": "외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 662,
        "window_size": 3,
        "char_count": 80,
        "word_count": 19,
        "page_number": 25,
        "window_text": "성능시험에 대한 상세사항\n\n- - 59 -\n1) 4등급 체외진단용 의료기기의 시험\n\n2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취방\n\n법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외이도,\n\n외비공, 인두, 직장 또는 자궁경부를 넘어서 귀, 코, 입, 항문관 또는\n\n질에 들어가는 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가.  식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라.  과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1.  임상적 민감도\n\n- 가. ",
        "original_sentence": "외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_664",
      "text": "해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 663,
        "window_size": 3,
        "char_count": 118,
        "word_count": 26,
        "page_number": 80,
        "window_text": "다만, 정맥채혈 등 피험자에게 중대한\n\n3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료기\n\n4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받은\n\n의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단용 의\n\n(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상시험\n\n❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의 가)부터\n\n(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되고,\n\n가) 다음 각 단의 어느 하나에 해당하는 기관에서 별표 14 임상적 성능시험\n\n관리기준에 의하여 실시한 자료\n\n➀「감염병의 예방 및 관리에 관한 시행규칙」 제4조제9호에 해당하는 기관\n\n➁「혈액관리법」 제6조제3항에 따라 허가받은 공급혈액원\n\n➂ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관\n\n나) 외국 자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 별표 14\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 60 -\n임상적 성능시험 관리기준에 의하여 실시한 시험자료 또는 이에 준하는\n\n다) 임상적 성능시험에 관한 자료 요건( 상기의 1)에서~ 4)까지) 중 어느\n\n❍ 임상적 성능시험에 관한 자료는 다음 중 어느 하나에 해당하는 자료 요건\n\n- 가.  식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라.  과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1.  임상적 민감도\n\n- 가.  실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n",
        "original_sentence": "해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_665",
      "text": "과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 664,
        "window_size": 3,
        "char_count": 72,
        "word_count": 10,
        "page_number": 65,
        "window_text": "식품의약품안전처장이 지정한 임상시험기관에서 시험한 자료\n- 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라.  과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1.  임상적 민감도\n\n- 가.  실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n 2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n",
        "original_sentence": "과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_666",
      "text": "임상적 민감도\n\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 665,
        "window_size": 3,
        "char_count": 14,
        "word_count": 4,
        "page_number": 31,
        "window_text": "외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고 시행규\n칙 별표 3 의료기기 임상시험 관리기준에 의하여 실시한 시험자료\n\n- 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라.  과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1.  임상적 민감도\n\n- 가.  실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n 2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n Ⅶ. ",
        "original_sentence": "임상적 민감도\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_667",
      "text": "실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 666,
        "window_size": 3,
        "char_count": 41,
        "word_count": 9,
        "page_number": 5,
        "window_text": "해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가 당시\n제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는 정부가\n\n허가 업무를 위임한 등록기관이 제출받아 승인하였음을 확인한 자료\n\n- 라.  과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1.  임상적 민감도\n\n- 가.  실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n 2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등. ",
        "original_sentence": "실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_668",
      "text": "2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 667,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 13,
        "window_text": "과학논문인용색인(Science Citation Index)에 등재된 전문학회지에\n<!-- PAGE_65 -->\n###### 1.  임상적 민감도\n\n- 가.  실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n 2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n",
        "original_sentence": "2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_669",
      "text": "Ⅶ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 668,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 6,
        "window_text": "임상적 민감도\n\n- 가.  실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n 2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n 5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n",
        "original_sentence": "Ⅶ. "
      }
    },
    {
      "chunk_id": "chunk_670",
      "text": "성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 669,
        "window_size": 3,
        "char_count": 90,
        "word_count": 23,
        "page_number": 3,
        "window_text": "실험물질\n1) 다양한 농도를 포함한 양성 임상검체를 이용하여 평가한다.\n\n 2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n 5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n - 다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등. "
      }
    },
    {
      "chunk_id": "chunk_671",
      "text": "평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 670,
        "window_size": 3,
        "char_count": 324,
        "word_count": 80,
        "page_number": 5,
        "window_text": "2) 임상검체가 양성 또는 음성임을 확인한 방법을 기술한 자료를\n\n제출한다.\n\n Ⅶ.  성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n 5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n - 다.  결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다. ",
        "original_sentence": "평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_672",
      "text": "5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 671,
        "window_size": 3,
        "char_count": 36,
        "word_count": 8,
        "page_number": 66,
        "window_text": "Ⅶ.  성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n 5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n - 다.  결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다.  임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n",
        "original_sentence": "5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_673",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 672,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "성능시험에 대한 상세사항\n\n- - 61 -\n※ 예시\n\n기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술한 자\n\n료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n 5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n - 다.  결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다.  임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2. ",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_674",
      "text": "결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 673,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 5,
        "window_text": "평가대상 제품의 결과와 관\n\n4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n※ 심장성 Troponin 검사의 목표 질환을 가지고 있는 양성 검체 50개\n\n5) 신선한 검체를 이용할 것을 권장하지만, 제조사에서 냉동검체의\n\n1) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로 검\n\n4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.\n\n 5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n - 다.  결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다.  임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2.  임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n",
        "original_sentence": "결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_675",
      "text": "임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 674,
        "window_size": 3,
        "char_count": 126,
        "word_count": 28,
        "page_number": 13,
        "window_text": "5) 검사를 시행할 집단에서의 유병률을 평가할 것을 권장한다.\n\n - 다.  결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다.  임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2.  임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n 2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n",
        "original_sentence": "임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_676",
      "text": "2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 675,
        "window_size": 3,
        "char_count": 220,
        "word_count": 53,
        "page_number": 67,
        "window_text": "- 다.  결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다.  임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2.  임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n 2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n 3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ. ",
        "original_sentence": "2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_677",
      "text": "임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 676,
        "window_size": 3,
        "char_count": 174,
        "word_count": 41,
        "page_number": 5,
        "window_text": "결과제시\n1) 임상적 민감도 및 95% 신뢰구간을 제시한다.  임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2.  임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n 2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n 3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다. ",
        "original_sentence": "임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_678",
      "text": "2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 677,
        "window_size": 3,
        "char_count": 67,
        "word_count": 14,
        "page_number": 13,
        "window_text": "임상적 민감도란\n\n질병이나 특정 상태를 가지는 대상군에서 검사 결과가 양성(판정\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 62 -\n기준치 이상)으로 나오는 환자의 비율이다.\n\n 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2.  임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n 2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n 3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다.  진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1. ",
        "original_sentence": "2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_679",
      "text": "3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 678,
        "window_size": 3,
        "char_count": 42,
        "word_count": 12,
        "page_number": 13,
        "window_text": "2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예측도,\n\n<!-- PAGE_67 -->\n###### 2.  임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n 2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n 3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다.  진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1.  3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n",
        "original_sentence": "3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_680",
      "text": "성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 679,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 3,
        "window_text": "임상적 특이도\n\n1) 진단의 목표가 되는 질환이 없음이 확인된 임상검체를 이용하여\n\n2) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다(예 :\n\n※ 심장성 Troponin 검사의 목표 질환을 가지지 않은 음성 검체\n\n1) 임상적 특이도란 질환이 없는 환자군에서 음성결과를 보이는 환\n\n자의 비율이다.\n\n 2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n 3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다.  진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1.  3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n - 2. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다. "
      }
    },
    {
      "chunk_id": "chunk_681",
      "text": "진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 680,
        "window_size": 3,
        "char_count": 300,
        "word_count": 72,
        "page_number": 68,
        "window_text": "2) 음성예측도와 양성예측도는 질환 유병률과 상관이 있으므로, 검\n\n사가 이용될 인구집단을 대상으로 산출되어야 한다.\n\n 3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다.  진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1.  3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n - 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3. ",
        "original_sentence": "진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_682",
      "text": "3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 681,
        "window_size": 3,
        "char_count": 76,
        "word_count": 19,
        "page_number": 5,
        "window_text": "3) 양성 결과를 보인 경우 임상소견 확인 및 확진 검사를 시행하여\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다.  진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1.  3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n - 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1. ",
        "original_sentence": "3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_683",
      "text": "- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 682,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "성능시험에 대한 상세사항\n\n- - 63 -\n진양성 유무를 확인토록 한다.  진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1.  3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n - 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_684",
      "text": "시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 683,
        "window_size": 3,
        "char_count": 137,
        "word_count": 34,
        "page_number": 6,
        "window_text": "진양성인 검체는 특이도 분석에\n\n4) 피험자 선정/제외 기준, 검체 종류와 수, 시험 상 주의사항, 통계\n\n5) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n2) 산출된 특이도의 95% 신뢰구간의 최하위값이 적합기준을 넘어\n\n3) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n4) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\n<!-- PAGE_68 -->\n###### 3\n\n<!-- PAGE_68 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n- 1.  3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n - 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n",
        "original_sentence": "시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_685",
      "text": "시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 684,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 3,
        "window_text": "3배치 각 1회 이상 또는 1배치 3회 이상의 시험규격에 따른 시험성적서\n또는 시험에 관한 자료를 제출하여 제품의 균일성을 제시한다.\n\n - 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n - 가. ",
        "original_sentence": "시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_686",
      "text": "표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 685,
        "window_size": 3,
        "char_count": 43,
        "word_count": 11,
        "page_number": 21,
        "window_text": "- 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n - 가.  표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1. ",
        "original_sentence": "표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_687",
      "text": "자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 686,
        "window_size": 3,
        "char_count": 36,
        "word_count": 8,
        "page_number": 24,
        "window_text": "시험규격 설정에 따른 시험 기준 및 방법에 관한 자료와 표준물질이\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 64 -\n사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n- 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n - 가.  표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. ",
        "original_sentence": "자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n"
      }
    },
    {
      "chunk_id": "chunk_688",
      "text": "- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 687,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도, 정\n- 1.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n - 가.  표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ. ",
        "original_sentence": "- 가. "
      }
    },
    {
      "chunk_id": "chunk_689",
      "text": "표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 688,
        "window_size": 3,
        "char_count": 126,
        "word_count": 30,
        "page_number": 69,
        "window_text": "표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자료를\n- 2.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n - 가.  표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n",
        "original_sentence": "표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_690",
      "text": "시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 689,
        "window_size": 3,
        "char_count": 72,
        "word_count": 17,
        "page_number": 31,
        "window_text": "자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n - 가.  표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n - 2. ",
        "original_sentence": "시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_691",
      "text": "이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 690,
        "window_size": 3,
        "char_count": 45,
        "word_count": 13,
        "page_number": 31,
        "window_text": "- 가.  표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n - 2.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다. ",
        "original_sentence": "이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_692",
      "text": "성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 691,
        "window_size": 3,
        "char_count": 50,
        "word_count": 14,
        "page_number": 3,
        "window_text": "표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및 결\n<!-- PAGE_69 -->\n###### 5\n\n<!-- PAGE_69 -->\n###### 검체보관 및 취급상(온도, 습도 등)의 조건 설정 근거자료\n\n- 1.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n - 2.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_693",
      "text": "- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 692,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n - 2.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_694",
      "text": "검체 취급 및 보관조건에 대한 시험 결과를 제시한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 693,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 24,
        "window_text": "이는\n\n원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n - 2.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1. ",
        "original_sentence": "검체 취급 및 보관조건에 대한 시험 결과를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_695",
      "text": "이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 694,
        "window_size": 3,
        "char_count": 77,
        "word_count": 21,
        "page_number": 3,
        "window_text": "성능시험에 대한 상세사항\n\n- - 65 -\n체의 사용 가능성 및 제한점 등을 포함한다.\n\n - 2.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1.  일반사항\n- 가. ",
        "original_sentence": "이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_696",
      "text": "이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 695,
        "window_size": 3,
        "char_count": 59,
        "word_count": 17,
        "page_number": 83,
        "window_text": "- 2.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1.  일반사항\n- 가.  국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다. ",
        "original_sentence": "이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_697",
      "text": "시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 696,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 5,
        "window_text": "검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1.  일반사항\n- 가.  국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n- 나. ",
        "original_sentence": "시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_698",
      "text": "일반사항\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 697,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 3,
        "window_text": "이는 제시된 시간,\n온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇 단계에\n\n대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1.  일반사항\n- 가.  국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n- 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. ",
        "original_sentence": "일반사항\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_699",
      "text": "국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 698,
        "window_size": 3,
        "char_count": 54,
        "word_count": 11,
        "page_number": 1,
        "window_text": "이 시험은 제시된 구간\n\n의 양측 한계치 이상에서 평가된 결과여야 하며, 조건 변화에 따른 결\n\n- 3.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1.  일반사항\n- 가.  국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n- 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n",
        "original_sentence": "국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_700",
      "text": "다만, 측정원리 및 측정항목이\n\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 699,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 3,
        "window_text": "시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계처리법,\n- 1.  일반사항\n- 가.  국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n- 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n - 2. ",
        "original_sentence": "다만, 측정원리 및 측정항목이\n\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_701",
      "text": "임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 700,
        "window_size": 3,
        "char_count": 103,
        "word_count": 23,
        "page_number": 13,
        "window_text": "일반사항\n- 가.  국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n- 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n - 2.  시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가. ",
        "original_sentence": "임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_702",
      "text": "분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 701,
        "window_size": 3,
        "char_count": 63,
        "word_count": 15,
        "page_number": 13,
        "window_text": "국내‧외 허가된 체외진단용 의료기기의 상관성을 확인할 수 있는\n비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n- 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n - 2.  시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가.  통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나. ",
        "original_sentence": "분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_703",
      "text": "- 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 702,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 21,
        "window_text": "다만, 측정원리 및 측정항목이\n\n- 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n - 2.  시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가.  통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나.  임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라. ",
        "original_sentence": "- 2. "
      }
    },
    {
      "chunk_id": "chunk_704",
      "text": "시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 703,
        "window_size": 3,
        "char_count": 65,
        "word_count": 16,
        "page_number": 1,
        "window_text": "임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n - 2.  시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가.  통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나.  임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라.  임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3. ",
        "original_sentence": "시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_705",
      "text": "통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 704,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 31,
        "window_text": "분석적\n\n성능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상\n\n관성의 추가 자료로 제시할 수 있다.\n\n - 2.  시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가.  통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나.  임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라.  임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3.  권장 시험방법\n- 가. ",
        "original_sentence": "통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_706",
      "text": "임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 705,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 31,
        "window_text": "- 2.  시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가.  통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나.  임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라.  임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3.  권장 시험방법\n- 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마. ",
        "original_sentence": "임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_707",
      "text": "임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 706,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 25,
        "window_text": "시험물질\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 66 -\n- 가.  통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나.  임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라.  임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3.  권장 시험방법\n- 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마.  결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4. ",
        "original_sentence": "임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_708",
      "text": "권장 시험방법\n- 가. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 707,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 40,
        "window_text": "통계적으로 해석 가능한 임상검체수를 포함하여 비교시험을 수행\n- 나.  임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라.  임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3.  권장 시험방법\n- 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마.  결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4.  결과제시\n- 나. ",
        "original_sentence": "권장 시험방법\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_709",
      "text": "해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 708,
        "window_size": 3,
        "char_count": 80,
        "word_count": 23,
        "page_number": 3,
        "window_text": "임상검체는 기 허가된 방법이거나 여타 검증된 방법으로 검사되어\n- 라.  임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3.  권장 시험방법\n- 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마.  결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4.  결과제시\n- 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n",
        "original_sentence": "해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마. "
      }
    },
    {
      "chunk_id": "chunk_710",
      "text": "결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 709,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 5,
        "window_text": "임상검체는 측정범위 내의 다양한 농도가 포함되도록 하고, 최소\n- 3.  권장 시험방법\n- 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마.  결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4.  결과제시\n- 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n - 다. ",
        "original_sentence": "결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_711",
      "text": "결과제시\n- 나. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 710,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 72,
        "window_text": "권장 시험방법\n- 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마.  결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4.  결과제시\n- 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n - 다.  판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n",
        "original_sentence": "결과제시\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_712",
      "text": "정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 711,
        "window_size": 3,
        "char_count": 85,
        "word_count": 13,
        "page_number": 13,
        "window_text": "해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가 제품 또는\n외국 허가 제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n- 마.  결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4.  결과제시\n- 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n - 다.  판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n - 라. ",
        "original_sentence": "정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_713",
      "text": "- 다. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 712,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n- 4.  결과제시\n- 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n - 다.  판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n - 라.  결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_714",
      "text": "판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 713,
        "window_size": 3,
        "char_count": 79,
        "word_count": 12,
        "page_number": 13,
        "window_text": "결과제시\n- 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n - 다.  판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n - 라.  결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n Ⅷ. ",
        "original_sentence": "판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_715",
      "text": "- 라. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 714,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 72,
        "window_text": "정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n의학적 결정치(medical decision point)에서의 바이어스를 제시한다.\n\n - 다.  판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n - 라.  결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n Ⅷ.  참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1. ",
        "original_sentence": "- 라. "
      }
    },
    {
      "chunk_id": "chunk_716",
      "text": "결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 715,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 24,
        "window_text": "- 다.  판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n - 라.  결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n Ⅷ.  참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1.  CLSI. ",
        "original_sentence": "결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n"
      }
    },
    {
      "chunk_id": "chunk_717",
      "text": "Ⅷ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 716,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 6,
        "window_text": "판정기준치(cut-off value)를 적용한 정성적 검사결과(양성과 음성)\n에 대해서는 비교검사와의 일치도(신뢰구간과 함께)를 제시한다.\n\n - 라.  결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n Ⅷ.  참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline. ",
        "original_sentence": "Ⅷ. "
      }
    },
    {
      "chunk_id": "chunk_718",
      "text": "참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 717,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 72,
        "window_text": "- 라.  결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n Ⅷ.  참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline.  CLSI document EP25-A. ",
        "original_sentence": "참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_719",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 718,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 72,
        "window_text": "결과가 불일치하는 경우, 불일치의 원인 분석에 대한 자료를 제출한다.\n Ⅷ.  참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n- 2.\n",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_720",
      "text": "Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 719,
        "window_size": 3,
        "char_count": 77,
        "word_count": 10,
        "page_number": 13,
        "window_text": "Ⅷ.  참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n- 2.\n CLSI.\n\n",
        "original_sentence": "Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline. "
      }
    },
    {
      "chunk_id": "chunk_721",
      "text": "CLSI document EP25-A. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 720,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 5,
        "window_text": "참고문헌\n\n- - 67 -\n<!-- PAGE_72 -->\n# Ⅷ\n\n<!-- PAGE_72 -->\n### 참고문헌\n\n- 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n- 2.\n CLSI.\n\n Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n",
        "original_sentence": "CLSI document EP25-A. "
      }
    },
    {
      "chunk_id": "chunk_722",
      "text": "Wayne, PA: Cinical\n\n- 2.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 721,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 13,
        "window_text": "CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n- 2.\n CLSI.\n\n Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n CLSI document EP5-A2. ",
        "original_sentence": "Wayne, PA: Cinical\n\n- 2.\n"
      }
    },
    {
      "chunk_id": "chunk_723",
      "text": "CLSI.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 722,
        "window_size": 3,
        "char_count": 7,
        "word_count": 1,
        "page_number": 72,
        "window_text": "Evaluation of Stability of In Vitro Diagnostic Reagents;\nApproved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n- 2.\n CLSI.\n\n Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n- 3.\n",
        "original_sentence": "CLSI.\n\n"
      }
    },
    {
      "chunk_id": "chunk_724",
      "text": "Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 723,
        "window_size": 3,
        "char_count": 117,
        "word_count": 13,
        "page_number": 13,
        "window_text": "CLSI document EP25-A.  Wayne, PA: Cinical\n\n- 2.\n CLSI.\n\n Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n- 3.\n CLSI.\n\n",
        "original_sentence": "Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n"
      }
    },
    {
      "chunk_id": "chunk_725",
      "text": "CLSI document EP5-A2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 724,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 13,
        "window_text": "Wayne, PA: Cinical\n\n- 2.\n CLSI.\n\n Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n- 3.\n CLSI.\n\n User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n",
        "original_sentence": "CLSI document EP5-A2. "
      }
    },
    {
      "chunk_id": "chunk_726",
      "text": "Wayne, PA: Cinical and Laboratory\n\n- 3.\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 725,
        "window_size": 3,
        "char_count": 40,
        "word_count": 7,
        "page_number": 13,
        "window_text": "CLSI.\n\n Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n- 3.\n CLSI.\n\n User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n CLSI\n\ndocument EP12-A2. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory\n\n- 3.\n"
      }
    },
    {
      "chunk_id": "chunk_727",
      "text": "CLSI.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 726,
        "window_size": 3,
        "char_count": 7,
        "word_count": 1,
        "page_number": 72,
        "window_text": "Evaluation\n\nof\n\nPrecision\n\nPerformance\n\nof\n\nQuantitative\n\nMeasurement Methods; Approved Guideline - Second Edition.\n\n CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n- 3.\n CLSI.\n\n User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n CLSI\n\ndocument EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n- 4. ",
        "original_sentence": "CLSI.\n\n"
      }
    },
    {
      "chunk_id": "chunk_728",
      "text": "User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 727,
        "window_size": 3,
        "char_count": 113,
        "word_count": 14,
        "page_number": 13,
        "window_text": "CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n- 3.\n CLSI.\n\n User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n CLSI\n\ndocument EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n- 4.  CLSI. ",
        "original_sentence": "User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n"
      }
    },
    {
      "chunk_id": "chunk_729",
      "text": "CLSI\n\ndocument EP12-A2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 728,
        "window_size": 3,
        "char_count": 24,
        "word_count": 3,
        "page_number": 5,
        "window_text": "Wayne, PA: Cinical and Laboratory\n\n- 3.\n CLSI.\n\n User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n CLSI\n\ndocument EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n- 4.  CLSI.  Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline. ",
        "original_sentence": "CLSI\n\ndocument EP12-A2. "
      }
    },
    {
      "chunk_id": "chunk_730",
      "text": "Wayne, PA: Cinical and Laboratory Standard\n\n- 4. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 729,
        "window_size": 3,
        "char_count": 49,
        "word_count": 8,
        "page_number": 5,
        "window_text": "CLSI.\n\n User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n CLSI\n\ndocument EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n- 4.  CLSI.  Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline.  CLSI document EP17-A.\n\n",
        "original_sentence": "Wayne, PA: Cinical and Laboratory Standard\n\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_731",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 730,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 72,
        "window_text": "User\n\nProtocol\n\nfor\n\nEvaluation\n\nof\n\nQualitative\n\nTest\n\nPerformance;\n\nApproved\n\nGuideline\n\n- -\nSecond\n\nEdition.\n\n CLSI\n\ndocument EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n- 4.  CLSI.  Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline.  CLSI document EP17-A.\n\n Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_732",
      "text": "Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 731,
        "window_size": 3,
        "char_count": 99,
        "word_count": 13,
        "page_number": 13,
        "window_text": "CLSI\n\ndocument EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n- 4.  CLSI.  Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline.  CLSI document EP17-A.\n\n Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5.  CLSI. ",
        "original_sentence": "Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline. "
      }
    },
    {
      "chunk_id": "chunk_733",
      "text": "CLSI document EP17-A.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 732,
        "window_size": 3,
        "char_count": 23,
        "word_count": 3,
        "page_number": 5,
        "window_text": "Wayne, PA: Cinical and Laboratory Standard\n\n- 4.  CLSI.  Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline.  CLSI document EP17-A.\n\n Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline. ",
        "original_sentence": "CLSI document EP17-A.\n\n"
      }
    },
    {
      "chunk_id": "chunk_734",
      "text": "Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 733,
        "window_size": 3,
        "char_count": 65,
        "word_count": 10,
        "page_number": 13,
        "window_text": "CLSI.  Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline.  CLSI document EP17-A.\n\n Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline.  CLSI\n\ndocument EP6-A. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5. "
      }
    },
    {
      "chunk_id": "chunk_735",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 734,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 72,
        "window_text": "Protocols for Determination of Limits of Detection and\nLimits of Quantitation; Approved Guideline.  CLSI document EP17-A.\n\n Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline.  CLSI\n\ndocument EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_736",
      "text": "Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 735,
        "window_size": 3,
        "char_count": 112,
        "word_count": 13,
        "page_number": 13,
        "window_text": "CLSI document EP17-A.\n\n Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline.  CLSI\n\ndocument EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6.  CLSI. ",
        "original_sentence": "Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline. "
      }
    },
    {
      "chunk_id": "chunk_737",
      "text": "CLSI\n\ndocument EP6-A. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 736,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 13,
        "window_text": "Wayne, PA: Cinical and Laboratory Standard Institute; 2004\n\n- 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline.  CLSI\n\ndocument EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n",
        "original_sentence": "CLSI\n\ndocument EP6-A. "
      }
    },
    {
      "chunk_id": "chunk_738",
      "text": "Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 737,
        "window_size": 3,
        "char_count": 121,
        "word_count": 23,
        "page_number": 13,
        "window_text": "CLSI.  Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline.  CLSI\n\ndocument EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n CLSI document EP9-A2-IR. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6. "
      }
    },
    {
      "chunk_id": "chunk_739",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 738,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 72,
        "window_text": "Evaluation of the Linearity of Quantitative Measurement\nProcedures: A Statistical Approach; Approved Guideline.  CLSI\n\ndocument EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n CLSI document EP9-A2-IR.  Wayne, PA: Cinical and Laboratory\n\n- 7. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_740",
      "text": "Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 739,
        "window_size": 3,
        "char_count": 118,
        "word_count": 15,
        "page_number": 13,
        "window_text": "CLSI\n\ndocument EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n CLSI document EP9-A2-IR.  Wayne, PA: Cinical and Laboratory\n\n- 7.  CLSI. ",
        "original_sentence": "Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n"
      }
    },
    {
      "chunk_id": "chunk_741",
      "text": "CLSI document EP9-A2-IR. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 740,
        "window_size": 3,
        "char_count": 25,
        "word_count": 3,
        "page_number": 13,
        "window_text": "Wayne, PA: Cinical and Laboratory Standard\n\nInstitute; 2003\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 68 -\n- 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n CLSI document EP9-A2-IR.  Wayne, PA: Cinical and Laboratory\n\n- 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition. ",
        "original_sentence": "CLSI document EP9-A2-IR. "
      }
    },
    {
      "chunk_id": "chunk_742",
      "text": "Wayne, PA: Cinical and Laboratory\n\n- 7. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 741,
        "window_size": 3,
        "char_count": 40,
        "word_count": 7,
        "page_number": 13,
        "window_text": "CLSI.  Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n CLSI document EP9-A2-IR.  Wayne, PA: Cinical and Laboratory\n\n- 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition.  CLSI document EP7-A. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory\n\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_743",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 742,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 72,
        "window_text": "Method Comparison and Bias Estimation Using Patient\nSamples; Approved Guideline - Second Edition (Interim Revision).\n\n CLSI document EP9-A2-IR.  Wayne, PA: Cinical and Laboratory\n\n- 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n- 8. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_744",
      "text": "Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 743,
        "window_size": 3,
        "char_count": 81,
        "word_count": 10,
        "page_number": 13,
        "window_text": "CLSI document EP9-A2-IR.  Wayne, PA: Cinical and Laboratory\n\n- 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n- 8.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9. ",
        "original_sentence": "Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition. "
      }
    },
    {
      "chunk_id": "chunk_745",
      "text": "CLSI document EP7-A. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 744,
        "window_size": 3,
        "char_count": 21,
        "word_count": 3,
        "page_number": 13,
        "window_text": "Wayne, PA: Cinical and Laboratory\n\n- 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n- 8.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9.  Guidance for industry and FDA staff/ Format for traditional and\n- 10. ",
        "original_sentence": "CLSI document EP7-A. "
      }
    },
    {
      "chunk_id": "chunk_746",
      "text": "Wayne, PA:\n\n- 8. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 745,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 13,
        "window_text": "CLSI.  Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n- 8.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9.  Guidance for industry and FDA staff/ Format for traditional and\n- 10.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection. ",
        "original_sentence": "Wayne, PA:\n\n- 8. "
      }
    },
    {
      "chunk_id": "chunk_747",
      "text": "Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 746,
        "window_size": 3,
        "char_count": 68,
        "word_count": 12,
        "page_number": 13,
        "window_text": "Interference Testing in Clinical Chemistry; Approved\nGuideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n- 8.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9.  Guidance for industry and FDA staff/ Format for traditional and\n- 10.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection.  Clinical Chemistry\n\nⅨ. ",
        "original_sentence": "Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9. "
      }
    },
    {
      "chunk_id": "chunk_748",
      "text": "Guidance for industry and FDA staff/ Format for traditional and\n- 10. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 747,
        "window_size": 3,
        "char_count": 70,
        "word_count": 12,
        "page_number": 13,
        "window_text": "CLSI document EP7-A.  Wayne, PA:\n\n- 8.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9.  Guidance for industry and FDA staff/ Format for traditional and\n- 10.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection.  Clinical Chemistry\n\nⅨ.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1. ",
        "original_sentence": "Guidance for industry and FDA staff/ Format for traditional and\n- 10. "
      }
    },
    {
      "chunk_id": "chunk_749",
      "text": "Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 748,
        "window_size": 3,
        "char_count": 108,
        "word_count": 16,
        "page_number": 13,
        "window_text": "Wayne, PA:\n\n- 8.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9.  Guidance for industry and FDA staff/ Format for traditional and\n- 10.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection.  Clinical Chemistry\n\nⅨ.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1.  심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2. ",
        "original_sentence": "Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection. "
      }
    },
    {
      "chunk_id": "chunk_750",
      "text": "Clinical Chemistry\n\nⅨ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 749,
        "window_size": 3,
        "char_count": 23,
        "word_count": 3,
        "page_number": 13,
        "window_text": "Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n- 9.  Guidance for industry and FDA staff/ Format for traditional and\n- 10.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection.  Clinical Chemistry\n\nⅨ.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1.  심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2.  심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3. ",
        "original_sentence": "Clinical Chemistry\n\nⅨ. "
      }
    },
    {
      "chunk_id": "chunk_751",
      "text": "부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 750,
        "window_size": 3,
        "char_count": 87,
        "word_count": 20,
        "page_number": 74,
        "window_text": "Guidance for industry and FDA staff/ Format for traditional and\n- 10.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection.  Clinical Chemistry\n\nⅨ.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1.  심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2.  심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3.  미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP. ",
        "original_sentence": "부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_752",
      "text": "심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 751,
        "window_size": 3,
        "char_count": 45,
        "word_count": 9,
        "page_number": 74,
        "window_text": "Linnet, K and Kondratovich, M. A Partly Noparametric Approach\nfor Determination of the Llimit of Detection.  Clinical Chemistry\n\nⅨ.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1.  심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2.  심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3.  미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP.  | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC. ",
        "original_sentence": "심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_753",
      "text": "심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 752,
        "window_size": 3,
        "char_count": 491,
        "word_count": 77,
        "page_number": 75,
        "window_text": "Clinical Chemistry\n\nⅨ.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1.  심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2.  심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3.  미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP.  | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC.  | Jul 01 1999 |\n| COULTER INC. ",
        "original_sentence": "심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_754",
      "text": "미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 753,
        "window_size": 3,
        "char_count": 323,
        "word_count": 74,
        "page_number": 5,
        "window_text": "부록\n\n- - 69 -\n<!-- PAGE_74 -->\n# Ⅸ\n\n<!-- PAGE_74 -->\n### 부록\n\n<!-- PAGE_74 -->\n###### 1.  심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2.  심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3.  미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP.  | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC.  | Jul 01 1999 |\n| COULTER INC.  | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC. ",
        "original_sentence": "미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP. "
      }
    },
    {
      "chunk_id": "chunk_755",
      "text": "| Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 754,
        "window_size": 3,
        "char_count": 185,
        "word_count": 45,
        "page_number": 5,
        "window_text": "심장성 트로포닌 표준물질 현황\n\n<!-- PAGE_74 -->\n###### 2.  심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3.  미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP.  | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC.  | Jul 01 1999 |\n| COULTER INC.  | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC.  | Jan 16 1998 |\n| BEHRING INC. ",
        "original_sentence": "| Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_756",
      "text": "| Jul 01 1999 |\n| COULTER INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 755,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 5,
        "window_text": "심장성 트로포닌 제품 국내 제조 및 수입 현황\n\n지멘스(주)\n\n2012-12-26\n\nIMMULITE 1000 Turbo Troponin I\n\n한국로슈진단(주)\n\n2012-12-11\n\nElecsys Troponin T hs STAT\n\n삼성전자(주)\n\n2013-05-23\n\nSamsung LABGEO IB Troponin I Test\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnT Test Kit\n\n영인과학(주)\n\n2013-01-11\n\nAQT90 FLEX TnI Test Kit\n\n한국애보트(주)\n\n2012-12-21\n\nArchitect STAT Troponin-I\n\n아산제약(주)\n\n2012-11-09\n\nPATHFAST cTnI\n\n지멘스(주)\n\n2012-12-21\n\nIMMULITE 1000 Troponin I\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 70 -\n<!-- PAGE_75 -->\n###### 3.  미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP.  | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC.  | Jul 01 1999 |\n| COULTER INC.  | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC.  | Jan 16 1998 |\n| BEHRING INC.  | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC. ",
        "original_sentence": "| Jul 01 1999 |\n| COULTER INC. "
      }
    },
    {
      "chunk_id": "chunk_757",
      "text": "| Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 756,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 5,
        "window_text": "미국 FDA 등록 심장성 트로포닌 제품 목록 (2013년 9월 현재)\n\nDOCUMEN\n\n**[표 시작]**\n\n| APPROVED | Jun 11 1996 |\n| --- | --- |\n**Nov 10 1997**\n**Oct 08 2002**\n| Oct 20 2010 | Dec 08 1998 |\n**Aug 16 2004**\n**May 18 2000**\n| Jun 14 2006 | Aug 23 1996 |\n**Mar 31 2003**\n**Nov 25 1997**\n**Dec 23 1998**\n| K010201 | BAYER ADVIA IMS SYSTEM | BAYER CORP.  | Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC.  | Jul 01 1999 |\n| COULTER INC.  | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC.  | Jan 16 1998 |\n| BEHRING INC.  | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC.  | Jun 16 2003 | BEHRING INC. ",
        "original_sentence": "| Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC. "
      }
    },
    {
      "chunk_id": "chunk_758",
      "text": "| Jan 16 1998 |\n| BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 757,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| Mar 29 2001 |\n**May 09 2012**\n| Apr 20 2001 | Dec 17 2004 | Nov 07 1996 |\n**Feb 21 2003**\n**Dec 14 1998**\n**Dec 19 2006**\n**Dec 10 1997**\n| Jun 05 2001 | Sep 10 2004 |\n| BEHRING INC.  | Jul 01 1999 |\n| COULTER INC.  | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC.  | Jan 16 1998 |\n| BEHRING INC.  | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC.  | Jun 16 2003 | BEHRING INC.  | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC. ",
        "original_sentence": "| Jan 16 1998 |\n| BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_759",
      "text": "| Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 758,
        "window_size": 3,
        "char_count": 53,
        "word_count": 16,
        "page_number": 5,
        "window_text": "| Jul 01 1999 |\n| COULTER INC.  | Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC.  | Jan 16 1998 |\n| BEHRING INC.  | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC.  | Jun 16 2003 | BEHRING INC.  | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC.  |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC. ",
        "original_sentence": "| Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC. "
      }
    },
    {
      "chunk_id": "chunk_760",
      "text": "| Jun 16 2003 | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 759,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 5,
        "window_text": "| Jun 14 2013 | Mar 19 2003 | Dec 16 1996 |\n**Dec 14 2007**\n| AMERICA INC.  | Jan 16 1998 |\n| BEHRING INC.  | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC.  | Jun 16 2003 | BEHRING INC.  | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC.  |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC.  |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP. ",
        "original_sentence": "| Jun 16 2003 | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_761",
      "text": "| Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 760,
        "window_size": 3,
        "char_count": 724,
        "word_count": 166,
        "page_number": 5,
        "window_text": "| Jan 16 1998 |\n| BEHRING INC.  | Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC.  | Jun 16 2003 | BEHRING INC.  | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC.  |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC.  |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP. ",
        "original_sentence": "| Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC. "
      }
    },
    {
      "chunk_id": "chunk_762",
      "text": "|\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 761,
        "window_size": 3,
        "char_count": 101,
        "word_count": 21,
        "page_number": 13,
        "window_text": "| Jul 01 1999 |\n| Mar 13 2001 | Nov 19 2004 |\n| INC.  | Jun 16 2003 | BEHRING INC.  | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC.  |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC.  |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP.  | BAYER | CORP. ",
        "original_sentence": "|\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC. "
      }
    },
    {
      "chunk_id": "chunk_763",
      "text": "|\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 762,
        "window_size": 3,
        "char_count": 708,
        "word_count": 133,
        "page_number": 5,
        "window_text": "| Jun 16 2003 | BEHRING INC.  | Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC.  |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC.  |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP.  | BAYER | CORP.  | CORP. ",
        "original_sentence": "|\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP. "
      }
    },
    {
      "chunk_id": "chunk_764",
      "text": "| Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 763,
        "window_size": 3,
        "char_count": 125,
        "word_count": 28,
        "page_number": 5,
        "window_text": "| Mar 19 2007 |\n| Sep 11 2001 | Jun 09 1999 |\n| Apr 26 1994 | Feb 10 1997 |\n| DIAGNOSTICS | Sep 13 2007 |\n| Aug 17 2005 | Feb 04 1998 |\n**Sep 29 2003**\n**Dec 14 2001**\n**Feb 10 1997**\n**Oct 04 1999**\n**Sep 09 1994**\n**Jul 03 2008**\n| CORPORATION | Sep 02 2003 | Jan 08 2002 |\n| Mar 02 2006 | Jul 23 1997 | Mar 03 1998 |\n**Jul 13 1995**\n**Aug 24 1999**\n| Dec 18 2001 | Aug 20 2003 | Jul 07 2008 |\n**Apr 27 1998**\n**Jul 28 1997**\n| Feb 01 2002 | Jul 11 2005 | Jul 13 1995 |\n| Dec 24 2003 | Aug 19 2009 | May 07 1998 |\n**Oct 08 1999**\n**TEL : 043-719-4652~4665  FAX : 043-719-4650**\n| MODIFICATION TO VITROS | CCTNI | CARESTART CARDIAC 3-IN-1 | SYSTEMS | TROPONIN-I CALIBRATORS | TRIAGE TROPONIN-I TRIAGE | I) | BIOSITE | INC.  |\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC.  |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP.  | BAYER | CORP.  | CORP.  | CORP. ",
        "original_sentence": "| Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP. "
      }
    },
    {
      "chunk_id": "chunk_765",
      "text": "| BAYER | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 764,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 25,
        "window_text": "|\n| REAGENT PACK | ACCESS BIO |\n| CARDIAC STATUS | ORTHO-CLINI | RESPONSE | ROCHE | PRINCETON | INC.  |\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP.  | BAYER | CORP.  | CORP.  | CORP.  |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP. ",
        "original_sentence": "| BAYER | CORP. "
      }
    },
    {
      "chunk_id": "chunk_766",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 765,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "|\n| K051925 | K973126 | IMMUNODIAGNOSTIC PRODUCTS | TROPONIN | BOEHRINGER MANNHEIM | CK-MB TRIAGE MYOGLOBIN | 오송보건의료행정타운 식품의약품안전평가원 | http://www.mfds.go.kr | INCORPORATE | Nov 29 2005 | BOEHRINGER | INCORPORATE | Oct 06 1997 |\n| K092848 | ELECSYS TROPONIN T |\n| K020662 | K033745 | RAMP TROPONIN I ASSAY | K981882 | CK-MB/MYOGLOBIN/TROPONIN I | BAYER DIAGNOSTICS ACS:180 | CAL | BIOMEDICAL | DIAGNOSTICS | BIOMEDITECH | Apr 12 2002 | May 17 2004 | Mar 19 2010 | Jul 06 1998 |\n| K952478 | TROPONIN I REAGENT PACK/ | 1/CK-MB/MYOGLOBIN | CARDIAC T TROPONIN T RAPID | TRIAGE TROPONIN-I AND | MANNHEIM | D | Nov 09 1995 |\n| CALCHECK 5 | 의료기기심사부 체외진단기기과 |\n| K993309 | AND ADVIA CENTAUR | DIAGNOSTICS | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP.  | BAYER | CORP.  | CORP.  | CORP.  |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP.  | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_767",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 766,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "| Dec 06 1999 |\n| TROPONIN I ULTRA ASSAY AND | ASSAY | CK-MB TRIAGE TROPONIN-I | RAPID TEST | “내가 지킨 청렴실천 모아지면 청렴사회” | CORP.  | BAYER | CORP.  | CORP.  | CORP.  |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP.  | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC.  | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_768",
      "text": "|\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 767,
        "window_size": 3,
        "char_count": 348,
        "word_count": 68,
        "page_number": 5,
        "window_text": "| BAYER | CORP.  | CORP.  | CORP.  |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP.  | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC.  | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ. ",
        "original_sentence": "|\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP. "
      }
    },
    {
      "chunk_id": "chunk_769",
      "text": "| Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 768,
        "window_size": 3,
        "char_count": 207,
        "word_count": 41,
        "page_number": 5,
        "window_text": "| CORP.  | CORP.  |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP.  | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC.  | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ.  부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC. ",
        "original_sentence": "| Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_770",
      "text": "| Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 769,
        "window_size": 3,
        "char_count": 193,
        "word_count": 44,
        "page_number": 5,
        "window_text": "| CORP.  |\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP.  | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC.  | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ.  부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC.  | CORP. ",
        "original_sentence": "| Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n"
      }
    },
    {
      "chunk_id": "chunk_771",
      "text": "K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 770,
        "window_size": 3,
        "char_count": 55,
        "word_count": 9,
        "page_number": 5,
        "window_text": "|\n| CALIBRATORS | 전화: 043-719-4652~4665 |\n| K983693 | DIMENSIONS (R) RXL CARDIAC | IMMULITE 2500 CK-MB 2500 | PATHFAST CTNI-II TEST | TROPONIN I ASSAY | DIAGNOSTIC | MITSUBISHI | DADE |\n| K052503 | CALIBRATOR FOR THE ADVIA | TROPONIN I ASSAY FOR THE | SPECTRAL | HEALTHCARE | BEHRING | Dec 14 2005 |\n| K973616 | BAYER IMMUNO 1 SYSTEM | BAYER CORP.  | Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC.  | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ.  부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC.  | CORP.  | CORP. ",
        "original_sentence": "K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ. "
      }
    },
    {
      "chunk_id": "chunk_772",
      "text": "부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 771,
        "window_size": 3,
        "char_count": 89,
        "word_count": 17,
        "page_number": 5,
        "window_text": "| Dec 05 1997 | Nov 04 1998 |\n| K034055 | K100130 | MYOGLOBIN 2500 STAT | PATHFAST CTNI CALIBRATORS | TROPONIN I CALIBRATOR | TROPONIN I ASSAY FOR THE | 팩스: 043-719-4650 | PRODUCTS | CHEMICAL | BEHRING INC.  | Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ.  부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC.  | CORP.  | CORP.  | CORP. ",
        "original_sentence": "부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC. "
      }
    },
    {
      "chunk_id": "chunk_773",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 772,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "| Jan 21 2004 | May 16 2011 |\n| K020950 | SPECTRAL'S 2 IN 1 (TNI-MYO) | K955284 | OPUS TROPONIN I | IMS SYSTEM | DIAGNOSTICS | LLC | DIAGNOSTICS | May 24 2002 | Jan 25 1996 |\n\n**[표 끝]**\n\nINC.\n\n K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ.  부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC.  | CORP.  | CORP.  | CORP.  |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_774",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 773,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "K021814\n\nACCUTNI AND ACCUTNI\n\nBECKMAN\n\nSep 27 2002\n\nⅨ.  부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC.  | CORP.  | CORP.  | CORP.  |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_775",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 774,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "부록\n\n- - 71 -\nCALIBRATORS ON THE ACCESS\n\n**[표 시작]**\n\n| IMMUNOASSAY SYSTEMS | COULTER INC.  | CORP.  | CORP.  | CORP.  |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP.  | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_776",
      "text": "|\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 775,
        "window_size": 3,
        "char_count": 170,
        "word_count": 45,
        "page_number": 5,
        "window_text": "| CORP.  | CORP.  | CORP.  |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP.  | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC.  | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC. ",
        "original_sentence": "|\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP. "
      }
    },
    {
      "chunk_id": "chunk_777",
      "text": "| Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 776,
        "window_size": 3,
        "char_count": 91,
        "word_count": 20,
        "page_number": 5,
        "window_text": "| CORP.  | CORP.  |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP.  | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC.  | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC.  |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ. ",
        "original_sentence": "| Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP. "
      }
    },
    {
      "chunk_id": "chunk_778",
      "text": "| BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 777,
        "window_size": 3,
        "char_count": 240,
        "word_count": 51,
        "page_number": 5,
        "window_text": "| CORP.  |\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP.  | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC.  | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC.  |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ.  부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ. ",
        "original_sentence": "| BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC. "
      }
    },
    {
      "chunk_id": "chunk_779",
      "text": "| Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 778,
        "window_size": 3,
        "char_count": 199,
        "word_count": 43,
        "page_number": 5,
        "window_text": "|\n| --- | --- | --- | --- | --- |\n**Oct 20 1997**\n**Oct 20 2010**\n| Aug 12 2004 | Apr 14 2006 | Dec 14 1998 |\n| K993353 | BAYER IMMUNO 1 SYSTEM ( IN | DADE | BAYER CORP.  | Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP.  | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC.  | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC.  |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ.  부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ.  부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n",
        "original_sentence": "| Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC. "
      }
    },
    {
      "chunk_id": "chunk_780",
      "text": "|\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 779,
        "window_size": 3,
        "char_count": 67,
        "word_count": 13,
        "page_number": 13,
        "window_text": "| Dec 06 1999 |\n| TROPONIN I | TNL-ULTRA ASSAY FOR THE | PATHFAST SAMPLE DILUENT 2 | CORP.  | BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC.  | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC.  |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ.  부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ.  부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n **[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL. ",
        "original_sentence": "|\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ. "
      }
    },
    {
      "chunk_id": "chunk_781",
      "text": "부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 780,
        "window_size": 3,
        "char_count": 195,
        "word_count": 35,
        "page_number": 13,
        "window_text": "| BAYER | MEDIENCE CO | DADE |\n\n**[표 끝]**\n\nK040733\n\nELECSYS TROPONIN T STAT\n\nROCHE\n\nMay 17 2004\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 72 -\nTEST\n\nDIAGNOSTICS\n\n**[표 시작]**\n\n| K983722 | STRATUS CS TROPONIN I |\n| --- | --- |\n| INC.  | Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC.  |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ.  부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ.  부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n **[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL.  |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ. ",
        "original_sentence": "부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ. "
      }
    },
    {
      "chunk_id": "chunk_782",
      "text": "부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 781,
        "window_size": 3,
        "char_count": 113,
        "word_count": 25,
        "page_number": 13,
        "window_text": "| Nov 04 1998 |\n| K053020 | K973650 | TROPONIN (TROP) METHOD | Dec 30 2005 | Oct 20 1997 |\n| K100594 | ELECSYS TROPONIN I | ROCHE | Apr 01 2010 | CALIBRATOR | VITRO DIAGNOSTIC SYSTEM) | BEHRING INC.  |\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ.  부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ.  부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n **[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL.  |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ.  부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n",
        "original_sentence": "부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n"
      }
    },
    {
      "chunk_id": "chunk_783",
      "text": "**[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 782,
        "window_size": 3,
        "char_count": 53,
        "word_count": 9,
        "page_number": 13,
        "window_text": "|\n| ADVIA CENTAUR SYSTEM | HEALTHCARE | CHEMISTRY |\n\n**[표 끝]**\n\nⅨ.  부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ.  부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n **[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL.  |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ.  부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n Ⅸ. ",
        "original_sentence": "**[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL. "
      }
    },
    {
      "chunk_id": "chunk_784",
      "text": "|\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 783,
        "window_size": 3,
        "char_count": 92,
        "word_count": 18,
        "page_number": 6,
        "window_text": "부록\n\n- - 73 -\nLLC\n\nDIMENSION VISTA CTNI FLEX\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 74 -\nCALCHECK 5\n\nDIAGNOSTICS\n\nNANO-DITEC\n\nK955868\n\nBOEHRINGER MANNHEIM\n\nBOEHRINGER\n\nFeb 14 1996\n\nⅨ.  부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n **[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL.  |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ.  부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n Ⅸ.  부록\n\n- - 79 -",
        "original_sentence": "|\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ. "
      }
    },
    {
      "chunk_id": "chunk_785",
      "text": "부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 784,
        "window_size": 3,
        "char_count": 195,
        "word_count": 47,
        "page_number": 5,
        "window_text": "부록\n\n- - 75 -\nCARDIAC T TROPNIN T\n\nMANNHEIM\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n- - 76 -\nSYSTEMS INC.\n\n **[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL.  |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ.  부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n Ⅸ.  부록\n\n- - 79 -",
        "original_sentence": "부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n"
      }
    },
    {
      "chunk_id": "chunk_786",
      "text": "Ⅸ. ",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 785,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 6,
        "window_text": "**[표 시작]**\n\n| CARDIAC TROPONIN-I (TROP) | DADE INTL.  |\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ.  부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n Ⅸ.  부록\n\n- - 79 -",
        "original_sentence": "Ⅸ. "
      }
    },
    {
      "chunk_id": "chunk_787",
      "text": "부록\n\n- - 79 -",
      "metadata": {
        "source": "(안내서-0637-02)체외진단용_시약_중_심장성_트로포닌_검사제품의_허가·심사_가이드라인.pdf",
        "chunk_index": 786,
        "window_size": 3,
        "char_count": 12,
        "word_count": 5,
        "page_number": 36,
        "window_text": "|\n| --- | --- |\n\n**[표 끝]**\n\nK983972\n\nIMMULITE TROPONIN I MODEL\n\nDIAGNOSTIC\n\nDec 07 1998\n\nⅨ.  부록\n\n- - 77 -\nLKTI1 AND LKT15\n\nPRODUCTS\n\n체외진단용 시약 중 심질환표지자 심장성 트로포닌 검사제품의 허가․심사 가이드라인\n\n편 집 위 원 장 정희교\n\n편 집 위 원\n\n오현주, 이원규, 김정환, 안영욱, 우승민, 김수영, 김현준\n\n문\n\n의\n\n처\n\n(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명 2로 187.\n\n Ⅸ.  부록\n\n- - 79 -",
        "original_sentence": "부록\n\n- - 79 -"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 787,
    "avg_chunk_length": 82.69123252858958,
    "min_chunk_length": 3,
    "max_chunk_length": 884,
    "total_characters": 65078,
    "total_words": 14580,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 2907,
    "heading_count": 87,
    "paragraph_count": 942,
    "list_item_count": 231,
    "table_cell_count": 1647,
    "tables_detected": 16,
    "chunks_generated": 787
  }
}